<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006583.pub4" GROUP_ID="MENSTR" ID="962006121519061033" MERGED_FROM="" MODIFIED="2015-08-28 02:27:51 +0100" MODIFIED_BY="Helen Nagels" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2015-08-28 13:16:06 +1200" NOTES_MODIFIED_BY="Helen E Nagels" REVIEW_NO="GA1334" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2015-08-28 02:27:51 +0100" MODIFIED_BY="Helen Nagels">
<TITLE MODIFIED="2011-11-15 15:36:22 +1300" MODIFIED_BY="[Empty name]">Laparoscopic entry techniques</TITLE>
<CONTACT MODIFIED="2015-08-28 02:27:51 +0100" MODIFIED_BY="Helen Nagels"><PERSON ID="F9B3654982E26AA20025F63939E7A472" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gaity</FIRST_NAME><LAST_NAME>Ahmad</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>gaityahmad@hotmail.com</EMAIL_1><EMAIL_2>gaityahmad@aol.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Pennine Acute Hospitals NHS Trust</ORGANISATION><CITY>Manchester</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-08-28 02:27:51 +0100" MODIFIED_BY="Helen Nagels"><PERSON ID="F9B3654982E26AA20025F63939E7A472" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gaity</FIRST_NAME><LAST_NAME>Ahmad</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>gaityahmad@hotmail.com</EMAIL_1><EMAIL_2>gaityahmad@aol.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Pennine Acute Hospitals NHS Trust</ORGANISATION><CITY>Manchester</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1409032255498799754134459095236" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>David</FIRST_NAME><LAST_NAME>Gent</LAST_NAME><POSITION>Foundation Doctor</POSITION><EMAIL_1>david.gent@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Pennine Acute Hospitals NHS Trust</ORGANISATION><CITY>Manchester</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1408272302453311890171642556707" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Daniel</FIRST_NAME><LAST_NAME>Henderson</LAST_NAME><POSITION>Academic Foundation Year 1 doctor</POSITION><EMAIL_1>danielhenderson@doctors.org.uk</EMAIL_1><MOBILE_PHONE>07850880579</MOBILE_PHONE><ADDRESS><ORGANISATION>Fairfield General Hospital</ORGANISATION><ADDRESS_1>Pennine Acute Trust</ADDRESS_1><ADDRESS_2>Rochdale Old Rd</ADDRESS_2><CITY>Bury</CITY><ZIP>BL9 7TD</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>07850880579</PHONE_1></ADDRESS></PERSON><PERSON ID="BF4EFA0882E26AA201E85210C841E42B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Helena</FIRST_NAME><LAST_NAME>O'Flynn</LAST_NAME><POSITION>Doctor</POSITION><EMAIL_1>hof_5@hotmail.com</EMAIL_1><EMAIL_2>Helena.O'flynn@student.manchester.ac.uk</EMAIL_2><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Pennine Acute Hospitals NHS Trust</ORGANISATION><ADDRESS_1>Delaunays Road</ADDRESS_1><ADDRESS_2>Crumpsall</ADDRESS_2><CITY>Manchester</CITY><ZIP>M8 5RB</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="A31897E482E26AA2003ED3F5104F9211" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Kevin</FIRST_NAME><LAST_NAME>Phillips</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>almyphillips@almyphillips.karoo.co.uk</EMAIL_1><ADDRESS><DEPARTMENT>Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Castle Hill Hospital</ORGANISATION><ADDRESS_1>Castle Road</ADDRESS_1><CITY>Cottingham</CITY><ZIP>HU16 5JQ</ZIP><REGION>North Humberside</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>0044- 1482875875 ext: 4259</PHONE_1></ADDRESS></PERSON><PERSON ID="0A9FF8B382E26AA200DE9984F9827998" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Andrew</FIRST_NAME><LAST_NAME>Watson</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>andy.watson@tgh.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Tameside &amp; Glossop Acute Services NHS Trust</ORGANISATION><ADDRESS_1>Fountain Street</ADDRESS_1><CITY>Ashton-Under-Lyne</CITY><ZIP>OL6 9RW</ZIP><REGION>Lancashire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 161 3316158</PHONE_1><PHONE_2>+44 1332 75148</PHONE_2><FAX_1>+44 161 331 6074</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-07-21 17:09:52 +1200" MODIFIED_BY="Helen E Nagels">
<UP_TO_DATE>
<DATE DAY="1" MONTH="9" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="9" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="10" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="8" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-08-20 10:32:01 +1200" MODIFIED_BY="Helen E Nagels">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-03-25 16:42:38 +1300" MODIFIED_BY="Helen E Nagels">
<DATE DAY="25" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>There has been no change to the conclusions of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-08-20 10:32:01 +1200" MODIFIED_BY="Helen E Nagels">
<DATE DAY="25" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>18 new studies have been added to the review at this update: <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>, <LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>, <LINK REF="STD-Channa-2009" TYPE="STUDY">Channa 2009</LINK>, <LINK REF="STD-Deveci-2013" TYPE="STUDY">Deveci 2013</LINK>, <LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>, <LINK REF="STD-Huang-2012" TYPE="STUDY">Huang 2012</LINK>, <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>, <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>, <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>, <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>, <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>, <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>, <LINK REF="STD-Phillips-2012" TYPE="STUDY">Phillips 2012</LINK>, <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>, <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>, <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>, <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>, <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>.</P>
<P>Authorship update - David Gent and Daniel Henderson added to authorship.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-08-17 15:03:43 +1200" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2015-03-25 16:12:30 +1300" MODIFIED_BY="Helen E Nagels">
<DATE DAY="13" MONTH="8" YEAR="2014"/>
<DESCRIPTION>
<P>Feedback received (summarised below) which will be addressed in the 2014 update of this review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-08-17 15:03:43 +1200" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="8" YEAR="2011"/>
<DESCRIPTION>
<P>Failed entry now considered a major complication. Implications of failed entry considered e.g. laparotomy, abandoned surgery etc. Protocol changed accordingly.</P>
<P>Three new comparisons were included in this update; Direct vision versus open-entry technique, 5 mm versus 3 mm secondary port trocars, STEP secondary trocars versus standard trocars.</P>
<P>Eleven new trials were included in this update: <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>, <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>, <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>, <LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>, <LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>, <LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>, <LINK REF="STD-Tinelli-2010" TYPE="STUDY">Tinelli 2010</LINK>, <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>, <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>, <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>, <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>.</P>
<P>Analysis demonstrated new conclusions.</P>
<P>Authorship updated - Helena O'Flynn added to authorship.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-09-21 11:25:56 +1200" MODIFIED_BY="Jane Clarke">
<DATE DAY="11" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-08-14 11:47:35 +1200" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-08-26 15:37:49 +1200" MODIFIED_BY="Helen E Nagels">
<INTERNAL_SOURCES MODIFIED="2015-08-24 22:25:58 +1200" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-08-24 22:25:58 +1200" MODIFIED_BY="[Empty name]">
<NAME>No sources of support provided</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2015-08-26 15:37:49 +1200" MODIFIED_BY="Helen E Nagels">
<SOURCE MODIFIED="2015-08-26 15:37:49 +1200" MODIFIED_BY="Helen E Nagels">
<NAME>None</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-08-28 13:16:06 +1200" MODIFIED_BY="Helen E Nagels">
<SUMMARY MODIFIED="2015-08-26 16:18:19 +1200" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-01-08 22:41:33 +1300" MODIFIED_BY="Julie A Brown">Laparoscopic entry techniques</TITLE>
<SUMMARY_BODY MODIFIED="2015-08-26 16:18:19 +1200" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>Cochrane review authors evaluated the benefits and risks of different laparoscopic entry techniques in gynaecological and non-gynaecological surgery.</P>
<P>
<B>Background</B>
</P>
<P>Laparoscopy is a procedure which uses a laparoscope, a thin tube with a light and camera on the end, like a telescope, that is inserted under general anaesthesia through a small cut (0.5 cm to 1 cm) in, or near, the umbilicus. The camera can project images onto external screens which allow surgeons to directly visualise the pelvic and abdominal organs. This permits keyhole surgery to be performed, which uses much smaller surgical tools without the need for large incisions. To perform laparoscopy, gas is gently pumped into the abdomen to increase the workspace for the camera and tools. The method by which incisions are made to introduce the laparoscope may influence the likelihood of complications.</P>
<P>Although laparoscopy is usually safe, a small minority of patients experience life-threatening complications, including injuries to surrounding blood vessels or the bowel. These complications often occur at the first step of the procedure when the abdominal wall is pierced using specialised instruments to insert the gas. Different doctors use different specialised instruments and techniques.</P>
<P>
<B>Study characteristics</B>
</P>
<P>Forty-six randomised controlled trials with a total of 7389 individuals undergoing laparoscopy were included in the systematic review. The RCTs compared 13 different laparoscopic entry techniques. The patients included in the review were men, women, and children requiring laparoscopic surgery for a range of gynaecological and non-gynaecological conditions. The duration of the included studies ranged from 5 months to 5 years. Sources of funding were not mentioned in 43 out of 46 studies. Three studies received funding from industry through either a grant or free use of medical equipment during their trials. The evidence is current to September 2014.</P>
<P>
<B>Key results</B>
</P>
<P>There was a reduction in the rate of failed entry with the use of an open-entry technique in comparison to a closed-entry technique (three RCTs, 665 participants, very low quality evidence). The evidence suggests that for every 1000 patients operated on, 31 patients in the closed-entry group will have failed entry compared to between 1 to 20 patients in the open-entry group.</P>
<P>Comparing closed techniques, a reduction in the risk of vascular injury (five RCTs, 1522 participants, low quality evidence) and a reduction in failed entry (seven RCTs, 3104 participants, moderate quality evidence) were demonstrated with the use of a direct trocar entry technique in comparison to Veress needle entry. Here the evidence suggests that for every 1000 patients operated on, eight patients in the Veress needle group will experience vascular injury compared to between 0 to 5 patients in the direct trocar group; and 64 patients in the Veress needle group will experience failed entry compared to between 10 to 20 patients in the Direct trocar group. The vascular injury risk depends on how the data are analysed and may be unreliable.</P>
<P>SILS (single incision laparoscopic surgery) was not shown to reduce major complication rates, but was shown to prolong operation times and possibly result in less bleeding at the incision sites.</P>
<P>Overall, there is insufficient evidence to recommend one laparoscopic entry technique over another. More research is required regarding safety of entry techniques and to discover if the risk of major complications differ between the techniques.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The GRADE scores for the majority of studies were low or very low. Limitations included imprecision and poor reporting of study methods.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-08-26 16:17:53 +1200" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2015-08-14 12:39:51 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopy is a common procedure in many surgical specialities. Complications arising from laparoscopy are often related to initial entry into the abdomen. Life-threatening complications include injury to viscera e.g. the bowel or bladder, or to vasculature e.g. major abdominal and anterior abdominal wall vessels. Minor complications can also occur, such as postoperative wound infection, subcutaneous emphysema, and extraperitoneal insufflation. There is no clear consensus as to the optimal method of laparoscopic entry into the peritoneal cavity.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-07-08 09:53:24 +1200" MODIFIED_BY="[Empty name]">
<P>To evaluate the benefits and risks of different laparoscopic entry techniques in gynaecological and non-gynaecological surgery.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-08-20 11:41:16 +1200" MODIFIED_BY="Helen E Nagels">
<P>This updated review has drawn on the search strategy developed by the Cochrane Menstrual Disorders and Subfertility Group. In addition, MEDLINE, EMBASE, CENTRAL and PsycINFO were searched through to September 2014.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-08-14 12:44:22 +1200" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs) in which one laparoscopic entry technique was compared with another.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-08-14 12:47:06 +1200" MODIFIED_BY="[Empty name]">
<P>Two authors independently selected studies, assessed risk of bias, and extracted data. We expressed findings as Peto odds ratios (Peto ORs) with 95% confidence intervals (CIs). We assessed statistical heterogeneity using the I² statistic. We assessed the overall quality of evidence for the main comparisons using GRADE methods.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-08-26 15:13:41 +1200" MODIFIED_BY="Helen E Nagels">
<P>The review included 46 RCTs including three multi-arm trials (7389 participants) and evaluated 13 laparoscopic entry techniques. Overall there was no evidence of advantage using any single technique for preventing major vascular or visceral complications. The evidence was generally of very low quality; the main limitations were imprecision and poor reporting of study methods.</P>
<P>
<B>Open-entry versus closed-entry</B>
<BR/>There was no evidence of a difference between the groups for vascular (Peto OR 0.14, 95% CI 0.00 to 6.82, three RCTs, n = 795, I<SUP>2 </SUP>= n/a; very low quality evidence) or visceral injury (Peto OR 0.61, 95% CI 0.06 to 6.08, three RCTs, n = 795, I<SUP>2 </SUP>= 0%; very low quality evidence). There was a lower risk of failed entry in the open-entry group (Peto OR 0.16, 95% CI 0.04 to 0.63, n = 665, two RCTs, I<SUP>2 </SUP>= 0%; very low quality evidence). This suggests that for every 1000 patients operated on, 31 patients in the closed-entry group will have failed entry compared to between 1 to 20 patients in the open-entry group. No events were reported in any of the studies for mortality, gas embolism or solid organ injury.</P>
<P>
<B>Direct trocar versus Veress needle entry</B>
<BR/>There was a lower risk of vascular injury in the direct trocar group (Peto OR 0.13, 95% CI 0.03 to 0.66, five RCTs, n = 1522, I<SUP>2</SUP> = 0%; low quality evidence) and failed entry (Peto OR 0.21, 95% CI 0.14 to 0.30, seven RCTs, n = 3104; I ²= 0%; moderate quality evidence). This suggests that for every 1000 patients operated on, 8 patients in the Veress needle group will experience vascular injury compared to between 0 to 5 patients in the direct trocar group; and that 64 patients in the Veress needle group will experience failed entry compared to between 10 to 20 patients in the direct trocar group. The vascular injury significance is sensitive to choice of statistical analysis and may be unreliable. There was no evidence of a difference between the groups for visceral (Peto OR 1.02, 95% CI 0.06 to 16.24, four RCTs, n = 1438, I<SUP>2 </SUP>= 49%; very low quality evidence) or solid organ injury (Peto OR 0.16, 95% Cl 0.01 to 2.53, two RCTs, n = 998, I<SUP>2 </SUP>= n/a; very low quality evidence). No events were recorded for mortality or gas embolism.</P>
<P>
<B>Direct vision entry versus Veress needle entry</B>
<BR/>There was no evidence of a difference between the groups in the rates of visceral injury (Peto OR 0.15, 95% CI 0.01 to 2.34, one RCT, n = 194; very low quality evidence). Other primary outcomes were not reported.</P>
<P>
<B>Direct vision entry versus open-entry</B>
<BR/>There was no evidence of a difference between the groups in the rates of visceral injury (Peto OR 0.13, 95% CI 0.00 to 6.50, two RCTs, n = 392; low quality evidence), solid organ injury (Peto OR 6.16, 95% CI 0.12 to 316.67, one RCT, n = 60, I<SUP>2 </SUP>= n/a; very low quality evidence), or failed entry (Peto OR 0.40, 95% CI 0.04 to 4.09, one RCT, n = 60; low quality evidence). Vascular injury was reported, however no events occurred. Our other primary outcomes were not reported.</P>
<P>
<B>Radially expanding (STEP) trocars versus non-expanding trocars</B>
<BR/>There was no evidence of a difference between the groups for vascular injury (Peto OR 0.24, 95% Cl 0.05 to 1.21, two RCTs, n = 331, I<SUP>2 </SUP>= 0%; low quality evidence), visceral injury (Peto OR 0.13, 95% CI 0.00 to 6.37, two RCTs, n = 331, I<SUP>2 </SUP>= n/a; low quality evidence), or solid organ injury (Peto OR 1.05, 95% CI 0.07 to 16.91, one RCT, n = 244; very low quality evidence). Other primary outcomes were not reported.</P>
<P>
<B>Comparisons of other laparoscopic entry techniques</B>
</P>
<P>There was a higher risk of failed entry in the group in which the abdominal wall was lifted before Veress needle insertion than in the not-lifted group (Peto OR 4.44, 95% CI 2.16 to 9.13, one RCT, n = 150; very low quality evidence). There was no evidence of a difference between the groups in rates of visceral injury or extraperitoneal insufflation. The studies had small numbers and excluded many patients with previous abdominal surgery, and women with a raised body mass index. These patients may have unusually high complication rates.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-08-26 16:17:53 +1200" MODIFIED_BY="[Empty name]">
<P>Overall, there is insufficient evidence to recommend one laparoscopic entry technique over another.</P>
<P>An open-entry technique is associated with a reduction in failed entry when compared to a closed-entry technique, with no evidence of a difference in the incidence of visceral or vascular injury.</P>
<P>An advantage of direct trocar entry over Veress needle entry was noted for failed entry and vascular injury. The evidence was generally of very low quality with small numbers of participants in most studies; our findings should be interpreted with caution.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-08-28 13:15:38 +1200" MODIFIED_BY="Helen E Nagels">
<BACKGROUND MODIFIED="2015-08-19 15:52:10 +1200" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2015-08-19 15:24:46 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopy is a common surgical procedure used in gynaecology whereby intra-abdominal access is gained via less extensive incisions and conducted with a laparoscope. Evidence suggests that laparoscopy provides significant benefits compared to laparotomy in terms of surgical outcomes for patients and cost for healthcare providers (<LINK REF="REF-Bijen-2009" TYPE="REFERENCE">Bijen 2009</LINK>). It is recognised that the majority of complications associated with laparoscopy occur at the time of entry. Opinion is divided as to the safest entry technique. While gynaecologists commonly use a closed method of entry, other surgical specialties routinely use open methods of entry.</P>
<P>There are both general risks associated with laparoscopic entry regardless of the technique used, and risks related to the particular method of entry. Estimates from one study of 25,764 laparoscopic gynaecological cases suggested complications related to entry had an incidence of 0.3% (<LINK REF="REF-Jansen-1997" TYPE="REFERENCE">Jansen 1997</LINK>; <LINK REF="REF-Jansen-2004" TYPE="REFERENCE">Jansen 2004</LINK>). The potentially life-threatening complications include bowel, major abdominal vessel, and anterior abdominal wall vessel perforation. Fortunately these are rare in recorded literature. The incidence of bowel wall perforation has been estimated at 0.0% to 0.5% of cases, with the incidence of major vessel injury estimated at 0.01% to 1.0% of cases (<LINK REF="REF-Magrina-2002" TYPE="REFERENCE">Magrina 2002</LINK>). While these low rates are reassuring, it still implies that over 250 individuals in the United Kingdom will suffer a serious complication each year (<LINK REF="REF-Middlesbrough-Consensus-1999" TYPE="REFERENCE">Middlesbrough Consensus 1999</LINK>). There are also other minor complications associated with laparoscopic entry, such as postoperative infection, subcutaneous emphysema, extraperitoneal insufflation, and trocar-site hernia (<LINK REF="REF-Magrina-2002" TYPE="REFERENCE">Magrina 2002</LINK>; <LINK REF="REF-Swank-2012" TYPE="REFERENCE">Swank 2012</LINK>).<BR/>
</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-08-19 15:52:10 +1200" MODIFIED_BY="[Empty name]">
<P>Many differing laparoscopic entry methods have been described. In response to feedback received since the last published version of this review, we have tried to include descriptions of the exact laparoscopic entry device used in each study. These can be found in the Intervention sections of the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables.</P>
<SUBSECTION>
<HEADING LEVEL="3">Closed Techniques</HEADING>
<P>The first closed technique involves the insertion of a Veress needle (a needle equipped with a spring-loaded obturator) into the peritoneal cavity, followed by gas insufflation (act of blowing) and insertion of a trocar (a sharp, pointed instrument with a cannula used to enter the body cavity). Finally the laparoscope is passed through the trocar once the obturator is removed. Numerous studies have shown that the Veress needle entry technique is highly favoured by gynaecologists worldwide (<LINK REF="REF-Lalchandani-2005" TYPE="REFERENCE">Lalchandani 2005</LINK>; <LINK REF="REF-Vilos-2007" TYPE="REFERENCE">Vilos 2007</LINK>). A second closed technique involves the insertion of a trocar directly into the peritoneal cavity (direct trocar entry), followed by laparoscopic inspection and then gas insufflation. The potential benefits of direct trocar entry are shorter operating times, immediate recognition of bowel or vascular injuries, and immediate recognition of failed entry (<LINK REF="REF-Krishnakumar-2009" TYPE="REFERENCE">Krishnakumar 2009</LINK>; <LINK REF="REF-Molloy-2002" TYPE="REFERENCE">Molloy 2002</LINK>).</P>
<P>The radially expanding access system, STEP&#8482;, (Inner Dyne, Sunnyvale, California, USA) is a closed technique and was developed to minimise tissue trauma. This system uses a pneumoperitoneum needle with a polymeric sleeve. Following routine insufflation the needle is removed, leaving the outer sleeve in situ. Direct dilatation of the sleeve results in a port 12 mm in size. The suggested benefits are that only one sharp instrument enters the abdominal cavity, less tissue trauma occurs and, in theory, fewer bowel and vascular injuries occur (<LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Open Techniques</HEADING>
<P>An open technique, as first described by Hasson, involves the peritoneum being cut down, followed by the insertion of a blunt trocar under direct visualisation, gas insufflation, and insertion of the laparoscope (<LINK REF="REF-Hasson-1971" TYPE="REFERENCE">Hasson 1971</LINK>). The potential benefits of this technique include the prevention of vascular injury, gas embolism, pre-peritoneal insufflation, and a low incidence of bowel injury (<LINK REF="REF-Vilos-2007" TYPE="REFERENCE">Vilos 2007</LINK>). It should be noted that the type of trocar used for primary port entry can influence complication rates (<LINK REF="REF-Fuller-2005" TYPE="REFERENCE">Fuller 2005</LINK>). This will be explored further in the <LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK>.</P>
<P>Single incision laparoscopic surgery (SILS) (Covidien Plc, Dublin, Ireland) was designed with the aim of reducing the invasiveness of entry into the peritoneal cavity when compared to traditional laparoscopic entry techniques (<LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>). Laparo-endoscopic single site (LESS) surgery (Olympus Medical Systems Corp., Tokyo, Japan) is another common term which is often used interchangeably with SILS, however neither has been universally adopted (<LINK REF="REF-Fader-2010" TYPE="REFERENCE">Fader 2010</LINK>). The SILS/LESS approach is an open technique. It involves a single intraumbilical 12 mm incision with the umbilicus being pulled out, exposing the fascia. Pneumoperitoneum is induced with an atraumatic trocar introduced into the abdomen. Second and third trocars are introduced to the left and right of the first trocar, leaving a small bridge of fascia between them to avoid leakage of carbon dioxide. The suggested benefits include a reduction in postoperative pain, and an improved cosmetic result (<LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>).</P>
<P>Several techniques for secondary port insertion have also been described. This is the insertion of additional trocars once the laparoscope has been introduced through the initial, primary, insertion site. As secondary ports are inserted under direct vision, that is the surgeon can directly observe the insertion of secondary trocars using the laparoscope intraperitoneally, complication rates should be lower. This review will analyse both primary and secondary port entry techniques.</P>
</SUBSECTION>
</INTERVENTION>
<THEORY MODIFIED="2015-08-14 16:40:30 +1200" MODIFIED_BY="[Empty name]">
<P>Observational studies have indicated that the incidence of vascular injury was reduced when using open-entry compared to closed-entry techniques (<LINK REF="REF-Molloy-2002" TYPE="REFERENCE">Molloy 2002</LINK>). It has been hypothesised that, as the closed technique involves blindly inserting trocars, an open technique may be a safer option for primary port insertion. Furthermore, among the closed-entry techniques, it is hypothesised that the use of direct vision should reduce complication rates even further as trocars are not inserted blindly.<BR/>
</P>
</THEORY>
<IMPORTANCE MODIFIED="2015-08-18 18:07:54 +1200" MODIFIED_BY="[Empty name]">
<P>There is no clear consensus as to the optimal method of entry into the peritoneal cavity (<LINK REF="REF-Merlin-2003" TYPE="REFERENCE">Merlin 2003</LINK>; <LINK REF="REF-Molloy-2002" TYPE="REFERENCE">Molloy 2002</LINK>). The Royal College of Obstetricians and Gynaecologists produced a national Green-top guideline in 2008 entitled 'Preventing entry-related gynaecological laparoscopic injuries' (<LINK REF="REF-RCOG-2008" TYPE="REFERENCE">RCOG 2008</LINK>). The document emphasised the need for an intraumbilical incision, a sharp Veress needle, and for pressure, not volume, of insufflated gas to determine when to place the trocar in the peritoneal cavity.</P>
<P>In 2007, a survey of gynaecologists with an interest in minimal access surgery in the United Kingdom revealed a wide variation in practice (<LINK REF="REF-Ahmad-2007" TYPE="REFERENCE">Ahmad 2007</LINK>). One-third of clinicians were unwilling to change their practice unless supported by good quality evidence.</P>
<P>This meta-analysis aimed to compare the different laparoscopic entry methods in terms of their influence on intraoperative and postoperative complications. The review will be updated every two years, as per Cochrane Collaboration recommendations</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-07-09 20:56:05 +1200" MODIFIED_BY="[Empty name]">
<P>To evaluate the benefits and risks of different laparoscopic entry techniques in gynaecological and non-gynaecological surgery.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-08-26 07:51:47 +1200" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-08-26 07:51:47 +1200" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-08-14 16:43:21 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) were included when one laparoscopic port entry technique was compared with another for primary or secondary port entry.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-08-14 16:45:16 +1200" MODIFIED_BY="[Empty name]">
<P>Men, women, and children undergoing diagnostic, operative or mixed laparoscopy, performed either by gynaecologists or general surgeons.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-08-26 07:51:47 +1200" MODIFIED_BY="[Empty name]">
<P>We analysed the following laparoscopic entry techniques.</P>
<OL>
<LI>Open-entry technique versus closed-entry technique (primary port entry).</LI>
<OL>
<LI>open-entry versus direct trocar entry</LI>
<LI>open-entry versus Veress needle entry</LI>
</OL>
<LI>Direct trocar entry versus Veress needle entry (primary port entry).</LI>
<LI>Direct vision entry versus Veress needle entry (primary port entry).</LI>
<LI>Direct vision entry versus open-entry (primary port entry).</LI>
<LI>Disposable instruments versus reusable instruments (primary port entry).</LI>
<LI>Radially expanding (STEP) trocars versus standard (non-expanding) trocars (primary port entry).</LI>
<LI>Trendelenburg position for entry versus supine position for entry (primary port entry).</LI>
<LI>Volume of gas used as an indicator for entry versus intra-abdominal pressure as an indicator for entry (primary port entry).</LI>
<LI>Comparisons of site of entry.</LI>
<LI>Comparisons of other laparoscopic entry techniques for primary or secondary port insertion.</LI>
<OL>
<LI>lifting versus not lifting the abdominal wall before Veress needle insertion (primary port entry).</LI>
<LI>carbon dioxide gas insufflation versus the use of a gasless abdominal wall retractor (primary port entry).</LI>
<LI>a closed technique versus a parallel technique of Veress needle insertion (primary port entry).</LI>
<LI>cutting trocar versus blunt trocar (primary port entry).</LI>
<LI>SILS laparoscopic entry versus modified Hasson laparoscopic entry (primary port entry).</LI>
<LI>direct trocar entry versus reusable pyramidal trocar (primary port entry).</LI>
<LI>5mm versus 3mm trocar for secondary port entry.</LI>
<LI>Radially expanding access device versus conventional (non-expanding) cutting tip trocar for secondary port entry.</LI>
</OL>
</OL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-08-26 07:02:09 +1200" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-08-17 14:26:19 +1200" MODIFIED_BY="[Empty name]">
<P>Major complications</P>
<OL>
<LI>Mortality</LI>
<LI>Vascular injury (major vessels and abdominal wall vessels)</LI>
<LI>Visceral injury (bladder or bowel)</LI>
<LI>Gas embolism</LI>
<LI>Solid organ injury</LI>
<LI>Failed entry (unable to access the peritoneal cavity)</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-08-26 07:02:09 +1200" MODIFIED_BY="[Empty name]">
<P>7. Extraperitoneal insufflation<BR/>8. Trocar site bleeding<BR/>9. Trocar site infection<BR/>10. Incisional hernia<BR/>11. Omentum injury<BR/>12. Uterine bleeding</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-08-19 15:25:43 +1200" MODIFIED_BY="[Empty name]">
<P>We sought all published and unpublished RCTs studying laparoscopic entry techniques. We used the following search strategies, without language restriction and in consultation with the Cochrane Menstrual Disorders and Subfertility Group (MDSG) Trials Search Co-ordinator.</P>
<ELECTRONIC_SEARCHES MODIFIED="2015-08-19 15:25:43 +1200" MODIFIED_BY="[Empty name]">
<P>We searched the following databases with no language restrictions.</P>
<OL>
<LI>The Cochrane Menstrual Disorders and Subfertility Group's (MDSG) Specialised Register of controlled trials for any trials with keywords in the title, abstract or keyword sections (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>).</LI>
<LI>Using Ovid software: The Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 9), MEDLINE (from 1966 to September 2014), EMBASE (from 1980 to September 2014), and PsycINFO (from 1980 to September 2014) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>; <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>; <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>).</LI>
</OL>
<P>We combined the MEDLINE search with the Cochrane highly sensitive search strategy for identifying randomised trials, which appears in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We combined the EMBASE search with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<A HREF="http://www.sign.ac.uk/methodology/filters.html#random">www.sign.ac.uk/methodology/filters.html#random</A>).<BR/>
</P>
<P>Other electronic sources of trials (searched through to September 2014) included:</P>
<UL>
<LI>trial registers for ongoing and registered trials: ClinicalTrials.gov, a service of the US National Institutes of Health (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>); and the World Health Organization International Trials Registry Platform search portal (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>);</LI>
<LI>citation indexes (<A HREF="http://scientific.thomson.com/products/sci/">scientific.thomson.com/products/sci/</A>);</LI>
<LI>conference abstracts in the Web of Science (<A HREF="http://www.wokinfo.com">www.wokinfo.com</A>);</LI>
<LI>LILACS database, as a source of trials from the Portuguese and Spanish speaking world (<A HREF="http://lilacs.bvsalud.org/en/">www.lilacs.bvsalud.org/en/</A>);</LI>
<LI>PubMed (<A HREF="http://www.ncbi.nlm.nih.gov/pubmed/">www.ncbi.nlm.nih.gov/pubmed/</A>): we took the random control filter for PubMed from the <I>Cochrane Handbook for Systematic.Reviews of Interventions </I>(<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>); and</LI>
<LI>for grey literature: OpenSIGLE database (<A HREF="http://opensigle.inist.fr/">www.opensigle.inist.fr/</A>) and Google.</LI>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-08-15 15:49:08 +1200" MODIFIED_BY="[Empty name]">
<P>We searched conference proceedings and handsearched the reference lists of articles retrieved by the search. We handsearched any relevant journals and conference abstracts that are not covered in the MDSG Specialised Register in liaison with the Trials Search Co-ordinator.<BR/>
</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-08-19 15:52:53 +1200" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2015-08-15 15:57:45 +1200" MODIFIED_BY="[Empty name]">
<P>Two review authors (DG and DH) independently examined the retrieved search results for relevant titles and abstracts. The two authors then independently selected the trials to be included in accordance with the above mentioned criteria. There were no disagreements about study inclusion. We extracted data and analysed trials for the following quality criteria: methodological details and descriptive data of participants and outcomes. We presented this information in the <LINK TAG="SEARCH_RESULTS" TYPE="SECTION">Results of the search</LINK> and the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables. Where necessary, authors corresponded with study investigators to clarify study eligibility (for example, with respect to participant eligibility criteria and allocation method). The selection of studies is summarised in the PRISMA (<LINK REF="REF-Moher-2009" TYPE="REFERENCE">Moher 2009</LINK>) flow chart (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-08-15 15:58:53 +1200" MODIFIED_BY="[Empty name]">
<P>Two authors (DG and DH) independently extracted data from eligible studies. Any discrepancies were discussed and final extraction was independently verified by GA.<BR/>
</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-08-15 16:17:16 +1200" MODIFIED_BY="[Empty name]">
<P>We assessed each included trial for the following criteria using the Cochrane 'Risk of bias' tool: sequence generation; allocation concealment; blinding of participants, providers and outcome assessors; completeness of outcome data; selective outcome reporting; and other potential sources of bias (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>). We presented the conclusions in the 'Risk of bias' table and incorporated the interpretation of review findings by means of sensitivity analyses. Two review authors (DG and DH) independently performed all assessments of the quality of trials. Any discrepancies were resolved by GA.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-08-19 15:52:53 +1200" MODIFIED_BY="[Empty name]">
<P>We used the numbers of events in the control and intervention groups of each study to calculate odds ratios (ORs) with 95% confidence intervals (CIs). We used the Peto OR, as we expected events to be rare. We performed statistical analysis in accordance with the guidelines in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Method of analysis for multi-arm trials</HEADING>
<P>Three studies (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>) undertook multi-arm trials. Bemelman 2000 and Angioli 2013 compared Hasson trocar entry with Veress needle entry and direct trocar entry. Tansatit 2006 compared direct trocar entry with Veress needle entry and reusable pyramidal trocars entry. To utilise these studies in meta-analysis we gave each of the studies three study IDs and split the 'control arm', where applicable, to avoid double-counting. This approach is recommended in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>, section 16.5.4 (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>).</P>
<P>Throughout the text we have referred to these studies with one reference (e.g. Angioli 1 2013, which includes Angioli 1 2013, Angioli 2 2013, and Angioli 3 2013).</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-08-19 15:26:44 +1200" MODIFIED_BY="[Empty name]">
<P>The primary analysis was per participant, randomised.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-08-15 16:42:57 +1200" MODIFIED_BY="[Empty name]">
<P>We analysed the data on an intention-to-treat (ITT) basis, as far as possible, and we made attempts to obtain missing data from the original investigators. We assumed complications were not to have occurred in participants with unreported outcomes. For all outcomes, we analysed only the available data.<BR/>
</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-08-15 16:44:01 +1200" MODIFIED_BY="[Empty name]">
<P>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta-analysis to provide a meaningful summary. We assessed statistical heterogeneity by the measure of the I<SUP>2</SUP> statistic. An I<SUP>2</SUP> value greater than 50% indicated substantial heterogeneity (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>). Where heterogeneity was present we investigated by examining clinical and methodological differences between the studies.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-08-15 16:44:25 +1200" MODIFIED_BY="[Empty name]">
<P>In view of the difficulty in detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-08-15 16:48:14 +1200" MODIFIED_BY="[Empty name]">
<P>We combined data from primary studies using a fixed-effect model with Review Manager 5 software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>).</P>
<P>An increase in the odds of a particular outcome was displayed graphically in the meta-analyses to the right of the centre line and a decrease in the odds of an outcome to the left of the centre line.<BR/>
</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-08-19 15:26:55 +1200" MODIFIED_BY="[Empty name]">
<P>We performed subgroup analyses for the following interventions.</P>
<OL>
<LI>Open-entry technique versus closed-entry technique.</LI>
<OL>
<LI>Open-entry technique versus Veress needle entry technique.</LI>
<LI>Open-entry technique versus direct trocar entry.</LI>
</OL>
</OL>
<P>Where we identified substantial heterogeneity, we examined clinical and methodological differences between studies, and took any statistical heterogeneity into account when interpreting the results.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-08-19 15:29:51 +1200" MODIFIED_BY="[Empty name]">
<P>We conducted sensitivity analyses for the primary outcomes to determine whether the conclusions were robust to arbitrary decisions made regarding the eligibility of studies and analysis. We aimed to perform a sensitivity analysis where eligibility was restricted to studies without high risk of bias.</P>
<SUBSECTION>
<HEADING LEVEL="3">Overall quality of the body of evidence: 'Summary of findings' table</HEADING>
<P>We prepared 'Summary of findings' tables (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>; <LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>; <LINK REF="SOF-05" TYPE="SOF">Summary of findings table 5</LINK>) using GRADEproGDT (<LINK REF="REF-GRADEproGDT-2015" TYPE="REFERENCE">GRADEproGDT 2015</LINK>). We used these tables to evaluate the overall quality of the body of evidence for the main review outcomes using GRADE criteria (study limitations [i.e. risk of bias], consistency of effect, imprecision, indirectness, and publication bias). We justified, documented, and incorporated judgements about evidence quality (high, moderate, or low) into the reporting of results for each outcome.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-08-28 13:15:38 +1200" MODIFIED_BY="Helen E Nagels">
<STUDY_DESCRIPTION MODIFIED="2015-08-27 12:44:45 +1200" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2015-08-17 12:10:30 +1200" MODIFIED_BY="[Empty name]">
<P>We identified 1237 articles from the search. For this update, 27 studies were potentially eligible for inclusion and we retrieved their full texts. Of these studies, we excluded nine, with reasons given below, and included 18 new studies in the updated review. In previous versions of this review, we had included 28 studies, and excluded three studies, as detailed below. Therefore, in total 46 randomised controlled trials (RCTs), covering 13 different laparoscopic entry techniques, were eligible for inclusion within this review. Further descriptive details about the included studies are provided in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables. All included trials were published reports (full papers or abstracts).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-08-27 12:44:45 +1200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Participants</HEADING>
<P>In total, forty-six RCTs with 7389 individuals undergoing laparoscopy were included in the systematic review. For this update, 18 new studies, with 2528 participants, were included. The number of participants in each trial ranged from 17 (<LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK>) to 1000 (<LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Interventions</HEADING>
<P>The interventions studied are listed below, together with the identified studies.</P>
<SUBSECTION>
<HEADING LEVEL="5">1. Open-entry technique versus closed-entry technique (primary port entry)</HEADING>
<P>Five RCTs investigated an open-entry technique with a closed-entry technique (direct trocar or Veress needle) (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.1. Open-entry versus direct trocar entry</HEADING>
<P>Two RCTs investigated an open technique with direct trocar entry (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2. Open-entry versus Veress needle entry</HEADING>
<P>Five RCTs investigated an open technique with Veress needle entry (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-2-2013" TYPE="STUDY">Angioli 2 2013</LINK>; <LINK REF="STD-Bemelman-2-2000" TYPE="STUDY">Bemelman 2 2000</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Direct trocar entry versus Veress needle entry (primary port entry)</HEADING>
<P>Eleven RCTs investigated direct trocar entry with Veress needle entry (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Bemelman-3-2000" TYPE="STUDY">Bemelman 3 2000</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Direct vision entry versus Veress needle entry (primary port entry)</HEADING>
<P>One RCT investigated direct vision entry with Veress needle entry (<LINK REF="STD-Tinelli-2010" TYPE="STUDY">Tinelli 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Direct vision entry versus open-entry (primary port entry)</HEADING>
<P>Three RCTs investigated direct vision entry versus an open technique (<LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>; <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Disposable instruments versus reusable instruments (primary port entry)</HEADING>
<P>We did not identify any RCTs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Radially expanding (STEP) trocars versus standard (non-expanding) trocars (primary port entry)</HEADING>
<P>Four RCTs compared radially expanding (STEP) trocars with standard trocars (<LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Trendelenburg position for entry versus supine position for entry (primary port entry)</HEADING>
<P>We did not identify any RCTs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Volume of gas used as an indicator for entry versus intra-abdominal pressure as an indicator for entry (primary port entry)</HEADING>
<P>We did not identify any RCTs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Comparisons of site of entry</HEADING>
<P>A single RCT compared the transfundal with the infraumbilical position for Veress needle insertion (<LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10. Comparisons of other laparoscopic entry techniques for primary or secondary port insertion</HEADING>
<P>We did not identify any RCTs.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.1. Lifting versus not lifting the abdominal wall before Veress needle insertion (primary port entry)</HEADING>
<P>A single RCT compared lifting and not lifting the abdominal wall before Veress needle insertion (<LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.2. Carbon dioxide gas insufflation versus the use of a gasless abdominal wall retractor (primary port entry)</HEADING>
<P>Four RCTs compared carbon dioxide gas insufflation with the use of a gasless abdominal wall retractor (<LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.3. A closed technique versus a parallel technique of Veress needle insertion (primary port entry)</HEADING>
<P>A single RCT compared a closed technique with a parallel technique of Veress needle insertion (<LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.4. Cutting trocar versus blunt trocar (primary port entry)</HEADING>
<P>Two RCTs compared cutting trocars with blunt trocars (<LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.5. SILS laparoscopic entry versus modified Hasson laparoscopic entry (primary port entry)</HEADING>
<P>Nine RCTs compared SILS laparoscopic surgery versus modified Hasson technique laparoscopy (<LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Deveci-2013" TYPE="STUDY">Deveci 2013</LINK>; <LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>; <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>; <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.6. Direct trocar entry versus reusable pyramidal trocar (primary port entry)</HEADING>
<P>A single RCT compared the use of a direct trocar entry (missile) with a reusable pyramidal trocar (<LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>).</P>
<P>
<B>10.7 5mm versus 3mm secondary port trocars</B>
</P>
<P>A single RCT compared the use of 5mm trocars with 3mm trocars for secondary port entry (<LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>).</P>
<P>
<B>10.8 Radially expanding access device (STEP) trocars versus standard (non-expanding) trocars for secondary port entry</B>
</P>
<P>Two RCTs compared the use of radially expanding trocars with standard trocars for secondary port entry (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention standardisation</HEADING>
<P>Several RCTs stated clearly that all operators had received standardised operative training in both interventions especially for the study (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>). Several RCTs also stated clearly that a standardised operative technique was deployed by all operators (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Channa-2009" TYPE="STUDY">Channa 2009</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Deveci-2013" TYPE="STUDY">Deveci 2013</LINK>; <LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>; <LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>; <LINK REF="STD-Huang-2012" TYPE="STUDY">Huang 2012</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>; <LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>; <LINK REF="STD-Tinelli-2010" TYPE="STUDY">Tinelli 2010</LINK>; <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>; <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>Studies reported the following primary outcome measures.</P>
<OL>
<LI>Mortality (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>).</LI>
<LI>Vascular injury (major vessels and abdominal wall vessels) (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>). Only two studies stated a clear definition for vascular injury (<LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>: major vascular injury and abdominal wall vascular injury; and <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>: laceration of large blood vessels).</LI>
<LI>Visceral injury (bladder or bowel) (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>; <LINK REF="STD-Tinelli-2010" TYPE="STUDY">Tinelli 2010</LINK>; <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>).</LI>
<LI>Gas embolism (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>).</LI>
<LI>Solid organ injury (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>).</LI>
<LI>Failed entry (unable to access the peritoneal cavity) (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>; <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).</LI>
</OL>
<P>Studies reported the following secondary outcome measures.</P>
<OL>
<LI>Extraperitoneal insufflation (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>; <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).</LI>
<LI>Trocar site bleeding (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>; <LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>; <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>; <LINK REF="STD-Tinelli-2010" TYPE="STUDY">Tinelli 2010</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>).</LI>
<LI>Trocar site infection (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>, <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>).</LI>
<LI>Incisional hernia (<LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>).</LI>
<LI>Omental injury (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).</LI>
<LI>Uterine bleeding (<LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>).</LI>
</OL>
<P>Several RCTs did not report any of our outcome measures: In <LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK> and <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK> outcome measures included operative technique and patient pain; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK> reported the ease of the operative technique; and <LINK REF="STD-Huang-2012" TYPE="STUDY">Huang 2012</LINK> reported levels of postoperative pain and analgesic use. We requested further information from these study authors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Addressing feedback from the previous version of this review</HEADING>
<P>We received feedback on trocar site bleeding for STEP secondary trocars versus standard secondary trocars, description of trocars, and inclusions of relevant other meta-analyses. These points are addressed in the <LINK TAG="FEEDBACK" TYPE="SECTION">Feedback</LINK> section at the end of the review.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-08-19 15:33:11 +1200" MODIFIED_BY="[Empty name]">
<P>We excluded three trials from the previous versions of this review: <LINK REF="STD-Joshipura-2009" TYPE="STUDY">Joshipura 2009</LINK> and <LINK REF="STD-Sandhu-2009" TYPE="STUDY">Sandhu 2009 </LINK>compared different interventions to maintain the pneumoperitoneum, while <LINK REF="STD-Kim-2009" TYPE="STUDY">Kim 2009</LINK> investigated the different surgical approaches which could be deployed to perform laparoscopic cholecystectomy.</P>
<P>We excluded a further nine trials from the updated version of this review; seven trials (<LINK REF="STD-Cardin-2011" TYPE="STUDY">Cardin 2011</LINK>; <LINK REF="STD-Dunne-2011" TYPE="STUDY">Dunne 2011</LINK>; <LINK REF="STD-Fagotti-2010" TYPE="STUDY">Fagotti 2010</LINK>; <LINK REF="STD-Garg-2012" TYPE="STUDY">Garg 2012</LINK>; <LINK REF="STD-Lu-2012" TYPE="STUDY">Lu 2012</LINK>; <LINK REF="STD-Sangrasi-2011" TYPE="STUDY">Sangrasi 2011</LINK>; <LINK REF="STD-Shayani_x002d_Nasab-2013" TYPE="STUDY">Shayani-Nasab 2013</LINK>) all compared different laparoscopic entry techniques and they were not RCTs. <LINK REF="STD-Warle-2013" TYPE="STUDY">Warle 2013</LINK> compared different pneumoperitoneum pressures to optimise live donor comfort and <LINK REF="STD-Han-2012" TYPE="STUDY">Han 2012</LINK> compared the effect of different methods of creating the peritoneal operating field (lifting abdomen, pneumoperitoneum) on stress response.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-08-26 07:42:53 +1200" MODIFIED_BY="[Empty name]">
<P>Further details about the risk of bias in the included studies are provided in the 'Risk of bias' tables that accompany the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Trial design</HEADING>
<P>All included trials stated that they were RCTs.</P>
</SUBSECTION>
<ALLOCATION MODIFIED="2015-08-19 13:31:16 +1200" MODIFIED_BY="[Empty name]">
<P>
<I>
<B>Random sequence generation</B>
</I>
</P>
<P>Twenty-six studies were at a low risk of bias: randomisation by random number tables was clearly stated in <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>; <LINK REF="STD-Channa-2009" TYPE="STUDY">Channa 2009</LINK>; <LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>; <LINK REF="STD-Huang-2012" TYPE="STUDY">Huang 2012</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>; <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK> or by computerised random number selection (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Deveci-2013" TYPE="STUDY">Deveci 2013</LINK>; <LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>; <LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>).</P>
<P>In 20 studies the method of randomisation was unclear (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>; <LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Phillips-2012" TYPE="STUDY">Phillips 2012</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>; <LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>; <LINK REF="STD-Tinelli-2010" TYPE="STUDY">Tinelli 2010</LINK>; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>; <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>; <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>).</P>
<P>
<B>
<I>Allocation concealment</I>
</B>
</P>
<P>Allocation concealment was reported in fourteen studies: <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>; <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK> (sealed envelopes). In all other studies the use of allocation concealment was unclear.</P>
</ALLOCATION>
<BLINDING MODIFIED="2015-07-08 10:59:08 +1200" MODIFIED_BY="[Empty name]">
<P>Five RCTs were single-blinded: <LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK> (patient); <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK> (observer). Six RCTs (<LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>; <LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>) (patient and observer) were double-blinded RCTs. The method of blinding was unclear for the remaining trials.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-08-19 12:38:35 +1200" MODIFIED_BY="[Empty name]">
<P>Intention-to-treat was referred to and used in four trials (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>). The other trials made no reference to an intention-to-treat analysis and there was no indication that it had been used.</P>
<P>Five RCTs reported exclusion of participants with the reasons for doing so (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>).</P>
<P>Two RCTs reported participants as lost to follow-up because of intraoperative complications (<LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK>).</P>
<P>
<LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK> reported one participant as lost to follow-up due to loss of a study diary.</P>
<P>Exclusions were stated but reasons not given in <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>.</P>
<P>In <LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>, eight patients were lost to long-term follow-up as they did not attend outpatient clinics</P>
<P>All other studies either stated no exclusions, loss to follow-up, or dropouts; or exclusions were not mentioned within the study.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2015-08-26 07:42:53 +1200" MODIFIED_BY="[Empty name]">
<P>The level of selective reporting was low for all of the studies.</P>
<P>
<LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK> was deemed to be at high risk of reporting bias as not all outcome values were included in the published results.<BR/>
<LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK> presented subgroups of data in relation to the level of bruising and nausea and vomiting.<BR/>
<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK> did not report a break down of the major complications they included in the study.<BR/>
<LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK> reported complications as the rate per trocar insertion instead of per number of participants.<BR/>
<LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK> used differing statistical analysis between outcomes.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2015-08-17 15:29:07 +1200" MODIFIED_BY="[Empty name]">
<P>We did not identify further potential sources of within-study bias.<BR/>
</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-08-28 13:15:38 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="3">1. Open-entry technique versus closed-entry technique (primary port entry)</HEADING>
<P>Four RCTs (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>) with a total of 859 participants compared an open-entry technique with a closed-entry technique (direct trocar or Veress needle) (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Mortality</HEADING>
<P>Two RCTs (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>) compared an open-entry technique with direct trocar or Veress needle entry. There were no events in any group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>One RCT compared an open-entry technique with both direct trocar entry and Veress needle entry (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>), and two RCTs (<LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>) compared an open-entry technique with Veress needle entry. There was no evidence of a difference between the groups for vascular injury rates (Peto OR 0.14, 95% CI 0.00 to 6.82, three RCTs, n = 795, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.3 Visceral injury (bladder or bowel)</HEADING>
<P>One RCT compared an open-entry technique with both direct trocar entry and Veress needle entry (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>), and two RCTs (<LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK>; <LINK REF="STD-Peitgen-1997" TYPE="STUDY">Peitgen 1997</LINK>) compared an open-entry technique with Veress needle entry. There was no evidence of a difference between the groups in visceral injury rates (Peto OR 0.61, 95% CI 0.06 to 6.08, three RCTs, n = 795, I<SUP>2 </SUP>= 0%; very low quality evidence). See <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>, <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.6 Failed entry</HEADING>
<P>One RCT compared an open-entry technique with both direct trocar entry and Veress needle entry (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>), and one RCT (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>) compared an open-entry technique with Veress needle entry. The open-entry technique was associated with a significant reduction in failed entry compared with Veress needle entry (Peto OR 0.16, 95% CI 0.04 to 0.67, two RCTs, n = 371, I<SUP>2 </SUP>= 0%; very low quality evidence) and, overall, the open-entry technique was associated with a significant reduction in incidence of failed entry versus closed-entry technique (Peto OR 0.16, 95% CI 0.04 to 0.63, n = 665, two RCTs, I<SUP>2 </SUP>= 0%; very low quality evidence).</P>
<P>This evidence suggests that for every 1000 patients operated on, 31 patients in the closed-entry group will have failed entry compared to between 1 to 20 patients in the open-entry group, i.e. there are 11 to 30 fewer failed entries per 1000 patients operated on using an open-entry technique compared with a closed-entry technique. See <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.7 Extraperitoneal insufflation</HEADING>
<P>There was evidence of a significant reduction in extraperitoneal insufflation in the open-entry group compared with the Veress needle entry group (Peto OR 0.26, 95% CI, 0.07 to 0.94, four RCTs, n = 865, I<SUP>2 </SUP>= 0%; low quality evidence). See <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.8 Trocar site bleeding</HEADING>
<P>There was no evidence of a difference between closed-entry or open-entry techniques in the rate of trocar site bleeding (Peto OR 0.39, 95% CI 0.07 to 2.06, two RCTs, n = 745, I<SUP>2 </SUP>= 0%; low quality evidence). See <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.9 Trocar site infection</HEADING>
<P>There was no evidence of a difference between closed-entry or open-entry techniques in the rate of trocar site infection (Peto OR 1.72, 95% CI 0.80 to 3.70, five RCTs, n = 1320, I<SUP>2 </SUP>= 0%; very low quality evidence). See <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.10 Incisional hernia</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.11 Omental injury</HEADING>
<P>There was a significant reduction in omental injury in the open-entry group compared with the closed-entry group (Peto OR 0.20, 95% CI 0.05 to 0.71, two RCTs, n = 665, I<SUP>2 </SUP>= 0%; moderate quality evidence). See <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>
</P>
<P>
<B>1.12 Uterine bleeding</B>
</P>
<P>This outcome was not reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Direct trocar entry versus Veress needle entry (primary port entry)</HEADING>
<P>Eleven RCTs investigated direct trocar entry compared with Veress needle entry (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Bemelman-3-2000" TYPE="STUDY">Bemelman 3 2000</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>), with a total of 3833 participants. <LINK REF="STD-Bemelman-3-2000" TYPE="STUDY">Bemelman 3 2000</LINK> and <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK> reported no complications in either group (<LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Mortality</HEADING>
<P>Five RCTs (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Bemelman-3-2000" TYPE="STUDY">Bemelman 3 2000</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>) reported this outcome. There were no events in any study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>Five RCTs reported this outcome (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>). There was a significant reduction in vascular injury in the direct trocar group compared with the Veress needle entry group (Peto OR 0.13, 95% CI 0.03 to 0.66, five RCTs, n = 1522, I<SUP>2 </SUP>= 0%; low quality evidence). This means that for every 1000 patients operated on, 8 patients in the Veress needle group will experience vascular injury compared to between 0 to 5 patients in the direct trocar group, i.e. there are between 3 to 8 fewer incidents of vascular injury per 1000 patients operated on using a direct trocar compared to a Veress needle. See <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>.</P>
<P>
<LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK> and <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK> both had three events of vascular injury each in the Veress needle arm of the study. In the <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK> study, bleeding was due to mesenteric laceration which required intracorporeal suturing in two cases and resolved spontaneously in the other case. In the <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK> study the three cases of vascular injury were due to epigastric vessel haemorrhage and the study authors did not provide information on how the bleeding was controlled. The epigastric vessel lesion was produced upon Veress needle insertion into the midline.</P>
<P>This result is sensitive to choice of statistical model and is no longer significant when a Mantel-Haenszel OR and/or random-effects model is used in preference to a Peto OR, meaning that the result may be unreliable.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.3 Visceral injury (bladder or bowel)</HEADING>
<P>Four RCTs reported this outcome (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>). Although there was one event in each study arm, there was no evidence of a difference between either entry technique overall (Peto OR 1.02, 95% CI 0.06 to 16.24, four RCTs, n = 1438, I<SUP>2 </SUP>= 49%; very low quality evidence). No cause was found to account for the heterogeneity between studies. See <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.4 Gas embolism</HEADING>
<P>Two RCTs (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>) reported this outcome. There were no events in either arm.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.5 Solid organ injury</HEADING>
<P>Two RCTs reported this outcome (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>). There was no evidence of a difference between the groups (Peto OR 0.16, 95% Cl 0.01 to 2.53, two RCTs, n = 998, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.6 Failed entry</HEADING>
<P>Seven RCTs reported this outcome (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>; <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK>). Meta-analysis demonstrated a reduction in failed entry into the abdomen with the use of direct trocar entry in comparison with the Veress needle entry technique (OR 0.21, 95% CI 0.14 to 0.30, seven RCTs, n = 3104, I<SUP>2 </SUP>= 0%; moderate quality evidence). This means that for every 1000 patients operated on, 64 patients in the Veress needle group will experience failed entry compared to between 10 to 20 patients in the Direct trocar group, i.e. there are between 44 to 54 fewer incidents of failed entry per 1000 patients operated on using a direct trocar compared to a Veress needle. See <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>
</P>
<P>Sensitivity analysis by excluding all studies with unclear randomisation found that the reduction in failed entry was still significant (Peto OR 0.21, 95% CI 0.14 to 0.32).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.7 Extraperitoneal insufflation</HEADING>
<P>There was evidence of a significant reduction in extraperitoneal insufflation with the use of direct trocar entry compared to Veress needle entry (Peto OR 0.19, 95% CI 0.14 to 0.26, nine RCTs, n = 3564, I<SUP>2 </SUP>= 0%; moderate quality evidence). See <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>
</P>
<P>Sensitivity analysis by excluding all studies with unclear randomisation demonstrated that the reduction in the complication rate with the use of direct trocar in comparison with the Veress needle was still significant for extraperitoneal insufflation (Peto OR 0.19, 95% CI 0.12 to 0.31).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.8 Trocar site bleeding</HEADING>
<P>This outcome was not reported</P>
<P>
<B>2.9 Trocar site infection</B>
</P>
<P>There was no significant difference between the groups for wound infection rates (Peto OR 0.52, 95% CI 0.16 to 1.62, four RCTs, n = 736, I<SUP>2 </SUP>= 62%; very low quality evidence). We did not find any cause for the substantial heterogeneity. See <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>
</P>
<P>
<B>2.10 Incisional hernia</B>
</P>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.11 Omental Injury</HEADING>
<P>There was evidence of a significant reduction in omental injury with the use of direct trocar entry compared with Veress needle entry (Peto OR 0.32, 95% CI 0.17 to 0.59, three RCTs, n = 1592, I<SUP>2 </SUP>= 36%; moderate quality evidence). See <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>
</P>
<P>Sensitivity analysis by excluding all studies with unclear randomisation demonstrated that the reduction in the complication rate with the use of direct trocar in comparison with the Veress needle was still significant for omental injury (Peto OR 0.25, 95% CI 0.12 to 0.52).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.12 Uterine bleeding</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Direct vision entry versus Veress needle entry (primary port entry)</HEADING>
<P>A single RCT (<A HREF="http://archie.cochrane.org/sections/documents/view?version=98338041089732078448111013125534&amp;format=REVMAN#STD-Tinelli-2010">Tinelli 2010</A>) with a total of 194 participants investigated direct vision entry compared with Veress needle entry. See <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.3 Visceral injury (bladder or bowel)</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 0.15, 95% CI 0.01 to 2.34, one RCT, n = 194, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.6 Failed entry</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.8 Trocar site bleeding</HEADING>
<P>There was no evidence of a difference between the groups in the rate of trocar site bleeding (Peto OR 0.55, 95% CI 0.11 to 2.78, one RCT, n = 194, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>
. 
</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Direct vision entry versus open-entry (primary port entry)</HEADING>
<P>Three RCTs (<LINK REF="STD-Minervini-2008" TYPE="STUDY">Minervini 2008</LINK>; <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK>; <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>) with a total of 452 participants investigated direct vision entry versus an open technique. See <LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">4.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was reported by <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK> and <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>. There were no events in either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.3 Visceral injury (bladder or bowel)</HEADING>
<P>This outcome was reported by <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK> and <LINK REF="STD-Tinelli-2013" TYPE="STUDY">Tinelli 2013</LINK>. There was one event in the open-entry group in <LINK REF="STD-Tinelli-2011" TYPE="STUDY">Tinelli 2011</LINK> where a bowel loop strictly adherent to the abdominal wall was cut. This was recognised immediately and required intracorporeal suturing. However, there was no evidence of a difference between direct vision entry and open-entry for visceral injury (Peto OR 0.13, 95% CI 0.00 to 6.50, two RCTs, n = 392, I<SUP>2 </SUP>= not applicable; low quality evidence). See <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.5 Solid organ injury</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 6.16, 95% CI 0.12 to 316.67, one RCT, n = 60, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.6 Failed entry</HEADING>
<P>There was no evidence of a difference between groups for this outcome (Peto OR 0.40, 95% CI 0.04 to 4.09, one RCT, n = 60, I<SUP>2 </SUP>= not applicable; low quality evidence). See <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">4.8 Trocar site bleeding</HEADING>
<P>There was no significant difference between the groups in rates of trocar site bleeding (Peto OR 6.16, 95% CI 0.12 to 316.67, one RCT, n = 60, I<SUP>2 </SUP>= not applicable; very low quality evidence).</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. Disposable instruments versus reusable instruments (primary port entry)</HEADING>
<P>No RCTs were identified for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">6. Radially expanding (STEP) trocars versus standard (non-expanding) trocars (primary port entry)</HEADING>
<P>Four RCTs with a total of 514 participants investigated the use of radially expanding (STEP) trocars with standard trocars for laparoscopic entry (<LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>; <LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>). See <LINK REF="SOF-05" TYPE="SOF">Summary of findings table 5</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">6.1 Mortality</HEADING>
<P>No RCTs reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 0.24, 95% Cl 0.05 to 1.21, two RCTs, n = 331, I<SUP>2 </SUP>= 0%; low quality evidence). See <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.3 Visceral injury (bladder or bowel)</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 0.13, 95% CI 0.00 to 6.37, two RCTs, n = 331, I<SUP>2 </SUP>= not applicable; low quality evidence). See <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4 Gas embolism</HEADING>
<P>No RCTs reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.5 Solid organ injury</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 1.05, 95% CI 0.07 to 16.91, one RCT, n = 244, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.6 Failed entry</HEADING>
<P>No RCTs reported this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">6.8 Trocar site bleeding</HEADING>
<P>Meta-analysis demonstrated that radially expanding (STEP) trocars were associated with a significant reduction in trocar site bleeding when compared with standard trocar entry (Peto OR 0.31, 95% Cl 0.15 to 0.62, three RCTs, n = 421, I<SUP>2 </SUP>= 60%; low quality evidence). We were unable to establish the cause of the substantial heterogeneity in this analysis. See <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>
</P>
<P>This result is sensitive to choice of statistical model and is no longer statistically significant when a Mantel-Haenszel OR and/or random-effects model is used in preference to a Peto OR, meaning that the result may be unreliable.</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">7 Trendelenburg position for entry versus supine position for entry (primary port entry)</HEADING>
<P>We did not find any RCTs for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">8 Volume of gas used as an indicator for entry versus intra-abdominal pressure as an indicator for entry (primary port entry)</HEADING>
<P>We did not find any RCTs for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">9. Comparisons of sites of entry</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">9.1 Transfundal versus infraumbilical insertion of the Veress needle (primary port entry)</HEADING>
<P>One RCT (<LINK REF="STD-Santala-1999" TYPE="STUDY">Santala 1999</LINK>) investigated transfundal versus infraumbilical insertion of the Veress needle.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">9.1.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">9.1.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">9.1.3 Visceral injury (bladder or bowel)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">9.1.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">9.1.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">9.1.6 Failed entry</HEADING>
<P>There was no evidence of a difference between the groups for failed entry rates (Peto OR 0.14, 95% CI 0.00 to 6.82, one RCT, n = 100, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">9.1.12 Uterine bleeding</HEADING>
<P>There was no significant difference between the groups in uterine bleeding rates (Peto OR 7.70, 95% CI 0.78 to 75.76, one RCT, n = 100, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>
</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">10. Comparisons of other laparoscopic entry techniques for primary or secondary port insertion</HEADING>
<P>Twenty-two RCTs compared other laparoscopic entry techniques.</P>
<SUBSECTION>
<HEADING LEVEL="5">10.1 Lifting versus not lifting the abdominal wall before Veress needle insertion (primary port entry)</HEADING>
<P>One RCT (<LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>) with 150 participants reported this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.1.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.1.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.1.3 Visceral injury (bladder or bowel)</HEADING>
<P>
<LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK> reported this outcome. There were no cases of visceral injury in either study arm.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.1.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.1.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.1.6 Failed entry</HEADING>
<P>Not lifting the abdominal wall before Veress needle insertion was associated with a significantly lower rate of failed entry than with lifting (Peto OR 4.44, 95% CI 2.16 to 9.13, n = 150, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.1.7 Extraperitoneal insufflation</HEADING>
<P>There was no evidence of a difference between the groups in the rate of extraperitoneal insufflation (Peto OR 4.43, 95% CI 0.98 to 20.10, one RCT, n = 150, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>. </P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.2 Carbon dioxide gas insufflation versus the use of a gasless abdominal wall retractor (primary port entry)</HEADING>
<P>Four RCTs with a total of 212 participants investigated the use of carbon dioxide gas insufflation compared with the use of a gasless abdominal wall retractor (<LINK REF="STD-Cravello-1999" TYPE="STUDY">Cravello 1999</LINK>; <LINK REF="STD-Johnson-1997" TYPE="STUDY">Johnson 1997</LINK>; <LINK REF="STD-Kitano-1993" TYPE="STUDY">Kitano 1993</LINK>; <LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.2.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 7.23, 95% CI 0.45 to 115.64, two RCTs, n = 186, I<SUP>2 </SUP>= 0%; very low quality evidence). See <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.3 Visceral injury (bladder or bowel)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.6 Failed entry</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.2.7 Extraperitoneal insufflation</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 7.58, 95% CI 0.77 to 74.97, one RCT, n = 83, I<SUP>2 </SUP>= not applicable; very low quality evidence).See <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.8 Trocar site bleeding</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 0.13, 95% CI 0.00 to 6.69, one RCT, n = 103, I<SUP>2 </SUP>= not applicable; very low quality evidence).See <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.2.9 Trocar site infection</HEADING>
<P>There was no evidence of a difference between the groups for this outcome (Peto OR 0.98, 95% CI 0.06 to 15.87, one RCT, n = 83, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>.</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.3 A closed technique versus a parallel technique of Veress needle insertion (primary port entry)</HEADING>
<P>A single RCT with 200 participants compared a closed technique with a parallel technique of Veress needle insertion (<LINK REF="STD-Ostrzenski-1999" TYPE="STUDY">Ostrzenski 1999</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.3.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.3.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was measured but there were no events in either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.3.3 Visceral injury (bladder or bowel)</HEADING>
<P>This outcome was measured but there were no events in either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.3.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.3.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.3.6 Failed entry</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>Extraperitoneal insufflation was measured, but there were no events in either group. No other secondary outcomes were reported.</P>
<SUBSECTION>
<HEADING LEVEL="5">10.4 Cutting trocar versus blunt trocar (primary port entry)</HEADING>
<P>Two RCTs including 195 participants investigated the use of a cutting trocar compared to a blunt trocar (<LINK REF="STD-Hamade-2007" TYPE="STUDY">Hamade 2007</LINK>; <LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.4.1 Mortality</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.4.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.4.3 Visceral injury (bladder or bowel)</HEADING>
<P>One RCT (<LINK REF="STD-Venkatesh-2007" TYPE="STUDY">Venkatesh 2007</LINK>) reported this outcome. There was no evidence of a difference between the groups (Peto OR 7.67, 95% CI 0.15 to 386.69, one RCT, n = 165, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.4.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.4.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.4.6 Failed entry</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.4.8 Trocar site bleeding</HEADING>
<P>There was no evidence of a difference between the two groups for trocar site bleeding (Peto OR 0.33, 95% CI 0.09 to 1.23, two RCTs, n = 195, I<SUP>2 </SUP>= 0%; low quality evidence).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.4.9 Trocar site infection</HEADING>
<P>There was no evidence of a difference between the two groups for trocar site infection (OR 7.67, 95% CI 0.15 to 386.69, one RCT, n = 165, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>.</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.5 Single incision (SILS) laparoscopic entry versus modified Hasson laparoscopic entry (primary port)</HEADING>
<P>Ten RCTs were identified which investigated the use of SILS entry compared to Modified Hasson technique (<LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Deveci-2013" TYPE="STUDY">Deveci 2013</LINK>; <LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>; <LINK REF="STD-Phillips-2012" TYPE="STUDY">Phillips 2012</LINK>; <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK>; <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>; <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.5.1 Mortality</HEADING>
<P>This outcome was reported by <LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>. There were no events in either group</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.5.2 Vascular injury (major vessels and abdominal wall vessels)</HEADING>
<P>This outcome was reported by <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>. There were no events in either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.5.3 Visceral injury (bladder or bowel)</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.5.4 Gas embolism</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.5.5 Solid organ injury</HEADING>
<P>This outcome was not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.5.6 Failed entry</HEADING>
<P>Five studies, comprising 497 patients, reported failed entry (<LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>; <LINK REF="STD-Phillips-2012" TYPE="STUDY">Phillips 2012</LINK>; <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>). There was no evidence of a difference between entry techniques (Peto OR 6.85, 95% CI 0.07 to 66.94, five RCTs, n = 497, I<SUP>2 </SUP>= 0%; very low quality evidence). See <LINK REF="CMP-007.05" TYPE="ANALYSIS">Analysis 7.5</LINK>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.5.9 trocar site infection</HEADING>
<P>Four studies reported trocar site infections (<LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>; <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>). There was no evidence of a difference between entry techniques (Peto OR 0.61, 95% CI 0.15 to 2.48, four RCTs, n = 286, I<SUP>2</SUP>= 0%; low quality evidence). See <LINK REF="CMP-007.05" TYPE="ANALYSIS">Analysis 7.5</LINK>. The other secondary outcomes were not reported.</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.6 Direct trocar entry versus reusable pyramidal trocar (primary port entry)</HEADING>
<P>A single study (<LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>) undertook a multi-arm trial. This was a single-blinded RCT with 100 participants. No complications were reported in either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.7 5 mm versus 3 mm trocars for secondary port entry</HEADING>
<P>A single RCT (<LINK REF="STD-Ghezzi-2005" TYPE="STUDY">Ghezzi 2005</LINK>) with a total of 102 participants compared a 5 mm secondary port entry with a 3 mm secondary port entry.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>None of the review's primary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.7.8 Trocar site bleeding</HEADING>
<P>There was no evidence of a difference between the groups in rates of trocar site bleeding (Peto OR 0.14, 95% CI 0.01 to 2.24, 1 RCT, n = 102, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.06" TYPE="ANALYSIS">Analysis 7.6</LINK>
</P>
<P>No other secondary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">10.8 Radially expanding access device (STEP) versus conventional (non-expanding) cutting tip trocar for secondary port entry</HEADING>
<P>Two RCTs (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>) with a total of 129 participants compared a radially expanding access device with a conventional cutting tip trocar.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>None of the review's primary outcomes were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">10.8.8 Trocar site bleeding</HEADING>
<P>There was no evidence of a difference between the groups for trocar site bleeding (Peto OR 0.13, 95% CI 0.01 to 2.14, 1 RCT, n = 68, I<SUP>2 </SUP>= not applicable; low quality evidence). See <LINK REF="CMP-007.07" TYPE="ANALYSIS">Analysis 7.7</LINK>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">10.8.9 Trocar site infection</HEADING>
<P>There was no evidence of a difference between the groups in the rate of trocar site infection (Peto OR 0.14, 95% CI 0.01 to 2.21, 1 RCT, n = 61, I<SUP>2 </SUP>= not applicable; very low quality evidence). See <LINK REF="CMP-007.07" TYPE="ANALYSIS">Analysis 7.7</LINK>
</P>
<P>No other primary outcomes were reported.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-08-26 10:08:49 +1200" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2015-08-26 09:39:32 +1200" MODIFIED_BY="[Empty name]">
<P>Given the restraints of data quality and sample size, this meta-analysis demonstrated no advantage of either open-entry or closed-entry technique in terms of a reduction in mortality or rate of vascular or visceral complications.</P>
<P>There was a reduction in the incidence of failed entry and extraperitoneal insufflation with an open-entry technique compared to the closed-entry method. A further advantage was found with open-entry in a reduction in the rate of omental injury.</P>
<P>When comparing direct trocar entry to Veress needle entry, this updated meta-analysis found a significant reduction in vascular complication rates in the direct entry cohort. However, we found that the benefit of direct entry for vascular injury was dependent on the choice of statistical model and the result is no longer significant when a Mantel-Haenszel Odds Ratio odds ratio and/or a random-effects model is used. This suggests the result may be unreliable and should be interpreted with caution. Both the <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK> and <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK> studies had three events of vascular injury in the Veress needle arm of the study; in the Karaca study bleeding was due to mesenteric vessel laceration and in the Prieto-Diaz-Chavez study, vascular injuries were due to epigastric vessel haemorrhage.</P>
<P>No new studies were found that compared radially expanding (STEP) trocars to standard non-expanding trocars. We can, therefore, draw the same conclusion as the 2012 update (<LINK REF="REF-Ahmad-2012" TYPE="REFERENCE">Ahmad 2012</LINK>): there is no evidence to suggest that radially expanding trocars are more or less safe in terms of reducing major complications during either primary or secondary port placement. However, a significant reduction in trocar site bleeding was noted with STEP trocars for primary port insertion when compared with non-expanding trocars. This result should be interpreted with caution because of substantial heterogeneity (I<SUP>2</SUP> = 60%) and dependence on choice of statistical model (the result is no longer significant when analysed with a Mantel-Haenszel odds ratio and/or random-effects model).</P>
<P>A single RCT suggests that lifting the abdominal wall for placement of a Veress needle increases the risks of failed entry, and no advantage was noted in terms of vascular or visceral complications.</P>
<P>The eight RCTs comparing single incision laparoscopic surgery (SILS) with traditional multi-trocar laparoscopy failed to report on the majority of the primary and secondary outcomes of this study. Notably, within these studies no significant difference was found in trocar site infection rates.</P>
<P>No significant difference in minor or major complications was demonstrated in the comparison between cutting and blunt trocars.<BR/>
</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-08-26 09:34:49 +1200" MODIFIED_BY="[Empty name]">
<P>Firstly, as considered above, it must be noted that studies were limited to small numbers and low quality data. Furthermore, many studies excluded patients with previous abdominal surgery, and women with a raised body mass index. These patients may have unusually high complication rates and their exclusion could be interpreted as a form of selection bias. Thus the strict inclusion criteria of these trials requires the results to be interpreted with caution in terms of relevance to the general population.</P>
<SUBSECTION>
<HEADING LEVEL="3">Open-entry versus closed-entry technique (primary port entry)</HEADING>
<P>Again, given restraints of data quality and sample size, no advantage was found for major complication rates &#8211; mortality, visceral injury or vascular injury. None of the included studies were sufficiently powered to detect major complications. Retrospective studies have reported that an open technique to establish pneumoperitoneum is safer than a blind technique, with the avoidance of both visceral and major vascular injury.</P>
<P>There is no universally accepted definition of failed entry. Akbar defined failed entry as failure to aspirate following Veress needle insertion on three consecutive attempts (<LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK>). Angioli defined failed entry as entry requiring more than three consecutive attempts (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>). Both of these study authors reported a high rate of failed entry in the Veress needle group. This is not consistent with routine practice, which classifies failed entry after two attempts of Veress needle insertion (<LINK REF="REF-RCOG-2008" TYPE="REFERENCE">RCOG 2008</LINK>).</P>
<P>Unlike the other four studies, <LINK REF="STD-Cogliandolo-1998" TYPE="STUDY">Cogliandolo 1998</LINK> had no exclusion criteria based on past medical/surgical history. Patients with a midline laparotomy scar and a body weight of less than 40 kg were excluded from <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>. <LINK REF="STD-Akbar-2008" TYPE="STUDY">Akbar 2008</LINK> excluded patients with previous upper abdominal surgery and para-umbilical hernia. <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK> was the most restrictive study excluding all those with previous abdominal surgery by laparoscopy or laparotomy, history of pelvic inflammatory disease, irritable bowel syndrome, suspicion of malignancy or malignancy at the histological examination. Caution is required when interpreting the results of these studies as patient populations often do include such comorbidities. Therefore, the results cannot necessarily be extrapolated to every cohort.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Direct trocar entry versus Veress needle entry (primary port entry)</HEADING>
<P>Direct trocar placement and Veress needle insertion are blind procedures with potential for serious injury. Because of their low incidence, any study investigating major complications occurring during primary port entry would require a large number of patients to be included. <LINK REF="REF-Molloy-2002" TYPE="REFERENCE">Molloy 2002</LINK> concluded that 828,204 patients would be required to show a reduction in bowel injury rates from 0.3% to 0.2%. The RCTs included in this meta-analysis had insufficient power to effectively demonstrate a significant difference in most major complications. Ten of the studies in this subgroup failed to undertake any power calculation, whereas <LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK> performed a power calculation that was based upon the incidence rate of failed entry (12%), which is substantially higher than other entry related complications.</P>
<P>Although several studies describe a similar approach for Veress needle insertion using a 450 degree angle at the level of the umbilicus, not all studies within this review state the exact technique used for insertion of the Veress needle. Thus, no conclusions can be made concerning the optimal method of Veress needle insertion.</P>
<P>Several studies reported higher complication rates within the Veress needle group, including a higher rate of vascular injury (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-3-2013" TYPE="STUDY">Angioli 3 2013</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>). There was also a significant reduction in the rates of extraperitoneal insufflation and omental injury associated with the use of direct trocar entry when compared to Veress needle entry. Extraperitoneal insufflation can result in failed laparoscopy and also increases the risk of gas embolism. Two RCTs (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>) reported gas embolism as an outcome, with no events in either arm.<BR/>
</P>
<P>It is difficult to interpret these result in the context of the general population, as several studies excluded patients based upon previous abdominal surgery (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Bemelman-1-2000" TYPE="STUDY">Bemelman 1 2000</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>; <LINK REF="STD-Karaca-2014" TYPE="STUDY">Karaca 2014</LINK>; <LINK REF="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TYPE="STUDY">Prieto-Díaz-Chávez 2006</LINK>; <LINK REF="STD-Tansatit-1-2006" TYPE="STUDY">Tansatit 1 2006</LINK>), obesity (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Borgatta-1990" TYPE="STUDY">Borgatta 1990</LINK>) or medical comorbidities (<LINK REF="STD-Angioli-1-2013" TYPE="STUDY">Angioli 1 2013</LINK>; <LINK REF="STD-Imran-2014" TYPE="STUDY">Imran 2014</LINK>). <LINK REF="STD-Byron-1993" TYPE="STUDY">Byron 1993</LINK>, <LINK REF="STD-Gunenc-2005" TYPE="STUDY">Gunenc 2005</LINK>, and <LINK REF="STD-Zakerah-2010" TYPE="STUDY">Zakerah 2010</LINK> did not state exclusion criteria.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Radially expanding (STEP) trocars versus standard trocars (primary port entry)</HEADING>
<P>An advantage in reduction of visceral or vascular injury rates was not seen in the meta-analysis. As the dilator and cannula in the STEP device radially expands the tissue tract created by the Veress needle, the defects in the abdominal wall are about 50% narrower and the incidence of trocar site bleeding is considerably less with STEP use (<LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>). In addition, the STEP device separates rather than cuts the tissue, leaving a slit-like defect that forms along the muscle fibres, as opposed to the clover-leaf defect left by the cutting styles of a conventional trocar (<LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>). Although a significant advantage was seen in reduction of trocar site bleeding, the reliability of this conclusion is undermined by both a high degree of heterogeneity (I<SUP>2</SUP> = 60%) and lack of statistical significance when a Mantel-Haenszel Odds Ratio and/or random-effects model is used.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Lifting or not lifting the abdominal wall before Veress needle insertion (primary port entry)</HEADING>
<P>Abdominal wall lifting is aimed at increasing skin resistance to facilitate cutaneous perforation with the Veress needle. The Royal College of Obstetricians and Gynaecologists currently recommends stabilising the lower abdominal wall when inserting the Veress needle perpendicular to the skin incision (<LINK REF="REF-RCOG-2008" TYPE="REFERENCE">RCOG 2008</LINK>).</P>
<P>Analysis demonstrated an increased risk of failed entry in the lifting group as compared to not lifting (<LINK REF="STD-Briel-2000" TYPE="STUDY">Briel 2000</LINK>). The result needs to be interpreted with caution as failed entry has been defined as a single attempt. This is not consistent with routine practice as discussed above for open-entry versus closed-entry technique (primary port entry).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">SILS versus Hasson technique for port entry (primary port)</HEADING>
<P>No advantage in reduction of any of the primary or secondary outcomes was found when comparing SILS to the Hasson technique.</P>
<P>Five studies reported no evidence of a difference in failed entry rates (<LINK REF="STD-Fonollosa-2012" TYPE="STUDY">Fonollosa 2012</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Perez-2013" TYPE="STUDY">Perez 2013</LINK>; <LINK REF="STD-Phillips-2012" TYPE="STUDY">Phillips 2012</LINK>; <LINK REF="STD-Vilallonga-2012" TYPE="STUDY">Vilallonga 2012</LINK>). Four studies showed no evidence of a difference in trocar site infection rates (<LINK REF="STD-Carter-2013" TYPE="STUDY">Carter 2013</LINK>; <LINK REF="STD-Lai-2011" TYPE="STUDY">Lai 2011</LINK>; <LINK REF="STD-Luna-2013" TYPE="STUDY">Luna 2013</LINK>; <LINK REF="STD-Villalobos-2014" TYPE="STUDY">Villalobos 2014</LINK>). Although <LINK REF="STD-Tsimoyiannis-2009" TYPE="STUDY">Tsimoyiannis 2009</LINK> demonstrated a reduction in pain using the SILS technique, no complications were reported.</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-08-19 12:35:21 +1200" MODIFIED_BY="[Empty name]">
<P>Only ten RCTs attempted blinding. Blinding of the surgeon is not possible in these studies, but this is unlikely to have affected the intraoperative events. While single-blinding, to minimise any Hawthorne effect, could be important when assessing delayed postoperative complications, such as pain and scarring, these outcomes were not considered in this systematic review.<BR/>
</P>
<P>The potential for loss to follow-up is relevant as delayed recognition of bowel injury and minor complications such as wound infection following discharge of the participants may have been missed. <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK> and <LINK REF="STD-Schulze-1999" TYPE="STUDY">Schulze 1999</LINK> reported patients as losses to follow-up because of intraoperative complications that required conversion to a different technique. <LINK REF="STD-Bisgaard-2007" TYPE="STUDY">Bisgaard 2007</LINK> stated loss of one participant due to loss of study diary. Only three trials specifically described an intention-to-treat approach (<LINK REF="STD-Agresta-2004" TYPE="STUDY">Agresta 2004</LINK>; <LINK REF="STD-Bhoyrul-2000" TYPE="STUDY">Bhoyrul 2000</LINK>; <LINK REF="STD-Feste-2000" TYPE="STUDY">Feste 2000</LINK>).</P>
<P>From the 'Summary of findings' tables (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>; <LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>; <LINK REF="SOF-05" TYPE="SOF">Summary of findings table 5</LINK>), it is evident that the GRADE scores for the majority of studies were deemed to be low or very low. As discussed, the conclusions drawn by this review are limited due to the lack of high quality studies.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-08-26 09:52:16 +1200" MODIFIED_BY="[Empty name]">
<P>Several outcomes reported within this review are variable with respect to their definition. For example failed entry, wound infection and trocar site bleeding have different definitions in different reviews. There is no universally agreed definition of failed entry. Study definitions have ranged from two to three attempts of Veress needle insertion before abandoning the procedure or converting to a different entry technique. Studies also differ as to the methods used to confirm the correct placement of the Veress needle; some clinicians use a saline test and others may use flow of gas and pressure within the cavity.</P>
<P>Twelve of the trials included within the review did not measure the complication rate as a primary outcome; therefore study authors did not predefine the complications that would be measured and the methodology of doing so. None of the included studies defined the method of identifying wound infections, for example clinical diagnoses or microbiological confirmation. Also, if power calculations were based upon the reduction in reported complication rates, a larger number of participants would be required to produce significant results.</P>
<P>A previous version of this review excluded studies investigating the use of secondary port insertion (<LINK REF="REF-Ahmad-2008" TYPE="REFERENCE">Ahmad 2008</LINK>). We have included these studies within this updated review and have reassessed the newly included studies to ensure they meet the inclusion criteria; we have assessed them for risk of bias.</P>
<P>As detailed above, feedback from the last update discussed the need to describe trocar information to make results more comparable (<LINK REF="FBK-01" TYPE="FEEDBACK">Feedback 1</LINK>). There is no universally accepted &#8216;standard&#8217; trocar and papers are not uniform in their reporting of trocar type. Seven studies provided no trocar information. The authors considered that in all studies that described their choice of trocars, the equipment used could be consider standard. Omissions have been followed up through email. Information on the individual trocar types has been added to the 'Intervention' section of all characteristics of included studies tables with omissions highlighted. No RCTs have been conducted that show an advantage exists for any individual trocar type for primary port entry. However, a recent review by <LINK REF="REF-Antoniou-2013" TYPE="REFERENCE">Antoniou 2013</LINK> concluded that blunt tip trocars are preferable to cutting trocars for cannulation of the abdominal wall under laparoscopic vision (i.e. secondary and further ports), as they are associated with a lower risk of abdominal wall bleeding and overall complications. As all trocar safety profiles meet industry standards, it could be postulated that, in the current climate of limited resource allocation and budgeting difficulties, cost be the deciding factor when choosing trocar type.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-08-26 10:08:49 +1200" MODIFIED_BY="[Empty name]">
<P>The Royal College of Obstetricians and Gynaecologists guidelines currently do not recommend a specific laparoscopic entry technique. However, for extremes of BMI they recommend open-entry (Hasson) technique. This review has not demonstrated any major safety advantage with the use of either an open-entry or closed-entry technique; however, this review was not designed to specifically identify the preferred entry technique for women at extremes of BMI (<LINK REF="REF-RCOG-2008" TYPE="REFERENCE">RCOG 2008</LINK>).</P>
<P>A meta-analysis by <LINK REF="REF-Song-2013" TYPE="REFERENCE">Song 2013</LINK> showed no significant differences between SILS and standard 4 port laparoscopy entry for perioperative complication rates, conversion rates or length of operation. The term &#8216;perioperative complications&#8217; was not further delineated in the paper and conversion included both addition of trocars and/or conversion to laparotomy. The outcomes reported in this review for the SILS technique were also corroborated by another recent meta-analysis (<LINK REF="REF-Antoniou-2014" TYPE="REFERENCE">Antoniou 2014</LINK>), which concluded that there were no significant differences between SILS and standard 4 port entry techniques, other than a prolonged operative time with SILS.</P>
<P>The results of the systematic review agree with the results of three other reviews of randomised and non-randomised data (<LINK REF="REF-Antoniou-2013" TYPE="REFERENCE">Antoniou 2013</LINK>; <LINK REF="REF-Merlin-2003" TYPE="REFERENCE">Merlin 2003</LINK>; <LINK REF="REF-Molloy-2002" TYPE="REFERENCE">Molloy 2002</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-08-26 16:19:10 +1200" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-08-26 16:19:10 +1200" MODIFIED_BY="[Empty name]">
<P>The open-entry technique is associated with a reduction in failed entry when compared to the closed-entry technique, with no evidence of a difference in the incidence of visceral or vascular injury.</P>
<P>Benefits were noted with the use of the direct trocar entry technique when compared to Veress needle entry. The use of the Veress needle was associated with an increased incidence of failed entry.</P>
<P>Not lifting the abdominal wall before Veress needle insertion was associated with a reduction in failed entry compared to lifting the abdominal wall before Veress needle insertion. This was the only other comparison that demonstrated evidence of a difference for one of our primary outcomes.</P>
<P>The low rate of reported complications associated with laparoscopic entry and the small number of participants within the included studies may account for the lack of significant difference in terms of major vascular and visceral injury between most entry techniques. Results should be interpreted with caution for outcomes where only single studies were included.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-08-19 15:55:07 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) of adequate power are required to detect a significant reduction in risks of major complications. In order to increase cohort size enough to gain the statistical power needed to be able to detect rare major complications, the number of patients required would need to be in the hundreds of thousands and it is unlikely that these studies could be performed. This dilemma has been explored recently by <LINK REF="REF-Cuss-2014" TYPE="REFERENCE">Cuss 2014</LINK> who suggest that the evidence for laparoscopic surgery may be at the limit of what is possible. In order to address this issue, we suggest that a centralised national register could be created. Although this would not produce RCT-level evidence, it would enable collation of all information on laparoscopic complications and thus provide cohort sizes large enough to reliably identify major complications. This could be modelled on the existing maternal mortality databases. The onus would be on individual surgeons to be transparent in their reporting of complications.</P>
<P>Further well designed RCTs of sufficient power are required to determine the optimal entry technique in patients with extreme BMI and those with previous abdominal and pelvic surgery.</P>
<P>Future meta-analyses ought to consider using individual patient data (IPD) analysis. Aggregate data meta-analysis means accepting the reporting methods of each individual study and using their outcomes for analysis. Therefore any selective bias, publication bias or flaws in reporting protocol will influence the meta-analysis outcome. Although much more resource intensive, as all raw data from individual studies must be obtained and reanalysed using advanced statistical methods, IPD analysis would allow all data analysis to be standardised and reported consistently.<BR/>
</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-08-14 16:22:40 +1200" MODIFIED_BY="Helen E Nagels">
<P>We acknowledge Dr Birgit Luehr, who translated several papers. We would like to thank the members of the Cochrane Menstrual Disorders and Subfertility Review Group, based in Auckland, New Zealand, who assisted with this review.</P>
<P>We thank also Dr James Duffy for his contributions to previous versions of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-08-28 13:15:40 +1200" MODIFIED_BY="Helen E Nagels">
<P>None known for any author.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-08-18 14:48:23 +1200" MODIFIED_BY="[Empty name]">
<P>Gaity Ahmad (GA)<BR/>Main review author, designed the review, screened the search results, organised the retrieval of the original RCTs, screened them against the inclusion criterion, extracted the data from the RCTs, wrote to the study authors when required, managed the data, interpreted the results, and supervised DG and DH throughout the process.</P>
<P>David Gent (DG)</P>
<P>Co-review author, organised the retrieval of the RCTs for the updated review, screened them against the inclusion criteria, extracted the data from RCTs, wrote to the study authors when required, managed the data, and helped interpret the results and write the discussion and conclusions.</P>
<P>Daniel Henderson (DH)</P>
<P>Co-review author, helped extract the data from RCTs, and helped interpret the results and write the discussion and conclusions.</P>
<P>Kevin Philipps (KP)<BR/>Helped design the review and helped draft the discussion and conclusions.</P>
<P>Andrew Watson (AW)<BR/>Helped design the original review, supervised all the steps undertaken for the original review, and helped draft the discussion and conclusions.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-08-28 13:16:06 +1200" MODIFIED_BY="Helen E Nagels">
<P>Studies reviewing secondary port entry were included in the 2012 update of the review. The new comparisons were 5 mm versus 3 mm trocar for secondary port entry and radially expanding access device versus conventional (non-expanding) cutting tip trocar for secondary port entry.</P>
<P>Failed entry was changed from a secondary outcome to a primary outcome in the 2012 update of the review as the authors deemed it to have serious consequences such as prolonged operative time and an increased risk of infection due to further incisions. Solid organ injury was added as a primary outcome in the 2012 update of the review.</P>
<P>Secondary outcome measures in the 2015 update were defined as: extraperitoneal insufflation, trocar site bleeding, trocar site infection, incisional hernia, omentum injury, and uterine bleeding.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-08-27 12:44:44 +1200" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-08-27 12:44:44 +1200" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-08-27 12:44:44 +1200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Agresta-2004" MODIFIED="2015-07-09 21:40:56 +1200" MODIFIED_BY="[Empty name]" NAME="Agresta 2004" YEAR="2004">
<REFERENCE MODIFIED="2015-07-09 21:40:56 +1200" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Agresta F, DeSimone P, Ciardo LF, Bedin N</AU>
<TI>Direct trocar insertion vs Veress needle in nonobese patients undergoing laparoscopic procedures: a randomized prospective single-center study</TI>
<SO>Surgical Endoscopy</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>12</NO>
<PG>1778-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akbar-2008" MODIFIED="2012-01-09 01:14:20 +1300" MODIFIED_BY="[Empty name]" NAME="Akbar 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-09 01:14:20 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akbar M, Khan IA, Naveed D, Khattak I, Zafar A, Wazir MS, et al</AU>
<TI>Comparison of closed and open methods of pneumoperitoneum in laparoscopic cholecystectomy</TI>
<SO>The Journal of Ayub Medical College Abbottabad</SO>
<YR>2008</YR>
<VL>20</VL>
<NO>2</NO>
<PG>85-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Angioli-1-2013" MODIFIED="2015-07-09 10:37:24 +1200" MODIFIED_BY="[Empty name]" NAME="Angioli 1 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-07-09 10:37:24 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Angioli R, Terranova C, De Cicco Nardone C, Cafà EV, Damiani P, Portuesi R, et al</AU>
<TI>A comparison of three different entry techniques in gynaecological laparoscopic surgery: a randomized prospective trial</TI>
<SO>European Journal of Obstetrics &amp; Gynaecology and Reproductive Biology</SO>
<YR>2013</YR>
<VL>171</VL>
<PG>339-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-11-03 08:21:08 +1300" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Angioli-2-2013" MODIFIED="2014-11-24 09:47:32 +1300" MODIFIED_BY="[Empty name]" NAME="Angioli 2 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-24 09:47:30 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Angioli R, Terranova C, De Cicco Nardone C, Cafà EV, Damiani P, Portuesi R, et al</AU>
<TI>A comparison of three different entry techniques in gynaecological laparoscopic surgery: a randomized prospective trial</TI>
<SO>European Journal of Obstetrics &amp; Gynaecology and Reproductive Biology</SO>
<YR>2013</YR>
<VL>171</VL>
<PG>339-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Angioli-3-2013" MODIFIED="2014-11-24 09:48:54 +1300" MODIFIED_BY="[Empty name]" NAME="Angioli 3 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-24 09:48:51 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Angioli R, Terranova C, De Cicco Nardone C, Cafà EV, Damiani P, Portuesi R, et al</AU>
<TI>A comparison of three different entry techniques in gynaecological laparoscopic surgery: a randomized prospective trial</TI>
<SO>European Journal of Obstetrics &amp; Gynaecology and Reproductive Biology</SO>
<YR>2013</YR>
<VL>171</VL>
<PG>339-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bemelman-1-2000" MODIFIED="2015-08-19 13:15:31 +1200" MODIFIED_BY="[Empty name]" NAME="Bemelman 1 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-08-19 13:15:31 +1200" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bemelman WA, Dunker MS, Busch OR, Den Boer KT, De Wit LT, Gouma DJ</AU>
<TI>Efficacy of establishment of pneumoperitoneum with the Veress Needle, Hasson trocar, and modified blunt trocar (TrocDoc): a randomized study</TI>
<SO>Journal of Laparoendoscopic and Advanced Surgical Techniques</SO>
<YR>2000</YR>
<VL>10</VL>
<NO>6</NO>
<PG>325-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bemelman-2-2000" MODIFIED="2015-08-19 13:15:38 +1200" MODIFIED_BY="[Empty name]" NAME="Bemelman 2 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-08-19 13:15:38 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bemelman WA, Dunker MS, Busch OR, Den Boer KT, De Wit LT, Gouma DJ</AU>
<TI>Efficacy of establishment of pneumoperitoneum with the Veress Needle, Hasson trocar, and modified blunt trocar (TrocDoc): a randomized study</TI>
<SO>Journal of Laparoendoscopic and Advanced Surgical Techniques</SO>
<YR>2000</YR>
<VL>10</VL>
<NO>6</NO>
<PG>325-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bemelman-3-2000" MODIFIED="2015-08-27 12:44:44 +1200" MODIFIED_BY="[Empty name]" NAME="Bemelman 3 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-08-19 13:15:42 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bemelman WA, Dunker MS, Busch OR, Den Boer KT, De Wit LT, Gouma DJ</AU>
<TI>Efficacy of establishment of pneumoperitoneum with the Veress needle, Hasson trocar, and modified blunt trocar (TrocDoc): a randomized study</TI>
<SO>Journal of Laparoendoscopic and Advanced Surgical Techniques</SO>
<YR>2000</YR>
<VL>10</VL>
<NO>6</NO>
<PG>325-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bhoyrul-2000" NAME="Bhoyrul 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhoyrul S, Payne J, Steffes B, Swanstrom L, Way LW</AU>
<TI>A randomized prospective study of radially expanding trocars in laparoscopic surgery</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>4</NO>
<PG>392-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bisgaard-2007" MODIFIED="2012-01-09 01:20:32 +1300" MODIFIED_BY="[Empty name]" NAME="Bisgaard 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-01-09 01:20:32 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bisgaard T, Jakobsen HL, Jacobsen B, Olsen SD, Rosenberg J</AU>
<TI>Randomized clinical trial comparing radially expanding trocars with conventional cutting trocars for the effects on pain after laparoscopic cholecystectomy</TI>
<SO>Surgical Endoscopy</SO>
<YR>2007</YR>
<VL>21</VL>
<PG>2012-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borgatta-1990" MODIFIED="2011-04-10 23:47:16 +1200" MODIFIED_BY="[Empty name]" NAME="Borgatta 1990" YEAR="1990">
<REFERENCE MODIFIED="2011-04-10 23:47:16 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borgatta L, Gruss L, Barad D, Kaali SG</AU>
<TI>Direct trocar Insertion vs. Veress Needle use for laparoscopic sterilization</TI>
<SO>The Journal of Reproductive Medicine</SO>
<YR>1990</YR>
<VL>35</VL>
<NO>9</NO>
<PG>891-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Briel-2000" NAME="Briel 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Briel JW, Plaisier PW, Meijer WS, Lange JF</AU>
<TI>Is it necessary to lift the abdominal wall when preparing a pneumoperitoneum?</TI>
<SO>Surgical Endoscopy</SO>
<YR>2000</YR>
<VL>14</VL>
<PG>862-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Byron-1993" MODIFIED="2011-04-10 23:47:16 +1200" MODIFIED_BY="[Empty name]" NAME="Byron 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-04-10 23:47:16 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Byron JW, Markenson G, Miyazawa K</AU>
<TI>A randomized comparison of Veress needle and direct trocar insertion for laparoscopy</TI>
<SO>Surgery</SO>
<YR>1993</YR>
<VL>177</VL>
<PG>259-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carter-2013" MODIFIED="2014-11-12 08:38:20 +1300" MODIFIED_BY="[Empty name]" NAME="Carter 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-12 08:38:13 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carter JT, Kaplan JA, Nguyen JN, Lin MYC, Rogers S, Harris HW</AU>
<TI>A prospective, randomised controlled trial of single-incision laparoscopic vs conventional 3-port laparoscopic appendectomy for treatment of acute appendicitis</TI>
<SO>American College of Surgeons</SO>
<YR>2014</YR>
<VL>218</VL>
<NO>5</NO>
<PG>950-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Channa-2009" MODIFIED="2014-11-12 08:38:41 +1300" MODIFIED_BY="[Empty name]" NAME="Channa 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-11-12 08:38:41 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Channa AC, Siddiqui AJ, Zafar SN</AU>
<TI>Open versus closed method of establishing pneumoperitoneum for laparoscopic cholecystectomy</TI>
<SO>Journal of the College of Physicians and Surgeons Pakistan</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>9</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cogliandolo-1998" NAME="Cogliandolo 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cogliandolo A, Manganaro T, Saitta FP, Micali B</AU>
<TI>Blind versus open approach to laparoscopic cholecystectomy</TI>
<SO>Surgical Laparoscopy and Endoscopy</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>5</NO>
<PG>353-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cravello-1999" MODIFIED="2012-01-11 14:03:02 +1300" MODIFIED_BY="[Empty name]" NAME="Cravello 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-01-11 14:03:02 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cravello L, D'Ercole C, Roger V, Samson D, Blanc B</AU>
<TI>Laparoscopic surgery in gynaecology: randomized prospective study comparing pneumoperitoneum and abdominal wall suspension</TI>
<SO>European Journal of Obstetrics, Gynecology, and Reproductive Biology</SO>
<YR>1999</YR>
<VL>83</VL>
<PG>9-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deveci-2013" MODIFIED="2014-11-24 09:49:52 +1300" MODIFIED_BY="[Empty name]" NAME="Deveci 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-24 09:49:52 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deveci U, Barbaros U, Kapakli MS, Manukyan MN, Simsek S, Kebudi A, et al</AU>
<TI>The comparison of single incision laparoscopic cholecystectomy and three port laparoscopic cholecystectomy: prospective randomized study</TI>
<SO>Jounal of the Korean Surgical Society</SO>
<YR>2013</YR>
<VL>85</VL>
<PG>275-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feste-2000" MODIFIED="2011-04-27 11:13:11 +1200" MODIFIED_BY="[Empty name]" NAME="Feste 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-04-27 11:13:11 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feste JR, Bojahr B, Turner DJ</AU>
<TI>Randomized trial comparing a radially expandable needle system with cutting trocars</TI>
<SO>Journal of the Society of Laparoendoscopic Surgeons</SO>
<YR>2000</YR>
<VL>4</VL>
<PG>11-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fonollosa-2012" MODIFIED="2014-11-24 09:50:22 +1300" MODIFIED_BY="[Empty name]" NAME="Fonollosa 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-24 09:50:22 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fonollosa EH, Andorrà EC, Domingo MIG, Lasa JC, Castejon RP, Lopez FC, et al</AU>
<TI>A randomised prospective comparative study between laparoscopic cholecystectomy and single port cholecystectomy in a major outpatient surgery unit</TI>
<SO>Cirugia Espanola</SO>
<YR>2012</YR>
<VL>90</VL>
<NO>10</NO>
<PG>641-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghezzi-2005" MODIFIED="2012-01-09 01:21:17 +1300" MODIFIED_BY="James M N Duffy" NAME="Ghezzi 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-01-09 01:21:17 +1300" MODIFIED_BY="James M N Duffy" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghezzi F, Cromi A, Colombo G, Uccella S, Bergamini V, Serati M et al</AU>
<TI>Minimizing ancillary ports size in gynaecologic laparoscopy: A randomized trial</TI>
<SO>The Journal of Minimally Invasive Gynaecology</SO>
<YR>2005</YR>
<VL>12</VL>
<PG>480-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gunenc-2005" MODIFIED="2015-08-19 13:16:40 +1200" MODIFIED_BY="[Empty name]" NAME="Gunenc 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-08-19 13:16:40 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gunenc MZ, Yesildaglar N, Bingol B, Onalan G, Tabak S, Gokmen B</AU>
<TI>The safety and efficacy of direct trocar insertion with elevation of the rectus sheath instead of the skin for pneumoperitoneum</TI>
<SO>Surgical Laparoscopy, Endoscopy and Percutaneous Techniques</SO>
<YR>2005</YR>
<VL>15</VL>
<NO>2</NO>
<PG>80-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hamade-2007" MODIFIED="2011-06-14 13:00:17 +1200" MODIFIED_BY="[Empty name]" NAME="Hamade 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-06-14 13:00:17 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hamade AM, Issa ME, Haylett KR, Ammori BJ</AU>
<TI>Fixity of ports to the abdominal wall during laparoscopic surgery:a randomized comparison of cutting versus blunt trocars</TI>
<SO>Surgical Endoscopy</SO>
<YR>2007</YR>
<VL>21</VL>
<PG>965-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2012" MODIFIED="2015-08-19 16:08:10 +1200" MODIFIED_BY="[Empty name]" NAME="Huang 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-08-19 16:08:10 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang SY, Wang SY, Yeh CN, Cheng CT, Tsai YY, Liu CC, et al</AU>
<TI>Bladeless trocar versus traditional trocar for patients undergoing laparoscopic cholecystectomy</TI>
<SO>European Surgery</SO>
<YR>2012</YR>
<VL>44</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-11-03 08:22:40 +1300" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Imran-2014" MODIFIED="2015-08-19 13:17:04 +1200" MODIFIED_BY="[Empty name]" NAME="Imran 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-08-19 13:17:04 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Imran M, Chohan MZ, Mehmood Z, Mehmood K, Asif K</AU>
<TI>Comparison of Veress needle and direct trocar insertion in establishing pneumoperitoneum for laparoscopic cholecystectomy</TI>
<SO>Pakistan Journal of Medical and Health Sciences</SO>
<YR>2014</YR>
<VL>8</VL>
<NO>3</NO>
<PG>652-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-1997" NAME="Johnson 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson PL, Sibert KS</AU>
<TI>Laparoscopy: gasless vs. CO2 pneumoperitoneum</TI>
<SO>The Journal of Reproductive Medicine</SO>
<YR>1997</YR>
<VL>42</VL>
<NO>5</NO>
<PG>255-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karaca-2014" MODIFIED="2015-08-19 13:18:33 +1200" MODIFIED_BY="[Empty name]" NAME="Karaca 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-08-19 13:18:33 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karaca AS, C&#807;apar M, Ali R</AU>
<TI>The first trocar entry in the laparscopic cholecystectomy, which technique?</TI>
<TO>Laparoskopik Kolesistektomide I&#775;lk Trokar Giris&#807;i, Hangi Teknik?</TO>
<SO>Journal of Clinical and Analytical Medicine</SO>
<YR>2014</YR>
<VL>5</VL>
<NO>1</NO>
<PG>1-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-11-03 08:20:56 +1300" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kitano-1993" NAME="Kitano 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kitano S, Iso Y, Tomikawa M, Moriyama M, Sugimachi K</AU>
<TI>A prospective randomized trial comparing pneumoperitoneum and U-shaped retractor elevation for laparoscopic cholecystectomy</TI>
<SO>Surgical Endoscopy</SO>
<YR>1993</YR>
<VL>7</VL>
<PG>311-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lai-2011" MODIFIED="2014-11-17 03:57:47 +1300" MODIFIED_BY="[Empty name]" NAME="Lai 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-17 03:57:44 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lai ECH, Yang GPC, Tang CN, Yih PCL, Chan OCY, Li MKW</AU>
<TI>Prospective randomized comparative study of single incision laparoscopic cholecystectomy versus conventional four-port laparoscopic cholecystectomy</TI>
<SO>The American Journal of Surgery</SO>
<YR>2011</YR>
<VL>202</VL>
<PG>254-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lam-2000" MODIFIED="2015-08-19 13:18:53 +1200" MODIFIED_BY="[Empty name]" NAME="Lam 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-08-19 13:18:53 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lam TY, Lee SW, Frcs H, Kwok, P</AU>
<TI>Radially expanding trocar: a less painful alternative for laparoscopic surgery</TI>
<SO>Journal of Laparoendoscopic and Advanced Surgical Techniques</SO>
<YR>2000</YR>
<VL>10</VL>
<NO>5</NO>
<PG>269-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luna-2013" MODIFIED="2015-08-19 13:21:42 +1200" MODIFIED_BY="[Empty name]" NAME="Luna 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-08-19 13:21:42 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luna RA, Nogueira DB, Varela PS, Rodrigues Neto Ede O, Norton MJR, Ribeiro Ldo C, et al</AU>
<TI>A prospective randomized comparison of pain, inflammatory response, and short-term outcomes between single port and laparoscopic cholecystectomy</TI>
<SO>Surgical Endoscopy</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>4</NO>
<PG>1254-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mettle-2000" NAME="Mettle 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mettler L, Maher P</AU>
<TI>Investigation of the effectiveness of the radially-expanding needle system, in contrast to the cutting trocar in enhancing patient recovery</TI>
<SO>Minimally Invasive Therapy and Allied Technologies</SO>
<YR>2000</YR>
<VL>9</VL>
<NO>6</NO>
<PG>397-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Minervini-2008" MODIFIED="2015-08-19 13:21:56 +1200" MODIFIED_BY="[Empty name]" NAME="Minervini 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-08-19 13:21:56 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Minervini A, Davenport K, Pefanis G, Keeley Jr FK, Timoney AG</AU>
<TI>Prospective study comparing the bladeless optical access versus hasson open trocar for the establishment of pneumoperitoneum in laparoscopic renal procedures</TI>
<SO>Archivo Italiano di Urologia e Andrologia</SO>
<YR>2008</YR>
<VL>80</VL>
<NO>3</NO>
<PG>95-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ostrzenski-1999" MODIFIED="2012-01-09 01:21:51 +1300" MODIFIED_BY="[Empty name]" NAME="Ostrzenski 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-01-09 01:21:51 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ostrzenski A</AU>
<TI>Randomized, prospective, single-blind trial of a new parallel technique of Veress pneumoperitoneum needle insertion versus the conventional closed method</TI>
<SO>Fertility and Sterility</SO>
<YR>1999</YR>
<VL>71</VL>
<NO>3</NO>
<PG>578-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peitgen-1997" MODIFIED="2014-11-19 11:58:31 +1300" MODIFIED_BY="[Empty name]" NAME="Peitgen 1997" YEAR="1997">
<REFERENCE MODIFIED="2014-11-19 11:58:28 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peitgen K, Nimtz K, Hellinger A, Walz MK</AU>
<TI>Open access or Veress needle technique for laparoscopic surgery?</TI>
<TO>Offener Zugang oder Veress-Nadel bei laparoskopischen Eingriffen?</TO>
<SO>Chirurg</SO>
<YR>1997</YR>
<VL>68</VL>
<PG>910-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez-2013" MODIFIED="2014-11-27 04:46:28 +1300" MODIFIED_BY="[Empty name]" NAME="Perez 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-11-27 04:46:25 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez EA, Piper H, Burkhalter LS, Fischer AC</AU>
<TI>Single-incision laparoscopic surgery in children: a randomized control trial of acute appendicitis</TI>
<SO>Surgical Endoscopy</SO>
<YR>2013</YR>
<VL>27</VL>
<PG>1367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phillips-2012" MODIFIED="2015-08-19 13:22:34 +1200" MODIFIED_BY="[Empty name]" NAME="Phillips 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-08-19 13:22:34 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phillips MS, Marks JM, Roberts K, Tacchino R, Onders R, DeNoto G, et al</AU>
<TI>Intermediate results of a prospective randomized controlled trial of traditional four-port laparoscopic cholecystectomy versus single-incision laparoscopic cholecystectomy</TI>
<SO>Surgical Endoscopy</SO>
<YR>2012</YR>
<VL>26</VL>
<PG>1296-1303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" MODIFIED="2015-08-19 13:24:47 +1200" MODIFIED_BY="[Empty name]" NAME="Prieto-Díaz-Chávez 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-08-19 13:24:47 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prieto-Di&#769;az-Cha&#769;vez E, Medina-Cha&#769;vez JL, Gonza&#769;lez-Ojeda A, Anaya-Prado R, Trujillo-Herna&#769;ndez B, Va&#769;squez C</AU>
<TI>Direct trocar insertion without pneumoperitoneum and the Veress needle in laparoscopic cholecystectomy: a comparative study</TI>
<SO>Acta Chirurgica Belgica</SO>
<YR>2006</YR>
<VL>106</VL>
<NO>5</NO>
<PG>541-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santala-1999" NAME="Santala 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santala M, Jarvela I, Kauppila A</AU>
<TI>Transfundal insertion of a Veress needle in laparoscopy of obese subjects: a practical alternative</TI>
<SO>Human Reproduction</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>9</NO>
<PG>2277-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schulze-1999" NAME="Schulze 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schulze S, Lyng KM, Bugge K, Perner A, Bendtsen A, Thorup J, et al</AU>
<TI>Cardiovascular and respiratory changes and convalescence in laparoscopic colonic surgery</TI>
<SO>Archives of Surgery</SO>
<YR>1999</YR>
<VL>134</VL>
<PG>1112-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tansatit-1-2006" NAME="Tansatit 1 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tansatit T, Wisawasukmongchol W, Bunyavejchevin S</AU>
<TI>A randomized, prospective study comparing the use of the missile trocar and the pyramidal trocar for laparoscopy access</TI>
<SO>Journal of The Medical Association of Thailand</SO>
<YR>2006</YR>
<VL>89</VL>
<NO>7</NO>
<PG>941-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tansatit-2-2006" MODIFIED="2012-01-11 14:07:14 +1300" MODIFIED_BY="[Empty name]" NAME="Tansatit 2 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-01-11 14:07:14 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tansatit T, Wisawasukmongchol W, Bunyavejchevin S</AU>
<TI>A randomized, prospective study comparing the use of the missile trocar and the pyramidal trocar for laparoscopy access</TI>
<SO>Journal of The Medical Association of Thailand</SO>
<YR>2006</YR>
<VL>89</VL>
<NO>7</NO>
<PG>941-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tansatit-3-2006" NAME="Tansatit 3 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tansatit T, Wisawasukmongchol W, Bunyavejchevin S</AU>
<TI>A randomized, prospective study comparing the use of the missile trocar and the pyramidal trocar for laparoscopy access</TI>
<SO>Journal of The Medical Association of Thailand</SO>
<YR>2006</YR>
<VL>89</VL>
<NO>7</NO>
<PG>941-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tinelli-2010" MODIFIED="2014-11-24 08:54:24 +1300" MODIFIED_BY="[Empty name]" NAME="Tinelli 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-01-11 14:07:56 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>TInelli A, Malvasi A, Istre O, Keckstein J, Stark M, Mettler L</AU>
<TI>Abdominal access in gynaecological laparoscopy: a comparison between direct optical and blind closed access by Veress needle</TI>
<SO>European Journal of Obstetrics, Gynecology, and Reproductive Biology</SO>
<YR>2010</YR>
<VL>148</VL>
<PG>191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tinelli-2011" MODIFIED="2015-08-19 13:25:39 +1200" MODIFIED_BY="[Empty name]" NAME="Tinelli 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-08-19 13:25:39 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tinelli A, Malvasia A, Guido M, Tsin DA, Hudelist G, Stark M, et al</AU>
<TI>Laparscopy entry in patients with previous abdominal and pelvic surgery</TI>
<SO>Surgical Innovation</SO>
<YR>2011</YR>
<VL>18</VL>
<NO>3</NO>
<PG>201-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-11-03 08:20:34 +1300" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tinelli-2013" MODIFIED="2015-08-19 13:27:23 +1200" MODIFIED_BY="[Empty name]" NAME="Tinelli 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-08-19 13:27:23 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tinelli A, Malvasi A, Mynbaev OA, Tsin DA, Davila F, Dominguez G, et al</AU>
<TI>Bladeless direct optical trocar insertion in laparoscopic procedures on the obese patient</TI>
<SO>Journal of the Society of Laparoendoscopic Surgeons</SO>
<YR>2013</YR>
<VL>17</VL>
<NO>4</NO>
<PG>521-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-11-03 08:20:40 +1300" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsimoyiannis-2009" MODIFIED="2012-01-09 01:22:23 +1300" MODIFIED_BY="[Empty name]" NAME="Tsimoyiannis 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-01-09 01:22:23 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsimoyiannis EC, Konstantinos TE, Pappas-Gogos G, Farantos C</AU>
<TI>Different pain scores in single trans umbilical incision laparoscopic cholecystectomy versus classic laparoscopic cholecystectomy:a randomized controlled trial</TI>
<SO>Surgical Endoscopy</SO>
<YR>2010</YR>
<VL>24</VL>
<PG>1842-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Venkatesh-2007" MODIFIED="2015-08-19 13:27:48 +1200" MODIFIED_BY="[Empty name]" NAME="Venkatesh 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-08-19 13:27:48 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Venkatesh R, Sundaram CP, Figenshau RS, Yan Yan, Andriole GL, Clayman RV, et al</AU>
<TI>Prospective randomized comparison of cutting and dilating disposable trocars for access during laparoscopic renal surgery</TI>
<SO>Journal of the Society of Laparoendoscopic Surgeons</SO>
<YR>2007</YR>
<VL>11</VL>
<PG>198-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vilallonga-2012" MODIFIED="2014-11-24 09:51:44 +1300" MODIFIED_BY="[Empty name]" NAME="Vilallonga 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-24 09:51:44 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vilallonga R, Barbaros U, Sümer A, Demirel T, Fort JM, González O, et al</AU>
<TI>Single-port transumbilical laparoscopic cholecystectomy: A prospective randomised comparison of clinical results of 140 cases</TI>
<SO>Journal of Minimal Access Surgery</SO>
<YR>2012</YR>
<VL>8</VL>
<NO>3</NO>
<PG>74-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villalobos-2014" MODIFIED="2015-08-19 13:32:09 +1200" MODIFIED_BY="[Empty name]" NAME="Villalobos 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-08-19 13:32:09 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villalobos Mori R, Escoll Rufino J, Herrerías González F, Mias Carballal MC, Escartin Arias A, Olsina Kissler JJ</AU>
<TI>Prospective, randomized comparative study between single-port laparoscopic appendectomy and conventional laparoscopic appendectomy</TI>
<SO>Cirugia Espanola</SO>
<YR>2014</YR>
<VL>92</VL>
<NO>7</NO>
<PG>472-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yim-2001" MODIFIED="2012-01-11 14:10:13 +1300" MODIFIED_BY="[Empty name]" NAME="Yim 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-01-11 14:10:13 +1300" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yim SF, Yuen PM</AU>
<TI>Randomized double-masked comparison of radially expanding access device and conventional cutting tip trocar in laparoscopy</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>97</VL>
<NO>3</NO>
<PG>435-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zakerah-2010" MODIFIED="2015-08-19 13:33:04 +1200" MODIFIED_BY="[Empty name]" NAME="Zakerah 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-08-19 13:33:04 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zakherah MS</AU>
<TI>Direct trocar versus veress needle entry for laparoscopy: A randomized clinical trial</TI>
<SO>Gynecologic and Obstetric Investigation</SO>
<YR>2010</YR>
<VL>69</VL>
<NO>4</NO>
<PG>260-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-08-19 16:08:36 +1200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Cardin-2011" MODIFIED="2015-08-19 13:33:26 +1200" MODIFIED_BY="[Empty name]" NAME="Cardin 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-08-19 13:33:26 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cardin JL, Johanet H</AU>
<TI>Intraoperative events and their outcome: data from 4007 laparoscopic interventions by the French "Club Coelio"</TI>
<SO>Journal of Visceral Surgery</SO>
<YR>2011</YR>
<VL>148</VL>
<NO>4</NO>
<PG>299-310</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunne-2011" MODIFIED="2015-07-10 05:25:14 +1200" MODIFIED_BY="[Empty name]" NAME="Dunne 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-07-10 05:25:10 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunne N, Booth MI, Dehn TC</AU>
<TI>Establishing pneumoperitoneum: Verres or Hasson? The debate continues</TI>
<SO>Annals of The Royal College of Surgeons of England</SO>
<YR>2011</YR>
<VL>93</VL>
<NO>1</NO>
<PG>22-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fagotti-2010" MODIFIED="2015-08-19 13:36:00 +1200" MODIFIED_BY="[Empty name]" NAME="Fagotti 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-08-19 13:36:00 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Fagotti A, Fanfani F, Rossitto C, Marocco F, Gallotta V, Romano F, et al</AU>
<TI>Laparoendoscopic single-site surgery for the treatment of benign adnexal disease: A prospective trial</TI>
<SO>Diagnostic and Therapeutic Endoscopy</SO>
<YR>2010 Feb 8 [Epub ahead of print]</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garg-2012" MODIFIED="2015-08-19 13:36:30 +1200" MODIFIED_BY="[Empty name]" NAME="Garg 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-08-19 13:36:30 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garg P, Thakur JD, Singh I, Nain N, Mittal G, Gupta V</AU>
<TI>A prospective controlled trial comparing single-incision and conventional laparoscopic cholecystectomy: caution before damage control</TI>
<SO>Surgical Laparoscopy, Endoscopy and Percutaneous Techniques</SO>
<YR>2012</YR>
<VL>22</VL>
<NO>3</NO>
<PG>220-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2012" MODIFIED="2015-08-19 13:36:57 +1200" MODIFIED_BY="[Empty name]" NAME="Han 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-08-19 13:36:57 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Han C, Ding Z, Fan J, Sun J, Qian Y</AU>
<TI>Comparison of the stress response in patients undergoing gynecological laparoscopic surgery using carbon dioxide pneumoperitoneum or abdominal wall-lifting methods</TI>
<SO>Journal of Laparoendoscopic and Advanced Surgical Techniques. Part A</SO>
<YR>2012</YR>
<VL>22</VL>
<NO>4</NO>
<PG>330-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Joshipura-2009" MODIFIED="2015-08-19 13:37:05 +1200" MODIFIED_BY="[Empty name]" NAME="Joshipura 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-08-19 13:37:05 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Joshipura VP, Haribhakti SP, Patel NR, Naik RP, Soni HN, Patel B, et al</AU>
<TI>A prospective randomized, controlled study comparing low pressure versus high pressure pneumoperitoneum during laparoscopic cholecystectomy</TI>
<SO>Surgical Laparoscopy, Endoscopy and Percutaneous Techniques</SO>
<YR>2009</YR>
<VL>19</VL>
<NO>3</NO>
<PG>234-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2009" MODIFIED="2015-08-19 16:08:36 +1200" MODIFIED_BY="[Empty name]" NAME="Kim 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-08-19 16:08:36 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim SS, Kim SH, Mun SP</AU>
<TI>Should subcostal and lateral trocars be used in laporoscopic cholecystectomy? A randomized, prospective study</TI>
<SO>Journal of Laparoendoscopic and Advanced Surgical Techniques</SO>
<YR>2009</YR>
<VL>19</VL>
<PG>6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2012" MODIFIED="2015-08-19 13:37:34 +1200" MODIFIED_BY="[Empty name]" NAME="Lu 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-08-19 13:37:34 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu C-C, Lin S-E, Chung K-C, Rau K-M</AU>
<TI>Comparison of clinical outcome of single-incision laparoscopic surgery using a simplified access system with conventional laparoscopic surgery for malignant colorectal disease</TI>
<SO>Colorectal Disease</SO>
<YR>2012</YR>
<VL>14</VL>
<NO>4</NO>
<PG>171-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sandhu-2009" MODIFIED="2011-04-27 11:15:05 +1200" MODIFIED_BY="[Empty name]" NAME="Sandhu 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-04-27 11:15:05 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sandhu T, Yamada S, Ariyakachn V, Chakrabandhu T, Chongrukust W, Ko-iam W</AU>
<TI>Low-pressure pneumoperitoneum versus standard pneumoperitoneum in laparoscopic cholecystectomy,a prospective randomized clinical trial</TI>
<SO>Surgical Endoscopy</SO>
<YR>2009</YR>
<VL>23</VL>
<PG>1044-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sangrasi-2011" MODIFIED="2015-08-13 13:18:51 +1200" MODIFIED_BY="Helen E Nagels" NAME="Sangrasi 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-08-13 13:18:51 +1200" MODIFIED_BY="Helen E Nagels" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sangrasi AK, Shaikh AR, Muneer A</AU>
<TI>Open versus close pneumoperitoneum: A pursuit for safer technique</TI>
<SO>Pakistan Journal of Medical Sciences</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>3</NO>
<PG>523-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shayani_x002d_Nasab-2013" MODIFIED="2015-08-19 13:37:58 +1200" MODIFIED_BY="[Empty name]" NAME="Shayani-Nasab 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-08-19 13:37:58 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shayani-Nasab H, Amir-Zagar MA, Mousavi-Bahar SH, Kashkouli AI, Ghorban-Poor M, Farimani M, et al</AU>
<TI>Complications of entry using direct trocar and/or veress needle compared with modified open approach entry in laparoscopy: Six-year experience</TI>
<SO>Urology Journal</SO>
<YR>2013</YR>
<VL>10</VL>
<NO>2</NO>
<PG>861-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warle-2013" MODIFIED="2015-08-19 13:38:15 +1200" MODIFIED_BY="[Empty name]" NAME="Warle 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-08-19 13:38:15 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warle MC, Berkers AW, Langenhuijson JF, Van der Jagt MF, Dooper PM, Kloke HJ, et al</AU>
<TI>Low-pressure pneumoperitoneum during laparoscopic donor nephrectomy to optimize live donors' comfort</TI>
<SO>Clinical Transplantation</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>4</NO>
<PG>478-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-08-26 10:30:25 +1200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-08-26 10:30:25 +1200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ahmad-2007" MODIFIED="2011-04-27 11:39:01 +1200" MODIFIED_BY="[Empty name]" NAME="Ahmad 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ahmad G, Duffy JMN, Watson AJS</AU>
<TI>Laparoscopic entry techniques and complications</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2007</YR>
<VL>99</VL>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Antoniou-2013" MODIFIED="2015-02-23 02:08:35 +1300" MODIFIED_BY="[Empty name]" NAME="Antoniou 2013" TYPE="JOURNAL_ARTICLE">
<AU>Antoniou SA, Antoniou GA, Koch OO, Pointner R, Granderath FA</AU>
<TI>Blunt versus bladed trocars in laparoscopic surgery: a systematic review and meta-analysis of randomized trials</TI>
<SO>Sugical Endoscopy</SO>
<YR>2013</YR>
<VL>27</VL>
<PG>2312-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Antoniou-2014" MODIFIED="2015-02-06 12:00:26 +1300" MODIFIED_BY="[Empty name]" NAME="Antoniou 2014" TYPE="JOURNAL_ARTICLE">
<AU>Antoniou SA, Koch OO, Antoniou GA, Lasithiotakis K, Chalkiadakis GE, Pointner R, et al</AU>
<TI>Meta-analysis of randomized trials on single-incision laparoscopic versus conventional laparoscopic appendectomy</TI>
<SO>The American Journal of Surgery</SO>
<YR>2014</YR>
<VL>207</VL>
<NO>4</NO>
<PG>613-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bijen-2009" MODIFIED="2015-08-19 13:39:38 +1200" MODIFIED_BY="[Empty name]" NAME="Bijen 2009" TYPE="JOURNAL_ARTICLE">
<AU>Bijen CB, Vermeulen KM, Mourits MJ, de Bock GH</AU>
<TI>Costs and effects of abdominal versus laparoscopic hysterectomy: systematic review of controlled trials</TI>
<SO>PLoS ONE</SO>
<YR>2009</YR>
<VL>4</VL>
<NO>10</NO>
<PG>7340</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cuss-2014" MODIFIED="2015-08-19 13:40:34 +1200" MODIFIED_BY="[Empty name]" NAME="Cuss 2014" TYPE="JOURNAL_ARTICLE">
<AU>Cuss A, Bhatt M, Abbott J</AU>
<TI>Coming to terms with the fact that the evidence for laparoscopic entry Is as good as it gets</TI>
<SO>Journal of Minimally Invasive Gynaecology</SO>
<YR>2014</YR>
<VL>22</VL>
<NO>3</NO>
<PG>3332-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2015-08-19 13:40:45 +1200" MODIFIED_BY="[Empty name]" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fader-2010" MODIFIED="2015-08-19 13:41:09 +1200" MODIFIED_BY="[Empty name]" NAME="Fader 2010" TYPE="JOURNAL_ARTICLE">
<AU>Fader AN</AU>
<TI>Laparoendoscopic single-site surgery in gynaecology</TI>
<SO>Current Opinions in Obstetrics and Gynaecology</SO>
<YR>2010</YR>
<VL>22</VL>
<PG>331-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fuller-2005" MODIFIED="2015-08-19 13:41:26 +1200" MODIFIED_BY="[Empty name]" NAME="Fuller 2005" TYPE="JOURNAL_ARTICLE">
<AU>Fuller J, Ashar BS, Carey-Corrado J</AU>
<TI>Trocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA</TI>
<SO>Journal of Minimally Invasive Gynaecology</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>4</NO>
<PG>302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADEproGDT-2015" MODIFIED="2015-08-26 10:29:25 +1200" MODIFIED_BY="[Empty name]" NAME="GRADEproGDT 2015" TYPE="COMPUTER_PROGRAM">
<TI>GRADEproGDT: GRADEpro Guideline Development Tool [www.guidelinedevelopment.org]</TI>
<YR>2015</YR>
<EN>01/06/2015</EN>
<PB>McMaster University (developed by Evidence Prime, Inc.)</PB>
<CY>Hamilton</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hasson-1971" MODIFIED="2015-02-06 08:10:36 +1300" MODIFIED_BY="[Empty name]" NAME="Hasson 1971" TYPE="JOURNAL_ARTICLE">
<AU>Hasson HM</AU>
<TI>A modified instrument and method for laparoscopy</TI>
<SO>American Journal of Obstetrics and Gynaecology</SO>
<YR>1971</YR>
<VL>110</VL>
<NO>6</NO>
<PG>886-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011a" MODIFIED="2015-08-15 16:20:47 +1200" MODIFIED_BY="[Empty name]" NAME="Higgins 2011a" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011b" MODIFIED="2015-08-19 13:41:50 +1200" MODIFIED_BY="[Empty name]" NAME="Higgins 2011b" TYPE="OTHER">
<AU>Higgins JPT, Deeks JJ, Altman DG (editors)</AU>
<TI>Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jansen-1997" MODIFIED="2015-08-19 13:42:47 +1200" MODIFIED_BY="[Empty name]" NAME="Jansen 1997" TYPE="JOURNAL_ARTICLE">
<AU>Jansen FW, Kapiteyn K, Trimbos-Kemper T, Hermans J, Trimbos JB.</AU>
<TI>Complications of laparoscopy: a prospective multicentre observational study</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>104</VL>
<NO>5</NO>
<PG>595-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jansen-2004" MODIFIED="2008-11-11 14:14:28 +1300" MODIFIED_BY="Julie A Brown" NAME="Jansen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Jansen FW, Kolkman W, Bakkum EA, de Kroon CD, Trimbos- Kemper TC, Trimbos JB</AU>
<TI>Complications of laparoscopy: an enquiry about closed versus open entry technique</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>190</VL>
<NO>3</NO>
<PG>634-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Krishnakumar-2009" MODIFIED="2015-08-19 13:43:13 +1200" MODIFIED_BY="[Empty name]" NAME="Krishnakumar 2009" TYPE="JOURNAL_ARTICLE">
<AU>Krishnakumar S, Tambe P</AU>
<TI>Entry complications in laparoscopic surgery</TI>
<SO>Journal of Gynaecological Endoscopy and Surgery</SO>
<YR>2009</YR>
<VL>1</VL>
<NO>1</NO>
<PG>4-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lalchandani-2005" MODIFIED="2015-08-19 13:43:25 +1200" MODIFIED_BY="[Empty name]" NAME="Lalchandani 2005" TYPE="JOURNAL_ARTICLE">
<AU>Lalchandani S, Philips K</AU>
<TI>Laparoscopic entry techniques - a survey of practices of consultant gynaecologists</TI>
<SO>Gynaecological Surgery</SO>
<YR>2005</YR>
<VL>2</VL>
<NO>4</NO>
<PG>245-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2015-08-19 14:41:06 +1200" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magrina-2002" MODIFIED="2015-02-06 08:16:39 +1300" MODIFIED_BY="[Empty name]" NAME="Magrina 2002" TYPE="JOURNAL_ARTICLE">
<AU>Magrina JF</AU>
<TI>Complications of laparoscopic surgery</TI>
<SO>Clinical Obstetrics and Gynaecology</SO>
<YR>2002</YR>
<VL>45</VL>
<NO>2</NO>
<PG>469-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Merlin-2003" MODIFIED="2012-01-11 14:17:08 +1300" MODIFIED_BY="Julie A Brown" NAME="Merlin 2003" TYPE="JOURNAL_ARTICLE">
<AU>Merlin TL, Hiller JE, Maddern GJ, Jamieson GG, Brown AR, Kolbe A</AU>
<TI>Systematic review of the safety and effectiveness of methods used to establish pneumoperitoneum in laparoscopic surgery</TI>
<SO>The British Journal of Surgery</SO>
<YR>2003</YR>
<VL>90</VL>
<PG>668-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Middlesbrough-Consensus-1999" MODIFIED="2015-08-19 14:06:00 +1200" MODIFIED_BY="[Empty name]" NAME="Middlesbrough Consensus 1999" TYPE="JOURNAL_ARTICLE">
<AU>Middlesbrough Consensus</AU>
<TI>A consensus document concerning laparoscopic entry techniques</TI>
<SO>Gynaecological Endoscopy</SO>
<YR>1999</YR>
<VL>8</VL>
<NO>6</NO>
<PG>403-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2009" MODIFIED="2015-08-19 14:08:13 +1200" MODIFIED_BY="[Empty name]" NAME="Moher 2009" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group</AU>
<TI>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</TI>
<SO>BMJ</SO>
<YR>2009</YR>
<VL>339</VL>
<PG>2535</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Molloy-2002" MODIFIED="2008-11-11 14:14:57 +1300" MODIFIED_BY="Julie A Brown" NAME="Molloy 2002" TYPE="JOURNAL_ARTICLE">
<AU>Molloy D, Kaloo PD, Cooper M, Nguyen TV</AU>
<TI>Laparoscopic entry: a literature review and analysis of techniques and complications of primary port entry</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>2002</YR>
<VL>42</VL>
<NO>3</NO>
<PG>246-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RCOG-2008" MODIFIED="2015-08-26 10:30:25 +1200" MODIFIED_BY="[Empty name]" NAME="RCOG 2008" TYPE="OTHER">
<AU>Royal College of Obstetricians and Gynaecologists</AU>
<TI>Preventing Entry-Related Gynaecological Laparoscopic Injuries (Green-top Guideline No. 49)</TI>
<SO>http://bsge.org.uk/userfiles/file/GtG%20no%2049%20Laparoscopic%20Injury%202008.pdf</SO>
<YR>2008. 23/12/2014</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-08-15 16:46:59 +1200" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Song-2013" MODIFIED="2015-08-19 14:17:17 +1200" MODIFIED_BY="[Empty name]" NAME="Song 2013" TYPE="JOURNAL_ARTICLE">
<AU>Song T, Kim ML, Jung YW, Yoon BS, Joo WD, Seong SJ</AU>
<TI>Laparoendoscopic single-site versus conventional laparoscopic gynaecologic surgery: a meta-analysis of randomized controlled trials</TI>
<SO>American Journal of Obstetrics and Gynaecology</SO>
<YR>2013</YR>
<VL>209</VL>
<NO>4</NO>
<PG>317</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Swank-2012" MODIFIED="2015-08-19 14:17:24 +1200" MODIFIED_BY="[Empty name]" NAME="Swank 2012" TYPE="JOURNAL_ARTICLE">
<AU>Swank HA</AU>
<TI>Systematic review of trocar-site hernia</TI>
<SO>British Journal of Surgery</SO>
<YR>2012</YR>
<VL>99</VL>
<NO>3</NO>
<PG>315-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vilos-2007" MODIFIED="2015-02-23 00:39:36 +1300" MODIFIED_BY="[Empty name]" NAME="Vilos 2007" TYPE="JOURNAL_ARTICLE">
<AU>Vilos GA, Ternamian A, Dempster J, Laberge PY</AU>
<TI>Laparoscopic entry: a review of techniques, technologies and complications</TI>
<SO>Journal of Obstetrics and Gynaecology Canada</SO>
<YR>2007</YR>
<VL>29</VL>
<NO>5</NO>
<PG>433-65</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-08-18 09:52:44 +1200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ahmad-2008" MODIFIED="2015-08-18 09:52:44 +1200" MODIFIED_BY="[Empty name]" NAME="Ahmad 2008" TYPE="COCHRANE_REVIEW">
<AU>Ahmad G, Duffy JMN, Phillips K, Watson A</AU>
<TI>Laparoscopic entry techniques</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2015-08-18 09:52:44 +1200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-18 09:52:35 +1200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006583"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ahmad-2012" MODIFIED="2015-08-18 09:48:42 +1200" MODIFIED_BY="[Empty name]" NAME="Ahmad 2012" TYPE="COCHRANE_REVIEW">
<AU>Ahmad G, O'Flynn H, Duffy JMN, Phillips K, Watson A</AU>
<TI>Laparoscopic entry techniques</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2015-08-18 09:48:42 +1200" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-18 09:48:35 +1200" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006583"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-08-26 11:06:33 +1200" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-08-26 11:06:33 +1200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-08-18 15:54:02 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agresta-2004">
<CHAR_METHODS MODIFIED="2015-08-18 15:24:06 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:24:28 +1200" MODIFIED_BY="[Empty name]">
<P>Non-obese paediatric and adult patients referred for urgent or scheduled laparoscopic and gynaecologic procedures. 275 in the direct trocar group and 323 in the Veress needle group. No patients lost to follow-up. Exclusion criteria based upon BMI &gt; 27, presence of massive bowel distension, and history of 2 or more abdominal operations. Power calculation made</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:24:56 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle (technique unclear) insertion versus direct trocar insertion (zero degree tilt on the table, umbilical incision, shielded trocars). No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. For the direct trocar insertion a 5 mm shielded trocar (dilating tip trocar, Endopath; Ethicon Endo-Surgery, Cincinnati, OH, USA) was used. Information on the Veress needle make was not supplied</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:25:06 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility and safety. Reported primary complications including mortality, visceral and solid organ injury and secondary complications including extraperitoneal insufflation, failed entry, and gas embolism</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:02 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Veneto, Italy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 15:54:06 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Akbar-2008">
<CHAR_METHODS MODIFIED="2015-08-18 15:28:20 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:28:28 +1200" MODIFIED_BY="[Empty name]">
<P>Patients with symptomatic gallstones with normal common bile duct scheduled for laparoscopic cholecystectomy were included. Exclusion criteria based upon patients with paraumbilical hernia, history of upper abdominal surgery and uncontrolled systemic illness</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:28:49 +1200" MODIFIED_BY="[Empty name]">
<P>In group A pneumoperitoneum was created by closed method (infra umbilical transverse incision, Veress needle) compared to open method in group B (supra umbilical incision). No cointervention. Standardised operative approach. Detailed information on the type and make of the trocars was not provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:28:58 +1200" MODIFIED_BY="[Empty name]">
<P>Assessing hospital stay, operating time and complications. Injury during induction, failure of technique and port site infection were reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:06 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at the Ayub Hospital Complex, Abbottabad</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:36:11 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Angioli-1-2013">
<CHAR_METHODS MODIFIED="2015-08-18 15:30:33 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with three arms. Patients presenting between February 2007 and May 2011, duration 4 years and 4 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:36:04 +1200" MODIFIED_BY="[Empty name]">
<P>656 participants assessed for eligibility. 57 patients did not meet inclusion criteria or refused to be randomised. 599 patients randomised. Inclusion criteria was non-obese adults (BMI &lt; 30 kg/m<SUP>2</SUP>) referred for scheduled laparoscopic gynaecological procedures for benign pathology. Exclusion criteria were previous abdominal surgery by laparoscopy or laparotomy, history of pelvic inflammatory disease, irritable bowel syndrome, suspicion of malignancy, or malignancy at the histological examination. Age of patients ranged from 18-70 years. There were 187 patients in the direct trocar entry group and 218 patients in the open-entry group. 3 patients from the open procedure group were excluded from analysis after randomisation because malignancy was found at histological examination</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:36:11 +1200" MODIFIED_BY="[Empty name]">
<P>Direct trocar entry versus open-entry. A sharp direct trocar was inserted at 90° through an infraumbilical skin incision aided by manual lifting of the abdominal wall by towel clips placed 3 cm on either side of the umbilicus. For the open-entry a 1 cm incision was made through the skin at the lower edge of the umbilical fossa followed by retraction of subcutaneous skin and adipose tissue with Zimmerman dissectors, incision of the anterior rectus fascia, incision of the peritoneum, and insertion of the trocar under direct vision. No information was provided on the make of the trocars</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:31:56 +1200" MODIFIED_BY="[Empty name]">
<P>Study was powered to detect the rate of minor complications (extraperitoneal insufflation, trocar site bleeding, omental injury, and surgical site infection). Failed entry and time of entry of the main trocar were evaluated. Major complications were also considered</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:11 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at University of Rome Campus Bio-Medico</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:36:23 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Angioli-2-2013">
<CHAR_METHODS MODIFIED="2015-08-18 15:33:13 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with three arms. Patients presenting between February 2007 and May 2011, duration 4 years and 4 months<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:36:19 +1200" MODIFIED_BY="[Empty name]">
<P>656 participants assessed for eligibility. 57 patients did not meet inclusion criteria or refused to be randomised. 599 patients randomised. Inclusion criteria was non-obese adults (BMI &lt; 30 kg/m<SUP>2</SUP>) referred for scheduled laparoscopic gynaecological procedures for benign pathology. Exclusion criteria were previous abdominal surgery by laparoscopy or laparotomy, history of pelvic inflammatory disease, irritable bowel syndrome, suspicion of malignancy, or malignancy at the histological examination. Age of patients ranged from 18-70 years. There were 194 patients in the Veress needle entry group and 218 patients in the open-entry group. 1 patient from the Veress needle group and 3 patients from the open procedure group were excluded from analysis after randomisation because malignancy was found at histological examination<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:36:23 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle entry versus open-entry. Veress needle was inserted at 45° at the level of the umbilicus to establish pneumoperitoneum, followed by insertion of the first transumbilical trocar in the saggital plane at an angle of 90° to the horizontal. For the open-entry a 1 cm incision was made through the skin at the lower edge of the umbilical fossa followed by retraction of subcutaneous skin and adipose tissue with Zimmerman dissectors, incision of the anterior rectus fascia, incision of the peritoneum, and insertion of the trocar under direct vision. No information was provided on the make of the trocars<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:35:21 +1200" MODIFIED_BY="[Empty name]">
<P>Study was powered to detect the rate of minor complications (extraperitoneal insufflation, trocar site bleeding, omental injury, and surgical site infection). Failed entry and time of entry of the main trocar were evaluated. Major complications were also considered<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:15 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at University of Rome Campus Bio-Medico<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:36:34 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Angioli-3-2013">
<CHAR_METHODS MODIFIED="2015-08-18 15:36:22 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with three arms. Patients presenting between February 2007 and May 2011, duration 4 years and 4 months<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:36:30 +1200" MODIFIED_BY="[Empty name]">
<P>656 participants assessed for eligibility. 57 patients did not meet inclusion criteria or refused to be randomised. 599 patients randomised. Inclusion criteria was non-obese adults (BMI &lt; 30 kg/m<SUP>2</SUP>) referred for scheduled laparoscopic gynaecological procedures for benign pathology. Exclusion criteria were previous abdominal surgery by laparoscopy or laparotomy, history of pelvic inflammatory disease, irritable bowel syndrome, suspicion of malignancy, or malignancy at the histological examination. Age of patients ranged from 18-70 years. There were 194 patients in the Veress needle entry group and 187 patients in the direct trocar entry group. 1 patient from the Veress needle group was excluded from analysis after randomisation because malignancy was found at histological examination<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:36:34 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle entry versus direct trocar entry. Veress needle was inserted at 45° at the level of the umbilicus to establish pneumoperitoneum, followed by insertion of the first transumbilical trocar in the saggital plane at an angle of 90° to the horizontal. Sharp direct trocar inserted at 90° through an infraumbilical skin incision aided by manual lifting of the abdominal wall by towel clips placed 3 cm on either side of the umbilicus. No information was provided on the make of the trocars<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:40:29 +1200" MODIFIED_BY="[Empty name]">
<P>Study was powered to detect the rate of minor complications (extraperitoneal insufflation, trocar site bleeding, omental injury, and surgical site infection). Failed entry and time of entry of the main trocar were evaluated. Major complications were also considered<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:21 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at University of Rome Campus Bio-Medico<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 15:54:28 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bemelman-1-2000">
<CHAR_METHODS MODIFIED="2015-08-18 15:41:10 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded, with three arms. Patients presenting between June and December 1999, duration 7 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:41:42 +1200" MODIFIED_BY="[Empty name]">
<P>62 patients eligible for laparoscopic surgery were enrolled in the study. Exclusion criteria was based upon age &lt; 18 years old, prior midline laparotomy or laparoscopy and body weight &lt; 40 kg. Exclusion criteria not based upon age, sex and procedures preformed. 20 participants in the Veress needle group, 20 in the Hasson trocar group and 20 in the Modified blunt trocar (TrocDoc) group. Two lost to follow-up. The TrocDoc trocar was derived from a sharp trocar (Storz, Tubingen, Germany)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:41:52 +1200" MODIFIED_BY="[Empty name]">
<P>Hasson trocars versus direct trocar. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:41:55 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility. Reported the patient mortality as an outcome</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:28 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Amsterdam, the Netherlands</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 15:47:11 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bemelman-2-2000">
<CHAR_METHODS MODIFIED="2015-08-18 15:42:43 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded, with three arms. Patients presenting between June and December 1999, duration 7 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:46:50 +1200" MODIFIED_BY="[Empty name]">
<P>Patients presenting between June and December 1999, 62 patients eligible for laparoscopic surgery were enrolled in the study. Exclusion criteria was based upon age &lt; 18 years old, prior midline laparotomy or laparoscopy and body weight &lt; 40 kg. Exclusion criteria not based upon age, sex and procedures preformed</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:47:09 +1200" MODIFIED_BY="[Empty name]">
<P>Hasson trocars (inserted through semi-circular subumbilical incision and abdominal fascia was incised between the sutures) versus Veress needle (Semi-circular subumbilical incision, needle inserted vertically to the incision and pneumoperitoneum achieved at intra-abdominal pressure of 15 mmHg before placement of needle). No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:47:11 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing Technical feasibility. Reported the patient mortality as an outcome</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 15:48:13 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bemelman-3-2000">
<CHAR_METHODS MODIFIED="2015-08-18 15:47:52 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded, with three arms. Patients presenting between June and December 1999, duration 7 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:48:00 +1200" MODIFIED_BY="[Empty name]">
<P>Patients presenting between June and December 1999, 62 patients eligible for laparoscopic surgery were enrolled in the study. Exclusion criteria was based upon age &lt; 18 years old, prior midline laparotomy or laparoscopy and body weight &lt; 40 kg. Exclusion criteria not based upon age, sex and procedures performed</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:48:08 +1200" MODIFIED_BY="[Empty name]">
<P>Direct trocar versus Veress needle. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:48:13 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility. Reported the patient mortality as an outcome</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 15:54:35 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhoyrul-2000">
<CHAR_METHODS MODIFIED="2015-08-18 15:48:36 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was double-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:48:50 +1200" MODIFIED_BY="[Empty name]">
<P>All adult patients under the care of the 16 participating laparoscopic general surgeons. Exclusion criteria based upon acute inflammatory conditions and conversion to laparotomy not due to an entry complication. Exclusion criteria was not base upon age, sex or type of procedure. 119 participants in the radially expanding (STEP) trocar group and 125 in the Veress needle group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:48:53 +1200" MODIFIED_BY="[Empty name]">
<P>Radially expanding (STEP) (technique unclear) trocars versus standard trocars (technique unclear). No cointervention. Standardised operative technique was deployed by all operators</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:49:02 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing safety. Reported primary complications including vascular, visceral and solid organ injury and secondary complications including incisional hernias and wound site bleeding. The control group used cutting trocars made by US Surgical Corp., Norwalk, Conn. Ethicon Endo-surgery, Cincinnati, Ohio. Origin Inc., Sunnyvale, CA. The STEP Group used radially expanding trocars produced by InnerDyne, Inc., Sunnyvale, CA</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:35 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at San Francisco, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:37:31 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bisgaard-2007">
<CHAR_METHODS MODIFIED="2015-08-18 15:50:14 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:52:24 +1200" MODIFIED_BY="[Empty name]">
<P>Participants undergoing elective cholecystectomy were enrolled within the study. "The criteria of exclusion specified ASA physical class 4, age younger than 18 and older than 75 years, and pregnancy. Patients with postoperative complications were included in the analysis. Patients were not invited to participate in the study if they had chronic pain diseases other than gallstone disease, if they received opioids or tranquillizers (treatment for more than 1 week before laparoscopic cholecystectomy), if they spoke a foreign language, if they had a mental disorder, or if they had a history of alcohol or drug abuse. Patients were excluded from the study (study data were not collected) if the operation was converted from a laparoscopic to an open procedure.&#8221; 39 participants in cutting group and 38 in radial group. Three participants excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:52:48 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic cholecystectomy was performed using two 10 mm and two 5 mm trocars. In the radially expanding group (radial group), the four trocars comprised the VersaStep system (Auto Suture, Radially Expanding Access [REA] system; Tyco Healthcare, Copenhagen), and in the conventional cutting group (cutting group), the four trocars were cutting bladed trocars (Endopath II; Ethicon Endosurgery, Inc., Cincinnati). Standardised general anaesthesia and analgesia. Standardised operative technique performed or supervised by experienced surgeons</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-26 10:37:31 +1200" MODIFIED_BY="[Empty name]">
<P>Primary outcome of study was incisional pain, pain 6 hours after the operation and postoperative pain on days 1 and 2. Secondary outcomes included need for fascial incision, active surgical haemostasis, supplementary need for opioids, moderate or severe nausea and bruising at trocar site</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:53:33 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at university hospital, Denmark</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:42:02 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borgatta-1990">
<CHAR_METHODS MODIFIED="2015-08-18 15:57:55 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 12:42:02 +1200" MODIFIED_BY="[Empty name]">
<P>Women undergoing elective laparoscopic sterilisation under general anaesthetic at an out-of-hospital surgical unit. Exclusion criteria not stated. Exclusion was not made on the basis of previous abdominal surgery (including Caesarean section), presence of intra-abdominal adhesions, age, weight, height and parity. 110 in the Veress needle group and 102 in the direct trocar group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:58:10 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle insertion (technique unclear) versus direct trocar insertion (technique unclear). No cointervention. Information on the type and make of the trocars was not accessible</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:58:17 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility and complications. Reported secondary complications including extraperitoneal insufflation, omentum injury and wound site infection, and failed entry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:58:19 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at New York, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 15:59:10 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Briel-2000">
<CHAR_METHODS MODIFIED="2015-08-18 15:58:43 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 15:58:51 +1200" MODIFIED_BY="[Empty name]">
<P>150 consecutive patients scheduled for laparoscopy. Exclusion criteria based upon previous abdominal surgery and obesity (BMI &gt; 40). Exclusion not based upon age or sex. 75 in the lifting group and 75 in the non-lifting group. None lost to follow-up<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:59:07 +1200" MODIFIED_BY="[Empty name]">
<P>Lifting of the abdominal wall before Veress needle insertion (abdominal wall lifted using two hands, the decision to reinsert the needle was made when the insufflation pressure was more than 10 mmHg) versus non-lifting (technique unclear). No cointervention. Trocar make and model were not stated in the paper</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:59:10 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility and safety. Reported secondary complications including extraperitoneal insufflation and failed entry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:54:46 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Rotterdam, the Netherlands</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:42:11 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Byron-1993">
<CHAR_METHODS MODIFIED="2015-08-18 15:59:30 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded between September 1988 and June 1989. 10 months duration</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 12:42:11 +1200" MODIFIED_BY="[Empty name]">
<P>Patients presenting between September 1988 and June 1989. 11 in the direct trocar group and 275 in the Veress needle group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 15:59:43 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle insertion versus direct trocar insertion. No cointervention. No standardised operative technique or training stated. Information on the type and the make of the trocars was not accessible</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 15:59:45 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility and complications. Reported secondary complications including extraperitoneal insufflation and also failed entry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:59:46 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Washington, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:40:30 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carter-2013">
<CHAR_METHODS MODIFIED="2015-08-18 16:00:15 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two study arms running from May 2010 to November 2012. 2 years and 7 months duration</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:39:53 +1200" MODIFIED_BY="[Empty name]">
<P>Participants consisted of patients who presented to the emergency department and were diagnosed with acute appendicitis on the basis of clinical and radiographic evaluation. The exclusion criteria were: phlegmon, mass, peri-appendicecal abscess, or diffuse peritonitis; earlier open laparotomy with incision through the umbilicus; BMI &gt; 35 kg/m<SUP>2</SUP>; age &lt; 18 years; mental illness, dementia, or inability to provide informed consent; chronic pain requiring daily medication; chronic opiate use; pregnancy; prisoners; alternative diagnosis found by diagnostic laparoscopy (postrandomisation). 75 patients were randomised - 37 patients in the single incision laparoscopic surgery (SILS) appendectomy group and 38 patients in the 3-port appendectomy group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:40:17 +1200" MODIFIED_BY="[Empty name]">
<P>SILS appendectomy vs conventional 3-port laparoscopic appendectomy. For SILS, the base of the umbilical stalk was everted and an incision was made within the stalk. The fascia was then retracted and incised. The peritoneum was entered with a gloved finger, Kelly clamp, or scissors. A SILS device (SILS Port; Covidien) was then inserted as the incision was retracted anteriorly. 5 mm trocars were placed and the abdomen was insufflated followed by diagnostic laparoscopy and appendectomy if indicated. For 3-port laparoscopy, an incision was made in the umbilical stalk, the fascia was retracted and incised, and a 12 mm Hasson port was placed through the fascia into the abdomen. The abdomen was inflated and diagnostic laparoscopy was performed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:02:11 +1200" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: mean pain score during the first 12 hours, hydromorphone use during the first 12 hours. Secondary outcomes: length of stay, wound infection, deep space infection, wound seroma, return to work, date of last opiate pain medication use, readmission within 30 days, body image score at 6 months, cosmetic appearance scale at 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-26 10:40:30 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at the department of surgery, University of California, San Francisco. The study was stopped after the first 75 patients because the SILS technique showed inferiority to the conventional 3-port technique in the primary outcome: postoperative pain</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 15:58:40 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Channa-2009">
<CHAR_METHODS MODIFIED="2015-08-18 16:03:12 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial of 12 months duration, running from January to December 2007. The trial had two study arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 15:58:40 +1200" MODIFIED_BY="[Empty name]">
<P>Patient requiring laparoscopic cholecystectomy. Exclusion criteria included patients &lt; 20 years old or &gt; 65 years old and those with comorbid conditions of chronic liver disease, chronic renal failure, and malignancy. 120 patients in total with 60 patients randomised to each study arm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:03:31 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic cholecystectomy with Hasson cannula or Veress needle entry. Details of the operative technique used were not included in the text. No mention of a standardised operative technique. Details of the type and make of the trocars were not included in the paper</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:03:43 +1200" MODIFIED_BY="[Empty name]">
<P>Outcomes under investigation were access time, minor complications (gas leak, extra-peritoneal insufflation, port-site haematoma, port-site wound infection, port-site hernia), and major complications (visceral injury, vascular injury, need for conversion, mortality). No power calculation was mentioned in the text</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:03:45 +1200" MODIFIED_BY="[Empty name]">
<P>Study was a single-centre study at the Jinnah Postgraduate Medical Centre (JPMC), Karachi</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:04:51 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cogliandolo-1998">
<CHAR_METHODS MODIFIED="2015-08-18 16:04:21 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:04:27 +1200" MODIFIED_BY="[Empty name]">
<P>150 patients, aged 16 to 77, undergoing laparoscopic cholecystectomy. Inclusion or exclusion criteria unspecified. 75 in the blind (Veress needle) group and 75 in the open trocar (Hasson trocar) group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:04:45 +1200" MODIFIED_BY="[Empty name]">
<P>Open (Veress needle) entry technique versus closed (Hasson trocar) entry technique. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. The technique of pneumoperitoneum has not been specified, in terms of the use of pressure or volume of gas for Veress needle entry. Standard Hasson trocar entry. Information on the type and make of the tocars was not included in the text</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:04:48 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility and complications. Reported primary complications including vascular and visceral injury and secondary complications including extraperitoneal insufflation and wound site bleeding and infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:04:51 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Messina, Italy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:23:41 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cravello-1999">
<CHAR_METHODS MODIFIED="2015-08-18 16:05:18 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:08:18 +1200" MODIFIED_BY="[Empty name]">
<P>All patients, who were seen either on an outpatient basis or an emergency basis, presented with an indication for laparoscopic surgery, were given the option to be included in the trial. Patients with intra-abdominal malignancy were excluded. 103 in insufflation with carbon dioxide gas group and. 51 in gasless abdominal wall retractor group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 12:23:41 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic surgery using insufflation of carbon dioxide gas versus a gasless abdominal wall retractor. No cointervention. Standardised operative technique was deployed by all operators. The trocars used were customised 10-12 mm long trocars equipped with balloons - blunt tip trocar, Origin Medsystems</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:05:41 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility and complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:55:12 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at Hospital de la Conception, Marseille, France</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:42:34 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deveci-2013">
<CHAR_METHODS MODIFIED="2015-08-18 16:06:29 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two study arms. Patients were recruited between January 2010 and January 2012. Duration 2 years and 1 month</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:42:01 +1200" MODIFIED_BY="[Empty name]">
<P>Patients with gallbladder disease requiring laparoscopic cholecystectomy. Exclusion criteria were: ASA score of &gt; III; patients with prior abdominal surgery; patients with choledocolithiasis and/or abnormal cholestasis enzyme values; pregnancy; ongoing peritoneal dialysis; presence of pancreatitis. 100 patients were randomised, with 50 patients undergoing single incision laparoscopic surgery (SILS) cholecystectomy and 50 patients receiving three-port conventional laparoscopic cholecystectomy (3PLC)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:42:34 +1200" MODIFIED_BY="[Empty name]">
<P>SILS cholecystectomy vs 3PLC. For SILS, a vertical incision was made through the skin and fascia of the umbilicus to allow passage of the SILS port (Covidien Inc, Norwalk, CT, USA) and cholecystectomy. In 3PLC, pneumoperitoneum was created with a Veress needle, followed by 10 mm trocar placement in the umbilicus and midepigastrium, and 5 mm trocar placement in the right upper abdomen. Cholecystectomy is then performed in the standard fashion</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:13:56 +1200" MODIFIED_BY="[Empty name]">
<P>Operating time, blood loss, success rate, conversion to open surgery, conversion to four port laparoscopy, complications (bile leakage, wound infection, hospital readmission, hernia), postoperative pain at six hours, postoperative pain at one day, tramadol use, duration of hospital stay, cosmetic satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:13:59 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study, Department of surgery, Maltepe University school of Medicine, Istanbul, Turkey</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:14:47 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feste-2000">
<CHAR_METHODS MODIFIED="2015-08-18 16:14:26 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:14:35 +1200" MODIFIED_BY="[Empty name]">
<P>Various operative and diagnostic laparoscopic procedure were performed by seven different surgeons on 87 consecutive women. Exclusion criteria not stated. Exclusion was not based upon age and weight. There was a significant difference in weight favouring the STEP trocar group (higher). 45 in the Radially expanding (STEP) trocar group and 42 in the Veress needle group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:14:44 +1200" MODIFIED_BY="[Empty name]">
<P>Radially expanding (STEP) trocars (technique not stated) versus standard trocars (technique not stated). No cointervention. The STEO device consisted of an access-insufflation needle, a radially expandable biocompatible polymeric sleeve, and a tapered blunt dilator/cannula. There was no specific information provided on the cutting trocars</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:14:46 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing safety. Reported primary complications including vascular and visceral injury</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:14:47 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre at Greifswald, Germany , Houston, USA, and Santa Barbara, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:45:03 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fonollosa-2012">
<CHAR_METHODS MODIFIED="2015-08-18 16:15:42 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms. Patients were recruited between October 2009 and June 2011, duration 1 and year 9 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:43:53 +1200" MODIFIED_BY="[Empty name]">
<P>A total of 50 patients were enrolled in the study, 26 into the single incision laparoscopic surgery (SILS) cholecystectomy group, and 24 into the 4 port laparoscopic cholecystectomy group (4PLC). Patients were included in the study if they suffered symptomatic cholelithiasis confirmed on ultrasonography. Exclusion criteria were: obesity (BMI &gt; 35), hepatitis, alcoholism, pregnancy, acute pancreatitis, cholecystitis, choledocholithiasis, previous surgery in the upper abdomen, prior ERCP</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:45:03 +1200" MODIFIED_BY="[Empty name]">
<P>SILS cholecystectomy verus 4-port laparoscopic cholecystectomy group (4PLC). For SILS an infraumbilical transverse incision is made, followed by dissection of subcutaneous tissue and the anterior rectus fascia, entry into the peritoneal cavity, and introduction of the SILS port (Covidien). 4PLC was performed by standard technique with the patient in the French position</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:18:49 +1200" MODIFIED_BY="[Empty name]">
<P>Operative time, morbidity, conversion between surgical approaches, failure of entry, reoperation, postoperative pain, postoperative analgesic requirement and postoperative nausea and vomiting</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:18:51 +1200" MODIFIED_BY="[Empty name]">
<P>The study was a single-centre trial at University Hospital Mutua de Terressa, University of Barcelona</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:19:50 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghezzi-2005">
<CHAR_METHODS MODIFIED="2015-08-18 16:19:13 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded from March 2004 and October 2004. 8 months duration. Both ports were inserted in the same patient with the side inserted randomised</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:19:29 +1200" MODIFIED_BY="[Empty name]">
<P>Consecutive patients undergoing operative laparoscopy because of a suspected benign adnexal mass at a university hospital from March 2004 through October 2004 were enrolled in the study. Patients with intra-abdominal malignancy were excluded. 50 participants in the 3 mm trocar group and 52 in the 5 mm trocar group for secondary port entry. No patients lost to follow-up. No further information was provided on the type and make of the trocars used</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:19:46 +1200" MODIFIED_BY="[Empty name]">
<P>5 mm trocars compared with 5 mm trocar group for secondary port entry. No cointervention. Standardised operative technique was reported</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:19:48 +1200" MODIFIED_BY="[Empty name]">
<P>Trocar site bleeding</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:19:50 +1200" MODIFIED_BY="[Empty name]">
<P>single-centre trial at the department of Obstetrics and Gynaecology, University of Insubria</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:21:13 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gunenc-2005">
<CHAR_METHODS MODIFIED="2015-08-18 16:20:29 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:20:36 +1200" MODIFIED_BY="[Empty name]">
<P>Both inclusion and exclusion criteria were not stated. Authors written to for clarification. 277participants in the direct trocar group and 301 in the Veress needle group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:21:05 +1200" MODIFIED_BY="[Empty name]">
<P>Direct trocar (elevation of rectus sheath &amp; 12-13 mm transfers subumbilical incision was made through the sheath and the sheath was grasped and elevated using two towel clips) versus Veress needle (10 mm transverse umbilical incision, needle inserted pointing towards the uterus and 10-15 mmHg intra-abdominal pressure used as a guide to place the primary trocar). No cointervention. Standardised operative technique was deployed by all operators. Direct entry was conducted with a 10 mm disposable shielded trocar. There was no further information on the type or make of the trocars</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:21:08 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing complication rates. Reported secondary complications including extraperitoneal insufflation and failed entry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:21:13 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Ankara, Turkey</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:22:39 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hamade-2007">
<CHAR_METHODS MODIFIED="2015-08-18 16:21:32 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial, which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:21:41 +1200" MODIFIED_BY="[Empty name]">
<P>Adults undergoing elective laparoscopic surgery; aged 16-80 years. No other exclusion criteria stated. 15 participants in cutting trocar group and 15 participants in the blunt trocar group. No loss to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:22:02 +1200" MODIFIED_BY="[Empty name]">
<P>Primary port insertion was accomplished using direct a blunt-tipped trocar at a site other than the umbilicus and without prior peritoneal insufflation as we have previously described. Secondary port insertion was then accomplished under direct laparoscopic vision using either a reusable cutting metal trocar (Mantis Surgical Limited, Newbury, Berkshire, UK), which had three sharp fixed blades, or a reusable blunt-tipped metal trocar (Mantis SurgicalLimited), which had a conical blunt tip. No cointervention. Standardised operative technique</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:22:36 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Port stability and traction forces required at beginning and at completion of surgery. Number of ports dislodged spontaneously and abdominal wall bleeding at trocar site</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:22:39 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at Manchester Royal Infirmary, UK</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 16:00:45 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2012">
<CHAR_METHODS MODIFIED="2015-08-18 16:24:51 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms. Patients presenting between October 2009 and May 2011, duration 1 year and 8 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 16:00:26 +1200" MODIFIED_BY="[Empty name]">
<P>91 consecutive patients undergoing elective laparoscopic cholecystectomy for gallbladder disease were included in the study. Inclusion criteria were 18-85 years old with normal basic hepatic function tests. Exclusion criteria were pregnancy, immunosuppressive drug therapy within the previous 6 months, immunosuppressive condition including acquired immunodeficiency syndrome, autoimmune disorders, organ transplantation, radiation therapy, or chemotherapy, within the previous 6 months, insulin dependent diabetes mellitus. There were 47 patients in the control (bladed trocar) group and 44 patients in the bladeless trocar group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 16:00:45 +1200" MODIFIED_BY="[Empty name]">
<P>Control (bladed trocar) versus bladeless trocar. All of the 91 patients received general anesthesia with the same protocol by one of the authors (Lin CC, anaesthesiologist). Laparoscopic cholecystectomy with four ports was conducted for all patients, including two 12 mm trocars and two 5 mm trocars. In the bladeless group, the two 12 mm trocars were bladeless (Ethicon, Endo-surgery, Cincinnati, Ohio, USA), whereas in the control group the 12 mm trocars were bladed (179771P-12 mm, Covidien). The same 5 mm trocars were applied in both groups (301601TP 5-6 mm diameter, Karl Storz). Patients in both groups received 1.0% ropivacaine 20 ml at port sites after wound closure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:26:38 +1200" MODIFIED_BY="[Empty name]">
<P>Level of pain using the Visual Anaolgue Scale at 1 hour, 6 hours, 24 hours postprocedure and at the time of discharge, and analgesia use (meperidine and acetaminophen) 1, 6, and 24 hours postprocedure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 15:55:40 +1200" MODIFIED_BY="[Empty name]">
<P>single-centre study at the Department of Surgery, Chang Gung Memorial Hospital, Taiwan</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 16:01:12 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Imran-2014">
<CHAR_METHODS MODIFIED="2015-08-18 16:26:58 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms. Patients recruited from August 2012 to July 2014; duration 2 years</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 16:01:05 +1200" MODIFIED_BY="[Empty name]">
<P>Patients admitted to the Surgical ward for laparoscopic cholecystectomy were screened for enrolment. Exclusion criteria: patients &lt; 20 or &gt; 65 years of age, coexisting chronic liver disease, chronic renal failure, or malignancy. 30 patients were randomised to the direct trocar entry group and 30 patients were randomised to the Veress needle entry group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:27:16 +1200" MODIFIED_BY="[Empty name]">
<P>Direct trocar entry versus Veress needle entry for laparoscopic cholecystectomy. Description of the techniques used is not included in the text. No information on the type and make of trocars is included in the text</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-19 16:01:12 +1200" MODIFIED_BY="[Empty name]">
<P>Access time, gas leak, extra-peritoneal insufflation, vascular injury, visceral injury, port-site haematoma, port-site infection, port-site hernia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:27:26 +1200" MODIFIED_BY="[Empty name]">
<P>The study was single-centre at Akhtar Saeed Trust Teaching Hospital, Lahore</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:46:34 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Johnson-1997">
<CHAR_METHODS MODIFIED="2015-08-18 16:31:15 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:46:34 +1200" MODIFIED_BY="[Empty name]">
<P>Women presenting for sterilisation and over the age of 21. Exclusion criteria was based upon weight (more than 100% of their ideal body weight). Exclusion was not based upon weight, height and prior abdominal or pelvic surgery. 10 patients were assigned to the gasless laparoscopy group, while 8 were assigned to the CO<SUP>
<SUB>2</SUB>
</SUP>
 laparoscopy group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:31:47 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic surgery using insufflation of carbon dioxide gas (technique unclear) versus a gasless abdominal wall retractor (technique unclear). No cointervention. Standardised operative training in both interventions especially for the study. Unable to access information on the type and make of the trocars</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:32:04 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility, ventilatory parameters, haemodynamic stability, and postoperative pain and nausea. Did not report any outcome measures. Authors have been written to. Outcome measures reported included ease of operative technique and patient pain and nausea</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:32:13 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at North Carolina, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 16:01:23 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karaca-2014">
<CHAR_METHODS MODIFIED="2015-08-19 12:39:06 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms. Patients presenting between January 2007 and July 2009, duration 2 years and 7 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 12:39:30 +1200" MODIFIED_BY="[Empty name]">
<P>400 patients undergoing laparoscopic cholecystectomy. Exclusion criteria was patients who had undergone previous abdominal surgery. 200 people were in the Veress needle entry group and 200 patients were in the direct trocar entry group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 12:39:45 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle entry versus direct trocar entry. Veress needle (Tyco or Ethicon) was inserted through a subumbilical incision to establish pneumoperitoneum. Direct trocar (Tyco or Ethicon) was inserted into the peritoneal cavity after a 10 mm subumbilical incision was made; entry was aided by lifting of the abdominal wall using towel clamps</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-19 16:01:23 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: assessing complication rates. Major complications requiring open surgery (mesenteric laceration, bleeding, organ perforation, solid organ injury, blood vessel injuries) and minor complications (subcutaneous emphysema, phison, and extraperitoneal insufflation)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-19 12:22:00 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at the Bartin National Hospital, Turkey</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:33:30 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kitano-1993">
<CHAR_METHODS MODIFIED="2015-08-18 16:32:52 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded from April to August 1991. Study duration of 5 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:33:09 +1200" MODIFIED_BY="[Empty name]">
<P>Patients referred for treatment of gallstones from April to Aug, 1991. Exclusion criteria was based upon previous abdominal surgery, concomitant common bile duct stones and gall bladder cancer. Exclusion was not based upon age and sex. 82 in the pneumoperitoneum group and 41 in the U-shaped retractor elevation group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:33:24 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic surgery using insufflation of carbon dioxide gas (technique unclear) versus a gasless abdominal wall retractor (technique unclear). No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. Information on the type and make of the trocar was not provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:33:27 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility. Reported primary complications including vascular and solid organ injury and secondary complications including extraperitoneal insufflation and wound infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:33:30 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre at Kitakyushu, Japan and Fukuoka, Japan</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:48:21 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lai-2011">
<CHAR_METHODS MODIFIED="2014-11-17 03:58:39 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:47:29 +1200" MODIFIED_BY="[Empty name]">
<P>Patients from 18 to 80 years of age, with preoperative diagnosis of symptomatic gallstones or gallbladder polyps, requiring elective cholecystectomy were invited to participate in the study. The exclusion criteria were patients with: ASA class IV and V; contraindications for laparoscopy; Mirizzi syndrome; suspected presence of common bile duct stones; suspected malignancy; previous upper abdominal surgery; long-term anticoagulation; previous history of cholangitis or cholecystitis; large gallstone &gt; 3cm; imaging diagnosis of contracted gallbladder or chronic cholecystitis. 27 patients were randomised to both the single incision laparoscopic surgery (SILS) cholecystectomy group and the conventional 4-port laparoscopic cholecystectomy group (4PLC).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:48:21 +1200" MODIFIED_BY="[Empty name]">
<P>SILS cholecystectomy vs 4PLC. For SILS cholecystectomy, a 20 mm umbilical incision was made by open technique through which the SILS Port (Covidien Inc, Norwalk, CT) was inserted. Pneumoperitoneum was generated, laparoscopic instruments were inserted into the peritoneal cavity, and cholecystectomy was performed. In conventional 4PLC, a subumbilical incision was made and the abdominal cavity was insufflated. Once pneumoperitoneum was established, a laparoscope was inserted through the subumbilical incision and three 5 mm trocars were inserted in the right subcostal region under direct vision. Surgical techniques were standardised among participating surgeons before starting the protocol</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:36:51 +1200" MODIFIED_BY="[Empty name]">
<P>The primary outcome was pain score at 6 hours after surgery and 7 days after surgery. Secondary outcomes were open conversion rate, complications, mortality, length of hospital stay, interval for resumption of normal physical activities, and cosmetic satisfaction of surgical scar</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:36:55 +1200" MODIFIED_BY="[Empty name]">
<P>Study was single-centre at the Department of Surgery, Pamela Youde Nethersole Eastern Hospital in Hong Kong</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 16:38:48 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lam-2000">
<CHAR_METHODS MODIFIED="2015-08-18 16:38:14 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 16:38:29 +1200" MODIFIED_BY="[Empty name]">
<P>Patients over the age of 18 and likely to benefit from laparoscopic cholecystectomy. Exclusion criteria was based upon the presence of inflammatory conditions and malignancy. 30 in the radially expanding (STEP) trocar group and 31 in the standard trocar group. Seven lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 16:38:41 +1200" MODIFIED_BY="[Empty name]">
<P>Radially expanding (STEP) 10 mm trocars versus standard metal 10 mm trocars for secondary port entry. No cointervention. No further information provided on type or make of trocars</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 16:38:45 +1200" MODIFIED_BY="[Empty name]">
<P>Major complications (specific complications not stated). Trocar site bleeding and wound infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 16:38:48 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at the Department of Surgery, United Christian hospital, Hong Kong</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:51:01 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luna-2013">
<CHAR_METHODS MODIFIED="2015-08-18 16:39:17 +1200" MODIFIED_BY="[Empty name]">
<P>Prospective randomised controlled trial with two study arms. Patients were recruited between January 2010 and December 2010 (duration 12 months)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:49:53 +1200" MODIFIED_BY="[Empty name]">
<P>Patients were invited to take part in the study if they had symptomatic cholelithiasis, diagnosed clinically and confirmed by abdominal ultrasound. Exclusion criteria: BMI &gt; 36 kg/m<SUP>2</SUP>. 40 patients were enrolled in the study: 20 patients into the single incision laparoscopic surgery (SILS) cholecystectomy group and 20 patients into the four-port laparoscopic cholecystectomy (4PLC) group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:50:41 +1200" MODIFIED_BY="[Empty name]">
<P>SILS cholecystectomy vs 4PLC. For SILSC a SITRACC device (EDLO, Rio Grande do Sul, Brazil), containing one 10 mm and three 5 mm working ports, was used. The SILS cholecystectomy intervention was not described in the text. 4PLC was done with conventional technique</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-26 10:51:01 +1200" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: IL-6 levels, c-reactive protein, and postoperative pain. Surgical site infection and the need for extra ports in the SILS group were also recorded</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:44:48 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at the division of general surgery, Federal Hospital of Servidores do Estado, Rio de Janero, Brazil</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 17:45:36 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mettle-2000">
<CHAR_METHODS MODIFIED="2015-08-18 17:45:07 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 17:45:15 +1200" MODIFIED_BY="[Empty name]">
<P>Three surgeons at 2 centres enrolled 100 patients undergoing elective laparoscopic gynaecological surgical procedures. Exclusion criteria was based upon acute inflammatory conditions. 49 participants in the Radially expanding (STEP) trocar group and 51 in the Veress needle group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 17:45:31 +1200" MODIFIED_BY="[Empty name]">
<P>Radially expanding (STEP) trocars (technique not stated) versus standard trocars (technique not stated). No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. The control device, the conventional trocar, was nondisposable, with either a sharp, cutting stylet or a blunt obturator. The STEP device consists of an access-insufflation needle, a radially-expandable polymeric sleeve and a tapered blunt dilator/cannula. No further information was provided on the trocars</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:45:33 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing complications. Reported primary complications including vascular and visceral injury and secondary complications including failed entry and wound bleeding</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:45:36 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre at Kiel, Germany and Victoria, Australia</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:27:10 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Minervini-2008">
<CHAR_METHODS MODIFIED="2015-08-18 17:46:02 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 17:46:15 +1200" MODIFIED_BY="[Empty name]">
<P>Patients admitted for transperitoneal laparoscopic procedures for renal pathology were included. No exclusion criteria. 27 participants in the open group and 33 to the bladeless group. No loss to follow-up stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 12:27:10 +1200" MODIFIED_BY="[Empty name]">
<P>Hasson trocar inserted by standard technique versus a 12 mm bladeless trocar (Ethicon Endosurgery, Cincinnati, OH). No cointervention. Standardised surgical technique deployed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:46:24 +1200" MODIFIED_BY="[Empty name]">
<P>Mean time to closure; failed entry, gas leak, intra-abdominal injury and port site herniation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:46:27 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at University of Florence, Italy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:36:28 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ostrzenski-1999">
<CHAR_METHODS MODIFIED="2015-08-19 12:35:36 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded between January 1992 and January 1995. Study duration 3 years</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 12:35:52 +1200" MODIFIED_BY="[Empty name]">
<P>Patients were recruited between Jan 1992 and Jan 1995. Elective diagnostic and/or operative laparoscopic cases were included. Exclusion criteria included previous abdominal surgery, abdominal or pelvic adhesions, severe endometriosis, fistulae formation, IBS, diaphragmatic herniae, cardiopulmonary disease and abdopelvic organ enlargement. Exclusion was not based upon age and BMI. 50 participants in the closed technique group and 50 in the parallel technique group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 12:36:19 +1200" MODIFIED_BY="[Empty name]">
<P>Closed (technique unclear) versus Parallel (Trenedenburg position, incision made at the lower end of the umbilicus, no abdominal wall elevation and Veress needle was advanced through the abdominal wall aiming towards the sacral hallow) technique of Veress needle insertion. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative techniques was deployed by all operators. A 20 cm Veress needle was used in patients &lt; 81kg and a 50 cm Veress needle was used in patients in &gt; 81kg. No further information was provided on Veress needle or trocar make<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-19 12:36:23 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing safety and efficacy. Reported primary complications including vascular and visceral injury and secondary complications including extraperitoneal insufflation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-19 12:36:28 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Washington, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 16:02:30 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peitgen-1997">
<CHAR_METHODS MODIFIED="2015-08-18 17:47:38 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two study arms. Study ran from July to November 1996, duration 5 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 17:47:52 +1200" MODIFIED_BY="[Empty name]">
<P>Adult patients aged 21-89 years requiring laparoscopic interventions (18 cholecystectomy; 12 staging-laparoscopy; 9 gastrostomy; 6 splenectomy; 2 liver cyst; 1 double cholecyst/splenectomy; 1 colostomy deviation; 1 explorative). 14 patients were excluded because of previous abdominal surgery. No other exclusion criteria were stated. 24 patients were randomised to the Veress needle entry group, and 26 were randomised to the open laparoscopic entry group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 16:02:30 +1200" MODIFIED_BY="[Empty name]">
<P>Veress needle entry vs open laparoscopic entry. For Veress needle entry, a 1 cm subumbilical transverse incision was made followed by Veress needle entry and insufflation of the peritoneum. In open-entry a subumbilical 1-1.5 cm incision was made down to through the linea alba and the peritoneum was incised with Lang scissors followed by insufflation. No further information was provided on Veress needle or trocar model or make</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:48:19 +1200" MODIFIED_BY="[Empty name]">
<P>Time from incision to introduction of the laparoscope, total operation time, gas use, subjective reporting of gas leakage at first injection site, number of attempts to insert Veress needle or trocar, complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:48:24 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at Essen, Germany</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:53:32 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez-2013">
<CHAR_METHODS MODIFIED="2015-08-18 17:48:51 +1200" MODIFIED_BY="[Empty name]">
<P>Single-blind randomised control trial with two treatment arms, running from June 2009 to January 2011, duration 1 year and 8 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:52:47 +1200" MODIFIED_BY="[Empty name]">
<P>Children presenting with a diagnosis of appendicitis. Age range to be considered a child not included in the text. Exclusion criteria not included in the text. 50 patients were enrolled in the study, 25 to the single incision laparoscopic surgery (SILS) appendectomy group and 25 to the standard three port laparoscopic appendectomy (3PLA) group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:53:32 +1200" MODIFIED_BY="[Empty name]">
<P>SILS appendectomy versus 3PLA. For SILS a single supraumbilical incision was made, subcutaneous tissue was removed, three 5 mm fascial incision were produced, and ports were inserted into the peritoneal cavity (5 mm 30<SUP>o</SUP> laparoscope through the middle port, and a 5 mm dissector and 5 mm grasper through the lateral ports). The appendix was then dissected free. The LAPA procedures were performed in standard three-port fashion with three separate skin incisions. Details of the laparoscopic instruments used are not included in the text. No further information was provided on trocar make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:50:24 +1200" MODIFIED_BY="[Empty name]">
<P>Operative time, operative conversions, analgesic usage, hospital length of stay, complications, patient follow-up evaluation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:50:27 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre study at the Division of Pediatric Surgery, Children's Medical Center of Dallas, University of Texas Southwestern Medical Center</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 10:56:23 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Phillips-2012">
<CHAR_METHODS MODIFIED="2015-08-18 17:51:01 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 10:54:26 +1200" MODIFIED_BY="[Empty name]">
<P>Patients presenting with biliary colic (radiographic diagnosis of gallstones or polyp), biliary dyskinesia with an ejection fraction of less than 30%, aged between 18-85 years of age, either gender, and a BMI &lt; 45 kg/m<SUP>2</SUP>, were invited to enrol in the study. Exclusion criteria: pregnancy, acute cholecystitis, previous right subcostal or upper midline incision, preoperative indication for endoscopic retrograde choleangiopancreatography, indication for intraoperative biliary imaging, ASA classification &gt; 3, ongoing peritoneal dialysis, presence of umbilical hernia or umbilical hernia repair. 117 patients were randomised to the single incision laparoscopic surgery (SILS) cholecystectomy group and 80 patients were randomised to the 4 port laparoscopic cholecystectomy (4PLC) group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 10:55:51 +1200" MODIFIED_BY="[Empty name]">
<P>SILS cholecystectomy vs 4PLC. For SILS, the umbilicus was inverted and incised through the fascia and the SILS port was placed into the peritoneal cavity with the assistance of a curved clamp. In 4PLC two or three 5 mm ports and one or two 10 mm or 12 mm ports were placed under the discretion of the surgeon. No further information was provided on trocar make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-26 10:56:23 +1200" MODIFIED_BY="[Empty name]">
<P>Primary aim of the study was to assess the feasibility and safety of SILS cholecystectomy versus 4PLC as indicated by intraoperative and postoperative adverse events up to 1 year, operative time, and estimated blood loss. Secondary outcomes were pain postprocedure and at specific points at follow-up, analgesic use postprocedure, cosmetic scar evaluation, quality of life pre- and postprocedure, and time required for insertion of SILS port vs four standard ports</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-19 12:31:29 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre study conducted at 10 hospital sites, based at the Western Reserve University, Cleveland, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:26:07 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<CHAR_METHODS MODIFIED="2015-08-18 17:54:27 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms, running from December 1997 to July 1999 - Duration 1 year and 8 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 17:54:43 +1200" MODIFIED_BY="[Empty name]">
<P>Patients inclusion criteria was lithiasic cholecystitis requiring cholecystectomy. Exclusion criteria was previous superior or high abdominal surgery. 42 people were randomised to the direct trocar insertion group, and 42 people were randomised to the Veress needle insertion group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-19 12:26:07 +1200" MODIFIED_BY="[Empty name]">
<P>Laparoscopic cholecystectomy with direct trocar entry vs laparoscopic cholecystectomy with Veress needle insertion. In the direct trocar insertion group, the umbilical stalk was clamped and incised, followed by incision of the rectus aponeurosis, blunt dissection of the aponeurosis with index finger, and entry into the abdominal cavity. The abdominal wall was then elevated and the first trocar was inserted. In the Veress needle group the abdominal wall was elevated and the Veress needle was introduced at a 45<SUP>o</SUP> angle towards the pelvis. Pneumoperitoneum was then established. No further information was provided on trocar or Veress needle make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:55:14 +1200" MODIFIED_BY="[Empty name]">
<P>Procedure complications (epigastric vessel bleeding, more than three attempts at establishing pneumoperitoneum, wall infection, preperitoneal insufflation), laparoscopic insertion time, duration of surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:55:20 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at the General Hospital and Familiar Medicine No.1, Colima, Mexico</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:34:15 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santala-1999">
<CHAR_METHODS MODIFIED="2015-08-18 17:55:42 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 12:34:15 +1200" MODIFIED_BY="[Empty name]">
<P>One hundred consecutive women with a BMI of &gt; 25 kg/m<SUP>2</SUP> attending clinic for sterilisation were enrolled into the trial. Exclusion criteria included history of pelvic inflammatory disease, adhesions obliterating the cul-de-sac, uterine fibroids and uterine cavity of more than 10 cm. Exclusion criteria was not based upon age, BMI, height and weight. 50 participants in the transfundal group and 50 in the infraumbilical group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:10:16 +1200" MODIFIED_BY="[Empty name]">
<P>Transfundal insertion versus infraumbilical insertion of the Veress needle. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. No further details were provided on Veress needle make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:58:01 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing efficacy and safety. Reported secondary complications including uterine bleeding and also failed entry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:58:06 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Washington, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 17:59:50 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schulze-1999">
<CHAR_METHODS MODIFIED="2015-08-18 17:59:01 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was not blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 17:59:22 +1200" MODIFIED_BY="[Empty name]">
<P>22 patients provided informed consent and entered the study. Exclusion criteria included extensive tumour growth and rectal surgery. Patients were randomised to either gasless (n = 9) or conventional CO<SUP>2</SUP> (n = 8) surgery. 5 lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 17:59:36 +1200" MODIFIED_BY="[Empty name]">
<P>Gasless (technique published elsewhere) versus conventional surgery (technique published elsewhere). No cointervention. Standardised operative technique was deployed by all operators. For gasless operations, retraction of the abdominal wall was achieved by the plantar lifting technique (Laparolift; Oregon Medical Systems, San Jose, CA). No further information was provided on trocar make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 17:59:44 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing cardiopulmonary and systemic changes. Reported any complications which occurred (Pneumonia, brachial artery embolism, incarcerated inguinal hernias). Authors reported changes in cardiovascular and respiratory function</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 17:59:50 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Copenhagen, Denmark</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 18:01:12 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tansatit-1-2006">
<CHAR_METHODS MODIFIED="2015-08-18 18:00:40 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:00:51 +1200" MODIFIED_BY="[Empty name]">
<P>Patients referred from the infertility clinic for laparoscopic diagnosis. Exclusion criteria based upon suspicion of adhesions, prior abdominal surgery, midline vertical scars, history of peritonitis and large pelvic/abdominal masses. Exclusion was not based upon age and BMI. 50 in the missile trocar group and 50 in the Veress needle group. None lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:01:03 +1200" MODIFIED_BY="[Empty name]">
<P>Direct trocar (technique not stated) versus Veress needle (technique not stated). All operators had learnt the technique on cadavers. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. Unable to access information on trocar or Veress needle make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:01:07 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility. Stated no carbon dioxide leakage, abdominal wall haematoma or serious complications occurred</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:01:12 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre at Bangkok, Thailand</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-24 22:56:06 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tansatit-2-2006">
<CHAR_METHODS MODIFIED="2015-08-18 18:02:09 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded. 50 in the missile trocar group and 50 in the Veress needle group. None lost to follow-up. Single-centre at Bangkok, Thailand</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:02:18 +1200" MODIFIED_BY="[Empty name]">
<P>Patients referred from the infertility clinic for laparoscopic diagnosis. Exclusion criteria based upon suspicion of adhesions, prior abdominal surgery, midline vertical scars, history of peritonitis and large pelvic/abdominal masses. Exclusion was not based upon age and BMI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-24 22:56:06 +1200" MODIFIED_BY="[Empty name]">
<P>Missile trocar (technique not stated) versus Veress needle (technique not stated). All operators had learnt the technique on cadavers. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. Unable to access information on trocar or Veress needle make or model</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:02:32 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility. Only stated the "primary complications did not occur"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 18:03:35 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tansatit-3-2006">
<CHAR_METHODS MODIFIED="2015-08-18 18:03:12 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was single-blinded. 50 in the missile trocar group and 50 in the Veress needle group. None lost to follow-up. Single-centre in Bangkok, Thailand</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:03:20 +1200" MODIFIED_BY="[Empty name]">
<P>Patients referred from the infertility clinic for laparoscopic diagnosis. Exclusion criteria based upon suspicion of adhesions, prior abdominal surgery, midline vertical scars, history of peritonitis and large pelvic/abdominal masses. Exclusion was not based upon age and BMI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:03:33 +1200" MODIFIED_BY="[Empty name]">
<P>Direct trocar (technique not stated) versus reusable Pyramidal trocar (technique not stated). All operators had learnt the technique on cadavers. No cointervention. Standardised operative training in both interventions especially for the study. Standardised operative technique was deployed by all operators. Unable to access information on trocar or Veress needle make or model<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:03:35 +1200" MODIFIED_BY="[Empty name]">
<P>Aim: Assessing technical feasibility. Only stated the "primary complications did not occur"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 18:12:36 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tinelli-2010">
<CHAR_METHODS MODIFIED="2015-08-18 18:04:07 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial from January 2004 to October 2008. Study duration 4 years 9 months. Investigated direct optical access versus Veress needle entry</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:04:24 +1200" MODIFIED_BY="[Empty name]">
<P>194 participants undergoing laparoscopy for simple, persistent ovarian cysts in multiple gynaecological centres. Patients with preceding open abdominal surgery or in presence of large ovarian cysts (larger than 9 cm diameter or more) and of previous periumbilical surgery, were excluded from the study, together with those reporting the following ultrasound patterns of malignancy. Participants' BMI between 20-28. 93 participants in direct optical access and 101 in Veress needle entry group. No loss to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:12:28 +1200" MODIFIED_BY="[Empty name]">
<P>Standardised operative technique applied. Participants were randomised for either direct optical access or Veress needle entry and pneumoperitoneum, prior to operative laparoscopy</P>
<P>10 mm intraumbilical incision was made and the abdominal wall was lifted upwards to enable the introduction of optical conical blunt-tipped trocar in abdomen. Secondly, an optical bladeless trocar, called &#8216;&#8216;Endopath&#8217;&#8217; Trocars (Ethicon, Johnson &amp; Johnson, Somerville, NJ, USA), with a 08 illuminated laparoscope (Karl Storz, Tuttlingen, Germany) inside, was inserted directly into the abdominal cavity by applying a constant axial penetration force, under direct visual identification of the abdominal wall layers, starting from subcutaneous fat tissue to the rectus sheath and the peritoneum, until finally verifying the intra-abdominal contents</P>
<P>The classical closed method, using the Veress needle (by Karl Storz Endoscopy, Germany) followed by pneumoperitoneum; a single-use, conical, blind blunt-tipped trocar (by Ethicon, Johnson &amp; Johnson, Somerville, NJ, USA) insertion was performed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:12:30 +1200" MODIFIED_BY="[Empty name]">
<P>Duration of entry, blood loss, vascular injuries, visceral injuries</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:12:36 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre trial at Vito Fazzi Hospital, Lecce, Italy, Santa Maria Hospital, Bari, Italy, Harvard Medical School, Boston, MA, USA, LKH Villach, Austria,The New European Surgical Academy (NESA), Berlin, Germany, University Hospitals Schleswig-Holstein, Campus Kiel, Germany</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 18:14:12 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tinelli-2011">
<CHAR_METHODS MODIFIED="2015-08-18 18:12:59 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Patients presenting from June 2005 to November 2009 were assessed; duration of study was 4 years and 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:13:36 +1200" MODIFIED_BY="[Empty name]">
<P>168 women eligible for laparoscopic surgery. Inclusion criteria included women within reproductive age, with utero-ovarian benign disease, and previous abdominopelvic surgery, either by laparoscopy or by laparotomy, with transverse or midline incision. Exlusion criteria was patients with a pelvic mass larger than 10 cm. 86 patients were assigned to the direct optical entry group and 82 patients were assigned to the open-entry (Hasson technique) group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:14:05 +1200" MODIFIED_BY="[Empty name]">
<P>Direct optical entry versus open-entry (Hasson technique). For direct optical entry, a 10 mm intraumbilical incision was made and extended to the fascia, followed by axial penetration of the fascia using an optical bladeless trocar (12 mm diameter, Endopath or Endopath Xcel; Ethicon Endo-Surgery, Cincinnati, Ohio) with a zero-degree illuminated laparoscope (Karl Storz, Tuttlingen, Germany). Open-entry was performed by classic Hasson's technique as described in the literature, using Hasson's trocar (Ethicon Endo-Surgery, Cincinnati, Ohio)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:14:08 +1200" MODIFIED_BY="[Empty name]">
<P>Time required for entry into the abdomen, blood loss, and occurrence of vascular and/or bowel injury</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:14:12 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre study at the Vito Fazzi Hospital, Lecce, Italy&#8232;; the Santa Maria Hospital, Bari, Italy&#8232;; the University of Salento, Lecce, Italy&#8232;; the The Mount Sinai Hospital of Queens, New York, NY, USA; Department of Gynecology and Obstetrics Wilhelminenspital der Stadt, Wien, Austria; The New European Surgical Academy (NESA), Berlin, Germany; The USP hospital, Mallorca, Spain&#8232;; and University Hospitals Schleswig-Holstein, Campus Kiel, Kiel, Germany</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-19 12:29:04 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tinelli-2013">
<CHAR_METHODS MODIFIED="2014-11-03 20:49:14 +1300" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Paritcipants recruited between January 2006 to December 2010, Duration 5 years</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-19 12:29:04 +1200" MODIFIED_BY="[Empty name]">
<P>245 patients assessed for eligibility for inclusion, 21 did not meet inclusion criteria, and 224 patients were randomised. Inclusion criteria were women of reproductive age (30-40 years old), BMI 30-40 kg/m<SUP>2</SUP>, defined as obese of class I-II, and with the presence of benign pelvic mass of uterine and/or ovarian origin. Exclusion criteria were: Primary: postmenopausal age due to differing physiological characteristics, previous abdominal and pelvic surgery(ies) because of scar tissue and postsurgical adhesions; Secondary: pelvic mass &gt; 10 cm in diameter on pelvic examination. 108 patients were randomised to the direct optical entry group and 116 patients were randomised to the open-entry (Hasson technique) group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:15:57 +1200" MODIFIED_BY="[Empty name]">
<P>Direct optical entry versus open-entry (Hasson technique). For direct optical entry, a 10 mm intraumbilical incision was made and extended to the fascia, followed by axial penetration of the fascia using an optical bladeless trocar (12 mm diameter, Endopath or Endopath Xcel; Ethicon Endo-Surgery, Cincinnati, Ohio) with a zero-degree illuminated laparoscope (Karl Storz, Tuttlingen, Germany). For open-entry, the umbilical skin was incised and dissected down to the fascia, and the fascia was then incised with a scalpel and bluntly divided allowing insertion of the Hasson trocar (Ethicon Endo-surgery, Cincinnati, Ohio) under direct visualisation aided by elevation of the abdominal wall at points lateral to the original incision</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:16:01 +1200" MODIFIED_BY="[Empty name]">
<P>Time required to establish intra-abdominal vision after pneumoperitoneum, blood loss, and occurrence of vascular and/or bowel injuries</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:16:06 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre study at the Department of Obstetrics and Gynaecology, Vito Fazzi Hospital, Lecce, Italy; Department of Obstetrics and Gynaecology, Santa Maria Hospital, Bari, Italy; Experimental Researches and Modeling Division, Moscow State University of Medicine and Dentistry, Moscow, Russia; Department of Gynecology, Division of Minimal Invasive Endoscopy, The Mount Sinai Hospital of Queens, New York, NY, USA; Hospital Regional de Poza Rica, Sesver, Monterrey, Mexico; Fundacion Hospitalaria, Buenos Aires, Argentina; Department of Gynecology and Obstetrics, University of Perugia, Perugia, Italy; Columbia University College of Physicians and Surgeons, New York, NY, USA; Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology, St. Luke&#8217;s-Roosevelt Hospital Center, New York, NY, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 11:01:44 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsimoyiannis-2009">
<CHAR_METHODS MODIFIED="2015-08-26 11:00:28 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised single-blinded trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:17:56 +1200" MODIFIED_BY="[Empty name]">
<P>Participants attending for laparoscopic cholecystectomy. Exclusion criteria included (a) BMI more than 30 kg/m<SUP>2</SUP>, (b) signs of acute cholecystitis or choledocholithiasis or attacks of acute pancreatitis, (c) ASA grade more than II, and (d) lack of written informed consent. 16 exclusions but no loss to follow-up. 20 participants in each group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 11:01:44 +1200" MODIFIED_BY="[Empty name]">
<P>Standardised operative technique applied. Single incision laparoscopic surgery (SILS) cholecystectomy versus classic four port laparoscopic cholecystectomy. No cointervention. For the classic four port approach, an 11 mm umbilical trocar was inserted using Hasson technique. Another 5 mm trocar was placed in the midepigastrium and two 5 mm trocars placed in right costal margin in mid-clavicular line and mid-axillary line. For SILS cholecystectomy, pneumoperitoneum was induced with a 10 mm atraumatic trocar (Versastep; Covidien, Norwalk, CT, USA). Second and third trocars of 5 mm (Versastep; Covidien, Norwalk, CT, USA)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:19:39 +1200" MODIFIED_BY="[Empty name]">
<P>Abdominal and shoulder pain. Requirement of analgesics and nausea and vomiting</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:19:41 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at General Hospital of Ioannina, Greece</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 11:03:31 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Venkatesh-2007">
<CHAR_METHODS MODIFIED="2015-08-18 18:20:38 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial investigating the use of cutting versus dilating disposable trocars in laparoscopic renal surgery</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:20:42 +1200" MODIFIED_BY="[Empty name]">
<P>Patients 18 years old undergoing laparoscopic transperitoneal renal procedures were invited to participate in the study. No other exclusion criteria stated. 56 participants</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 11:03:31 +1200" MODIFIED_BY="[Empty name]">
<P>Comparison of 4-trocar types included 2 cutting (single or pyramidal bladed) and 2 dilating trocars (radially or axially dilating) type. Reference trocar: A standardised lateral 5 mm, noncutting, metal trocar (Storz EndoTIP, Storz Inc., Tuttlingen, Germany). The cutting trocars included a pyramidal bladed (Ethicon Inc., Cincinnati, OH) and single bladed trocar (Ethicon Inc., Cincinnati, OH). Dilating trocars evaluated were an axially dilating (Ethicon Inc., Cincinnati, OH) and a radially dilating Step-system (US Surgicals Inc., CA)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:24:04 +1200" MODIFIED_BY="[Empty name]">
<P>Mean pain scores at 3 hours, 24 hours and 1 week postoperatively. All complications, such as abdominal wall vessel bleeding, intra-abdominal vascular or visceral injuries, related to the trocar deployment were documented. Trocar related events during the operative procedure, such as gas leakage, trocar dislodgment, problems in handling the reducer mechanism and failure of trocar seal integrity, were documented</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:24:11 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre trial at Washington University School of Medicine, Division of Urology, St. Louis, Missouri, USA, Indiana University Medical Center, Department of Urology, Indianapolis, USA, University School of Medicine, Medical Statistics, St. Louis, Missouri, USA, UCI Medical Center, Department of Urology, Irvine, California, USA, Columbia University Medical Center, Department of Urology, New York, USA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 11:04:06 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vilallonga-2012">
<CHAR_METHODS MODIFIED="2015-08-18 18:24:31 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial with two arms. Patients enrolled between July 2009 and March 2010, duration 9 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:24:35 +1200" MODIFIED_BY="[Empty name]">
<P>Adult patients presenting with gallbladder pathology (all patients had documented gallstones) requiring either elective surgery or urgent surgery in the emergency room. 140 patients were enrolled in the study with 69 in the single port access group and 71 in the standard laparoscopy group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 11:04:06 +1200" MODIFIED_BY="[Empty name]">
<P>Single incision laparoscopic surgery (SILS) cholecystectomy versus standard laparoscopic cholecystectomy. In the single port access group, a 22 mm intraumbilical incision was made, the umbilicus was pulled out and incised longitudinally, and a SILS Port (Covidien, Inc., Norwalk, CT, USA) or TriPort (Advanced Surgical Concepts, Wicklow, Ireland) was introduced into the peritoneal cavity. In the standard laparoscopy group, Jason trocars and standard trocars were placed under direct vision</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:24:53 +1200" MODIFIED_BY="[Empty name]">
<P>Blood loss, operative time, complications (intraoperative, seroma, hernia), length of stay, pain postprocedure, cosmetic satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-19 12:31:40 +1200" MODIFIED_BY="[Empty name]">
<P>Multi-centre trial - Vall d'Hebron Universitary Hospital (Barcelona, Spain) and Istanbul university, Istanbul Faculty of Medicine (Istanbul, Turkey)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-26 11:06:33 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Villalobos-2014">
<CHAR_METHODS MODIFIED="2015-08-18 18:25:20 +1200" MODIFIED_BY="[Empty name]">
<P>Prospective randomised controlled trial from January 2011 to September 2012 (1 year 9 months duration)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-26 11:05:57 +1200" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria were patients presenting with acute appendicitis and onset of symptoms less than 48 hours, and 15-65 years of age. Exclusion criteria were: BMI &gt; 30 kg/m<SUP>2</SUP>, ASA &gt; I, previous history of abdominal surgery, unable to give informed consent, and unavailability of surgeons trained in single incision laparoscopic surgery (SILS). 120 patients were randomised: 60 patients to the SILS appendectomy group, and 60 patients to the three-port laparoscopic appendectomy (3PLA) group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-26 11:06:33 +1200" MODIFIED_BY="[Empty name]">
<P>SILS appendectomy versus 3PLA. For SILS a 2.5 cm - 3 cm transumbilical incision was made followed by insertion of the SILS port (Covidien SILS port). In CLA a 1 cm periumbilical incision was made to place the Hasson trocar, and another 5 mm incision and 11 mm incision were made in the suprapubic region</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:26:31 +1200" MODIFIED_BY="[Empty name]">
<P>Surgery duration, start of oral intake, length of hospital stay, amount of postoperative pain, pathological diagnosis on resection, cost of procedure, postsurgery complications (wound infection, intra-abdominal abscess, postsurgery ileus, hernia, other unspecified complication)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:26:36 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at the University Hospital Arnau de Vilanova, Lerida, Spain</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 18:27:15 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yim-2001">
<CHAR_METHODS MODIFIED="2015-08-18 18:26:58 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial which was double-blinded between September 1997 and March 1998. Study duration 7 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:27:01 +1200" MODIFIED_BY="[Empty name]">
<P>Between Sept 1997 and March 1998, women scheduled for laparoscopic surgery for adnexal masses in a university teaching hospital were recruited. Exclusion criteria not stated. 34 in the radially expanding (STEP) trocar group and 34 in the standard trocar group. No patients lost to follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:27:09 +1200" MODIFIED_BY="[Empty name]">
<P>Radially expanding (STEP) trocars compared to standard trocars for secondary port entry. Standardised operative technique applied. The STEP device was a 10mm rapidly expanding access device. A size-matched disposable trocar with a linear cutting blade (Endopath; Ethicon Endosurgery, Cincinnati, OH) was used for the standard trocar</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:27:12 +1200" MODIFIED_BY="[Empty name]">
<P>Incisional hernia, trocar site bleeding and trocar site infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:27:15 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at Prince of Wales Hospital, The Chinese University of Hong Kong, SAR, Hong Kong</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-08-18 18:28:31 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zakerah-2010">
<CHAR_METHODS MODIFIED="2015-08-18 18:27:55 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial investigated the use of direct trocar and Veress needle entry. Unclear duration of study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-08-18 18:28:08 +1200" MODIFIED_BY="[Empty name]">
<P>One thousand patients scheduled to undergo diagnostic laparoscopy were recruited for the study. No exclusion criteria stated but demographics examined. 500 participants in direct trocar group and 500 participants in Veress needle group. No loss to follow-up stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-08-18 18:28:21 +1200" MODIFIED_BY="[Empty name]">
<P>Standardised operative technique stated. "The technique of DT entry started with an intraumbilical skin incision wide enough to accommodate the diameter of a sharp trocar/canal system. The anterior abdominal wall was adequately elevated by hand, and the trocar was inserted directly into the abdominal cavity, aiming towards the pelvic hollow. After removal of the sharp trocar, the laparoscope was inserted to confirm the presence of omentum or bowel in the visual field, then pneumoperitoneum was started." No further information was provided on the make or model of Veress needle or direct trocar</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-08-18 18:28:25 +1200" MODIFIED_BY="[Empty name]">
<P>Length of procedure, gas usage, failed entry and minor intraoperative complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-08-18 18:28:31 +1200" MODIFIED_BY="[Empty name]">
<P>Single-centre trial at Department of Obstetrics and Gynecology, Women&#8217;s Health Centre, Assiut University, Assiut , Egypt</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ASA: American Society of Anaesthesiologists<BR/>ERCP: endoscopic retrograde cholangiopancreatography<BR/>SILC: single incision laparoscopic cholecystectomy<BR/>SILS: single incision laparoscopic surgery<BR/>TPLC: three-port laparoscopic cholecystectomy<BR/>4PLC: four-port laparoscopic cholecystectomy<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-08-19 13:13:24 +1200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-08-19 13:13:24 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cardin-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-19 13:13:24 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared two laparoscopic entry techniques but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:02 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dunne-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:02 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared two laparoscopic entry techniques but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:04 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fagotti-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:04 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared two laparoscopic entry techniques but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:07 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garg-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:07 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared two laparoscopic entry techniques but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:12 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:12 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared the effect of different methods of creating the peritoneal operating field (lifting abdomen, pneumoperitoneum) on stress response as opposed to different entry techniques</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:15 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Joshipura-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:15 +1200" MODIFIED_BY="[Empty name]">
<P>Study evaluated the maintenance of the pneumoperitoneum as opposed to port entry technique</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:17 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:17 +1200" MODIFIED_BY="[Empty name]">
<P>Study evaluated the differences between operative technique as opposed to port entry</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:19 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:19 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared two laparoscopic entry techniques but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:21 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sandhu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:21 +1200" MODIFIED_BY="[Empty name]">
<P>Study evaluated the maintenance of the pneumoperitoneum as opposed to port entry technique</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:43 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sangrasi-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:43 +1200" MODIFIED_BY="[Empty name]">
<P>Studies compared Veress needle entry to open-entry (Hasson) but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:49 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shayani_x002d_Nasab-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:49 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared two laparoscopic entry techniques but was not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-08-18 18:31:53 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Warle-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-08-18 18:31:53 +1200" MODIFIED_BY="[Empty name]">
<P>Study compared different pneumoperitoneum pressures to optimise live donor comfort as opposed to port entry technique</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-08-26 10:59:19 +1200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-08-26 10:56:51 +1200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:25:13 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agresta-2004">
<DESCRIPTION>
<P>Method of randomisation unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:29:21 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Akbar-2008">
<DESCRIPTION>
<P>"Selected patients were randomised into group A and B using sealed envelopes containing questionnaire. Seventy ProForma, 35 for each group were prepared and sealed in blank envelopes. Each envelope contained one out of these seventy ProForma. After informed consent, an envelope was randomly fetched and opened"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:23:47 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-1-2013">
<DESCRIPTION>
<P>Patients were randomly assigned to one of the three groups based on computer-generated sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:23:53 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-2-2013">
<DESCRIPTION>
<P>Patients were randomly assigned to one of the three groups based on computer-generated sequence<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:23:58 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-3-2013">
<DESCRIPTION>
<P>Patients were randomly assigned to one of the three groups based on computer-generated sequence<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:42:13 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-1-2000">
<DESCRIPTION>
<P>Method of randomisation unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:47:16 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-2-2000">
<DESCRIPTION>
<P>Method of randomisation unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:48:15 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-3-2000">
<DESCRIPTION>
<P>Method of randomisation unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:49:10 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhoyrul-2000">
<DESCRIPTION>
<P>"Randomization was determined from randomization tables before patient enrolment<BR/>was begun"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:56:40 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bisgaard-2007">
<DESCRIPTION>
<P>"Patients were consecutively enrolled in the trial by the medical staff in the surgical unit several days before the operation. After induction of anaesthesia, the surgeon randomised the patients to laparoscopic cholecystectomy using radially expanding trocars (radial group) or conventional cutting trocars (cutting group) by the sealed envelope method based on a block-randomised computer-generated list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:58:29 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borgatta-1990">
<DESCRIPTION>
<P>Method not explicitly stated "assigned randomly"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:17 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Briel-2000">
<DESCRIPTION>
<P>Method not stated but described as 'randomised'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:53 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Byron-1993">
<DESCRIPTION>
<P>Truly randomised - random number tables</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:02:28 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carter-2013">
<DESCRIPTION>
<P>Patients were assigned to each study arm in a 1:1 ratio by a computerised random number generator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:04:09 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Channa-2009">
<DESCRIPTION>
<P>Participants were randomised to one of two groups using a random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:04:53 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cogliandolo-1998">
<DESCRIPTION>
<P>"All patients were entered into two groups according to a computerized random number selection"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-23 18:16:27 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cravello-1999">
<DESCRIPTION>
<P>"Patients were randomized by a random number table before the induction of anesthesia"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-26 10:42:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deveci-2013">
<DESCRIPTION>
<P>Patients were randomly assigned to undergo SILS or 3PLC cholecystectomy according to a computer-generated table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-23 18:24:55 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feste-2000">
<DESCRIPTION>
<P>Method of randomisation unclear. "Patients were randomized to treatment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:19:01 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonollosa-2012">
<DESCRIPTION>
<P>Patients randomised using a computer-generated random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-23 18:35:28 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghezzi-2005">
<DESCRIPTION>
<P>"Patients were randomised according to a computer-generated list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:21:19 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunenc-2005">
<DESCRIPTION>
<P>Stated as randomised within the paper, exact method not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:24:10 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hamade-2007">
<DESCRIPTION>
<P>A computer-generated randomisation list was produced by an independent statistician and was opened by an independent person who produced envelopes containing the number of the study patient and a card labelled "blunt" or "sharp". The envelopes were sealed and placed in the operating theatre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 16:01:00 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2012">
<DESCRIPTION>
<P>"91 consecutive patients were included in the study and allocated into a control group or bladeless trocar application group according to random number table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:27:28 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Imran-2014">
<DESCRIPTION>
<P>Patients were randomised to each group using a random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-23 18:45:50 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Johnson-1997">
<DESCRIPTION>
<P>"A randomization protocol consisting of a randomization block design"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:39:55 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karaca-2014">
<DESCRIPTION>
<P>Method of randomisation not described. Author contacted for clarification</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:33:42 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kitano-1993">
<DESCRIPTION>
<P>"Forty-two patients were randomly allocated to the pneumoperitoneum (P) group and 41 to the U-shaped retractor (U) group by using a system of randomized numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:36:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lai-2011">
<DESCRIPTION>
<P>Patients randomised using computer-generated random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:38:55 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>Truly randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:44:51 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luna-2013">
<DESCRIPTION>
<P>Method of randomisation is not mentioned in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:45:42 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mettle-2000">
<DESCRIPTION>
<P>"Patients were randomised into either Step (S; n = 49) or conventional technique (C; n = 51) groups according to which kind of laparoscopic access device was assigned from the randomisation table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:46:29 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Minervini-2008">
<DESCRIPTION>
<P>Method of randomisation not clearly stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:36:37 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ostrzenski-1999">
<DESCRIPTION>
<P>"To prevent bias related to preoperative expectations, patients were randomized by sealed envelope in the operating room after the induction of anesthesia"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:48:31 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peitgen-1997">
<DESCRIPTION>
<P>No mention of method used for randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:50:39 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2013">
<DESCRIPTION>
<P>Patients were randomised using Random Allocation Software 1.0, using random number generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-26 10:56:51 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Phillips-2012">
<DESCRIPTION>
<P>Patients randomised to SILS cholecystectomy and 4PLC in a 1.5:1 ratio</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:55:26 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<DESCRIPTION>
<P>Patients were assigned to the two treatment groups using a random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-16 03:02:28 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santala-1999">
<DESCRIPTION>
<P>"For allocation into study groups, we used sealed envelopes prepared in blocks of 20"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:59:53 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schulze-1999">
<DESCRIPTION>
<P>Method of randomisation unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-23 19:23:24 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-1-2006">
<DESCRIPTION>
<P>Method of randomisation unclear. "Allocated by simple randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-06 18:40:10 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-2-2006">
<DESCRIPTION>
<P>Method of randomisation unclear. "Allocated by simple randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-06 18:40:15 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-3-2006">
<DESCRIPTION>
<P>Method of randomisation unclear. "Allocated by simple randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:12:50 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2010">
<DESCRIPTION>
<P>The study provided, in every suitable gynaecological centre, the allocation of all suitable consecutive patients with ovarian cysts to either of the two procedures, with a randomisation ratio of 1:1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-03 20:42:54 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2011">
<DESCRIPTION>
<P>"The method of randomisation was in parallel assignment, at a randomisation ratio of 1:1"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:16:13 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2013">
<DESCRIPTION>
<P>Method of allocation was controlled by a statistician who assigned patients to surgery with a 1:1 randomisation ratio</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:19:48 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsimoyiannis-2009">
<DESCRIPTION>
<P>"Randomly assigned to two groups using a closed envelope containing information regarding placement into group A or B"</P>
<P> </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:24:13 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatesh-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:25:00 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vilallonga-2012">
<DESCRIPTION>
<P>Paper states that after surgeons enrolled the patients they randomised them into the two different groups in an alternative way. There is no explicit mention of the method of randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:26:42 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villalobos-2014">
<DESCRIPTION>
<P>Random selection of outcome from box containing closed envelopes containing different interventions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:27:22 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yim-2001">
<DESCRIPTION>
<P>"The allocation of trocars was based on computer-generated random numbers that were put inside consecutively labelled, sealed, opaque envelopes. Numbers were disclosed at surgery"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:29:21 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zakerah-2010">
<DESCRIPTION>
<P>They were randomly assigned to either direct trocar (group A, n = 500 patients) or Veress needle (group B, n = 500 patients) entry for pneumoperitoneum by a computer-generated randomisation table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-08-19 15:55:22 +1200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 15:55:22 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agresta-2004">
<DESCRIPTION>
<P>"Because of an 8% post hoc deviation of patient allocation due to the sealed-envelope randomisation method adopted, the level of significance was set at 0.01"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:29:32 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akbar-2008">
<DESCRIPTION>
<P>"Selected patients were randomised into group A and B using sealed envelopes containing questionnaire. Seventy ProForma, 35 for each group were prepared and sealed in blank envelopes. Each envelope contained one out of these seventy ProForma. After informed consent, an envelope was randomly fetched and opened"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:32:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-1-2013">
<DESCRIPTION>
<P>The allocation codes were kept in opaque sealed envelopes and broken after randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:35:32 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-2-2013">
<DESCRIPTION>
<P>The allocation codes were kept in opaque sealed envelopes and broken after randomisation<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:40:41 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-3-2013">
<DESCRIPTION>
<P>The allocation codes were kept in opaque sealed envelopes and broken after randomisation<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-09 00:58:59 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-1-2000">
<DESCRIPTION>
<P>"After informed consent was obtained, the sealed envelope method was used to reveal the method of establishment of the pneumoperitoneum for that patient after induction of anesthesia. Patients were thereby randomly allocated into three groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-16 02:56:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-2-2000">
<DESCRIPTION>
<P>"After informed consent was obtained, the sealed envelope method was used to reveal the method of establishment of the pneumoperitoneum for that patient after induction of anesthesia. Patients were thereby randomly allocated into three groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-16 02:56:19 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-3-2000">
<DESCRIPTION>
<P>"After informed consent was obtained, the sealed envelope method was used to reveal the method of establishment of the pneumoperitoneum for that patient after induction of anesthesia. Patients were thereby randomly allocated into three groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:49:12 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhoyrul-2000">
<DESCRIPTION>
<P>Allocation concealment not referred to</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:56:47 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bisgaard-2007">
<DESCRIPTION>
<P>"Patients were consecutively enrolled in the trial by the medical staff in the surgical unit several days before the operation. After induction of anaesthesia, the surgeon randomised the patients to laparoscopic cholecystectomy using radially expanding trocars (radial group) or conventional cutting trocars (cutting group) by the sealed envelope method based on a block-randomised computer-generated list"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:58:32 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borgatta-1990">
<DESCRIPTION>
<P>Not referred to within paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:18 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Briel-2000">
<DESCRIPTION>
<P>Not referred to within the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:54 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Byron-1993">
<DESCRIPTION>
<P>Not referred to within paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:02:31 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carter-2013">
<DESCRIPTION>
<P>"the patient was unaware of the randomisation until after the completion of the operation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:04:10 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Channa-2009">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:04:56 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cogliandolo-1998">
<DESCRIPTION>
<P>"All patients were entered into two groups according to a computerized random number selection"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:05:46 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cravello-1999">
<DESCRIPTION>
<P>No reference to allocation concealment was made within the text of the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:14:17 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deveci-2013">
<DESCRIPTION>
<P>No mention of allocation concealment in text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:14:55 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feste-2000">
<DESCRIPTION>
<P>Not referred to within the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:19:04 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonollosa-2012">
<DESCRIPTION>
<P>No mention of concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:19:58 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghezzi-2005">
<DESCRIPTION>
<P>Not referred to within paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:21:20 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunenc-2005">
<DESCRIPTION>
<P>Allocation concealment not referred to within the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:24:18 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hamade-2007">
<DESCRIPTION>
<P>A computer-generated randomisation list was produced by an independent statistician and was opened by an independent person who produced envelopes containing the number of the study patient and a card labelled "blunt" or "sharp". The envelopes were sealed and placed in the operating theatre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:26:48 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2012">
<DESCRIPTION>
<P>No reference to allocation concealment was made within the text of the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:27:29 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Imran-2014">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:32:20 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Johnson-1997">
<DESCRIPTION>
<P>No reference to allocation concealment made</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:39:56 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karaca-2014">
<DESCRIPTION>
<P>No reference to allocation concealment was made within the text of the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:33:44 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kitano-1993">
<DESCRIPTION>
<P>No reference to allocation concealment made</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:24:16 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lai-2011">
<DESCRIPTION>
<P>The computer-generated random numbers were stored in sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:38:56 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>Not referred to within the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:44:52 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luna-2013">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:45:46 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mettle-2000">
<DESCRIPTION>
<P>No reference to allocation concealment made</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:46:31 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Minervini-2008">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:36:40 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ostrzenski-1999">
<DESCRIPTION>
<P>"To prevent bias related to preoperative expectations, patients were randomized by sealed envelope in the operating room after the induction of anesthesia"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:48:32 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peitgen-1997">
<DESCRIPTION>
<P>No mention of allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:50:42 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez-2013">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:52:48 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Phillips-2012">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:55:30 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-16 03:02:29 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santala-1999">
<DESCRIPTION>
<P>"For allocation into study groups, we used sealed envelopes prepared in blocks of 20"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:59:53 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schulze-1999">
<DESCRIPTION>
<P>Allocation concealment not discussed within the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-23 19:23:50 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-1-2006">
<DESCRIPTION>
<P>"Allocated by simple randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-06 18:40:28 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-2-2006">
<DESCRIPTION>
<P>"Allocated by simple randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-06 18:40:33 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-3-2006">
<DESCRIPTION>
<P>"Allocated by simple randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:12:51 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2010">
<DESCRIPTION>
<P>The study provided, in every suitable gynaecological centre, the allocation of all suitable consecutive patients with ovarian cysts to either of the two procedures, with a randomisation ratio of 1:1</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:14:22 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2011">
<DESCRIPTION>
<P>No mention of allocation concealment techniques in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:16:14 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2013">
<DESCRIPTION>
<P>Patients randomised using sealed numbered containers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:19:53 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tsimoyiannis-2009">
<DESCRIPTION>
<P>"Randomly assigned to two groups using a closed envelope containing information regarding placement into group A or B"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:24:14 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatesh-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:25:01 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vilallonga-2012">
<DESCRIPTION>
<P>No mention of allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:26:42 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villalobos-2014">
<DESCRIPTION>
<P>Intervention selections were in closed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:27:25 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yim-2001">
<DESCRIPTION>
<P>"The allocation of trocars was based on computer-generated random numbers that were put inside consecutively labelled, sealed, opaque envelopes. Numbers were disclosed at surgery"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:29:30 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zakerah-2010">
<DESCRIPTION>
<P>They were randomly assigned to either direct trocar (group A, n = 500 patients) or Veress needle (group B, n = 500 patients) entry for pneumoperitoneum by a computer-generated randomisation table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-08-19 12:39:57 +1200" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:25:21 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Agresta-2004">
<DESCRIPTION>
<P>Unclear, no reference made</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:29:43 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Akbar-2008">
<DESCRIPTION>
<P>"All the patients were operated upon under general anaesthesia by the same anaesthesia team. The surgical team consisted of a surgeon (principal author), two assistants and one scrub nurse"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:32:13 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angioli-1-2013">
<DESCRIPTION>
<P>Blinding not mentioned in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:35:34 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angioli-2-2013">
<DESCRIPTION>
<P>Blinding not mentioned in the study<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:40:43 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angioli-3-2013">
<DESCRIPTION>
<P>Blinding not mentioned in the study<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:42:16 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-1-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:47:21 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-2-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:48:17 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-3-2000">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:49:16 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhoyrul-2000">
<DESCRIPTION>
<P>Double-blinded - participants and observers. "Patients and postoperative observers were blinded to the choice of trocar used in the operations"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:57:21 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bisgaard-2007">
<DESCRIPTION>
<P>"The trial was patient- and observer-blinded. At the end of the operation, the incisions were covered with nontransparent standard dressings (5.5 cm), and the patients were instructed to keep the dressings on for the first 2 postoperative days. The patient and the surgical staff, including the nurses, were blinded to the type of trocar used. The operating surgeon and the anaesthesiologist in charge did not participate in the postoperative assessment and did not attend to the patients"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:58:33 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borgatta-1990">
<DESCRIPTION>
<P>Not referred to within paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:59:18 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Briel-2000">
<DESCRIPTION>
<P>Not referred to within the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:59:55 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Byron-1993">
<DESCRIPTION>
<P>Single-blinded, patients only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:02:32 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carter-2013">
<DESCRIPTION>
<P>The study was unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:04:11 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Channa-2009">
<DESCRIPTION>
<P>No mention of blinding of participants or assessors in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:04:58 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cogliandolo-1998">
<DESCRIPTION>
<P>No blinding mentioned within study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:05:48 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cravello-1999">
<DESCRIPTION>
<P>Absent</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:14:17 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deveci-2013">
<DESCRIPTION>
<P>No mention of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:15:06 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feste-2000">
<DESCRIPTION>
<P>Double-blinded, patients and observer only. "Patients were blinded as to which type of instrument was used". "A blinded, trained observer assessed the operative wounds"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:19:05 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fonollosa-2012">
<DESCRIPTION>
<P>No mention of blinding in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:20:01 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghezzi-2005">
<DESCRIPTION>
<P>Single-blinded, patients only. "The patients were blinded with respect to the surgical technique assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:21:21 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunenc-2005">
<DESCRIPTION>
<P>Blinding not referred to within paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:23:05 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hamade-2007">
<DESCRIPTION>
<P>Not stated within study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:26:49 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2012">
<DESCRIPTION>
<P>Blinding not mentioned in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:27:30 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Imran-2014">
<DESCRIPTION>
<P>No mention of blinding in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 15:43:31 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Johnson-1997">
<DESCRIPTION>
<P>Single-blinded, patients only. "The subjects were not informed of their treatment group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-19 12:39:57 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karaca-2014">
<DESCRIPTION>
<P>No mention of blinding of either participants, personnel, or outcome assessors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:33:46 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kitano-1993">
<DESCRIPTION>
<P>No reference to blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-11-17 04:00:40 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lai-2011">
<DESCRIPTION>
<P>The patients were not blinded from the study, but the outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 16:38:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>Single-blinded study (patients only)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:44:53 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luna-2013">
<DESCRIPTION>
<P>No mention of allocation concealment in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:45:47 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mettle-2000">
<DESCRIPTION>
<P>No reference to blinding within paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:46:32 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Minervini-2008">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-19 12:36:42 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrzenski-1999">
<DESCRIPTION>
<P>Single-blinded, patients only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:48:33 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peitgen-1997">
<DESCRIPTION>
<P>No mention of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:50:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2013">
<DESCRIPTION>
<P>Hospital staff and patients were blinded to each procedure by using similar dressings in each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:52:50 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Phillips-2012">
<DESCRIPTION>
<P>Patient blinded up to a week after the procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:55:30 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<DESCRIPTION>
<P>No mention of blinding in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:58:38 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Santala-1999">
<DESCRIPTION>
<P>Not stated within study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 17:59:54 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schulze-1999">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:01:19 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-1-2006">
<DESCRIPTION>
<P>Unclear as not stated in study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:02:46 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-2-2006">
<DESCRIPTION>
<P>Unclear as not stated in study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:03:39 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tansatit-3-2006">
<DESCRIPTION>
<P>Unclear as not stated in study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:12:53 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2010">
<DESCRIPTION>
<P>Unclear - not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:14:23 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2011">
<DESCRIPTION>
<P>Blinding not mentioned in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:16:15 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2013">
<DESCRIPTION>
<P>No mention of blinding in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:20:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsimoyiannis-2009">
<DESCRIPTION>
<P>Single-blinded - "All patients were informed about the intervention technique". "Surgeons were informed about the group of each patient in the operating room. Two other investigators, blinded to the group of each patient, independently recorded postoperative pain score, need for analgesics, and incidences of nausea and vomiting"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:24:14 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatesh-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:25:02 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vilallonga-2012">
<DESCRIPTION>
<P>No mention of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:26:43 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villalobos-2014">
<DESCRIPTION>
<P>No mention of blinding in the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:27:32 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yim-2001">
<DESCRIPTION>
<P>Double-blinded, patient and observer. "Patients and assessors were masked to trocar<BR/>assignments"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-08-18 18:29:35 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zakerah-2010">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-08-26 10:59:19 +1200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:25:26 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agresta-2004">
<DESCRIPTION>
<P>No loss to follow-up or exclusions reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:29:54 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Akbar-2008">
<DESCRIPTION>
<P>No loss to follow-up or lost data reported. However, some participants excluded if operation converted to open cholecystectomy- figures not given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:32:18 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-1-2013">
<DESCRIPTION>
<P>3 patients from the open procedure group were excluded from analysis after randomisation because malignancy was found at histological examination. Outcomes unlikely to be affected by small number exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:26:01 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-2-2013">
<DESCRIPTION>
<P>1 patient from the Veress needle group and 3 patients from the open procedure group were excluded from analysis after randomisation because malignancy was found at histological examination. Outcomes unlikely to be affected by small number exclusions<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:40:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-3-2013">
<DESCRIPTION>
<P>1 patient from the Veress needle group was excluded from analysis after randomisation because malignancy was found at histological examination. Outcomes unlikely to be affected by small number exclusions<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:42:30 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-1-2000">
<DESCRIPTION>
<P>Reported patients as lost to follow-up because of intraoperative complications, which required conversion to a different technique, and therefore an intention-to-treat analysis may have been of value</P>
<P>"Two patients were withdrawn from inclusion during surgery, and no time-motion analysis was performed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:47:40 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-2-2000">
<DESCRIPTION>
<P>Reported patients as lost to follow-up because of intraoperative complications, which required conversion to a different technique, and therefore an intention-to-treat analysis may have been of value.</P>
<P>"Two patients were withdrawn from inclusion during surgery, and no time-motion analysis was performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:48:22 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bemelman-3-2000">
<DESCRIPTION>
<P>Reported patients as lost to follow-up because of intraoperative complications, which required conversion to a different technique, and therefore an intention-to-treat analysis may have been of value.</P>
<P>"Two patients were withdrawn from inclusion during surgery, and no time-motion analysis was performed"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:49:46 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhoyrul-2000">
<DESCRIPTION>
<P>"Five participants converted to laparotomy". "One participant who originally consented to participate and later refused was removed from the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:57:02 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bisgaard-2007">
<DESCRIPTION>
<P>3 exclusions from trial. "One of the three excluded patients underwent conversion to an open procedure (radial group) and the remaining two patients (one from each surgical group) had no study data available due to loss of their study diary"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:58:33 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borgatta-1990">
<DESCRIPTION>
<P>No data issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:59:20 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Briel-2000">
<DESCRIPTION>
<P>No loss to follow-up or exclusions reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 15:59:58 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Byron-1993">
<DESCRIPTION>
<P>No incomplete data issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-26 10:40:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carter-2013">
<DESCRIPTION>
<P>All patients completed short-term follow-up. 6 patients out of 37 lost to follow-up after 6 months in the SILS group. 2 patients out of 38 lost to follow-up after 6 months in the 3-port group. An intention-to-treat analysis was performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:04:13 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Channa-2009">
<DESCRIPTION>
<P>No patients excluded after randomisation, and no patients dropped out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:05:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cogliandolo-1998">
<DESCRIPTION>
<P>No exclusion or dropouts. However, three cases converted to open surgery because of difficulty in recognising location of anatomical structures and in two cases conversion was due to major complications related to the introduction of the first trocar</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:05:53 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cravello-1999">
<DESCRIPTION>
<P>9 participants converted from gasless laparoscopy technique - reasons given for all exclusions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:38:02 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deveci-2013">
<DESCRIPTION>
<P>No patients lost to follow-up or dropped out</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:15:15 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feste-2000">
<DESCRIPTION>
<P>Reported patients as lost to follow-up as required conversion to a different technique</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 16:00:05 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonollosa-2012">
<DESCRIPTION>
<P>No dropouts or exclusions after enrolment and randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:20:14 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghezzi-2005">
<DESCRIPTION>
<P>FIve exclusions. Five patients converted to laparotomy - reasons stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:38:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gunenc-2005">
<DESCRIPTION>
<P>No exclusions or loss to follow-up stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:23:12 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hamade-2007">
<DESCRIPTION>
<P>Complications not predefined by study; however primary aim was port stability and friction forces. No loss to follow-up or lost data reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:38:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2012">
<DESCRIPTION>
<P>No exclusions or dropouts reported. Conversion rate was zero</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:27:31 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Imran-2014">
<DESCRIPTION>
<P>No patients dropped out and none lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:32:31 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Johnson-1997">
<DESCRIPTION>
<P>No outcome measures reported; authors have been written to for clarification. No dropouts or exclusions stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:40:00 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karaca-2014">
<DESCRIPTION>
<P>No patients were lost to follow-up and no dropouts were recorded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:33:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kitano-1993">
<DESCRIPTION>
<P>No exclusions or dropouts stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-26 10:48:39 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lai-2011">
<DESCRIPTION>
<P>From the SILS group, 3 patients refused to participate after randomisation. We felt this small number would have no effect on their results. No patients were lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 16:39:06 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>No patients dropped out or were lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:44:57 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luna-2013">
<DESCRIPTION>
<P>No patients dropped out or were lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:38:21 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mettle-2000">
<DESCRIPTION>
<P>No loss to follow-up or exclusions stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:46:35 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Minervini-2008">
<DESCRIPTION>
<P>No exclusions or dropouts stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:36:46 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrzenski-1999">
<DESCRIPTION>
<P>No exclusions or dropouts reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:48:37 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peitgen-1997">
<DESCRIPTION>
<P>14 patients excluded prior to randomisation due to previous abdominal surgery. No patients lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:50:48 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2013">
<DESCRIPTION>
<P>No patients were lost to follow-up or dropped out after randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:52:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Phillips-2012">
<DESCRIPTION>
<P>Patients dropped out from the long-term follow-up, but no one dropped out immediately postsurgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:55:35 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<DESCRIPTION>
<P>No patients lost to follow-up and no patients dropped out after randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 17:58:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santala-1999">
<DESCRIPTION>
<P>No exclusions, dropouts or loss to follow-up stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-26 10:59:19 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schulze-1999">
<DESCRIPTION>
<P>Reported patients as lost to follow-up because of conversion to a different technique, and therefore an intention-to-treat analysis may have been of value. "Five patients were excluded because of conversion from laparoscopic to open surgery (2 in the gasless group and 3 in the CO2 group)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-19 12:40:50 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-1-2006">
<DESCRIPTION>
<P>No exclusions or dropouts included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:02:48 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-2-2006">
<DESCRIPTION>
<P>No exclusions or dropouts included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:03:42 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-3-2006">
<DESCRIPTION>
<P>No exclusions or dropouts included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:12:54 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2010">
<DESCRIPTION>
<P>All outcomes reported. No exclusions stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:14:27 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2011">
<DESCRIPTION>
<P>No exclusions or dropouts reported. No conversion between intervention groups or to laparotomy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:16:17 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2013">
<DESCRIPTION>
<P>No dropouts were recorded. Everyone that was randomised was included in the final analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:20:20 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsimoyiannis-2009">
<DESCRIPTION>
<P>No loss to follow-up stated. Sixteen patients were excluded after randomisation because of: signs of acute cholecystitis (9 patients), clinical and laboratory findings of choledocholithiasis (3 patients; preoperative endoscopic retrograde cholangiopancreatography was performed), attacks of acute pancreatitis (2 patients), and ASA grade III classification (2 patients)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:24:17 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatesh-2007">
<DESCRIPTION>
<P>No exclusions or loss to follow-up stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:25:05 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vilallonga-2012">
<DESCRIPTION>
<P>No patients dropped out and no patients were lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:26:46 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villalobos-2014">
<DESCRIPTION>
<P>No drop outs or patients lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:27:37 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yim-2001">
<DESCRIPTION>
<P>No exclusions or dropouts reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-08-18 18:29:39 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zakerah-2010">
<DESCRIPTION>
<P>No exclusions or dropouts stated. No loss to follow-up stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-08-26 10:32:32 +1200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-26 10:32:32 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agresta-2004">
<DESCRIPTION>
<P>Data were presented as number of cases and percentages; no conversion of data. P values stated as non-significant for outcomes as opposed to actual value. No omission of outcomes and no subsets of data. Power calculation performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:30:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akbar-2008">
<DESCRIPTION>
<P>No power calculation; therefore power calculation set as 33%. Data were presented as number of cases and percentages; no conversion of data. P values stated for outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:32:20 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-1-2013">
<DESCRIPTION>
<P>No conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:35:43 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-2-2013">
<DESCRIPTION>
<P>All outcomes reported with accompanying significance values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:40:57 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-3-2013">
<DESCRIPTION>
<P>All outcomes reported with P values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:24:57 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-1-2000">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. P values stated for outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:25:04 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-2-2000">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. P values stated for outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:25:10 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-3-2000">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. P values stated for outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:49:56 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhoyrul-2000">
<DESCRIPTION>
<P>Data were presented as number of cases and percentages; no conversion of data. P values stated for outcome. No omission of outcomes and no subsets of data. Power calculation performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 15:57:37 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bisgaard-2007">
<DESCRIPTION>
<P>Some data subgrouped; e.g. little, moderate and severe suggillations. No omission of outcome or selective use of data. No conversion of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:58:35 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borgatta-1990">
<DESCRIPTION>
<P>No reporting issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:22 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Briel-2000">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Byron-1993">
<DESCRIPTION>
<P>No selective reporting issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:03:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carter-2013">
<DESCRIPTION>
<P>All outcome results published with corresponding P values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:04:14 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Channa-2009">
<DESCRIPTION>
<P>No selective reporting issues present, but significance values not attached to all outcomes where an event happened</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:25:15 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cogliandolo-1998">
<DESCRIPTION>
<P>Data were presented as number of cases and percentages; no conversion of data. P values stated for total major complications. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:05:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cravello-1999">
<DESCRIPTION>
<P>Data were presented as number of cases and percentages; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:14:20 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deveci-2013">
<DESCRIPTION>
<P>No reporting bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:15:21 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feste-2000">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:19:06 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonollosa-2012">
<DESCRIPTION>
<P>All outcomes fully reported with significance values attached</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:20:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghezzi-2005">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:25:21 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gunenc-2005">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:23:24 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hamade-2007">
<DESCRIPTION>
<P>No conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:26:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2012">
<DESCRIPTION>
<P>No conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:27:32 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Imran-2014">
<DESCRIPTION>
<P>Data for all outcomes published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:32:41 +1200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Johnson-1997">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. Not all outcomes reported and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:40:02 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karaca-2014">
<DESCRIPTION>
<P>P values stated for minor and major complications as groups. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:33:56 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kitano-1993">
<DESCRIPTION>
<P>Data were presented as number of cases and percentages; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 16:01:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lai-2011">
<DESCRIPTION>
<P>Data for all outcome measures were published along side significance values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:39:08 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>Major complications (specific complications not stated) not recorded, authors have been contacted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:44:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Luna-2013">
<DESCRIPTION>
<P>All primary outcomes reported with corresponding significance values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:45:57 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mettle-2000">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:46:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Minervini-2008">
<DESCRIPTION>
<P>Data were presented as number of cases and percentages; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:36:50 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrzenski-1999">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:48:39 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peitgen-1997">
<DESCRIPTION>
<P>All outcomes clearly reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:50:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2013">
<DESCRIPTION>
<P>No selective reporting bias was identified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:53:00 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Phillips-2012">
<DESCRIPTION>
<P>All outcome data published with corresponding P values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:55:33 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<DESCRIPTION>
<P>All outcomes stated with corresponding significance values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:58:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santala-1999">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:00:31 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schulze-1999">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:01:29 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-1-2006">
<DESCRIPTION>
<P>Data were presented as number of cases and means; no conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:02:57 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-2-2006">
<DESCRIPTION>
<P>Data were presented as number of cases and means; no conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:03:49 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-3-2006">
<DESCRIPTION>
<P>Data were presented as number of cases and means; no conversion of data. P values stated for each outcome. No omission of outcomes and no subsets of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:12:55 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2010">
<DESCRIPTION>
<P>All P values stated. No conversion of data. No subgroups of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-03 20:41:47 +1300" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2011">
<DESCRIPTION>
<P>No conversion of data. P values not stated for each outcome. No omission of outcomes and no subsets of data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:16:19 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2013">
<DESCRIPTION>
<P>No conversion of data. P values were stated for all outcomes. Values for all outcomes recorded in the published study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:25:31 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsimoyiannis-2009">
<DESCRIPTION>
<P>Data were presented in an appropriate manner and not converted. P values were stated. None of the stated outcomes were omitted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:25:37 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venkatesh-2007">
<DESCRIPTION>
<P>Outcomes reported with number of trocar insertions as opposed to number of participants. Complication outcomes not specifically pre defined. Data were not converted. Power calculation performed for pain scores</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:25:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vilallonga-2012">
<DESCRIPTION>
<P>All outcomes were published with significance values</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:26:48 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Villalobos-2014">
<DESCRIPTION>
<P>No selective reporting bias identified. All outcomes reported with no conversion of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:27:43 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yim-2001">
<DESCRIPTION>
<P>Data were presented as number of cases; no conversion of data. No omission of outcomes and no subsets of data. Power calculation performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:29:41 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zakerah-2010">
<DESCRIPTION>
<P>All outcomes reported, but different statistical analysis used for outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-08-26 10:37:17 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:25:46 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Agresta-2004">
<DESCRIPTION>
<P>No other bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:30:09 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Akbar-2008">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:32:22 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-1-2013">
<DESCRIPTION>
<P>No other sources of bias identified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:35:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-2-2013">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:40:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angioli-3-2013">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:42:36 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-1-2000">
<DESCRIPTION>
<P>No other bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:47:47 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-2-2000">
<DESCRIPTION>
<P>No other bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:48:34 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bemelman-3-2000">
<DESCRIPTION>
<P>No other bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:49:59 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhoyrul-2000">
<DESCRIPTION>
<P>No other bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-26 10:37:17 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bisgaard-2007">
<DESCRIPTION>
<P>P values not stated for some outcomes; i.e. moderate and severe bruising. No other risk of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:58:36 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Borgatta-1990">
<DESCRIPTION>
<P>No evidence of additional bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 15:59:23 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Briel-2000">
<DESCRIPTION>
<P>P values not stated for failed entry but for all other outcomes. No power calculation performed. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:00:01 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Byron-1993">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:03:08 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carter-2013">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:04:16 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Channa-2009">
<DESCRIPTION>
<P>No other source of bias identified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:05:16 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cogliandolo-1998">
<DESCRIPTION>
<P>No power calculation mentioned. No other selective bias issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:06:03 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cravello-1999">
<DESCRIPTION>
<P>P values not stated for each outcome. Power calculation not stated. No other bias concerns identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:14:20 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deveci-2013">
<DESCRIPTION>
<P>No other source of bias identified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:15:27 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feste-2000">
<DESCRIPTION>
<P>P values not stated for each outcome. Power calculation not mentioned. No additional bias issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:19:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fonollosa-2012">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:20:17 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghezzi-2005">
<DESCRIPTION>
<P>P values stated for each outcome. No power calculation stated. No sources of additional bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:21:25 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gunenc-2005">
<DESCRIPTION>
<P>No other bias issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:23:18 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hamade-2007">
<DESCRIPTION>
<P>No other risk of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:26:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2012">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:27:36 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Imran-2014">
<DESCRIPTION>
<P>P values not published alongside outcome results. No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:32:45 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Johnson-1997">
<DESCRIPTION>
<P>Power calculation not stated. P values not stated for each outcome. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:40:03 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karaca-2014">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:34:07 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kitano-1993">
<DESCRIPTION>
<P>P values not published for each outcome. No power calculation mentioned. No further bias issues identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:38:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lai-2011">
<DESCRIPTION>
<P>No other sources of bias were identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 16:39:11 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2000">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:45:00 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Luna-2013">
<DESCRIPTION>
<P>No other sources of bias identified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:45:50 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mettle-2000">
<DESCRIPTION>
<P>Power calculation not stated. No evidence of further bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:46:49 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Minervini-2008">
<DESCRIPTION>
<P>P values not stated for each outcome. Power calculation not performed. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-19 12:36:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ostrzenski-1999">
<DESCRIPTION>
<P>P values not stated for each outcome. Power calculation not stated. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:48:43 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peitgen-1997">
<DESCRIPTION>
<P>Not all P values published alongside outcomes. Power calculation not mentioned. No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:50:52 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez-2013">
<DESCRIPTION>
<P>No other sources of bias were identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:53:01 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Phillips-2012">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:55:39 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006">
<DESCRIPTION>
<P>No other source of bias identified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 17:58:53 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Santala-1999">
<DESCRIPTION>
<P>P values not stated for each outcome. Power calculation not stated. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:00:34 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schulze-1999">
<DESCRIPTION>
<P>Power calculation not stated. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:01:30 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-1-2006">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:02:58 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-2-2006">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:03:51 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tansatit-3-2006">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:12:56 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2010">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:14:30 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tinelli-2011">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:16:20 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tinelli-2013">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:20:29 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tsimoyiannis-2009">
<DESCRIPTION>
<P>No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:24:22 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Venkatesh-2007">
<DESCRIPTION>
<P>P values not stated for all outcomes. No other sources identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:25:10 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vilallonga-2012">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:26:50 +1200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Villalobos-2014">
<DESCRIPTION>
<P>No other source of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:27:46 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yim-2001">
<DESCRIPTION>
<P>P values not stated for each outcome. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-08-18 18:29:44 +1200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zakerah-2010">
<DESCRIPTION>
<P>P values not stated for demographics. No power calculation performed. No other sources of bias identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-08-24 22:45:57 +1200" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-08-24 22:40:52 +1200" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-08-14 13:35:02 +1200" MODIFIED_BY="[Empty name]">Open-entry compared to closed-entry for patients undergoing laparoscopy</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Open-entry compared to closed-entry for patients undergoing laparoscopy</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>patients undergoing laparoscopy<BR/>
<B>Setting: </B>surgical<BR/>
<B>Intervention: </B>open-entry techniques<BR/>
<B>Comparison: </B>closed-entry techniques</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with closed-entry techniques</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with open-entry techniques</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Vascular injury </B>
<BR/>
<B>(major vessels and abdominal wall vessels)</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.14</B>
<BR/>(0.00 to 6.82)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>795<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Visceral injury (bladder or bowel)</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>2 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
<BR/>(0 to 13)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.61</B>
<BR/>(0.06 to 6.08)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>795<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Failed entry</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>31 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5 per 1000</B>
<BR/>(1 to 20)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.16</B>
<BR/>(0.04 to 0.63)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>665<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% CI) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI). The control group rate is based on the mean rate in the comparison group.<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Studies lacked information on randomisation, allocation concealment, blinding, and dropouts.<BR/>
<SUP>2</SUP>The result crossed the line of no effect and was imprecise with wide CIs.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2015-08-24 22:43:52 +1200" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2015-06-24 06:53:09 +1200" MODIFIED_BY="[Empty name]">Direct trocar entry compared to Veress needle entry for patients undergoing laparoscopy</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Direct trocar entry compared to Veress needle entry for patients undergoing laparoscopy</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>patients undergoing laparoscopic surgery<BR/>
<B>Setting: </B>surgical<BR/>
<B>Intervention: </B>direct trocar entry<BR/>
<B>Comparison: </B>Veress needle entry</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Veress needle entry</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Direct trocar entry</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Vascular injury</B>
<BR/>
<B>(major vessels and abdominal wall vessels)</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>8 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
<BR/>(0 to 5)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.13</B>
<BR/>(0.03 to 0.66)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>1522<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>LOW</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Visceral injury (bladder or bowel) </B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
<BR/>(0 to 21)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 1.02</B>
<BR/>(0.06 to 16.24)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>1438<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>I<SUP>2</SUP> = 49%</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Solid organ injury</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>4 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
<BR/>(0 to 10)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.16</B>
<BR/>(0.01 to 2.53)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>998<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Failed entry</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>64 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>14 per 1000</B>
<BR/>(10 to 20)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.21</B>
<BR/>(0.14 to 0.30)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>3104<BR/>(7 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>MODERATE</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI). The control group rate is based on the mean rate in the comparison group.<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Studies lacked information on randomisation, allocation concealment, and blinding.<BR/>
<SUP>2</SUP>This result is no longer statistically significant when the Mantel-Haenszel OR and/or random-effects model are used, suggesting lack of reliability.<BR/>
<SUP>3</SUP>The result crossed the line of no effect and was imprecise with wide CIs.<BR/>
<SUP>4</SUP>Unexplained heterogeneity present.<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2015-08-14 13:41:11 +1200" MODIFIED_BY="[Empty name]" NO="3" READONLY="YES">
<TITLE MODIFIED="2015-08-14 13:40:29 +1200" MODIFIED_BY="[Empty name]">Direct vision entry compared to Veress needle entry for patients undergoing laparoscopy</TITLE>
<TABLE COLS="7" ROWS="7">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Direct vision entry compared to Veress needle entry for patients undergoing laparoscopy</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>patients undergoing laparoscopy<BR/>
<B>Setting: </B>surgical<BR/>
<B>Intervention: </B>direct vision entry<BR/>
<B>Comparison: </B>Veress needle entry</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Veress needle entry</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with Direct vision entry</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Visceral injury (bowel)</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>20 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>3 per 1000</B>
<BR/>(0 to 45)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.15</B>
<BR/>(0.01 to 2.34)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>194<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;</P>
<P>
<B>VERY LOW</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI). The control group rate is based on the mean rate in the comparison group.<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Studies lacked information on randomisation, allocation concealment, and blinding.<BR/>
<SUP>2</SUP>The result crossed the line of no effect and was imprecise with wide CIs.<BR/>
<SUP>3</SUP>Evidence was based on a single trial.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2015-08-24 22:45:20 +1200" MODIFIED_BY="[Empty name]" NO="4" READONLY="YES">
<TITLE MODIFIED="2015-08-14 13:41:33 +1200" MODIFIED_BY="[Empty name]">Direct vision entry compared to open-entry for patients undergoing laparoscopy</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Direct vision entry compared to open-entry for patients undergoing laparoscopy</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>patients undergoing laparoscopy<BR/>
<B>Setting: </B>surgical<BR/>
<B>Intervention: </B>direct vision entry trocars<BR/>
<B>Comparison: </B>open-entry</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with open-entry</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with direct vision entry trocars</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Visceral injury (bladder or bowel) </B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
<BR/>(0 to 32)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.13</B>
<BR/>(0.00 to 6.50)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>392<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>LOW</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Solid organ injury</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 6.16</B>
<BR/>(0.12 to 316.67)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>60<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Failed entry</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>74 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>31 per 1000</B>
<BR/>(3 to 247)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.40</B>
<BR/>(0.04 to 4.09)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>60<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>LOW</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI). The control group rate is based on the mean rate in the comparison group.<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Studies lacked information on randomisation allocation concealment, and blinding.<BR/>
<SUP>2</SUP>The result crossed the line of no effect and was imprecise with wide CIs.<BR/>
<SUP>3</SUP>The evidence was based on a single trial.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-05" MODIFIED="2015-08-24 22:45:57 +1200" MODIFIED_BY="[Empty name]" NO="5" READONLY="YES">
<TITLE MODIFIED="2015-08-14 13:43:25 +1200" MODIFIED_BY="[Empty name]">Radially expanding (STEP) trocars for primary port entry compared to standard (non-expanding) trocars for patients undergoing laparoscopy</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Radially expanding (STEP) trocars for primary port entry compared to standard (non-expanding) trocars for patients undergoing laparoscopy</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>patients undergoing laparoscopy<BR/>
<B>Setting: </B>surgical<BR/>
<B>Intervention: </B>radially expanding (STEP) trocars<BR/>
<B>Comparison: </B>non-expanding trocars</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with non-expanding trocars</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with radially expanding (STEP) trocars</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Vascular injury (major vessels and abdominal wall vessels)</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>30 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>7 per 1000</B>
<BR/>(2 to 36)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.24</B>
<BR/>(0.05 to 1.21)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>331<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;</P>
<P>
<B>LOW</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Visceral injury (bladder or bowel)</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>6 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>1 per 1000</B>
<BR/>(0 to 37)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 0.13</B>
<BR/>(0.00 to 6.37)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>331<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>LOW</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>Major complication - Solid organ injury</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>8 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>8 per 1000</B>
<BR/>(1 to 120)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>
<B>OR 1.05</B>
<BR/>(0.07 to 16.91)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>244<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>VERY LOW</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI). The control group rate is based on the mean rate in the comparison group.<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Studies lacked adequate information on allocation concealment and blinding.<BR/>
<SUP>2</SUP>The result crossed the line of no effect and was imprecise with wide CIs.<BR/>
<SUP>3</SUP>Evidence was based on a single trial.<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-08-26 15:40:33 +1200" MODIFIED_BY="Helen E Nagels">
<COMPARISON ID="CMP-001" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="1">
<NAME>Open-entry technique versus closed-entry technique (primary port entry)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.820467167072353" CI_START="0.0026853936013588454" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.31731052126128756" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="316" TOTAL_2="479" WEIGHT="100.0" Z="1.0">
<NAME>Vascular injury (major vessels and abdominal wall vessels)</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-17 13:15:05 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="0.0" Z="0.0">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-17 03:35:43 +1300" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.0" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.820467167072353" CI_START="0.0026853936013588454" DF="0" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2015-08-17 13:15:49 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.31731052126128756" STUDIES="3" TAU2="0.0" TOTAL_1="209" TOTAL_2="292" WEIGHT="100.0" Z="1.0">
<NAME>Open-entry versus Veress needle entry</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-24 10:09:00 +1300" MODIFIED_BY="[Empty name]" ORDER="113" O_E="0.0" SE="0.0" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2011-12-12 10:30:28 +1300" MODIFIED_BY="[Empty name]" ORDER="80" O_E="-0.5" SE="2.0" STUDY_ID="STD-Cogliandolo-1998" TOTAL_1="75" TOTAL_2="75" VAR="0.25" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-12-10 00:05:37 +1300" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.0" STUDY_ID="STD-Peitgen-1997" TOTAL_1="26" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.38243001269284105" CI_END="6.08249794318948" CI_START="0.06124376546403956" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6103401326049267" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.7840819707452137" LOG_CI_START="-1.2129381153287606" LOG_EFFECT_SIZE="-0.21442807229177352" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.5363059257766027" P_Q="1.0" P_Z="0.6738292605098963" Q="0.0" RANDOM="NO" SCALE="521.58" SORT_BY="WEIGHT" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="316" TOTAL_2="479" WEIGHT="99.99999999999999" Z="0.42089841949707807">
<NAME>Visceral injury (bladder or bowel)</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-17 13:16:18 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="0.0" Z="0.0">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-17 03:36:15 +1300" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.38243001269284105" CI_END="6.08249794318948" CI_START="0.06124376546403956" DF="1" EFFECT_SIZE="0.6103401326049267" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.7840819707452137" LOG_CI_START="-1.2129381153287606" LOG_EFFECT_SIZE="-0.21442807229177352" MODIFIED="2015-08-17 13:16:32 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5363059257766027" P_Z="0.6738292605098963" STUDIES="3" TAU2="0.0" TOTAL_1="209" TOTAL_2="292" WEIGHT="99.99999999999999" Z="0.42089841949707807">
<NAME>Open-entry versus Veress needle entry technique</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-12-10 00:07:13 +1300" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.0" STUDY_ID="STD-Peitgen-1997" TOTAL_1="26" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="12.511600265923562" CI_START="0.0035322252659502388" EFFECT_SIZE="0.21022319229039632" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0973128606297105" LOG_CI_START="-2.451951607291667" LOG_EFFECT_SIZE="-0.6773193733309782" MODIFIED="2014-11-24 10:09:56 +1300" MODIFIED_BY="[Empty name]" ORDER="114" O_E="-0.3588039867109635" SE="2.0848555175994847" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="0.23006368583128223" WEIGHT="31.6583403243349"/>
<DICH_DATA CI_END="16.1376669084362" CI_START="0.06196682616352898" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2078407471126154" LOG_CI_START="-1.2078407471126154" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-08-03 02:44:09 +1200" MODIFIED_BY="[Empty name]" ORDER="81" O_E="0.0" SE="1.41898326752415" STUDY_ID="STD-Cogliandolo-1998" TOTAL_1="75" TOTAL_2="75" VAR="0.4966442953020134" WEIGHT="68.34165967566508"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.1387381664872295" CI_END="0.633100210489269" CI_START="0.0423097620414315" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.16366526587575372" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.19852754208694331" LOG_CI_START="-1.3735594172209113" LOG_EFFECT_SIZE="-0.7860434796539274" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="3" P_CHI2="0.9329822810366335" P_Q="0.903480025898693" P_Z="0.008734991347068538" Q="0.01470554267928393" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="250" TOTAL_2="415" WEIGHT="100.0" Z="2.622255520053175">
<NAME>Failed entry</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="12.200150212152971" CI_START="0.003532203821238699" DF="0" EFFECT_SIZE="0.20758954019664108" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="1.0863651778802845" LOG_CI_START="-2.451954243971793" LOG_EFFECT_SIZE="-0.6827945330457541" MODIFIED="2015-08-17 13:16:52 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.44938898918668335" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="11.028214972744749" Z="0.7564340773451339">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="12.200150212152971" CI_START="0.003532203821238699" EFFECT_SIZE="0.20758954019664108" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0863651778802845" LOG_CI_START="-2.451954243971793" LOG_EFFECT_SIZE="-0.6827945330457541" MODIFIED="2014-11-17 03:36:47 +1300" MODIFIED_BY="[Empty name]" ORDER="78" O_E="-0.36394557823129253" SE="2.0784263433595265" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.23148919431718268" WEIGHT="11.028214972744749"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.12403262380794333" CI_END="0.6668421025905463" CI_START="0.037869906960457694" DF="1" EFFECT_SIZE="0.1589127067997395" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-0.17597698780998025" LOG_CI_START="-1.4217057618612032" LOG_EFFECT_SIZE="-0.7988413748355917" MODIFIED="2015-08-17 13:17:05 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7247013495096573" P_Z="0.011946868964660202" STUDIES="2" TAU2="0.0" TOTAL_1="143" TOTAL_2="228" WEIGHT="88.97178502725525" Z="2.5137098165380287">
<NAME>Open-entry versus Veress needle entry technique</NAME>
<DICH_DATA CI_END="0.9167729191785474" CI_START="0.016657033656247548" EFFECT_SIZE="0.12357474406161391" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.037738223938014986" LOG_CI_START="-1.7784023367483108" LOG_EFFECT_SIZE="-0.9080702803431628" MODIFIED="2011-12-12 10:31:05 +1300" MODIFIED_BY="[Empty name]" ORDER="82" O_E="-2.0" SE="1.02247471629109" STUDY_ID="STD-Akbar-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.9565217391304348" WEIGHT="45.56898388432082"/>
<DICH_DATA CI_END="1.612966206414543" CI_START="0.026549281063871725" EFFECT_SIZE="0.20693741363181922" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.20762526849160848" LOG_CI_START="-1.575947234816817" LOG_EFFECT_SIZE="-0.6841609831626043" MODIFIED="2014-11-24 10:10:53 +1300" MODIFIED_BY="[Empty name]" ORDER="115" O_E="-1.435215946843854" SE="1.0476793172696501" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="0.9110521958918776" WEIGHT="43.40280114293443"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1922038680920934" CI_END="0.9379547511123472" CI_START="0.07259278394294094" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.2609382045537862" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.027818112384499584" LOG_CI_START="-1.1391065480260554" LOG_EFFECT_SIZE="-0.5834623302052775" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="4" P_CHI2="0.5509553482342204" P_Q="1.0" P_Z="0.03958160786289369" Q="0.0" RANDOM="NO" SCALE="131.15683787422273" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="351" TOTAL_2="514" WEIGHT="100.0" Z="2.05808882169816">
<NAME>Extraperitoneal insufflation</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-17 13:17:25 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="0.0" Z="0.0">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-17 03:45:40 +1300" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.0" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1922038680920934" CI_END="0.9379547511123472" CI_START="0.07259278394294094" DF="2" EFFECT_SIZE="0.2609382045537862" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-0.027818112384499584" LOG_CI_START="-1.1391065480260554" LOG_EFFECT_SIZE="-0.5834623302052775" MODIFIED="2015-08-17 13:17:41 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5509553482342204" P_Z="0.03958160786289369" STUDIES="4" TAU2="0.0" TOTAL_1="244" TOTAL_2="327" WEIGHT="100.0" Z="2.05808882169816">
<NAME>Open-entry versus Veress needle entry technique</NAME>
<DICH_DATA CI_END="16.31547760037558" CI_START="0.061291494156259334" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2125997913431255" LOG_CI_START="-1.2125997913431255" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 10:53:17 +1300" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="1.4245742398014511" STUDY_ID="STD-Akbar-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.4927536231884058" WEIGHT="20.99706633662331"/>
<DICH_DATA CI_END="1.1010452455566875" CI_START="0.038071159913457525" EFFECT_SIZE="0.20473902807120278" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.04180516592166566" LOG_CI_START="-1.4194038913406044" LOG_EFFECT_SIZE="-0.6887993627094694" MODIFIED="2014-11-24 10:11:40 +1300" MODIFIED_BY="[Empty name]" ORDER="116" O_E="-2.1528239202657806" SE="0.8583214333373448" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="1.357375746404565" WEIGHT="57.84007919934223"/>
<DICH_DATA CI_END="2.15468078613177" CI_START="0.008273731913646363" EFFECT_SIZE="0.13351872971212334" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3333829389560677" LOG_CI_START="-2.082298555269163" LOG_EFFECT_SIZE="-0.8744578081565477" MODIFIED="2011-12-12 10:53:24 +1300" MODIFIED_BY="[Empty name]" ORDER="84" O_E="-1.0" SE="1.41898326752415" STUDY_ID="STD-Cogliandolo-1998" TOTAL_1="75" TOTAL_2="75" VAR="0.4966442953020134" WEIGHT="21.162854464034467"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-12-10 00:11:41 +1300" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="0.0" STUDY_ID="STD-Peitgen-1997" TOTAL_1="26" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.939053109039298" CI_END="2.063911361980831" CI_START="0.07487685921307165" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.3931147421291876" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.31469104187512764" LOG_CI_START="-1.1256523808169485" LOG_EFFECT_SIZE="-0.40548066947091044" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="5" P_CHI2="0.6252982814758739" P_Q="0.593014612326526" P_Z="0.26979924594562466" Q="0.28566105038122547" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="290" TOTAL_2="455" WEIGHT="100.0" Z="1.1035250289195442">
<NAME>Trocar site bleeding</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.698215585840222" CI_START="0.011527683243192042" DF="0" EFFECT_SIZE="0.20647483584834733" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.5679922245656469" LOG_CI_START="-1.9382579655410306" LOG_EFFECT_SIZE="-0.6851328704876918" MODIFIED="2015-08-17 13:17:56 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2839044473654567" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="33.02807496872106" Z="1.0715895452746194">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="3.698215585840222" CI_START="0.011527683243192042" EFFECT_SIZE="0.20647483584834733" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5679922245656469" LOG_CI_START="-1.9382579655410306" LOG_EFFECT_SIZE="-0.6851328704876918" MODIFIED="2014-11-17 03:49:27 +1300" MODIFIED_BY="[Empty name]" ORDER="92" O_E="-0.7278911564625851" SE="1.472183767807187" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.4613982576151354" WEIGHT="33.02807496872106"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6533920586580722" CI_END="4.096826954826379" CI_START="0.07119004598858497" DF="1" EFFECT_SIZE="0.5400493489685589" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.6124476202501451" LOG_CI_START="-1.1475807265097997" LOG_EFFECT_SIZE="-0.2675665531298273" MODIFIED="2015-08-17 13:18:12 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4189028143941078" P_Z="0.5512265783547823" STUDIES="2" TAU2="0.0" TOTAL_1="183" TOTAL_2="268" WEIGHT="66.97192503127894" Z="0.5959231379055869">
<NAME>Open-entry versus Veress needle entry technique</NAME>
<DICH_DATA CI_END="9.541416285397391" CI_START="0.0838646892188782" EFFECT_SIZE="0.8945322305444314" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.9796128442303417" LOG_CI_START="-1.0764208580671084" LOG_EFFECT_SIZE="-0.0484040069183833" MODIFIED="2014-11-24 10:12:39 +1300" MODIFIED_BY="[Empty name]" ORDER="117" O_E="-0.07641196013289031" SE="1.2077243742604897" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="0.685589783777221" WEIGHT="49.07628150445041"/>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2011-12-12 10:53:42 +1300" MODIFIED_BY="[Empty name]" ORDER="85" O_E="-0.5" SE="2.0" STUDY_ID="STD-Cogliandolo-1998" TOTAL_1="75" TOTAL_2="75" VAR="0.25" WEIGHT="17.895643526828536"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.898858573805786" CI_END="3.9022438687915577" CI_START="0.6903485435545486" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.6413130022682811" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" I2="38.76124499610969" I2_Q="75.67514297640957" ID="CMP-001.06" LOG_CI_END="0.5913144069244627" LOG_CI_START="-0.16093158705406452" LOG_EFFECT_SIZE="0.21519140993519909" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="6" P_CHI2="0.17935494031736388" P_Q="0.04260474078720489" P_Z="0.26213678976843746" Q="4.111021080330267" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="351" TOTAL_2="514" WEIGHT="100.0" Z="1.1213550264979526">
<NAME>Trocar site infection</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="168.43228306670918" CI_START="1.5016460691339268" DF="0" EFFECT_SIZE="15.903637187208991" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="2.226425335465403" LOG_CI_START="0.17656758357688895" LOG_EFFECT_SIZE="1.201496459521146" MODIFIED="2015-08-17 13:18:27 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.021583831832766038" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="13.467045207933923" Z="2.297612881717569">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="168.43228306670932" CI_START="1.5016460691339262" EFFECT_SIZE="15.903637187208991" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.226425335465403" LOG_CI_START="0.17656758357688876" LOG_EFFECT_SIZE="1.201496459521146" MODIFIED="2014-11-17 03:50:39 +1300" MODIFIED_BY="[Empty name]" ORDER="93" O_E="1.9081632653061225" SE="1.204096590418833" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.6897271898938583" WEIGHT="13.467045207933923"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7878374934755186" CI_END="2.924331403341002" CI_START="0.4543188042905241" DF="2" EFFECT_SIZE="1.1526399032287207" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.46602658801449737" LOG_CI_START="-0.34263928733109195" LOG_EFFECT_SIZE="0.06169365034170272" MODIFIED="2015-08-17 13:18:39 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6744090590151705" P_Z="0.7648989376656979" STUDIES="4" TAU2="0.0" TOTAL_1="244" TOTAL_2="327" WEIGHT="86.53295479206608" Z="0.29905387733313116">
<NAME>Open-entry versus Veress needle entry technique</NAME>
<DICH_DATA CI_END="5.003484634210659" CI_START="0.05062706699319604" EFFECT_SIZE="0.5033008561244556" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6992725703968845" LOG_CI_START="-1.2956172321147825" LOG_EFFECT_SIZE="-0.298172330858949" MODIFIED="2011-12-12 10:53:55 +1300" MODIFIED_BY="[Empty name]" ORDER="86" O_E="-0.5" SE="1.1718081448591355" STUDY_ID="STD-Akbar-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.7282608695652174" WEIGHT="14.219422109650813"/>
<DICH_DATA CI_END="4.636408975440322" CI_START="0.24912998228055133" EFFECT_SIZE="1.0747411250607453" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.6661817378918676" LOG_CI_START="-0.6035740028712283" LOG_EFFECT_SIZE="0.031303867510319626" MODIFIED="2014-11-24 10:13:33 +1300" MODIFIED_BY="[Empty name]" ORDER="118" O_E="0.1295681063122922" SE="0.7458608075165288" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="1.7975642652950852" WEIGHT="35.09775978038618"/>
<DICH_DATA CI_END="6.988740815785396" CI_START="0.408605709011881" EFFECT_SIZE="1.6898637211722911" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8443989345414431" LOG_CI_START="-0.38869556972746744" LOG_EFFECT_SIZE="0.22785168240698778" MODIFIED="2011-12-12 10:54:01 +1300" MODIFIED_BY="[Empty name]" ORDER="87" O_E="1.0" SE="0.7243258157237968" STUDY_ID="STD-Cogliandolo-1998" TOTAL_1="75" TOTAL_2="75" VAR="1.9060402684563758" WEIGHT="37.21577290202909"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-12-10 00:13:58 +1300" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="0.0" STUDY_ID="STD-Peitgen-1997" TOTAL_1="26" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.03837426893353585" CI_END="0.7139159790585046" CI_START="0.05375366924321953" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.19589692035802936" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-0.146352897437299" LOG_CI_START="-1.2695918853157198" LOG_EFFECT_SIZE="-0.7079723913765094" METHOD="PETO" MODIFIED="2015-08-26 15:40:19 +1200" MODIFIED_BY="Helen E Nagels" NO="7" P_CHI2="0.9809957725062448" P_Q="0.962648723939958" P_Z="0.01348441206821817" Q="0.002193049692640662" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="250" TOTAL_2="415" WEIGHT="100.0" Z="2.4707126517528746">
<NAME>Omental injury</NAME>
<GROUP_LABEL_1>Open</GROUP_LABEL_1>
<GROUP_LABEL_2>Closed</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours open</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours closed</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1749115367005416" CI_START="0.019390269491905473" DF="0" EFFECT_SIZE="0.20535851776266248" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="0.3374415969669167" LOG_CI_START="-1.7124161549215968" LOG_EFFECT_SIZE="-0.6874872789773401" MODIFIED="2015-08-17 13:18:52 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.18861851675417932" STUDIES="1" TAU2="0.0" TOTAL_1="107" TOTAL_2="187" WEIGHT="30.02595917644388" Z="1.31467688953893">
<NAME>Open-entry versus direct trocar entry</NAME>
<DICH_DATA CI_END="2.174911536700543" CI_START="0.019390269491905456" EFFECT_SIZE="0.20535851776266248" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.337441596966917" LOG_CI_START="-1.7124161549215973" LOG_EFFECT_SIZE="-0.6874872789773401" MODIFIED="2014-11-17 03:53:17 +1300" MODIFIED_BY="[Empty name]" ORDER="94" O_E="-1.0918367346938775" SE="1.204096590418833" STUDY_ID="STD-Angioli-1-2013" TOTAL_1="107" TOTAL_2="187" VAR="0.6897271898938583" WEIGHT="30.02595917644388"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.03618121924089379" CI_END="0.900794253499326" CI_START="0.04091186044567967" DF="1" EFFECT_SIZE="0.1919717916503219" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="-0.04537439300948452" LOG_CI_START="-1.3881507707357739" LOG_EFFECT_SIZE="-0.7167625818726293" MODIFIED="2015-08-17 13:19:05 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.849141810354478" P_Z="0.03640059225968892" STUDIES="2" TAU2="0.0" TOTAL_1="143" TOTAL_2="228" WEIGHT="69.97404082355612" Z="2.09242412845403">
<NAME>Open-entry versus Veress needle entry technique</NAME>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2011-12-12 10:57:44 +1300" MODIFIED_BY="[Empty name]" ORDER="88" O_E="-0.5" SE="2.0" STUDY_ID="STD-Akbar-2008" TOTAL_1="35" TOTAL_2="35" VAR="0.25" WEIGHT="10.883273711836907"/>
<DICH_DATA CI_END="1.1010452455566875" CI_START="0.038071159913457525" EFFECT_SIZE="0.20473902807120278" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.04180516592166566" LOG_CI_START="-1.4194038913406044" LOG_EFFECT_SIZE="-0.6887993627094694" MODIFIED="2014-11-24 10:14:14 +1300" MODIFIED_BY="[Empty name]" ORDER="119" O_E="-2.1528239202657806" SE="0.8583214333373448" STUDY_ID="STD-Angioli-2-2013" TOTAL_1="108" TOTAL_2="193" VAR="1.357375746404565" WEIGHT="59.09076711171921"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="2">
<NAME>Direct trocar entry versus Veress needle entry (primary port entry)</NAME>
<DICH_OUTCOME CHI2="5.70908189600712E-4" CI_END="0.6587175218256978" CI_START="0.026209923136140335" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.1313961019797786" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.18130078421143184" LOG_CI_START="-1.581534252674119" LOG_EFFECT_SIZE="-0.8814175184427755" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.9809374117883379" P_Q="1.0" P_Z="0.013605558046043567" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="734" TOTAL_2="788" WEIGHT="100.0" Z="2.4675122119273123">
<NAME>Vascular injury (major vessels and abdominal wall vessels)</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 11:01:39 +1300" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Agresta-2004" TOTAL_1="275" TOTAL_2="323" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-24 11:21:47 +1300" MODIFIED_BY="[Empty name]" ORDER="121" O_E="0.0" SE="0.0" STUDY_ID="STD-Angioli-3-2013" TOTAL_1="187" TOTAL_2="193" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-19 11:50:48 +1300" MODIFIED_BY="[Empty name]" ORDER="104" O_E="0.0" SE="0.0" STUDY_ID="STD-Imran-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.2953610035538903" CI_START="0.013857335368928534" EFFECT_SIZE="0.13397854996258948" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.11239081861236076" LOG_CI_START="-1.8583202723090606" LOG_EFFECT_SIZE="-0.8729647268483499" MODIFIED="2014-11-18 12:25:24 +1300" MODIFIED_BY="[Empty name]" ORDER="81" O_E="-1.5" SE="1.1576054499844726" STUDY_ID="STD-Karaca-2014" TOTAL_1="200" TOTAL_2="200" VAR="0.7462406015037594" WEIGHT="50.48414279148153"/>
<DICH_DATA CI_END="1.2732322755395769" CI_START="0.013032302470265308" EFFECT_SIZE="0.12881439410926074" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.10490763914710838" LOG_CI_START="-1.8849788489233996" LOG_EFFECT_SIZE="-0.8900356048881456" MODIFIED="2014-11-18 12:24:51 +1300" MODIFIED_BY="[Empty name]" ORDER="99" O_E="-1.5" SE="1.1688691731895926" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TOTAL_1="42" TOTAL_2="42" VAR="0.7319277108433736" WEIGHT="49.51585720851846"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9687872478183412" CI_END="16.24478387750528" CI_START="0.06353343470910587" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.0159167858860378" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="49.207310180004306" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="1.2107139378151206" LOG_CI_START="-1.1969976654440575" LOG_EFFECT_SIZE="0.006858136185531571" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.1605769606695574" P_Q="1.0" P_Z="0.9910913732468105" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="692" TOTAL_2="746" WEIGHT="100.0" Z="0.011165539848308675">
<NAME>Visceral injury (bladder or bowel)</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 11:01:51 +1300" MODIFIED_BY="[Empty name]" ORDER="93" O_E="0.0" SE="0.0" STUDY_ID="STD-Agresta-2004" TOTAL_1="275" TOTAL_2="323" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.039272150035574" CI_START="0.00276883503772502" EFFECT_SIZE="0.13960867941894026" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8475277560789258" LOG_CI_START="-2.5577029179777413" LOG_EFFECT_SIZE="-0.8550875809494076" MODIFIED="2014-11-24 11:22:18 +1300" MODIFIED_BY="[Empty name]" ORDER="122" O_E="-0.4921052631578947" SE="2.0002493541045756" STUDY_ID="STD-Angioli-3-2013" TOTAL_1="187" TOTAL_2="193" VAR="0.2499376731301939" WEIGHT="49.993766535994794"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-19 11:52:17 +1300" MODIFIED_BY="[Empty name]" ORDER="105" O_E="0.0" SE="0.0" STUDY_ID="STD-Imran-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" MODIFIED="2014-11-12 23:18:09 +1300" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.5" SE="2.0" STUDY_ID="STD-Karaca-2014" TOTAL_1="200" TOTAL_2="200" VAR="0.25" WEIGHT="50.00623346400521"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="151.91" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="475" TOTAL_2="523" WEIGHT="0.0" Z="0.0">
<NAME>Solid organ injury</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.530995189053581" CI_START="0.009680790795472195" EFFECT_SIZE="0.1565312586340962" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.40329131964680887" LOG_CI_START="-2.014089164997156" LOG_EFFECT_SIZE="-0.8053989226751735" MODIFIED="2011-12-12 11:01:26 +1300" MODIFIED_BY="[Empty name]" ORDER="91" O_E="-0.919732441471572" SE="1.419981262906253" STUDY_ID="STD-Agresta-2004" TOTAL_1="275" TOTAL_2="323" VAR="0.49594643463361787" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-12 23:19:31 +1300" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="0.0" STUDY_ID="STD-Karaca-2014" TOTAL_1="200" TOTAL_2="200" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.5764543115255907" CI_END="0.3008375885824196" CI_START="0.14232963868985468" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.2069253616337614" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="102" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-0.5216679011454217" LOG_CI_START="-0.8467046531192366" LOG_EFFECT_SIZE="-0.6841862771323292" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="4" P_CHI2="0.8598150139578372" P_Q="1.0" P_Z="1.5674050851931325E-16" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1518" TOTAL_2="1586" WEIGHT="100.0" Z="8.251254381251854">
<NAME>Failed entry</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1168632415412678" CI_START="0.02166599284092543" EFFECT_SIZE="0.15555690597182073" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.047999997573838465" LOG_CI_START="-1.664221404693042" LOG_EFFECT_SIZE="-0.8081107035596018" MODIFIED="2014-11-27 12:06:47 +1300" MODIFIED_BY="[Empty name]" ORDER="96" O_E="-1.839464882943144" SE="1.0057673273242" STUDY_ID="STD-Agresta-2004" TOTAL_1="275" TOTAL_2="323" VAR="0.9885643697059363" WEIGHT="3.603670681235468"/>
<DICH_DATA CI_END="1.7885601213819582" CI_START="0.05266689131802357" EFFECT_SIZE="0.3069167664507344" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.25250354328039315" LOG_CI_START="-1.2784623152721404" LOG_EFFECT_SIZE="-0.5129793859958736" MODIFIED="2014-11-24 11:22:57 +1300" MODIFIED_BY="[Empty name]" ORDER="123" O_E="-1.460526315789474" SE="0.8992969237169809" STUDY_ID="STD-Angioli-3-2013" TOTAL_1="187" TOTAL_2="193" VAR="1.2364990425306428" WEIGHT="4.507481235914756"/>
<DICH_DATA CI_END="2.325486963980841" CI_START="0.008943485427908302" EFFECT_SIZE="0.14421497417103873" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3665139093228933" LOG_CI_START="-2.0484931962922666" LOG_EFFECT_SIZE="-0.8409896434846865" MODIFIED="2014-11-27 12:06:46 +1300" MODIFIED_BY="[Empty name]" ORDER="97" O_E="-0.9622641509433962" SE="1.418587128316317" STUDY_ID="STD-Borgatta-1990" TOTAL_1="102" TOTAL_2="110" VAR="0.49692170899562854" WEIGHT="1.8114573501264803"/>
<DICH_DATA CI_END="3.269034225729329" CI_START="0.12598003153444629" EFFECT_SIZE="0.641742187209603" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.514419467526706" LOG_CI_START="-0.899698287276555" LOG_EFFECT_SIZE="-0.19263940987492448" MODIFIED="2011-12-12 11:02:26 +1300" MODIFIED_BY="[Empty name]" ORDER="98" O_E="-0.6428571428571428" SE="0.8306597691672162" STUDY_ID="STD-Byron-1993" TOTAL_1="111" TOTAL_2="141" VAR="1.4492844946743637" WEIGHT="5.283160310320259"/>
<DICH_DATA CI_END="0.5680881129760703" CI_START="0.0730578739340618" EFFECT_SIZE="0.20372361115306398" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="13" LOG_CI_END="-0.245584298071641" LOG_CI_START="-1.1363329703959348" LOG_EFFECT_SIZE="-0.6909586342337878" MODIFIED="2014-11-27 12:06:45 +1300" MODIFIED_BY="[Empty name]" ORDER="99" O_E="-5.811418685121107" SE="0.52323017940033" STUDY_ID="STD-Gunenc-2005" TOTAL_1="301" TOTAL_2="277" VAR="3.6527035656429625" WEIGHT="13.315410862589935"/>
<DICH_DATA CI_END="0.7375747431670032" CI_START="0.020279519449308822" EFFECT_SIZE="0.12230151818098663" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.13219396328170913" LOG_CI_START="-1.6929423404129695" LOG_EFFECT_SIZE="-0.9125681518473393" MODIFIED="2014-11-18 12:29:59 +1300" MODIFIED_BY="[Empty name]" ORDER="102" O_E="-2.5" SE="0.9167913225559697" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TOTAL_1="42" TOTAL_2="42" VAR="1.1897590361445782" WEIGHT="4.337097196376367"/>
<DICH_DATA CI_END="0.3097115481366635" CI_START="0.1242456293237327" EFFECT_SIZE="0.19616397785288534" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="70" LOG_CI_END="-0.509042600912099" LOG_CI_START="-0.9057188798096898" LOG_EFFECT_SIZE="-0.7073807403608944" MODIFIED="2014-11-27 12:06:14 +1300" MODIFIED_BY="[Empty name]" ORDER="100" O_E="-30.0" SE="0.23300960980369365" STUDY_ID="STD-Zakerah-2010" TOTAL_1="500" TOTAL_2="500" VAR="18.41841841841842" WEIGHT="67.14172236343673"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.4945947762126313" CI_END="0.2640805793586249" CI_START="0.13794536552722966" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.1908630190693527" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="139" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-0.5782635358907946" LOG_CI_START="-0.8602928856868655" LOG_EFFECT_SIZE="-0.71927821078883" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="5" P_CHI2="0.9275035630302718" P_Q="1.0" P_Z="1.5668299524831596E-23" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1748" TOTAL_2="1816" WEIGHT="100.00000000000001" Z="9.997253044974801">
<NAME>Extraperitoneal insufflation</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.3705271194231295" CI_START="0.05930448950571484" EFFECT_SIZE="0.14823603362682006" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="19" LOG_CI_END="-0.4311799998714568" LOG_CI_START="-1.2269124281575705" LOG_EFFECT_SIZE="-0.8290462140145136" MODIFIED="2014-11-27 12:12:41 +1300" MODIFIED_BY="[Empty name]" ORDER="101" O_E="-8.737458193979933" SE="0.4674171673143096" STUDY_ID="STD-Agresta-2004" TOTAL_1="275" TOTAL_2="323" VAR="4.577102959231905" WEIGHT="12.561875883675807"/>
<DICH_DATA CI_END="0.6810852319836767" CI_START="0.027149389628863006" EFFECT_SIZE="0.13598179412549824" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="-0.1667985364513971" LOG_CI_START="-1.5662399297508784" LOG_EFFECT_SIZE="-0.8665192331011378" MODIFIED="2014-11-24 11:23:24 +1300" MODIFIED_BY="[Empty name]" ORDER="124" O_E="-2.9526315789473685" SE="0.8220388017707349" STUDY_ID="STD-Angioli-3-2013" TOTAL_1="187" TOTAL_2="193" VAR="1.4798420541006734" WEIGHT="4.061431953057067"/>
<DICH_DATA CI_END="1.0205940180260675" CI_START="0.01963336844669458" EFFECT_SIZE="0.14155457742651148" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.008853018487802547" LOG_CI_START="-1.7070051832164965" LOG_EFFECT_SIZE="-0.8490760823643471" MODIFIED="2014-11-27 12:12:42 +1300" MODIFIED_BY="[Empty name]" ORDER="102" O_E="-1.9245283018867925" SE="1.0079036013161873" STUDY_ID="STD-Borgatta-1990" TOTAL_1="102" TOTAL_2="110" VAR="0.9843782425818165" WEIGHT="2.7016297024655094"/>
<DICH_DATA CI_END="1.1040024300297948" CI_START="0.0650577840666138" EFFECT_SIZE="0.26799990989158057" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.042970029323768213" LOG_CI_START="-1.1867007333079511" LOG_EFFECT_SIZE="-0.5718653519920914" MODIFIED="2011-12-12 11:04:09 +1300" MODIFIED_BY="[Empty name]" ORDER="103" O_E="-2.5238095238095237" SE="0.7223146929383164" STUDY_ID="STD-Byron-1993" TOTAL_1="111" TOTAL_2="141" VAR="1.9166689252062046" WEIGHT="5.260304905306099"/>
<DICH_DATA CI_END="0.41926378104463047" CI_START="0.03438426650357424" EFFECT_SIZE="0.12006697123994914" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.3775126533890826" LOG_CI_START="-1.46364023573516" LOG_EFFECT_SIZE="-0.9205764445621212" MODIFIED="2014-11-27 12:12:43 +1300" MODIFIED_BY="[Empty name]" ORDER="104" O_E="-5.2076124567474045" SE="0.6379967182883282" STUDY_ID="STD-Gunenc-2005" TOTAL_1="301" TOTAL_2="277" VAR="2.4567621376971016" WEIGHT="6.742592710792766"/>
<DICH_DATA CI_END="0.90904132492943" CI_START="0.01626205188855087" EFFECT_SIZE="0.12158485594365534" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.041416373344730466" LOG_CI_START="-1.7888246575332594" LOG_EFFECT_SIZE="-0.915120515438995" MODIFIED="2014-11-19 11:53:10 +1300" MODIFIED_BY="[Empty name]" ORDER="106" O_E="-2.0" SE="1.026436275942851" STUDY_ID="STD-Imran-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.9491525423728814" WEIGHT="2.6049526388552837"/>
<DICH_DATA CI_END="0.661152694702021" CI_START="0.12716200575625086" EFFECT_SIZE="0.28995431152072765" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="19" LOG_CI_END="-0.17969822764268598" LOG_CI_START="-0.8956426304741426" LOG_EFFECT_SIZE="-0.5376704290584142" MODIFIED="2014-11-27 12:12:43 +1300" MODIFIED_BY="[Empty name]" ORDER="84" O_E="-7.0" SE="0.42054928620514814" STUDY_ID="STD-Karaca-2014" TOTAL_1="200" TOTAL_2="200" VAR="5.654135338345864" WEIGHT="15.517795204179809"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-18 12:28:17 +1300" MODIFIED_BY="[Empty name]" ORDER="101" O_E="0.0" SE="0.0" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TOTAL_1="42" TOTAL_2="42" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.3097115481366635" CI_START="0.1242456293237327" EFFECT_SIZE="0.19616397785288534" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="70" LOG_CI_END="-0.509042600912099" LOG_CI_START="-0.9057188798096898" LOG_EFFECT_SIZE="-0.7073807403608944" MODIFIED="2011-12-12 11:04:20 +1300" MODIFIED_BY="[Empty name]" ORDER="105" O_E="-30.0" SE="0.23300960980369365" STUDY_ID="STD-Zakerah-2010" TOTAL_1="500" TOTAL_2="500" VAR="18.41841841841842" WEIGHT="50.54941700166766"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.1426520481846207" CI_END="0.585505243655732" CI_START="0.17161184654420833" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.31698522997937423" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="33" I2="36.359483349252216" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-0.23246921112867713" LOG_CI_START="-0.7654527356528338" LOG_EFFECT_SIZE="-0.49896097339075546" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="6" P_CHI2="0.2077696039001249" P_Q="1.0" P_Z="2.428327278472113E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="789" TOTAL_2="803" WEIGHT="100.0" Z="3.66970269263025">
<NAME>Omental injury</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.957906610066169" CI_START="0.13948975992038792" EFFECT_SIZE="0.5225972856652343" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.29179197260490475" LOG_CI_START="-0.8554576732025901" LOG_EFFECT_SIZE="-0.28183285029884264" MODIFIED="2014-11-24 11:24:30 +1300" MODIFIED_BY="[Empty name]" ORDER="126" O_E="-1.4289473684210527" SE="0.6739001209246586" STUDY_ID="STD-Angioli-3-2013" TOTAL_1="187" TOTAL_2="193" VAR="2.2019574949385685" WEIGHT="21.58299470845784"/>
<DICH_DATA CI_END="2.0497973731839645" CI_START="0.18161282285934138" EFFECT_SIZE="0.6101389081460078" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.3117109322472541" LOG_CI_START="-0.7408534911648662" LOG_EFFECT_SIZE="-0.2145712794588061" MODIFIED="2014-11-27 12:12:36 +1300" MODIFIED_BY="[Empty name]" ORDER="107" O_E="-1.2924528301886795" SE="0.6182815525902057" STUDY_ID="STD-Borgatta-1990" TOTAL_1="102" TOTAL_2="110" VAR="2.6159378537841302" WEIGHT="25.640718763035245"/>
<DICH_DATA CI_END="0.43742767275952105" CI_START="0.08076943607079477" EFFECT_SIZE="0.18796485429608023" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="20" LOG_CI_END="-0.3590937458831948" LOG_CI_START="-1.0927529493360417" LOG_EFFECT_SIZE="-0.7259233476096183" MODIFIED="2011-12-12 11:10:27 +1300" MODIFIED_BY="[Empty name]" ORDER="108" O_E="-9.0" SE="0.43095504777983024" STUDY_ID="STD-Zakerah-2010" TOTAL_1="500" TOTAL_2="500" VAR="5.384384384384385" WEIGHT="52.77628652850691"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.989162445824388" CI_END="1.6204858790312993" CI_START="0.16490364976620228" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5169371681808669" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="62.44913005157407" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.20964525092792893" LOG_CI_START="-0.7827697321312195" LOG_EFFECT_SIZE="-0.2865622406016452" METHOD="PETO" MODIFIED="2015-08-26 15:40:25 +1200" MODIFIED_BY="Helen E Nagels" NO="7" P_CHI2="0.04623632868212768" P_Q="1.0" P_Z="0.25768123312496694" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="361" TOTAL_2="375" WEIGHT="100.0" Z="1.1318887370624302">
<NAME>Trocar site infection</NAME>
<GROUP_LABEL_1>Direct trocar</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct trocar</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7966625721319573" CI_START="0.02345894924191401" EFFECT_SIZE="0.13670723039611418" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.0987255858699347" LOG_CI_START="-1.6296914444224682" LOG_EFFECT_SIZE="-0.8642085151462015" MODIFIED="2014-11-24 11:24:01 +1300" MODIFIED_BY="[Empty name]" ORDER="125" O_E="-2.460526315789474" SE="0.8992969237169809" STUDY_ID="STD-Angioli-3-2013" TOTAL_1="187" TOTAL_2="193" VAR="1.2364990425306428" WEIGHT="42.019957936238605"/>
<DICH_DATA CI_END="7.3555064062239195" CI_START="0.002879914541984532" EFFECT_SIZE="0.14554459750517934" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8666125780639174" LOG_CI_START="-2.54062039921827" LOG_EFFECT_SIZE="-0.8370039105771763" MODIFIED="2014-11-27 12:11:01 +1300" MODIFIED_BY="[Empty name]" ORDER="109" O_E="-0.4811320754716981" SE="2.001425516930807" STUDY_ID="STD-Borgatta-1990" TOTAL_1="102" TOTAL_2="110" VAR="0.24964400142399432" WEIGHT="8.483654315980248"/>
<DICH_DATA CI_END="79.2580798474003" CI_START="0.7926619155333293" EFFECT_SIZE="7.926213559659736" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.899043546653485" LOG_CI_START="-0.10091200754528452" LOG_EFFECT_SIZE="0.8990657695541002" MODIFIED="2014-11-19 11:53:50 +1300" MODIFIED_BY="[Empty name]" ORDER="107" O_E="1.5" SE="1.1747837924760145" STUDY_ID="STD-Imran-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.7245762711864407" WEIGHT="24.623281854337815"/>
<DICH_DATA CI_END="4.991886578092105" CI_START="0.05109497853043689" EFFECT_SIZE="0.5050349864454858" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6982647090725388" LOG_CI_START="-1.2916217789979691" LOG_EFFECT_SIZE="-0.29667853496271523" MODIFIED="2014-11-18 12:27:27 +1300" MODIFIED_BY="[Empty name]" ORDER="100" O_E="-0.5" SE="1.1688691731895926" STUDY_ID="STD-Prieto_x002d_D_x00ed_az_x002d_Ch_x00e1_vez-2006" TOTAL_1="42" TOTAL_2="42" VAR="0.7319277108433736" WEIGHT="24.873105893443334"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2015-08-20 15:15:15 +1200" MODIFIED_BY="Helen E Nagels" NO="3">
<NAME>Direct vision entry versus Veress needle entry (primary port entry)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-20 15:15:06 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="93" TOTAL_2="101" WEIGHT="0.0" Z="0.0">
<NAME>Visceral injury (bladder or bowel)</NAME>
<GROUP_LABEL_1>Direct vision</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct vision</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3410187426609017" CI_START="0.00898518109240014" EFFECT_SIZE="0.14503267681288615" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3694048907584018" LOG_CI_START="-2.046473165451219" LOG_EFFECT_SIZE="-0.8385341373464086" MODIFIED="2011-12-12 11:16:01 +1300" MODIFIED_BY="[Empty name]" ORDER="110" O_E="-0.9587628865979382" SE="1.4190987290067785" STUDY_ID="STD-Tinelli-2010" TOTAL_1="93" TOTAL_2="101" VAR="0.4965634821031787" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-20 15:15:15 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="93" TOTAL_2="101" WEIGHT="0.0" Z="0.0">
<NAME>Trocar site bleeding</NAME>
<GROUP_LABEL_1>Direct vision</GROUP_LABEL_1>
<GROUP_LABEL_2>Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct vision</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Veress needle</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.7789529787990217" CI_START="0.10822138056237979" EFFECT_SIZE="0.548399606020617" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.44388119837115264" LOG_CI_START="-0.9656869301447129" LOG_EFFECT_SIZE="-0.26090286588678" MODIFIED="2011-12-12 11:16:18 +1300" MODIFIED_BY="[Empty name]" ORDER="111" O_E="-0.8762886597938144" SE="0.8279872961649868" STUDY_ID="STD-Tinelli-2010" TOTAL_1="93" TOTAL_2="101" VAR="1.4586552286780874" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2015-08-26 15:40:33 +1200" MODIFIED_BY="Helen E Nagels" NO="4">
<NAME>Direct vision entry versus open-entry technique (primary port entry)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-26 15:40:33 +1200" MODIFIED_BY="Helen E Nagels" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="194" TOTAL_2="198" WEIGHT="0.0" Z="0.0">
<NAME>Visceral injury (bladder or bowel)</NAME>
<GROUP_LABEL_1>Direct vision</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-entry</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct vision</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-entry</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.5029703184780665" CI_START="0.002554701172211987" EFFECT_SIZE="0.1288919931395107" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8131117717611497" LOG_CI_START="-2.5926598927305715" LOG_EFFECT_SIZE="-0.889774060484711" MODIFIED="2014-11-27 04:19:48 +1300" MODIFIED_BY="[Empty name]" ORDER="109" O_E="-0.5119047619047619" SE="2.000567134564072" STUDY_ID="STD-Tinelli-2011" TOTAL_1="86" TOTAL_2="82" VAR="0.24985827664399093" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-27 04:19:15 +1300" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="0.0" STUDY_ID="STD-Tinelli-2013" TOTAL_1="108" TOTAL_2="116" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-26 15:40:33 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="33" TOTAL_2="27" WEIGHT="0.0" Z="0.0">
<NAME>Solid organ injury</NAME>
<GROUP_LABEL_1>Direct vision</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-entry</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct vision</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-entry</GRAPH_LABEL_2>
<DICH_DATA CI_END="316.6691886965229" CI_START="0.11985243229243792" EFFECT_SIZE="6.160647084304638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5006058094090426" LOG_CI_START="-0.9213531479426722" LOG_EFFECT_SIZE="0.789626330733185" MODIFIED="2011-12-12 11:26:18 +1300" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.44999999999999996" SE="2.010075630518424" STUDY_ID="STD-Minervini-2008" TOTAL_1="33" TOTAL_2="27" VAR="0.24750000000000003" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-26 15:40:33 +1200" MODIFIED_BY="Helen E Nagels" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="33" TOTAL_2="27" WEIGHT="0.0" Z="0.0">
<NAME>Failed entry</NAME>
<GROUP_LABEL_1>Direct vision</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-entry</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct vision</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-entry</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.087756416169521" CI_START="0.03994422947943795" EFFECT_SIZE="0.4040820218019111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6114850088817321" LOG_CI_START="-1.3985459519257253" LOG_EFFECT_SIZE="-0.3935304715219966" MODIFIED="2011-12-12 11:26:26 +1300" MODIFIED_BY="[Empty name]" ORDER="113" O_E="-0.6499999999999999" SE="1.180702136192025" STUDY_ID="STD-Minervini-2008" TOTAL_1="33" TOTAL_2="27" VAR="0.7173305084745765" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-26 15:40:33 +1200" MODIFIED_BY="Helen E Nagels" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="33" TOTAL_2="27" WEIGHT="0.0" Z="0.0">
<NAME>Trocar site bleeding</NAME>
<GROUP_LABEL_1>Direct vision</GROUP_LABEL_1>
<GROUP_LABEL_2>Open-entry</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours direct vision</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours open-entry</GRAPH_LABEL_2>
<DICH_DATA CI_END="316.6691886965229" CI_START="0.11985243229243792" EFFECT_SIZE="6.160647084304638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5006058094090426" LOG_CI_START="-0.9213531479426722" LOG_EFFECT_SIZE="0.789626330733185" MODIFIED="2011-12-12 11:26:35 +1300" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.44999999999999996" SE="2.010075630518424" STUDY_ID="STD-Minervini-2008" TOTAL_1="33" TOTAL_2="27" VAR="0.24750000000000003" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2015-08-20 15:16:16 +1200" MODIFIED_BY="Helen E Nagels" NO="5">
<NAME>Radially expanding (STEP) trocars versus standard (non-expanding) trocars (primary port entry)</NAME>
<DICH_OUTCOME CHI2="0.07926606043988893" CI_END="1.213141453354501" CI_START="0.04627922416727077" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.23694565888912503" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.08391144293551846" LOG_CI_START="-1.3346139302452973" LOG_EFFECT_SIZE="-0.6253512436548895" METHOD="PETO" MODIFIED="2015-08-19 17:48:52 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7782945064425116" P_Q="1.0" P_Z="0.08397306077721728" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="164" TOTAL_2="167" WEIGHT="100.0" Z="1.7280845847720807">
<NAME>Vascular injury (major vessels and abdominal wall vessels)</NAME>
<GROUP_LABEL_1>Radially expand'g</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours radially expand'g</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.164323577420329" CI_START="0.002814097562979451" EFFECT_SIZE="0.1419898078018798" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8551751925754573" LOG_CI_START="-2.550660849925752" LOG_EFFECT_SIZE="-0.8477428286751474" MODIFIED="2011-12-12 11:39:00 +1300" MODIFIED_BY="[Empty name]" ORDER="120" O_E="-0.48770491803278687" SE="2.000604950525522" STUDY_ID="STD-Bhoyrul-2000" TOTAL_1="119" TOTAL_2="125" VAR="0.24984883095941954" WEIGHT="17.3470944306033"/>
<DICH_DATA CI_END="1.5902812097895445" CI_START="0.04376975874472669" EFFECT_SIZE="0.26382991659165655" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.20147392750364088" LOG_CI_START="-1.358825847175387" LOG_EFFECT_SIZE="-0.578675959835873" MODIFIED="2011-12-12 11:39:04 +1300" MODIFIED_BY="[Empty name]" ORDER="121" O_E="-1.5862068965517242" SE="0.9165278112549103" STUDY_ID="STD-Feste-2000" TOTAL_1="45" TOTAL_2="42" VAR="1.190443270746343" WEIGHT="82.6529055693967"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-20 15:16:16 +1200" MODIFIED_BY="Helen E Nagels" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="164" TOTAL_2="167" WEIGHT="0.0" Z="0.0">
<NAME>Visceral injury (bladder or bowel)</NAME>
<GROUP_LABEL_1>Radially expand'g</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours radially expand'g</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 11:39:13 +1300" MODIFIED_BY="[Empty name]" ORDER="122" O_E="0.0" SE="0.0" STUDY_ID="STD-Bhoyrul-2000" TOTAL_1="119" TOTAL_2="125" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.365113056651621" CI_START="0.002494444706815777" EFFECT_SIZE="0.12600564500231182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8038061219635759" LOG_CI_START="-2.6030261184199053" LOG_EFFECT_SIZE="-0.8996099982281646" MODIFIED="2011-12-12 11:39:18 +1300" MODIFIED_BY="[Empty name]" ORDER="123" O_E="-0.5172413793103449" SE="2.001190122092827" STUDY_ID="STD-Feste-2000" TOTAL_1="45" TOTAL_2="42" VAR="0.24970273483947683" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.907920574654767" CI_START="0.06528745841211774" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.0506546346698151" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="1.2280901990534696" LOG_CI_START="-1.1851702377989253" LOG_EFFECT_SIZE="0.021459980627272134" METHOD="PETO" MODIFIED="2015-07-10 04:08:30 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.9721929231544147" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="125" WEIGHT="100.0" Z="0.03485806048620296">
<NAME>Solid organ injury</NAME>
<GROUP_LABEL_1>Radially expand'g</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours radially expand'g</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.907920574654767" CI_START="0.06528745841211774" EFFECT_SIZE="1.0506546346698151" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2280901990534696" LOG_CI_START="-1.1851702377989253" LOG_EFFECT_SIZE="0.021459980627272134" MODIFIED="2011-12-12 11:38:51 +1300" MODIFIED_BY="[Empty name]" ORDER="119" O_E="0.024590163934426257" SE="1.417561126438919" STUDY_ID="STD-Bhoyrul-2000" TOTAL_1="119" TOTAL_2="125" VAR="0.49764129293974924" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.958455525631804" CI_END="0.6207954248916937" CI_START="0.15207344452136626" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.30725640531384363" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="29" I2="59.664859558356916" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="-0.20705149238068815" LOG_CI_START="-0.8179466170103108" LOG_EFFECT_SIZE="-0.5124990546954995" METHOD="PETO" MODIFIED="2015-08-20 13:08:09 +1200" MODIFIED_BY="Helen E Nagels" NO="4" P_CHI2="0.08380798240684184" P_Q="1.0" P_Z="0.001007047683712593" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="206" TOTAL_2="215" WEIGHT="100.0" Z="3.2885503544426045">
<NAME>Trocar site bleeding</NAME>
<GROUP_LABEL_1>Radially expand'g</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours radially expand'g</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.39141313930268734" CI_START="0.042053463058054505" EFFECT_SIZE="0.12829761491977434" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.4073645996517668" LOG_CI_START="-1.376198234703738" LOG_EFFECT_SIZE="-0.8917814171777524" MODIFIED="2011-12-14 12:09:12 +1300" MODIFIED_BY="[Empty name]" ORDER="124" O_E="-6.340163934426229" SE="0.5690976730333672" STUDY_ID="STD-Bhoyrul-2000" TOTAL_1="119" TOTAL_2="125" VAR="3.087638022103444" WEIGHT="39.758949649305414"/>
<DICH_DATA CI_END="1.6777138719487508" CI_START="0.2468278692222433" EFFECT_SIZE="0.6435111033833913" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.22471789545004303" LOG_CI_START="-0.6076058058782124" LOG_EFFECT_SIZE="-0.19144395521408467" MODIFIED="2011-12-14 12:09:13 +1300" MODIFIED_BY="[Empty name]" ORDER="125" O_E="-1.8441558441558445" SE="0.48891106222898645" STUDY_ID="STD-Bisgaard-2007" TOTAL_1="38" TOTAL_2="39" VAR="4.18350480688143" WEIGHT="53.870225649415"/>
<DICH_DATA CI_END="2.238214979761721" CI_START="0.008503620219311721" EFFECT_SIZE="0.13795988604325585" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.34990179802802285" LOG_CI_START="-2.07039614410333" LOG_EFFECT_SIZE="-0.8602471730376535" MODIFIED="2011-12-14 12:02:58 +1300" MODIFIED_BY="[Empty name]" ORDER="126" O_E="-0.98" SE="1.4216949918759918" STUDY_ID="STD-Mettle-2000" TOTAL_1="49" TOTAL_2="51" VAR="0.4947515151515152" WEIGHT="6.370824701279584"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2015-08-19 17:49:14 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Comparisons of sites of entry</NAME>
<DICH_OUTCOME CHI2="3.0464710547184772" CI_END="19.892995814829757" CI_START="0.38304665986368097" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.7604248951117514" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="67.17513536026655" I2_Q="67.17513536026655" ID="CMP-006.01" LOG_CI_END="1.2987001912630223" LOG_CI_START="-0.41674832032103404" LOG_EFFECT_SIZE="0.4409759354709942" METHOD="PETO" MODIFIED="2015-08-19 17:49:14 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.08091300849494953" P_Q="0.08091300849494953" P_Z="0.31361631228304576" Q="3.0464710547184772" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="100" TOTAL_2="100" WEIGHT="200.0" Z="1.0076629473115577">
<NAME>Transfundal versus infraumbilical insertion of the Veress needle</NAME>
<GROUP_LABEL_1>Transfundal</GROUP_LABEL_1>
<GROUP_LABEL_2>Infraumbilical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours transfundal</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours infraumbilical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.820467167072353" CI_START="0.0026853936013588454" DF="0" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2015-08-19 15:00:53 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.31731052126128756" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.0">
<NAME>Failed entry</NAME>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232082" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" MODIFIED="2011-12-12 12:26:48 +1300" MODIFIED_BY="[Empty name]" ORDER="127" O_E="-0.5" SE="2.0" STUDY_ID="STD-Santala-1999" TOTAL_1="50" TOTAL_2="50" VAR="0.25" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="75.76384530340333" CI_START="0.7825895070004321" DF="0" EFFECT_SIZE="7.700129242061292" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="1.879462008651887" LOG_CI_START="-0.10646597943861165" LOG_EFFECT_SIZE="0.8864980146066377" MODIFIED="2015-08-19 15:00:53 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.08015008683436836" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.7498158960596661">
<NAME>Uterine bleeding</NAME>
<DICH_DATA CI_END="75.76384530340333" CI_START="0.7825895070004321" EFFECT_SIZE="7.700129242061292" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.879462008651887" LOG_CI_START="-0.10646597943861165" LOG_EFFECT_SIZE="0.8864980146066377" MODIFIED="2011-12-12 12:26:58 +1300" MODIFIED_BY="[Empty name]" ORDER="128" O_E="1.5" SE="1.1665439307064442" STUDY_ID="STD-Santala-1999" TOTAL_1="50" TOTAL_2="50" VAR="0.7348484848484849" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2015-08-26 07:45:47 +1200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Comparisons of other laparoscopic entry techniques for primary or secondary port insertion</NAME>
<DICH_OUTCOME CHI2="3.031591627024842E-6" CI_END="8.506272151053167" CI_START="2.313229173143596" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="4.435871604827525" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.9297392734884983" LOG_CI_START="0.36421866074351944" LOG_EFFECT_SIZE="0.6469789671160089" METHOD="PETO" MODIFIED="2015-08-19 17:49:42 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9986107666786272" P_Q="0.9986107666787942" P_Z="7.306464857194832E-6" Q="3.0315916262962725E-6" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="225" TOTAL_2="225" WEIGHT="200.0" Z="4.484559698530848">
<NAME>Lifting versus not lifting the abdominal wall before Veress needle insertion</NAME>
<GROUP_LABEL_1>Lifting</GROUP_LABEL_1>
<GROUP_LABEL_2>Not lifting</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lifting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours not lifting</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-19 14:59:53 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="0.0" Z="0.0">
<NAME>Visceral injury (bladder or bowel)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 12:39:07 +1300" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="0.0" STUDY_ID="STD-Briel-2000" TOTAL_1="75" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.12801343225903" CI_START="2.156856668854616" DF="0" EFFECT_SIZE="4.437095519003664" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="9" I2="0.0" ID="CMP-007.01.02" LOG_CI_END="0.9603762704933839" LOG_CI_START="0.3338212855783066" LOG_EFFECT_SIZE="0.6470987780358451" MODIFIED="2015-08-19 14:59:53 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="5.155651468566856E-5" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="100.0" Z="4.048456495999432">
<NAME>Failed entry</NAME>
<DICH_DATA CI_END="9.12801343225903" CI_START="2.156856668854616" EFFECT_SIZE="4.437095519003664" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="9" LOG_CI_END="0.9603762704933839" LOG_CI_START="0.3338212855783066" LOG_EFFECT_SIZE="0.6470987780358451" MODIFIED="2011-12-12 22:35:49 +1300" MODIFIED_BY="[Empty name]" ORDER="134" O_E="11.0" SE="0.368041499636312" STUDY_ID="STD-Briel-2000" TOTAL_1="75" TOTAL_2="75" VAR="7.38255033557047" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="20.10297885125512" CI_START="0.9764370178291755" DF="0" EFFECT_SIZE="4.430495764471797" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" I2="0.0" ID="CMP-007.01.03" LOG_CI_END="1.3032604157691408" LOG_CI_START="-0.01035576434887058" LOG_EFFECT_SIZE="0.646452325710135" MODIFIED="2015-08-19 14:59:53 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.05372321332312949" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="100.0" Z="1.9290616167657066">
<NAME>Extraperitoneal insufflation</NAME>
<DICH_DATA CI_END="20.10297885125512" CI_START="0.9764370178291755" EFFECT_SIZE="4.430495764471797" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.3032604157691408" LOG_CI_START="-0.01035576434887058" LOG_EFFECT_SIZE="0.646452325710135" MODIFIED="2011-12-12 12:39:26 +1300" MODIFIED_BY="[Empty name]" ORDER="135" O_E="2.5" SE="0.7716246467062825" STUDY_ID="STD-Briel-2000" TOTAL_1="75" TOTAL_2="75" VAR="1.679530201342282" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.0454747079523266" CI_END="10.845948624875339" CI_START="0.6668047893253854" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.6892620712463025" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" I2="1.1240883019966823" I2_Q="25.843018193984626" ID="CMP-007.02" LOG_CI_END="1.0352675429367966" LOG_CI_START="-0.17600128951272273" LOG_EFFECT_SIZE="0.4296331267120368" METHOD="PETO" MODIFIED="2015-08-24 23:56:13 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3998867342513751" P_Q="0.2565957348319844" P_Z="0.16441177486054193" Q="4.045472087641854" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="230" TOTAL_2="225" WEIGHT="400.0" Z="1.390385738264292">
<NAME>Carbon dioxide gas insufflation versus gasless abdominal wall retractor</NAME>
<GROUP_LABEL_1>Carbon dioxide</GROUP_LABEL_1>
<GROUP_LABEL_2>Gasless abdo retractor</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CO2</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours gasless retractor</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.6203104717612002E-6" CI_END="115.63671167693569" CI_START="0.45226198357455627" DF="1" EFFECT_SIZE="7.231741740206849" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-007.02.01" LOG_CI_END="2.0630957332851425" LOG_CI_START="-0.3446099168255788" LOG_EFFECT_SIZE="0.8592429082297819" MODIFIED="2015-08-19 14:59:59 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.998708436186237" P_Z="0.1618391267743528" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="92" WEIGHT="100.0" Z="1.3989128231055843">
<NAME>Vascular injury</NAME>
<DICH_DATA CI_END="365.3595577091636" CI_START="0.14379832285878713" EFFECT_SIZE="7.248316469291747" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5627204728583433" LOG_CI_START="-0.8422461791646916" LOG_EFFECT_SIZE="0.8602371468468258" MODIFIED="2011-12-12 12:40:38 +1300" MODIFIED_BY="[Empty name]" ORDER="136" O_E="0.49514563106796117" SE="2.00009426625509" STUDY_ID="STD-Cravello-1999" TOTAL_1="52" TOTAL_2="51" VAR="0.24997643510227163" WEIGHT="50.00127263629976"/>
<DICH_DATA CI_END="363.72678042332996" CI_START="0.14312712892780213" EFFECT_SIZE="7.215204071690858" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5607752784038924" LOG_CI_START="-0.8442780404053258" LOG_EFFECT_SIZE="0.8582486189992834" MODIFIED="2011-12-12 12:40:44 +1300" MODIFIED_BY="[Empty name]" ORDER="137" O_E="0.49397590361445787" SE="2.0001451747543015" STUDY_ID="STD-Kitano-1993" TOTAL_1="42" TOTAL_2="41" VAR="0.2499637102627377" WEIGHT="49.99872736370025"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="74.9670012957804" CI_START="0.7665483085507012" DF="0" EFFECT_SIZE="7.580621876891017" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-007.02.02" LOG_CI_END="1.874870139274261" LOG_CI_START="-0.11546047032572994" LOG_EFFECT_SIZE="0.8797048344742655" MODIFIED="2015-08-19 14:59:59 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.08317279726039024" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="41" WEIGHT="100.0" Z="1.7325662221934592">
<NAME>Extraperitoneal insufflation</NAME>
<DICH_DATA CI_END="74.9670012957804" CI_START="0.7665483085507012" EFFECT_SIZE="7.580621876891017" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.874870139274261" LOG_CI_START="-0.11546047032572994" LOG_EFFECT_SIZE="0.8797048344742655" MODIFIED="2011-12-12 12:41:04 +1300" MODIFIED_BY="[Empty name]" ORDER="138" O_E="1.4819277108433735" SE="1.169130052374448" STUDY_ID="STD-Kitano-1993" TOTAL_1="42" TOTAL_2="41" VAR="0.7316011032080127" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.689270898423591" CI_START="0.002632765220027743" DF="0" EFFECT_SIZE="0.13270749703281032" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-007.02.03" LOG_CI_END="0.8253787841284793" LOG_CI_START="-2.5795878678945554" LOG_EFFECT_SIZE="-0.8771045418830382" MODIFIED="2015-08-24 23:56:13 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.3126120616705408" STUDIES="1" TAU2="0.0" TOTAL_1="52" TOTAL_2="51" WEIGHT="100.0" Z="1.0097563285948028">
<NAME>Trocar site bleeding</NAME>
<DICH_DATA CI_END="6.689270898423591" CI_START="0.002632765220027743" EFFECT_SIZE="0.13270749703281032" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8253787841284793" LOG_CI_START="-2.5795878678945554" LOG_EFFECT_SIZE="-0.8771045418830382" MODIFIED="2011-12-12 12:41:28 +1300" MODIFIED_BY="[Empty name]" ORDER="139" O_E="-0.5048543689320388" SE="2.00009426625509" STUDY_ID="STD-Cravello-1999" TOTAL_1="52" TOTAL_2="51" VAR="0.24997643510227163" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.873802528368921" CI_START="0.05999674686045057" DF="0" EFFECT_SIZE="0.9758977979313871" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-007.02.04" LOG_CI_END="1.2006809733380719" LOG_CI_START="-1.22187229726398" LOG_EFFECT_SIZE="-0.010595661962954047" MODIFIED="2015-08-24 23:55:06 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.9863210856299589" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="41" WEIGHT="100.0" Z="0.017144816662454553">
<NAME>Trocar site infection</NAME>
<DICH_DATA CI_END="15.873802528368921" CI_START="0.05999674686045057" EFFECT_SIZE="0.9758977979313871" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2006809733380719" LOG_CI_START="-1.22187229726398" LOG_EFFECT_SIZE="-0.010595661962954047" MODIFIED="2011-12-12 12:41:46 +1300" MODIFIED_BY="[Empty name]" ORDER="140" O_E="-0.012048192771084265" SE="1.4230197829837365" STUDY_ID="STD-Kitano-1993" TOTAL_1="42" TOTAL_2="41" VAR="0.4938307446654086" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-08-19 17:50:08 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="150" TOTAL_2="150" WEIGHT="0.0" Z="0.0">
<NAME>A closed technique versus a parallel technique of Veress needle insertion</NAME>
<GROUP_LABEL_1>Closed technique</GROUP_LABEL_1>
<GROUP_LABEL_2>Parallel Veress needle</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours closed</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours parallel V needle</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-19 15:00:13 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Vascular injury</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 12:42:34 +1300" MODIFIED_BY="[Empty name]" ORDER="141" O_E="0.0" SE="0.0" STUDY_ID="STD-Ostrzenski-1999" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-19 15:00:13 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Visceral injury (bladder or bowel)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 12:42:44 +1300" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.0" STUDY_ID="STD-Ostrzenski-1999" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-08-19 15:00:13 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Extraperitoneal insufflation</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-12-12 12:42:53 +1300" MODIFIED_BY="[Empty name]" ORDER="143" O_E="0.0" SE="0.0" STUDY_ID="STD-Ostrzenski-1999" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.615779831230184" CI_END="1.9510647938657388" CI_START="0.1770230262296998" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5876932824019163" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="35.005565479919156" I2_Q="50.71418126691647" ID="CMP-007.04" LOG_CI_END="0.2902716923320348" LOG_CI_START="-0.7519702392083352" LOG_EFFECT_SIZE="-0.23084927343815015" METHOD="PETO" MODIFIED="2015-08-24 23:55:31 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.20219264424962013" P_Q="0.1314696364119513" P_Z="0.3852648662478063" Q="4.057962414769591" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="258" TOTAL_2="267" WEIGHT="300.0" Z="0.8682365353067509">
<NAME>Cutting trocar versus blunt trocar</NAME>
<GROUP_LABEL_1>Cutting</GROUP_LABEL_1>
<GROUP_LABEL_2>Blunt</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cutting</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours blunt</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="386.6860365802045" CI_START="0.15205104156906524" DF="0" EFFECT_SIZE="7.667855933847074" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-007.04.01" LOG_CI_END="2.58735848977243" LOG_CI_START="-0.8180106005369603" LOG_EFFECT_SIZE="0.8846739446177351" MODIFIED="2015-08-19 15:00:17 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.30851159541620166" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="100.0" Z="1.018350154434631">
<NAME>Visceral injury (bladder or bowel)</NAME>
<DICH_DATA CI_END="386.6860365802045" CI_START="0.15205104156906524" EFFECT_SIZE="7.667855933847074" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.58735848977243" LOG_CI_START="-0.8180106005369603" LOG_EFFECT_SIZE="0.8846739446177351" MODIFIED="2011-12-12 12:37:47 +1300" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.509090909090909" SE="2.000330660496597" STUDY_ID="STD-Venkatesh-2007" TOTAL_1="81" TOTAL_2="84" VAR="0.24991735537190082" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5578174164605935" CI_END="1.2304466420988514" CI_START="0.0858836507158419" DF="1" EFFECT_SIZE="0.325077297937734" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-007.04.02" LOG_CI_END="0.09006278541430032" LOG_CI_START="-1.0660895029869883" LOG_EFFECT_SIZE="-0.48801335878634405" MODIFIED="2015-08-19 15:00:17 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.45514108208982407" P_Z="0.09800432255187827" STUDIES="2" TAU2="0.0" TOTAL_1="96" TOTAL_2="99" WEIGHT="100.0" Z="1.654606606398327">
<NAME>Trocar site bleeding</NAME>
<DICH_DATA CI_END="2.115817851176342" CI_START="0.007504153802096514" EFFECT_SIZE="0.12600564500231182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3254782769576692" LOG_CI_START="-2.1246982734139985" LOG_EFFECT_SIZE="-0.8996099982281646" MODIFIED="2011-12-12 12:37:55 +1300" MODIFIED_BY="[Empty name]" ORDER="130" O_E="-1.0" SE="1.439245834257849" STUDY_ID="STD-Hamade-2007" TOTAL_1="15" TOTAL_2="15" VAR="0.48275862068965514" WEIGHT="22.26564744068478"/>
<DICH_DATA CI_END="1.9299279927905229" CI_START="0.0942370130813803" EFFECT_SIZE="0.4264629520869574" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2855411054237716" LOG_CI_START="-1.0257784876549378" LOG_EFFECT_SIZE="-0.37011869111558315" MODIFIED="2011-12-12 12:38:01 +1300" MODIFIED_BY="[Empty name]" ORDER="131" O_E="-1.4363636363636365" SE="0.7702756201111073" STUDY_ID="STD-Venkatesh-2007" TOTAL_1="81" TOTAL_2="84" VAR="1.6854182624470873" WEIGHT="77.73435255931521"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="386.6860365802045" CI_START="0.15205104156906524" DF="0" EFFECT_SIZE="7.667855933847074" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-007.04.03" LOG_CI_END="2.58735848977243" LOG_CI_START="-0.8180106005369603" LOG_EFFECT_SIZE="0.8846739446177351" MODIFIED="2015-08-24 23:55:31 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.30851159541620166" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="100.0" Z="1.018350154434631">
<NAME>Trocar site infection</NAME>
<DICH_DATA CI_END="386.6860365802045" CI_START="0.15205104156906524" EFFECT_SIZE="7.667855933847074" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.58735848977243" LOG_CI_START="-0.8180106005369603" LOG_EFFECT_SIZE="0.8846739446177351" MODIFIED="2011-12-12 12:38:13 +1300" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.509090909090909" SE="2.000330660496597" STUDY_ID="STD-Venkatesh-2007" TOTAL_1="81" TOTAL_2="84" VAR="0.24991735537190082" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.929978821663291" CI_END="3.925596406110362" CI_START="0.357275354771862" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1842798861266817" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" I2_Q="68.2415194396234" ID="CMP-007.05" LOG_CI_END="0.5939056473757649" LOG_CI_START="-0.4469969408525252" LOG_EFFECT_SIZE="0.07345435326161986" METHOD="PETO" MODIFIED="2015-07-15 09:26:40 +1200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5595408423345527" P_Q="0.07598475990523379" P_Z="0.7820709473117644" Q="3.148765250588366" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="452" TOTAL_2="432" WEIGHT="200.0" Z="0.2766212487673867">
<NAME>SILS versus Hasson entry technique</NAME>
<GROUP_LABEL_1>SILS</GROUP_LABEL_1>
<GROUP_LABEL_2>Hasson entry technique</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SILS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Hasson entry</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-11-27 13:22:24 +1300" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="24" WEIGHT="0.0" Z="0.0">
<NAME>Mortality</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-27 13:22:24 +1300" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.0" SE="0.0" STUDY_ID="STD-Fonollosa-2012" TOTAL_1="26" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-11-27 13:22:56 +1300" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="27" WEIGHT="0.0" Z="0.0">
<NAME>Vascular injury (major vessels and abdominal wall vessels)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-27 13:22:56 +1300" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2011" TOTAL_1="24" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.02769995077643378" CI_END="66.94008198044466" CI_START="0.7013018562305343" DF="2" EFFECT_SIZE="6.851657007550071" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-007.05.03" LOG_CI_END="1.8256862398955698" LOG_CI_START="-0.15409501159371525" LOG_EFFECT_SIZE="0.8357956141509273" MODIFIED="2015-06-25 04:08:21 +1200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9862454957781741" P_Z="0.0979531249649413" STUDIES="5" TAU2="0.0" TOTAL_1="261" TOTAL_2="236" WEIGHT="100.0" Z="1.6548588900314871">
<NAME>Failed entry (unable to access the peritoneal cavity)</NAME>
<DICH_DATA CI_END="345.89823132946685" CI_START="0.1353365342095049" EFFECT_SIZE="6.841978355514407" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.5389483413557414" LOG_CI_START="-0.8685849494201577" LOG_EFFECT_SIZE="0.8351816959677919" MODIFIED="2014-11-27 13:24:47 +1300" MODIFIED_BY="[Empty name]" ORDER="117" O_E="0.48" SE="2.001601922563589" STUDY_ID="STD-Fonollosa-2012" TOTAL_1="26" TOTAL_2="24" VAR="0.24960000000000002" WEIGHT="33.7562503698016"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-11-27 13:24:59 +1300" MODIFIED_BY="[Empty name]" ORDER="118" O_E="0.0" SE="0.0" STUDY_ID="STD-Lai-2011" TOTAL_1="24" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-21 06:42:19 +1300" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="0.0" STUDY_ID="STD-Perez-2013" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="291.40430224875786" CI_START="0.09954053904591975" EFFECT_SIZE="5.385772119774607" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.4644959593389215" LOG_CI_START="-1.0020000117330992" LOG_EFFECT_SIZE="0.7312479738029112" MODIFIED="2014-11-27 13:25:13 +1300" MODIFIED_BY="[Empty name]" ORDER="119" O_E="0.40609137055837563" SE="2.0362368928395056" STUDY_ID="STD-Phillips-2012" TOTAL_1="117" TOTAL_2="80" VAR="0.2411811693163957" WEIGHT="32.617676025343606"/>
<DICH_DATA CI_END="441.4542226733464" CI_START="0.17012297024332915" EFFECT_SIZE="8.66611236874123" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.6448856753629313" LOG_CI_START="-0.7692370433749744" LOG_EFFECT_SIZE="0.9378243159939784" MODIFIED="2014-11-27 13:25:29 +1300" MODIFIED_BY="[Empty name]" ORDER="120" O_E="0.5369127516778524" SE="2.0054725851666664" STUDY_ID="STD-Vilallonga-2012" TOTAL_1="69" TOTAL_2="80" VAR="0.24863744876356922" WEIGHT="33.6260736048548"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7535136202984909" CI_END="2.477734026554828" CI_START="0.148036521844641" DF="2" EFFECT_SIZE="0.6056361344464959" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" ID="CMP-007.05.04" LOG_CI_END="0.3940546850105338" LOG_CI_START="-0.8296311273152721" LOG_EFFECT_SIZE="-0.21778822115236918" MODIFIED="2015-06-25 04:08:29 +1200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6860830558976228" P_Z="0.4853911341132475" STUDIES="4" TAU2="0.0" TOTAL_1="141" TOTAL_2="145" WEIGHT="100.0" Z="0.6976579533996222">
<NAME>Trocar site infection</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-21 06:43:16 +1300" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.0" SE="0.0" STUDY_ID="STD-Carter-2013" TOTAL_1="37" TOTAL_2="38" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.674004770239982" CI_START="0.0029806425192674996" EFFECT_SIZE="0.15123975969049575" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8850220648242806" LOG_CI_START="-2.5256901075698988" LOG_EFFECT_SIZE="-0.8203340213728091" MODIFIED="2014-11-27 13:26:46 +1300" MODIFIED_BY="[Empty name]" ORDER="122" O_E="-0.47058823529411764" SE="2.0034692133618845" STUDY_ID="STD-Lai-2011" TOTAL_1="24" TOTAL_2="27" VAR="0.2491349480968858" WEIGHT="12.872108957137174"/>
<DICH_DATA CI_END="5.057289137848246" CI_START="0.04849784079915892" EFFECT_SIZE="0.49524499339486505" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7039177840423391" LOG_CI_START="-1.3142775964469091" LOG_EFFECT_SIZE="-0.305179906202285" MODIFIED="2014-11-27 13:27:24 +1300" MODIFIED_BY="[Empty name]" ORDER="123" O_E="-0.5" SE="1.1854979567276382" STUDY_ID="STD-Luna-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.7115384615384616" WEIGHT="36.763210758191185"/>
<DICH_DATA CI_END="7.280114333926823" CI_START="0.1373604800874892" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8621381999453998" LOG_CI_START="-0.8621381999453998" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-02-21 06:44:04 +1300" MODIFIED_BY="[Empty name]" ORDER="133" O_E="0.0" SE="1.0128484926016907" STUDY_ID="STD-Villalobos-2014" TOTAL_1="60" TOTAL_2="60" VAR="0.9747899159663865" WEIGHT="50.36468028467164"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.2367278404334536" CI_START="0.008503123565745414" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.13791001852711263" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-007.06" LOG_CI_END="0.34961314342222577" LOG_CI_START="-2.070421509794264" LOG_EFFECT_SIZE="-0.8604041831860193" METHOD="PETO" MODIFIED="2015-08-19 15:00:27 +1200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.16341818741633657" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="1.3936669947687261">
<NAME>5 mm versus 3 mm secondary port trocars</NAME>
<GROUP_LABEL_1>5 mm</GROUP_LABEL_1>
<GROUP_LABEL_2>3 mm</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 5 mm</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 3 mm</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2367278404334536" CI_START="0.008503123565745414" DF="0" EFFECT_SIZE="0.13791001852711263" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-007.06.01" LOG_CI_END="0.34961314342222577" LOG_CI_START="-2.070421509794264" LOG_EFFECT_SIZE="-0.8604041831860193" MODIFIED="2015-08-19 15:00:27 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.16341818741633657" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="1.3936669947687261">
<NAME>Trocar site bleeding</NAME>
<DICH_DATA CI_END="2.2367278404334536" CI_START="0.008503123565745414" EFFECT_SIZE="0.13791001852711263" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.34961314342222577" LOG_CI_START="-2.070421509794264" LOG_EFFECT_SIZE="-0.8604041831860193" MODIFIED="2015-07-11 04:02:21 +1200" MODIFIED_BY="[Empty name]" ORDER="144" O_E="-0.9803921568627451" SE="1.4215403346641005" STUDY_ID="STD-Ghezzi-2005" TOTAL_1="50" TOTAL_2="52" VAR="0.49485917449876476" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.0990157583647417E-4" CI_END="0.960836637843771" CI_START="0.018472439535113704" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.13322536055755677" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-007.07" LOG_CI_END="-0.01735044512429028" LOG_CI_START="-1.733475746320662" LOG_EFFECT_SIZE="-0.8754130957224763" METHOD="PETO" MODIFIED="2015-08-26 07:45:47 +1200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.9884406685504257" P_Q="0.9884406685504432" P_Z="0.04554396978853527" Q="2.0990157583583558E-4" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="64" TOTAL_2="65" WEIGHT="200.0" Z="1.9995954118439236">
<NAME>Radially expanding (STEP) trocars versus standard (non-expanding) trocars (secondary port entry)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expanding 2ndary</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard 2ndary</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1434661568193665" CI_START="0.008042379524746589" DF="0" EFFECT_SIZE="0.13129572853520916" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-007.07.01" LOG_CI_END="0.33111663082652965" LOG_CI_START="-2.0946154361306433" LOG_EFFECT_SIZE="-0.8817494026520567" MODIFIED="2015-08-19 15:00:33 +1200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.15418986122418102" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="34" WEIGHT="100.0" Z="1.4248870236980298">
<NAME>Trocar site bleeding</NAME>
<DICH_DATA CI_END="2.1434661568193656" CI_START="0.008042379524746596" EFFECT_SIZE="0.13129572853520916" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3311166308265294" LOG_CI_START="-2.094615436130643" LOG_EFFECT_SIZE="-0.8817494026520567" MODIFIED="2015-07-11 04:54:31 +1200" MODIFIED_BY="[Empty name]" ORDER="145" O_E="-1.0" SE="1.42488702369803" STUDY_ID="STD-Yim-2001" TOTAL_1="34" TOTAL_2="34" VAR="0.4925373134328358" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.2132920555769138" CI_START="0.008257214198147324" DF="0" EFFECT_SIZE="0.13518737583796936" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-007.07.02" LOG_CI_END="0.3450387251593476" LOG_CI_START="-2.0831664493429476" LOG_EFFECT_SIZE="-0.8690638620917998" MODIFIED="2015-08-24 23:55:57 +1200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.16062962589577023" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="31" WEIGHT="100.0" Z="1.4029571206348672">
<NAME>Trocar site infection</NAME>
<DICH_DATA CI_END="2.2132920555769138" CI_START="0.008257214198147324" EFFECT_SIZE="0.13518737583796936" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3450387251593476" LOG_CI_START="-2.0831664493429476" LOG_EFFECT_SIZE="-0.8690638620917998" MODIFIED="2015-07-11 04:01:26 +1200" MODIFIED_BY="[Empty name]" ORDER="146" O_E="-0.9836065573770492" SE="1.4263397393121147" STUDY_ID="STD-Lam-2000" TOTAL_1="30" TOTAL_2="31" VAR="0.49153453372749256" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-08-26 15:40:27 +1200" MODIFIED_BY="Helen E Nagels">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-08-15 15:53:37 +1200" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjIAAAM5CAYAAAAdfNsuAABoi0lEQVR42uydD2QdS9/HX+qqiqoS
8YiqChERFREiqiqiRFU9HhUqquq6LlVRcUV5REVElaiIqCoRcVVUqbqiKkJFVVSVKyKiqkRURVWJ
uKqi5n2/451jzubszu45SZqcfD4cyTm7Ozuz8/v99rvzZ+d/jMf//M//8OHDJ+UHsoHN4B8A2xJb
/CADANluzMC1AuocdoGQweAACNZcI6DuYY/aGYYGQLDm2gA2AAgZAAI1cG0AGwCEDACBmmsD2AAA
QgaAQM21AWwAEDIAQKDm2gA2AAgZAAI11wawAYByEzILCwvUBBCouTaADQBsnZD5559/zLVr10xF
RYU5ePCg6ezsNF+/fs1tX11dNf/5z3/stkOHDtntnz9/LioTSmMrneVnOc7POG+x59yqvJaaznYe
v1P1QaAu/tp8+/bN1NbWZo4/4ubNm+bw4cO5+KOY5J83+jlw4AAigDLAfhIyN27cMPfu3TM/fvyw
HwUNBQtHe3u7efToUW67/j979uxPM/Td4Cx7ScjslvP/7OMJ1D/v2mxsbJiLFy8W3CcUf4aGhszo
6Ghu++DgoGlra4s9119//WX6+voQAZQB9pOQOXr0qA0QftDxW05++eWXTccU+s3x7Nkzu11PRSdP
njSzs7MFn5ziDN//Tfm6fv26fRqrrq42k5OTiS0yAwMD5siRI/bprqenJ1W+CvHhwwdz4cIF+wSo
Y+rq6szTp08Lnlf/v3792lRVVZnm5uZUeQmlH1fu9+/fm8bGxoI3imPHjpn19fXE66n/x8fHzfHj
x+110LmfP3+e2/79+3dz5coVmy/laW5uLjadUuotdH3SHF9sGQnUO38Tk/BYWVkpuE8o/tTU1NhW
mzTxR+nIPwr5QSn+muQXrsVIx2m7yvrx48fE84XsO0usQsgAQqYAclo5XbRFxvH48WNz5syZ2OP9
G8f09LQNRHGGHrohDg8Pm9u3b1vHV3fW6dOnY2+o9+/ftzcw7atgqOBw586dVPmKomD48OHD3FOg
ngj9axLNQ3d3t93v06dPqfISSj+p3KqPaGDTuX7//fdUN3kJKBdodT38m8KtW7ds/YqpqSlTX19f
lJAJ1Vvo+oSOL6WMBOqdv4nNzMykvn7R+OOztrZmBUdXV1fB7bKrUGtMMf6a5Bd3797NazFSWhI9
SecL2XeWWIWQAYRMAf7880/ruI6lpSX71ORaUvS/fotDQcg5fcjQQzdEPcEosDnevn0be0NtamrK
e7JzT3Np8pUGv989mgf/CSxNXkLpJ5VbgbSjoyPvWO3/999/p7rJR/Pqb1eAjua7GCETqrfQ9Qkd
X0oZCdQ/7yaWZp9o/HFcunTJtnroE2frekBYXl4O5iGrvyb5RUNDQ56t6v/KysrE84Xsu9RYhZCB
fS1kvnz5YgOGnkocerrVU4d74lCftfq749AThM6l4NDf31+SkIk+Sev8cTdU7Zs06C8pX4VQc7AC
qp7+FKzizluoDKG8hNIPlVvdJk5MKgj6TeSlCJCklotS0onmP3R9QseXkjcC9e4VMoXiTxR146i7
JYr8oaWlpag8ZLXHuAeQQvvHnS/JvrPGKoQMIGT+HwWPy5cvb5qRpP5q/2lE/6svOCQCXMtBb2/v
lgmZpJtWmpkKcfmKMjExYZ/CxsbGbLO4moSzCJlQXkLph8qtAY+a6SHUjP3gwYNdLWSy1lXoeIRM
+QmZuPhTaL9C9jEyMmJFTjF5KMYei4lRWew7baxCyABCxnsS0o2xULNsVLRIyKh5Nw3z8/OJTh39
rvP7v7W2tuY1wS4uLsamp6c09aEXk68oGoTnpxXNVyhQhfISSj9UbgV71YumoWqAoqa2bsVNXtNj
i+laypr/0PUJHY+QKS8hkxR/1M3ii5to141DrcS68ReTh5A9JvmFjo12LfmDlQudL4t9h2IVQgYQ
Mv/Hq1ev7OBd/90MPhqoppYDPQnJmTVQTSPu41BLg0bdi+hAS9181V/snNgf1KZZDerG8vOpAbFq
fXCD4jTQNe6mpe4vN4BOH333p2km5SuKum7cLCIFGTVZZxEyobyE0g+V27XE/Pvf/7b1kza4hG7y
6upSs7Z48eJF7GDfUustdH3SlB8hUx5CJhR/1Mqi7hVnK//973/tJ4rGtLjBtFnzELLHJL/QvmoN
csdqKrn/vpxC5wvZd5ZYhZABhMz/oWm7hV4q5dDTvm6WesrQRyImqQVATaIa8+GmvjqHFJoJ4NLx
nVT7yvm1bzSfGpOjJzC1PGhGQNJNSzMW1Nqh9HVz9QNbUr6ivHz50gZG7aegooF3WYRMKC+h9EPl
FpoCqt9Cb0vOcpNXveodHsqXrpXG3xTar9R6C12fNMcjZMpDyITijx6gXPxRS3Bc95HsMa7VJE0+
k+wxyS+c2HIDkfWAodckhM6XZN9ZYhVCBhAysGdRoFXLDhCouTaADQBCBvYUevLUE+RemtFAoOba
ADYAgJABi8YaaZmIpC4+IFBzbQAbAIQMABCouTaADQBCBoBAzbUBbAAAIQNAoObaADYACBkAIFBz
bQAbAIQMAIEauDaADcDPEzKhF6rBzlMudVJutkWg3t3XZrfY236NqfgH/DQh468LUg7GuJfyH/dG
2r1SJ3rjqN48qlV6t8K2dnvdEaizX5udrPMke4vaaqnnTTp+L/jvduQJ/4CfJmTSrEgNuyv47xb8
NZf2g23hG1t/bbbymialFbLVrTzXXrB7hAyUjZAptL6J/moRNL3+3q31EQ0AAwMDdo0QrS3S09MT
NO6JiQm7roj217op/ovctF1ri2iV2+bm5sRzrK+v27VZoi+C0yKUWoW2kDO5dVD0EjktBKdFK5Mc
r9BTnK6D0p+dnU0sa9J10dt4tU6V1nOprq42k5OTBVtk4uokS5nGx8dj6y9rmeLOFbc2Tim2Vcq1
R8jsflEe8oGQDyXZdpLfpPGpUnx3K+y+UAwsJXa5MinPR48eNaOjo5viTSjO4x+wp1tkzp8/n3Oa
6OqrWuBMwUTOrQXd5NRaDDLJuNWcq/R0jJzrxo0bedslbrTNLdSWdI5r167ZFWd9tCK30o2WR/vJ
gd3KtEpXi7qlDQa+c2v1Wy30GEfouiiPboVdrXh7+vTp1AtRZi2TFr2Lq78sZSrm+pViW8Vee4TM
3hAyIR8I+VDItpP8Jmlbqb67FXYfjYGlxi6Vp7e3N5fnU6dObboeSXnCP2DPCxlf+Uf3kSiJrjKb
dJPRsVqp2fHPP//YVpWk8yWdY2lpyR7vtuvviRMn8loKHFpBVq01fsuNWobSBgM9IWll6jSEroue
tPy8aAXdYoRMmjIl1V+WMhVz/UqxrWLziZDZG0Im5AMhH8piP1m2leq7W2H30e2lxq7W1lazurqa
GG+S8oR/wJ4XMqFWimjzqZomk4w7GiSSnqLSnOPMmTP2iUM8fPjQPqUVSq9QvkLn9n9TS4BrUQot
0BjKc/RpR9ekGCGzk2Uq5lyl2Fax+UTI7A0hE/KBkA9lsZ8s20r13a20+63y8+iA46R4g5CBfSdk
kkRLWuMOOWToHFNTU6aurs7+r/ETMzMzqQJnmgAS/U191zpfR0eHbarNctOPK3MoL6Ggu1NlKuZc
WxnQ0+YTIbM3hUzW2LJdQqZU390OIVOqn2d5cELIwL4TMhIOa2trmYx7fn4+9/3r1692AFrS+dKc
Q4PU1HetbqWkvEabZ/0nlei5l5eXY51RZUhy1FCe1dTr52VxcbEoIZO1TEkBJk2Zsp5rqwN6mnwi
ZPaGkAn5QMiHtkvIlOq722H3pcaulpYWOzbG8ffffyNkoHyFjEbEq6/UOU3IwDUIzQ1800ffNaI+
ybi1XU6l/f/73/+aixcvJhp/mnNoMJ5mEEQHGkfzqpH5Lp179+6Z2travKcWN6B0ZWXFdlH5x9fX
19vZMyI0GC6UZ3WBDQ4O5gbftbe3xwaWpDoJlSlUf1nLlPVcpdhWsflEyOwNIRPygZAPhewnyd5C
A+hL8d2ttPutil3Rwb4qD0IGylbISAhI6Tu1n8bA+/r6bKuKjpEDuZH2ccb99OlT869//csO4Pzj
jz9sq0zI+EPn+PLli93mP3UUSs9NYdRHo/7fv3+f2+ZukGpaVpDQjdM/Xl0bGnTnpie6G2scoTwP
DQ3ZAXua5qlZCHGBJVQnSWUK1V/WMmU9Vym2VUo+ETK7X8iEfCDkQyH7SbK3UCtJKb67lXa/VbFL
SHwpv3rgU56LbbnFP2DXCxmCPwC2zLUpb/TuLX+2KDYACBmMG7hZA9dm16LWIw2Ud+/GUevOdg+Y
xwagbIVMdBogADdrrg1sL5rJqfffKP7qzb7q0pegwQYAIQPAzRq4NoANAEIGgEDNtQFsAAAhA0Cg
5toANgAIGQAgUHNtABsAhAwAgZprA9gAAEIGgEDNtVlYWODi4h8AOytkMGYgUHNttmrfrK9voI7w
D0DIAACBetcImazXnDrCP2AfChn9rnVttA6SXqDkGBgYsOt0aJ2Pnp4e+9v6+rp9zbVed+2jxdG0
WmshYy6UjtCq1VovSbiVW9+8eWO/r66ublrVGoBAvfeujd4se/36dbuOkdb8mZyczNv3w4cPdm0j
LbSotYPq6urs2mwuTf8T2t8dowUbtTaR9jl37px5+/ZtqvMJrVnk1jBSTJudnU0VzwD/gJ8sZLq7
u23AcQulaYExrZ7qXm+t4ONWmb527ZpdmdVneHjYOnjUmJPSuXz5snny5In9/9GjR7YJWfu77wpE
AATqvX1tFBvcytJa4PX06dN5+zY2NtrVpd0qz6Ojo/ahKi7dNPu3trbahyFtV4y5evVq6uP9VaWn
p6dNTU1NqngG+Af8ZCGjJxifpqYm66w+zqGXlpZsq4zbrr9qPXFp+OdJSmdiYsKKIvHbb7+Zrq4u
+xEKPAoSAATqvX1t1MqrFluHWkdC11GtIVmueXR/vwVG8UdxKO3xEjWPHz8uuF9SPAP8A36ykImi
p5Jos67v7GfOnLFPJkJPN2qqLZReUjoSRHo6EmrCnZ+fz63OquZedTcBEKj39rVRDPCREIjuq67t
W7du2QeZhoaGvO2F0s26fzQPScerFUbfJVr6+/szxUVsAP+AXSRkQs6pVVUlNpwI0QJlhdILpaPF
zNTc7ATM8ePHzeLi4rYvNw9AoP45Qia6r1pm6+vrzdjYmI0j6t5OEiZZ9xf+zKfQ8U7oKMZ1dHTk
rRiNaME/YA8JGYmTtbW1xAQlOtT/HR2U66cXSufixYvm119/zXUpue4l9x2AQL23r43Gq/hdS3pQ
8ffVIGA/RriB/3Hpptlfrb0Ondt/MAod76NW4izxDBvAP2AXCRkN5nUD9PTR97a2trx9NMhNsxCi
g9389ELpjIyMmMrKSnPv3j37/cGDB3Y2geu2AiBQ7+1ro67nwcHB3GDf9vb2vH31QORmDUnktLS0
5G1XPND4OyeGQvvr/7Nnz9oZkTqn4o8/2Dd0vFprNHNJaNCv36KUJi5iAwC7RMiIvr4++/SiZlmN
gXEzmhwKFNqm4JSUXlI6r169ypt27QYCvnv3jhoDAnWZXJuhoSH7wKJpy5r54+/78uVLO2BWgkEi
QgNt/e16UFLscN1Dof31v86hc+kYiRp/MkPoeHUradyMupG0jxM1aeMiNgDwE4QMABCouTaADQBC
BoBAzbUBbAAAIQNAoObaADYAgJABIFBzbQAbAIQMABCouTaADQBCBoBAzbUBbAAAIQNAoObaADYA
CBkAIFBzbQAbAIQMAIGaawPYAABCBoBAzbX5SXmkfvEPQMgAEKi5NuQRGwBAyAAQqMvj2mitIq1Z
pLWLtHr07Oxs3vaBgQG7LlJFRYXp6enJ2/bhwwe7npEWjlQadXV1uQUf3Tm1NlJVVZVpbm62v2lx
yStXrthjtP/c3Fze/lqoVgtHurWUtDBkoTLofy1eG7evy7vWXTp69KgZHR3d9/aBfwBCBoBAXXbX
xhcA09PTdsFGhxZ3lFjQStIbGxtmcnLSLhLpaGxstKtnu9WmJRYkWvxzdnd3221u8cZbt27ZhSDF
1NSUXRjS3//8+fO5RSSjq1tHhYxEVNy+yndvb29uVe9Tp04hZPAPQMgAEKjL7dpIeDhhEaWpqckK
AR9f6BRCrSP+Of2VrYWESzTNpP2j4iXtvq2trWZ1dTX3/e3btwgZ/AMQMgAE6nK7NmqF0TaJlv7+
/rxtauHQNv/jCxWhriO1snR1dZmGhoZY4eGnmSWPSUImad+DBw/mbZN4QsjgH4CQASBQl+G1kRhR
N09HR4ftjnFERUuUiYkJ28IyNjZmZmZmbPfRbhEy0fMgZPAP2AEbw9AACNI/8/rMz8/n7afBv2tr
a7H7ayCtv315eTkoNmpraxO7lrZKyLS0tNixMY6///4bIYOPwE4IGYwNgAC9k9dILSqauSSiA2bv
3r1rbt++nRvMq+9tbW257Zox5GYpLS4uWvEQEhvqhlJ3lnjx4sWmwb5bJWSig32Vb4QMfgI7JGSc
wfHhwyfdB4q/ialbSWNb3BRmJ2ocfX19tuVFY040S8jNPhIvX760g391nASJBg2HxMa3b99MZ2en
PUbn1SDc7RAyYnBw0E4dr66utjOwouNmsAGAbRQyQCAAwHa3DgmoY8eOYQMACBluBgDY7u6nsrLS
DmB278C5efNm3kBmbAAAIUMgAMB2dy2aRaW3Cas7SW/2/eOPP6ygwQYAEDIEAgBsF7ABAIQMgQAA
2wVsABAyQCAAwHYBGwCEDBAIANsFbAAAIUMgAMB2ARsAhAwQCACwXcAGACEDBALAdrFdbAAbAIQM
EAgA2wVsAAAhQyAAwHYBGwCEDBAIALBdwAYAIQMEAsB2ARsAQMgQCACwXcAGACEDBAIAbBewAUDI
AIEAAPsF6h4QMkAwAGwYqHMAhAwBAWA32DGf/fMBQMgAQgYA/wUAhAyBEADwXwCEDBAIAQD/BUDI
AIEQAP8FAIQMgRAA8F8AhAwQCAEA/wVAyACBEADwXwCEDBAIAfBfAEDIEAgBAP8FQMgAgRAA8F8A
hAwQCAHwXwBAyBAIAQD/BQCEDIEQAPBfAIQMEAgBAP8FQMgAgRAA/wUAhAyBEADwXwCEDBAIAQD/
BUDIAIEQAP8FAIQMgRAA8F8AQMgQCAEA/wVAyACBEADwXwCEDBAIAfBfAEDIEAgBAP8FQMgAgRAA
8F8AhAwQCAHwXwBAyBAIAQD/BQCEDIEQAPBfAIQMEAgBAP8FQMgAgRAA/wUAhAyBEADwXwCEDBAI
AQD/BUDIAIEQAP8FAIQMgRAA9pzfRj8AgJBByAAAQgYAEDIIGQDYSTEDAAgZhAwAIGQAACGDkAEA
hAwAQgYQMgCAkAFAyABCBgD/BQCEDIEQAPBfAIQMEAhhb9oJHz580n0AIQMIGcBGAPAZQMgADgfY
BwC+AwgZnA2wDQDAhxAygKMBtgGADwFCBnA0wDYA8CFAyACOBtgGAD4ECBkcDbANAMCHEDKAowG2
AYAPAUIGcDTANsqChYUFLsIevQ74EEIGcDTY5bbx+PHjxP0KbS/0JtQDBw7gO//Ps2fPzC+//GKa
mprs94MHD+658vhpbVW6O3UdiK+AkMHRYJ/YxsrKimlra4vdL7Td8ddff5m+vj585/+RiHn+/PmO
++h2CZn9HKuIrwgZwNFgF9tGR0eHeffuXex+oe3ix48fprGx0ayvryfm4/Xr16aqqso0Nzfnfh8Y
GDBHjhwxFRUVpqenJ++Y79+/mytXrphDhw6Zuro6Mzc3l7f95s2b9jhtl9j6+PFj4vmUz+vXr5vD
hw+b6upqMzk5mVcu14qilqWTJ0+a2dnZ2PJ8+PDBXLhwwZ5bxyh/T58+zZ07zRo+SWWPu17R655U
nkJ1Ft0+MTFhKisrbR66u7vNt2/fgi0ySfWS5bqkuQ5Z6oT4CggZhAzsM9sYHBw0o6OjsfuFtjvu
378fbI3R8bpR6ub76dOn3HHj4+P2t42NDXsjvnPnTu6YW7du2W4tMTU1Zerr63Pb7t69a/OmY/VR
Wrq5Jp1veHjY3L592/72+fNnc/r06bxy+a0o09PTpqamJrY8Em4PHz7MnV95keiIu+7R76GyF8p/
lFB50ggZdX1JACoNCYobN24EhUxSvWS9LqHrkKVOiK+AkEHIwD6yjTdv3pizZ8/G7hfaHr2pLy8v
B/Pht5gI3UR1A/Pxb1S6QUa3OxoaGmzLgN9KoJaFpPOpZcM/5u3bt3nl0g3X3aCLwR8jFBIyobIX
yn+UUHnSCBm/NeWff/4xx44dCwqZpHrJel1C16HUOiG+AkIGIQNlaBvqAtJNcHV1teB+oe0+S0tL
pqWlpah86Gk7acCwtqe5ORbaP+58PrqB+vvpid+1UvT39wfLpK4ftU50dXVZYZUkIqLfQ2VP49Oh
8qQRMlEREXcNoy1XW3VdQtcha50QXwEhg5CBfWAbV69eNU+ePIndL7TdZ2RkxI5VKSYfoVlOSTfM
QttCN/HQMe4mrO4SjQ3q7e2NPb/GlqhlYmxszMzMzNjunyxCJlT2YoRMmmuQ5RoVI2SyXpc0M93S
1gnxFRAyCBnYJ7YRGoiaZqCq4+LFi/YmU0w+NHhzbW0t9pja2trYLgwdG+1a8qf2Fjpfa2tr3jGL
i4uxvjM/P5/oVxpg6+ddXWtZhEyo7Gl8OlSeaBqF8qhyOr5+/WrLFRIySfWS9bqErkOWOiG+AkIG
IQP72DZC+8Vt13iGuMGooeM1YNcNVtVH3zX7yKHuCXUtiBcvXmwa7KvWIHfsvXv37A026XwahKoB
zG5wbHt7+6axH5olIzTANKnl4fjx47nZOBIQ6l5LumFrFo/GvDjhESp7mnoLlccfKKtp9JpNFM2j
zqljlcZ///tfK0xDQiapXkLXJet1yFInxFdAyCBkACGTebtuLGkGfsYdr9lOeopXa4putL4o0lTg
zs5Oew6NtdBgVh83/VofzVh6//598HxDQ0N2ULCm+2rGjL+fujB0HnV36JzuBlqIly9fWhGn/XSz
jb40MHp+zcRRGf1Wo6Syp623pPK4G7/KI5Gn8kTzKNHxr3/9yw6q/eOPP2yrTEjIJNVL6LpkvQ5Z
6oT4CggZhAxgG4BtANcJIQM4GmAbgG1wnQAhAzgaYBuwbezFdY/wIUDI4GiAbQAAPoSQARwNsA0A
fAgQMoCjAbYBgA8BQgZHA8A2APAhQMjgaIBtAAA+hJABHA2wDQB8CBAygKMBtkE5AdsChAyOBtgG
5QTAthAygKNBGdiGftc6Nlpjp7m5Off7wMCAXbdH6xf19PRsOmZsbMyu7XP06FHz6NEju8if1snx
Fyh0uLWQtFCgFgLUYoHr6+vm2LFjdr0eHy0iqJWQ0+RDaztdv37dnre6utpMTk7iA0B8BYQMjgb7
Tch0d3dbUeAW6dOig+Pj4/a3jY0NKxC0yJ9/zNWrV+22v/76ywqJ33//3X6PrkwsgTM6Oppb1Vhp
a2FHce3aNbvdZ3h42IqXNPnQvm7FZK3cfPr0aXwAiK+AkMHRYL8JGbWQ+DQ1NW1ayVorGccdo+9r
a2sFz6UVi9XK4tD/askRS0tLtlXGnUt/T5w4kUs7lA+1IPlpa/VlfACIr4CQwdFgnwmZKGpR0e/+
58CBA7HHJH33j/PTd5w5c8a2uoiHDx+aCxcupM6Hn44TQvgAEF8BIYOjwT4XMoXER1rhEv0eFRvR
7VNTU6aurs7+r7ExMzMzqfMRShuA+AoIGRwN9qGQkaDwu4pKETJKK9q1FF1t+fjx43a8i7qVsuSj
tbU1L+3FxUV8AIivgJDB0WC/CxkNwHWDaPXRd802KkbI6NiRkZFcWvfu3TO1tbV5+2sAr2Yd+QN5
0+RDXVGDg4O5wb7t7e34ABBfASGDo8F+FzKir6/PzkZS64nGrbgZTVmFjHDTr/XRjKX379/nbf/y
5Ys9j8RIlnyIoaEhO3hYU7Q1ywkfAOIrIGRwNMA2AAAfQsgAjgbYBgA+BAgZwNEA2wDAhwAhg6MB
tgEA+BBCBnA0wDYA8CFAyACOBtgGAD4ECBnA0QDbAMCHACGDowG2AQD4EEIGcDTANgDwIUDIAI4G
2AYAPgQIGRwNsA0uAgA+hJABHA2wDQB8CBAygKMBtgGADwFCBnA0wDYA8CFAyOBogG0AAD6EkAEc
DbANAHwIEDKAowH2AYDvAEIGZwPARgDwGaAmcTgoIzvhw4dPug8gZAAhA4B/AABCBgjUAPgHACBk
CNQA+AcAIGSAQA2AfwAAQgYI1AD4BwAgZIBADYB/AABChkANgH8AAEIGCNQA+AcAIGSAQA2AfwAA
QoZADYB/AABCBgjUAPgHACBkgEANgH8AAEIGCNQA+AcAIGQI1AD4BwAgZIBADYB/AABCBgjUAPgH
ACBkCNQA+AcXAQAhAwRqAPwDABAyQKAGwD8AACEDBGoA/AMAEDIEagD8AwAQMkCgBsA/AAAhAwRq
APwDABAyBGoAwD8AEDJAoAbAPwAAIQMEagD8AwAQMkCgBsA/AAAhQ6AGwD8AACEDBGoA/AMAEDJA
oAbAPwAAIUOgBgD8AwAQMgRqAPwDABAyQKAGwD8AACEDBGoA/AMAEDIEagD8AwAQMkCgBsA/AAAh
AwRqAPwDABAyBGoAwD8AACFDoAbAPwAAIQMEagD8AwAQMkCgBsA/oIj657N/PggZAjUA/gHUPZRV
nWMFOCsA/gHUO+zZuscScFgA/AOoc9izNoA14LQA+AdQ54CQAZwWAP8A6hwQMoDTAuAfQJ0DQgan
BcA/gDoHhAzgtAD4B1DngJABnBYA/wDqHBAyOC0A4B/UeSKPHz/etN8///xjrl27ZioqKszBgwdN
Z2en+fr1a267/r9w4YI5dOiQ3efSpUvm8+fP+ARCBjBKgO3xizSvL4f9FxNXVlZMW1vbpv1u3Lhh
7t27Z378+GE/N2/etGLGMTAwYPr7+3Pb//zzT9PX18c9AyEDGCUAQgZ2LiZ2dHSYd+/ebdrv6NGj
VqA4NjY2bMuM4+zZs2ZxcTFv+7lz5xLz8fr1a1NVVWWam5vzBNGRI0dsq05PT0/eMd+/fzdXrlyx
rT51dXVmbm4ub7vElY7Tdomxjx8/Jp5P5bl+/bo5fPiwqa6uNpOTk3nlfvbsmfnll1/MgQMHzMmT
J83s7CxCBhAyALtRzAAxUQwODprR0dFUsVOiQqLAITHgCx33W1I+uru77TGfPn2yv92/f9+Mj4/b
3ySEJCzu3LmTO+bWrVu220tMTU2Z+vr63La7d+/avLsWIaUl0ZN0vuHhYXP79m37m7rBTp8+nVdu
iZjnz5/b/6enp01NTQ1CBhAyAAgZ2I0x8c2bN7ZVJW3sVNeRhIV/049S6Dc/fb/FRDQ1NW0SQ754
kHCJbnc0NDRYceULrcrKysTzqWXGP+bt27d55ZZQc8KpXG0A70fIACBkYM/HxPX1dXtTX11dTRU7
v3z5YgfzqtXEoe6XrEKm0P7RLk8/3aT0QuePO5+PRJK/n1ph9F0CS+N/EDKAkAFAyMAujIlXr141
T548SRU7JV4uX768aUZSoW6kUNdSGjGSVhgV2pZ3w04hZArtp3E16sbS2KHe3l6EDCBkAPAP2G11
XmjwdyGRq5YYTcFeXl7elIZu9Jqi7fj27ZsdcJslHxpQu7a2FntMbW1tbNeSjo12LfmDkQudr7W1
Ne8YDVaO84n5+fmy8ReEDIEaAP+Asq/z6H6vXr0yZ86cyet+8tFsIzdwVp+xsbHE7phC+dCAXT8N
fffFkMbkqLtHvHjxYtNg35GRkdyxmiou4ZN0vocPH9oBzm6wb3t7e95+Sl8zl4QG/Sa1CCFkgEAN
P91O+OyfDzEx+37Hjh1LvJaaCSQhoFYQfc6fP5/3wry0+dC7Z9QlpTT0gj03w8i18ujdNRIUGtyr
wbk+bvq1Ppqx9P79++D5hoaG7KBgTfnWTCd/P3Ur6Tzq8tI5nahByABCBrARoM4pOyBkAKcF7AOo
e8oNCBmcFrANwAYoMyBkAKcFbAOwAcoMCBnAaQHbAGyAMgNCBnBawDYAG8DuASGD0wK2AdgAZQaE
DOC0gG0ANkCZASEDOC1gG4ANUOYdY2FhASEDOC3sPdt4/Phx4n6Fthd6+2loMTx8hzKWY5lLPdfP
PF5v8dXbfLXytfDXbULIAIEK9oRtrKys2HVe4vYLbXf89ddf9rXr+A5lRMjsneMlYrS+UjnaCkIG
p4V9Yhtazffdu3ex+4W2Cy1G19jYaNbX1xPzoTVdqqqqTHNzc+53LcKn9V+0bkxPT0/eMVqxV2vJ
HDp0yNTV1Zm5ubm87W7NGW2X2Pr48WPi+ZTP69ev2zVuqqurzeTkZF653NOpWpa0yvDs7CzxoQzL
HGdzly5dsos0+vZw7ty5oC3m3TBjVt32fSXJBkM+keZ4nw8fPti1nJRv2bby/vTp01y+0qzVlZSf
OL9GyACBCnbENrQi7ujoaOx+oe0OLUIXao3R8d3d3TYQuwXydNz4+Lj9bWNjwwblO3fu5I7RKsDq
1hJTU1ObVgFW3twqwEpLN5qk8w0PD+dWHdYqwKdPn84rl/90qtWHa2pqiA9lVuYkm5OdtLS02G1a
uFH1v7S0FLTFLEImZIMhnwgdH0UPGFr92vmJfEaiIy6/0e+h/BTyM4QMEKhgR2zjzZs35uzZs7H7
hbZHg+Xy8nIwH36LiVC/vAKgjy8edLOIbndotV49JfutN1rdN+l8emL0j9Gqwn65FODdzYr4UJ5l
DtmcbtwSC7pZ37hxI5UtZhEyIRsM5S90fBr8sWwhIRPKTyE/Q8gAgQq23TbUBaSAuLq6WnC/0HYf
PbHqKbaYfKgFJGnAsLanCcaF9o87n48CtL+fWmH0XcG7v7+f+FCGZQ7ZnLt5SxR/+fIllS1mETIh
G8zqE9HjC6GuH7UodXV12QeApPxGv4fys5ttCyFDoIIyto2rV6+aJ0+exO4X2u4zMjJix6oUk4/Q
LKekm0ehbaEbSugYF/TVdaCxQb29vcSHMitzmpl158+fty0wOyFkotuL8Ymk+p2YmLBlGRsbMzMz
M7b7J4uQCeUHIQMEKvgpthEa4JdmAKDj4sWL9sZfTD40oHZtbS32mNra2tjmfB0b7Vryp44WOl9r
a2veMYuLi7G+Mz8/XzZ+hZBJb3P37t2zY0J04/e7lpJsMUkYqMvV/y1kg6H8ZbFhoUHBfnrR/ISE
TCg/CBkgUMGusY3QfnHb1V+eZpBfoeM1YNcNXNRH3zX7yKHmcHX3CM0miQ72VWuQO1Y3IN1sks6n
QY8awOwGSra3t+ftp/Q1U0Vo0G/SUzjxYW+WOcnmZMenTp3Ku4lrxl7IFuMGjOvVBZox5G8P2WDI
J0LHRzl+/HhulpJEj7qBk4SMZjdpzIsTS6H8IGSAQAV7XsgocMc9qaY5XrOd9NSo1hQFfV8UaeZI
Z2enPYf69jWw0cdNv9ZHM5bev38fPN/Q0JAd/6DppBrY6e+nbiWdR83pOqcTNcSH8ipznM3J1vzp
1/pf20O26J/LCWDZkIS1bCialyQbDPlEmuN9Xr58aR82lCeJr+jLLaPHapCzzuu3biblByEDBCrA
NgAboMyAkAGcFrANwAawe0DI4LSAbQA2QJkBIQM4LWAbgA1QZkDIAE4L2AZgA5QZEDI4LWAbgA1Q
ZkDIAE4L2AZgA5QZEDKA0wK2AdhAKWVKKhd2DwgZAhVgG4AN7HohE7eERlyZFxYWYtNM2rab2O58
blf6O319ETIEKsA2KHeZXYukNbTK8VMI/421UTtJ2paGDx8+5C1dsF32Gc3nVlNK+n659FZjvVFY
q4nvRL4RMgRtwDYoN9ei7FtksnRHZb1uaVeCL7VOtrs+typ9f92pn2GHCBkCFZS5bbinJa0Jo8Xx
Zmdnc9u0YJzWLtICcnV1dWZubi4vPa1JVFVVZZqbm3O/DwwM2LVftO5RT0/PpvMlbVeaWnFYC9y5
dY78ABg6Xms9Xb9+3a4HU11dbSYnJ/GJfSJkspQ5bqX30La0Nq4FHF+9epVrndG6RPIh2bP8yC3e
6NLW4ozOz86dO5e3flOcf8blM+qTofPH+XiaVq2k2JG29Q8hAwgZKNk2fLGgVX21sJxDK/1qcTkx
NTW1aaXf7u5uKx7c4nFauE5CRL9tbGxYIaHF5xyh7UpTQVeBXURXng4dPzw8nFuhVysCnz59Gp/Y
5/EhbYtMUiuO/z1kg1pU8ujRo7nvjY2NdqVqt2r06OioFRp+2q2trWZ1ddVuf/Lkibl69Woq/yyU
z6hPhs4f8vG0LS1JeSu1hQshg9MCJNqGgpoLZFEU1OJWtHZPkj7qA4/u7we30PZCafr5Dh2vp1A9
YTr0ZItPIGS2UsiEbPDRo0fm8uXLiXlSC4aftt8Co7TdWJKQfxbKZ9R/QucP+XgSafOGkAECFWyr
behJStsUPPv7+zc9cWVJT/tHm479oBnaHtcNkCV9HwVofAIhs5VCJmSDEjHRm7u6e9Ty0dXVZRoa
GoJjeHw7TvLPtAIh6fxZfTxt7EDIAIEKdtQ2FOjUrNzR0WF6e3uLDnJ+QA89CaZN0/8tdHyh/OIT
CJmtFDIhG1S3krqXHBMTE7bVY2xszMzMzNgun5CQic7qifPPNAIhdP5ShEzavCFkgEAFO2Yb8/Pz
efvV1tZmanbWgL+1tbXY9EPbQ0ImdLzGGvhdS4uLi/gEQmZLhUySDWqwq27oPhp47u+/vLy86VxL
S0u577LfY8eOpfLPNAIhdP6sPp42diBkgEAFO2YbelrT7AMRHVyr5mg1H4sXL14EBwLevXs3N9hW
H31va2tLvT0kZELHa1Dj4OBgbrCvZo/gEwiZQmiWjsaTOOHr75e0LckGNeVaU699NAPPzRKSsG5p
adl0kz979qz58uWLTU9p+4N9k/wzKZ9pz5/k49H0s8SOJCETShchQ6DiIkAm21DTsPrN3XRnF5iE
msg7Ozvt79rHH5QYl15fX599ClTzuGYgudkTabaHhEya9IeGhkxlZaWdHqsZJvgEQqYQmmkkG3Ld
OP5+SduSbFA3dk139nn58qUdDCwf0naNn4ne5GWnslelJ1HjD9hN8s9QPtOcP8nHo+lniR1JQiaU
LkKGQMVFAGwDsAHsHhAyOC1gG4ANUGZAyABOC9gGYAOUGRAygNMCtgHYAGUGhAxOC9gGYAOUGRAy
gNMCtgHYAGUGhAzgtIBtADZAmQEhAzgtYBuADWD3gJDBaQHbAGyAMgNCBnBawDYAG6DMgJABnBaw
DcAGKDMgZHBawDYAG6DMgJABnBawDcAGKDMgZACnBWwDsAHKDAgZwGkB2wBsgDIDQganBWwDsAHK
DAgZwGkB+wDqnrLDrqp7LAGHBWwEqHOuAezZOscKcFYoIzvhs38+gN1j9wgZhAwA/gEAez0GcAkI
1AD4BwAgZIBADYB/AABCBgjUAPgHACBkCNQA+AcAIGSAQA2AfwAAQgYI1AD4BwAgZAjUAIB/AABC
hkANgH8AAEIGCNQA+AcAIGSAQA2AfwAAQoZADYB/AABCBgjUAPgHACBkgEANgH8AAEKGQA0A+AcA
IGQI1AD4BwAgZIBADYB/AABCBgjUAPgHACBkCNQA+AcAIGSAQA2AfwAAQgYI1AD4BwAgZAjUAIB/
AABChkANgH8AAEIGCNQA+AcAIGSAQA2AfwAAQoZADYB/AABCBgjUAPgHACBkgEANgH8AAEKGQM1F
AMA/AAAhQ6AGwD8AACEDBGoA/AMAEDJAoAbAPwAAIUOgBsA/AAAhAwRqAPwDABAyQKAGwD8AACED
BGoA/AMAEDIEagD8AwAQMkCgBsA/AAAhAwRqAPwDABAyBGoA/AMAEDJAoAbAP2AP1j+f/fNByBCo
AfAPoO6hrOocK8BZAfAPoN5hz9Y9loDDAuAfQJ3DnrUBrAGnBcA/gDoHhAzgtAD4B1DngJABnBYA
/wDqHBAyOC0A/gHUOSBkAKcFwD+AOgeEDOC0APgH7I86X1hY2FXpbHeaCBkgUAPgH1Bina+vr5sr
V66YgwcPmsrKStPT02O+fv0am86zZ8/ML7/8YpqamrLfPAN2pzxsBVuVTlKaaX1oN/kaQoZADYB/
QNnV+e+//27u3Lljfvz4YT8jIyPm4sWLselIxDx//ry4m2fA7rbKLrfDvotNEyEDBGoA/AO2sc7V
0iAB49D/hw8fjk0juoZPwdffx4iXJLuLWx9oYGDAHDlyxFRUVNjWIselS5fMixcvct/VUnTu3LlU
6wx9+PDBXLhwwRw6dMgKs7q6OvP06dO8vLx+/dpUVVWZ5ubmYLm/f/9uW7WUntKam5uLLXNceVwZ
lJ8DBw6YkydPmtnZWYQMTgsA+AdkETK6KSd1zWx61f0WCZlC2+/fv2/Gx8dt/jY2Nszk5KRtPRKf
Pn0yLS0tdtu3b99MTU2NWVpaSnWexsZG8/Dhw1wr1OjoqBUtfj66u7vtNp0nVO5bt26Zx48f2/+n
pqZMfX19wf2SyiP81q7p6WlbJoQMTgsA+Ack1LlaEtSd5ATBjRs3bIvAbhAyGofjiyzh39wlDIaH
h60YUL5LsW+/zDr+48ePqcst4RLNZ6H9QuWRmHKCaLttgAhAoAbAP6As6lwDe9VNo9aA2tpa2xKw
W1pklKdot05UZEkcaJDyly9fMtm3uo7UktLV1WUaGhqC+Uwqt/KZpkyh8uja6zeVqb+/HyGD01JN
APgHZK3zxcVFU11dva1CJm4cSzStpJYhx/nz522LSBYhMzExYY8ZGxszMzMztvtoJ4RMmvJIYKl7
qqOjw/T29iJkcFoAwD8gS50/efLEtlIUK2SWl5e3rEVGA17X1tZi9793754dcyJBkqVrSYOZ/XST
8pym3GrJStO1FCqPz/z8/Jb7KUKGQA2Af0DZ1blaJiRehGbzqCXg7du3qdPxB6iurKzY2UDFChnN
+tHYFA04Fnfv3jW3b9/ODcrV97a2NrtNrSinTp3KEwnv3r0rmE6U48eP52YpqQVKg4ZD+YymGR3s
q24hoZlUcYN9k8rj6kIzl4SuaVJLD0KGQA2AfwB1/n9ItGiKsRsjExpsGk3H3XDVbaLjdSMuVsho
0K7G5/hjdPr6+mwLin6TSHKziDo7O/OmX+t/bY9Lx+fly5d2kK3yLfGgMofyGU3T30eDpJUfpafx
Nr4QjKYVVx6hbiUdr2uptJyoQcjgtACAf1Dn1Dk2gJDBaQHwD6DOASEDOC0A/gHUOSBkAKcFwD+A
OgeEDE4LgH8AdQ4IGcBpAfAPoM4BIQM4LQD+AdQ5IGSoMADAP4A6B4QMTguAfwB1DmZhYQEhAzgt
AP4B5VznpZ7rZx+flF70bcF7yZcQMjgtAP4B1Pk+FDJJaSNkgEANgH/AT67zgYEBc+TIEVNRUWF6
enpyv1+6dClvPSOt/XPu3Dn7vxZPvHLlil1Msa6uzszNzRW+YQZWktbiidevX7frD1VXV5vJyclN
x8TlL+3xcZw4ccJ8+fLF/u9WwH7z5o39vrq6arf7+dVf/+N+GxkZsQtRujWS3CKaCBkgUAPgH7DN
dX7//n0zPj5uBcHGxoYVAlogUWhBQ60MrW1aGFELLS4tLdltWvHZLTA5NTUVu+JzSMgMDw/nVoT+
/PmzOX36dN72pPylOT6Jy5cv51b+fvToke020vncdwm1UHn0/fz583ZlbLEdq1YjZHBaAMA/qPOY
Om9qarIiwEeCxRcSEgsSDzdu3Mj9LuESPa4YIaOVt9W649DK0f72UP5CxycxMTFhrl27Zv//7bff
TFdXl/2Iq1evWtGURsg4EbPb/QshQ6AGwD+g7OpcrQfRLhN1kUTFTmVlZa4bxh2X6oYZEDLRdCRa
otuT8hc6Pgm1LjU2Ntr/T548aebn582xY8fsd3WXqbspjZDZK/6FkCFQA+AfUHZ1HhUthVDXiVpg
dkLIRLeH8hc6PsTRo0dtl5QTMBrrsri4mPuOkAECNQD+Abu4ztUSsba2FnvcvXv37BiVsbGxvK6l
2traorqW3KBaR2tra17XkESEvz2Uv9DxIS5evGh+/fXXXJeS615y3xEyQKAGwD9gF9f53bt3c4Nl
9dH3trY2u02DfU+dOpUnKt69e2f/12Df6elp+79mNsUN9vVn8aysrJgLFy7kbX/48KEZHBzMDdZt
b2/P256UvzTHh9CMI3WbSbCJBw8e2JlYEm+FyqNtGhPjxBNCBgjUAPgH/OQ67+vrs9OXNWtHQkMC
RnR2duZNv9b/2i40i0nbJVQaGhrsINtC53KzeNRFpFYcTeGO5mVoaMiKCU2x1uDi6Pa4/KU9Pqns
r169ypt27QYLO8EWPV6DnpUP92I8hAwQqAHwD6DOtxXNSAKEDE4LgH8Adb4nUTcYIGRwWgD8A6hz
QMgATguAfwB1DggZwGkB8A+gzgEhg9MC4B9AnQNCBnBaAPwDqHNAyABOC4B/AHUOCBkqjIsAgH8A
dQ4IGZwWAP8A6hwQMoDTAuAfQJ0DQgZwWgD8A7amzvX769evTVVVlWlubs79PjAwYNcuqqioMD09
PXnHfPjwwa55pAUUtY5SXV2defr0aW671lNy6ytpocnZ2dm842/evGnT1fFaAFKLMPr50YKNx48f
t8f7i06G0sauETIEagD8A/ahkOnu7rarR7vFGLXwosSEftvY2DCTk5N2sURHY2OjXXXarUg9Ojpq
hZDDFx9aIbumpia3TatXa393rM515cqVvPxIJDlx4xadTJM2IGQI1AD4B+xDIeO3iIimpiYrMnxC
gkEtJA6JmsePHxfcTytlf//+Pfdd/2vl6qT8+HlPShsQMgRqAPwD9qGQiaJWD/3uf3yhItQdpcUY
u7q6rDjx01FLib5LEPX398cKHv98SflJmzYgZAjUAPgHIGQKig2fiYkJU19fb8bGxszMzIztkoqm
I6EzNTVlOjo6TG9vb0HRUvAGGxAySWkDQoZADYB/AELGDqJdW1uLTevw4cN525eXl2PTn5+fz9um
tKNdSwcPHswkZOLSBoQMgRoA/wCEjB2Qe/v27dyAXH3X7CKHZhS5WUqLi4umpaUlLx211mh2kYgO
1lVaIyMjubTv3btnamtrUwuZpLQBIUOgBsA/ACFj6evrsy0vai3RLCI3o0m8fPnSDv6ViJCw0OBb
Px11/WjcjJs+7YSHw02/1kczlt6/f59ayCSljV0jZAjUAPgHUOeAkAGcFgD/AOocEDKA0wLgH0Cd
A0IGpwUA/IM6B2wAIYPTAuAfQJ0DQgZwWgD8A6hzQMgATguAfwB1DggZnBYA/wDqHBAygNMC4B9A
nQNCBnBaAPwDqHNAyFBhAIB/AHUOCBmcFgD/AOocEDKA0wLgH0CdA0IGcFoA/AOoc0DI4LQA+AdQ
54CQAZwWAP8A6hwQMoDTAuAfQJ0DQoYKAwD8A6hzQMjgtAD4B1DngJABnBYA/wDqHBAygNMC4B9A
nQNCBqcFwD+AOgeEDOC0APgHUOeAkAGcFgD/AOocEDKA0wLgH0CdA0IGpwXAP4A6B4QM4LQA+AdQ
54CQAZwWAP8A6hwQMjgtAP4B1DkgZACnBcA/gDoHhAzgtAD4B1DngJABnBYA/wDqHBAyOC0A/gHU
OSBkAKcFwD+AOgeEDOC0APgHUOeAkMFpAfAP/IM6B4QM4LQA+AdQ54CQAZwWAP8A6hwQMoDTAuAf
QJ0DQganBcA/gDoHhAzgtAC7zi+iHyAmAkIGcFoAhAwQEwEhAzgtwE6KGSAmAkIGcFoAhAwQEwEh
AzgtAEIGiImAkAGcFgAhA8REQMjgtAD4B1DngJABnBYA/wDqfFexsLCAkAGcFsrDTvjsnw8xMZ0P
HDhwoOyvx8GDBzPFhl9++cUcPnzYXLt2zayvr+ft++XLF9PT02Oqqqrsfg0NDWZycjJ1rEHIAEIG
sBGgzreo7H/99Zfp6+vb99ej0HYJmN7eXnP9+vW835qbm834+Lj5/v27/e3NmzfmxIkTZmJiYlfZ
IUKGgAXYB1D3ZV3uHz9+mMbGxk0tDg7dnNX6IJaXl22aummL1dVVu90xMDBgjhw5YioqKmxrRTQv
r1+/ti0YEgFpjilUHomH48eP2xYktYQ8f/48b5+bN2/atA4dOmTa2trMx48fC7aOZLleukZK03Hr
1i1z9+7dTfvpuvhlS5P2s2fPbDlUnpMnT5rZ2VmEDMEKANsAbCBtme/fv5/YGnP58mXz5MkT+/+j
R49s94yOcd+vXLmSS0ciQzf9jY0N281y586dvLx0d3fb7Z8+fUp1TKHyXLhwISdOJGIkAhwSF6Oj
ozY9fZS+y1+xLTIOX8jU19eblZWVLakLX4xNT0+bmpoahAyBCgDbAGwgbZnVGqOWljjUVaIxIuK3
334zXV1d9iOuXr2aGxfS1NRkxYOPf1NWXpwAcYSOKVSeaBp+GTVOxXX1CP1fWVlZkpCRYBkeHrYi
zBcfW1UXaqF6/PjxjtgAUZBABdgGYANlVealpSXT0tIS3EdiR6jrY35+3hw7dsx+r6ury4kg3dyT
BhAXykvomDTl8X8rdKwvOtIImeinurradlepxcihbqutqgu1wmibRF1/fz9ChkBFNQG2AdhA2jKP
jIzYm3SIo0ePms+fP+cEjMaoLC4u5r7HiYhQXrLOlAoJmUItJXk38gwtMhr/c+7cOSvcokjY6XpE
kdh5+vRp5rrQ2KGpqSnT0dFhBxYjZAhUANgGYAMpynzx4kV7Aw2h/X799ddcl5LrXnLfhVpr1tbW
MuUldExWIaP0ol1L/pTrrF1LEiYak6NZXT5qOdHYnih//vmnOXXqVNH2J9G01XaKkCFQAbYB2EDZ
llnjUdzA2yTUcqOxJvfu3bPfHzx4YLtX/Ju5Btrevn07N9BW3zVrKCkvoWOyChkdr7y69JTf2tra
3HblWWNsfLETSl8tM7pO/jiir1+/2vE4Sv+ff/6x59KAaLVcvXz5MlNdaOCwZi6J6OBlhAyBCqCs
bGOr3kq6HW833QtvTEXIbEY3zehg20K8evUqb9r127dv7fd3797l7afZT3qBnFpB1JLhi6S4vCQd
k1XICDf9Wh/NWHr//n1um2ZE6TxxL8aLy+OLFy/MmTNn8n7TIGDN6NJ51EWmadfaL2tdqFtJoshN
J3eiBiHDzQoglW3oaUozMhSMFNw6Ozvt05Z/XJbBiO6dEBq4lznIBOw39FbStGxVOklppvXFn/WG
U2Ii7EcbwBpwWihD27hx44ZtHnZN0Xqak5iJI/QG1EIv6NoqIbNV9r0dflJsmggZygwIGcBpoQTb
UJ+237SuwX1xLRahN6AWenNoqCk8rZCJeytp3FtRL126lNfMrZYizcBI83bTDx8+2CZ+jSeQMNMU
W38mRvQNraFyazyCmviVntKam5uLLXPSW15LfQMqQgYQMoDTQtnbhm66ukEXIvQG1ELn2SohU2h7
0ltRNc5A7wfRtm/fvtnBinofSJrzSKw9fPgw10qlN6X616TQG1qTyq3XubsXfmmGjAY3Ftov9JbX
Ut+AipABhAzgtFD2tqHpk7rxxt3gk96AutNCJvRWVAkDvZFUYkBdaKX4SfTFZklvV41+l3CJG1Dq
7xcqT6lvQEXIAEIGcFooa9vQwnjqkvHf4OlI8wbUnRYyad6KKnGgabNu0b+010JdRxJ0ek+IZlSE
8plU7qTppNH9kspT6htQETKAkAGcFsrWNiReNJWy0Ns6Rdo3oG6FkIkbxxJNK81bUc+fP29bRLII
Ga2to2PGxsbMzMyM7T7aCSGTpjylvAEVIQMIGcBpoSxtQzd5TcFO6jZK+wbUkJDRObaqRSb0VlTN
xtKYEwmSLF1LeqeHn25SntOUWy8kS9O1lOUtr8W8ARUhAwgZwGmh7GxDL/rSi6709s4k0r4BtVD3
jxugqhdoaTZQsUIm+lbSpLeiKq/+q9IlEtzLy0JvN9U6Om6WktbTUZdaKJ/RNKODfdUtJDSTKm6w
b+gtr6W+ARUhAwgZwGmh7GxDi94VeuldlLRvQI0e62646jZRy4RuxMUKmUJvJY17K6reheNPv9b/
2h6Xjo9esS7hpnxLPGiAbSif0TT9fTRrSvlRehpvo7fCxqWV9JbXUt+AipABhAzgtIBtADZAmQEh
AzgtYBuADVBmQMgATgvYBmADlBkQMjgtYBuADVBmQMgATgvYBmADlBkQMoDTArYB2ABlBoQMTguA
bQBCBrB7hAxOC9gGYAOUGRAygNMCtgHYAGXeMhYWFvZMXn5GXhEyOC1gG2Vddr0dV2/J1YrS2MD+
KfM///xj1xerqKiwb1HWm5e/fv1a/A0y4zphW0ncG6p/BqG8RLfvhE0iZAhUgG2Uddn9taCwgf1T
Zi0iqkVF3bpWWtldYma7rud2XvvdVK9ZBR1CBghUULJtfPjwwa7po0UPdVOvq6vLLZjot1hofR8t
vDg7O5tqmxgYGDBHjhyxT709PT0FW0K2Ol3dlK5fv27XK6qurjaTk5OxZY9bX0o3NaWta6JFG7UY
pH+M1jyqqqoyzc3NxIc9WuajR4/mrR22sbGR2JoQsiv//yw26I7VKu1arNStoxUV13E2GVojze2j
FeArKyttuR89emQXJFX+Cp0ryb+StofyUmi7/o6MjCSWPZQfhAxCBva5bTQ2NpqHDx/mnkxHR0ft
TbpQi4VWcNZiimm23b9/3wZnpambhIK5Flbc7nSHh4dzK0h//vzZnD59OngT8VGA1zVw10Pnu3Ll
St7+3d3ddlua1cCJD3ujzFq13Lf7KCG78v8vxgb1MOHESXRl8zQ2GboGV69etf7y119/WQHz+++/
2+/Rc4X8K7S9mBaZ8+fPx5Y9dD6EDEIGsI2C6MnIoeCu1Z8LkbRNY06iq2X7gmS70lUriW5KDq00
nUXIaHVp/3j9rydZf3+/hYb4UB5l/vPPP82tW7dit4fsyv+/GBuM2pS/fxqbDF2DaKvi2tpaweND
/hXaXoyQSSp76HwIGYQMYBsWdZUoiHd1ddmg6e+rFhF9V0Dp7+/POy5pm56qok3JvkDarnT9pzmh
IJhFyPhpFUpzL/sYQqYwX758MZcuXbJP/HGE7Mr/v1QbjP5Wqk2GxqVE8x7yr6TtWzFGJkt+EDII
GcA2zMTEhKmvr7d96DMzM7a7JLqvhM7U1JTp6Ogwvb29qbalCTbbkW70JhLyi+i20PEImfIqs8TL
5cuXbRdQKXaVJGSy2mDW9LZSyIT8K7R9q4VMVtGCkEHIwD60DfWX+83My8vLsfvOz8+n3qZBun66
SWxluq2trXnN8IuLi5luIko/2ozvDwJFyOy+MmUVCX5LjKZgy+ZDhOzK/79UG4z+VqpNZhEyIf8K
bd9qIZMljiBkEDKwT21DswXcLCUF3JaWlrx91VqjWUQiOhAvaZsGKLoBj/rou2ZbbHe6Grg8ODiY
G2jZ3t6eebCvZlG49DVFt7a2FiGzy4VM3IyZuDK/evXKnDlzxqyurqY6T8iu/P9LtcHobyGb1Ewm
jTPxxU6xQibkX6HtobxEt6cpe9L5EDIIGcA2zMuXL+3gOYkFCQgNsvX3VRePxs24qZFOYIS2ib6+
Ptvio6dHzcrwZ/lsV7piaGjIDobUlE3Nesh6E3FTXfXR7JD379+XlZCJu/mX66cQx44dS71vGruK
HluqDUZ/S7JJzeKRL8RNH88iZNL4V9L2UF6i29OUPZQfhAxCBrANwAb2XYsM7E+7xxoIVIBtADaw
K4UMdg8IGQIVYBuADVBmQMgATgvYBmADlBkQMoDTArYB2ABlBoQMTguAbQBCBrB7hAxOC9gGYAOU
GRAygNMCtgHYAGUGhAzgtLCPbGNhYYFKJD5QZvwOIYPTArZRQhDIkEaxi9rF/R/3plAgPhRT5q26
Frstna3Oy1b43c8uG0KGQAUImR0993bfeLABysw13V/lQ8hgdLAPbGNgYMCuCaN1XHp6euKDQCQN
Hac1UI4ePWpGR0cTW1a0UJzWiNGicefOnTNv374NniNubaDGxsZNZdjY2LDr56yvr1PZxIdMwlj/
j4+P2wVU3fpeWqzUoQUOne3W1dWZubm5VP4R/U1rhiltnUOrOs/OzsYe69ZW0jm1SKL8J21+o4Ty
r7XNqqqqTHNzc6LfpY0XcemJDx8+2PWSlBflW/lxi9YiZAAhA0XZhha0U1DUyrISA5OTk3Zht1Cg
1jG9vb25FX5PnTqVKEhaW1vtSsPa/8mTJ+bq1auphUz0f60m7N8EXH5+//13Kpr4UJSQ0c3ViYXo
iuu3bt2yi6mKqakpu7hqMULGFxzT09N2sdZC+2mFZz0YuBWf5aMSImnzGyWU/+7ubnsetxhjUpnS
xIuk9PQQotXBXdlUTokehAwgZKBo22hqarIBxScuwPr/O2HiUAtLkgjxW2B0Pp23WCGjYNzR0ZGX
Zz39/f3331Q08aEoIeO3eES368Yf9ZFihIxu2E5QJO2nld/ViuK3qGgl7bT5jRLKf1Ja0XTTxIss
eRNqVULIAEIGirYNPclFm5D9wJJ28K2CWxoR4p+3WCEj1Ky+tLSUE1GuGRuID8UImVBLSqqbZCAd
tcLou8RAf39/7H6Fbuxx/pKmbtPmP02ZssSLuN/U9aRWoq6uLivadnIcE3dIAhWUoW2Enobiglo0
OGYVMr4QKkbIDA4OmmvXrtn/1ez+4MEDKpn4sKuFjLuJuxZFdc2mPV/W82yXkMkSLwr9NjExYVuI
xsbGzMzMjO1+QsgAQgZKsg0NOlxbW8scqFtaWuzYGIe6dZJEiGs9EWoq18DcUoSMzq0Bg+re0sDD
b9++UcnEh20RMrW1tUV1LS0vL8eef35+PvZY+WS0aylO+Kep27T5T1OmLPGi0G+aHOAfn3SNEDIE
KoBUtqGBhbdv384NvtN3zZIIBbXoYF8dkyRCzp49a758+WL31/myDvaVaFHfux/g1RLz73//2w4u
BOLDdgkZdYOoW0i8ePEidrCvP5h3ZWXFDsiNjrXRzCURHaAbHew7MjKS88l79+5ZMVKskEmb/zR+
lyVeFPpNXcJultLi4qJ9IELIAEIGSraNvr4++6Skpz4FXzfbIBTw1b2j1pDq6mo7myGpu0jbta/2
kaiJTicN/a+ZETrWP4emkWof3vpLfNhOIaPWvs7OTis8NKYj7tUBTpyo+0XCQ6LF365uJR3vpkw7
UVMoD276tT4S7O/fvy9ayKTNf1q/SxsvCv328uVLOzhYeZGg0uBnhAwgZGBX2IaCpd9dtBMogOoJ
D4gPlBkQMjgtYBuZ0HRQDVp075PQE6Q/eHG70Xn1ZBid/QHEB2IiIGRwWsA2gmjGgaY8q3lZb/b9
448/rKDZKdR3ry4qBvkSHygzIGRwWsA2ABugzICQAZwWsA3ABigzIGQApwVsA7ABygwIGQIVALYB
CBnA7hEyOC1gG4ANUGZAyABOC9gGYAOUGRAygNMCtgHYAGUGhAxOC9gGYAOUGRAygNMCtgHYAGUG
hAzgtIBtADZAmQEhQ4UBYBuAkMHusXuEDE4L2AZgA5QZEDKA0wK2AdgAZQaEDOC0gH0AdU/ZIXvd
Ywk4LGAjQJ1zDWDP1jlWgLNCGdkJn/3zAeweu0fIIGQA8A8A2OsxgEtAoAbAPwAAIQMEagD8AwAQ
MkCgBsA/AAAhQ6AGwD8AACEDBGoA/AMAEDJAoAbAPwAAIUOgBgD8AwAQMgRqAPwDABAyQKAGwD8A
ACEDBGoA/AMAEDIEagD8AwAQMkCgBsA/AAAhAwRqAPwDABAyBGoAwD8AACFDoAbAPwAAIQMEagD8
AwAQMkCgBsA/AAAhQ6AGwD8AACEDBGoA/AMAEDJAoAbAPwAAIUOgBgD8AwAQMgRqAPwDABAyQKAG
wD8AACEDBGoA/AMAEDIEagD8AwAQMkCgBsA/AAAhAwRqAPwDABAyBGouAgD+AQAIGQI1AP4BAAgZ
IFAD4B8AgJABAjUA/gEACBkCNcA+9IvoBwAQMoCQAUDIAABCBhAyADspZgAAIQMIGQCEDAAgZAAh
A4CQAQCEDCBkABAyAICQQcgA4B8AgJABAjUA/gEACBkgUMN22Amf/fMBAIQMQgawEaDOARAyQMAC
7AOoewCEDBCsANsAbAAAIUOgAmwDsAEAhAwQqADbAGwAACEDBCrANgAbAEDIEKgAsA3ABgAQMgQq
wDYAGwBAyACBCrCNn8DCwgKVT3wAQMgQqKDcbePbt2+mtrZ20++rq6vmP//5jzl48KA5dOiQ6ezs
NJ8/f94z5Va+t/La7WUfIz4AQgYIVFCWtrGxsWEuXrxYcJ/29nbz6NEj8+PHD/vR/2fPnt1XPlEu
fkV8AIQMEKigLG2jra3NrKysFNznl19+SfWbf57x8XFz/Phxc+DAAbvv8+fP8/YZGBgwR44cMRUV
Faanpyf3+4kTJ8yXL1/s/8vLyzatN2/e2O9qGdL2Qjx79syeR+c7efKkmZ2dzeUluuZQoTL6v0ms
Xb9+3Rw+fNhUV1ebycnJxBaZuLIk5Yv4AICQAQIVbKFtzMzMxO7jWmQcjx8/NmfOnEk8z4ULF8zH
jx/td4kYX/jcv3/fCh0JBrUESSjcuXPHbrt8+bJ58uSJ/V/nVLeQ9nffr1y5UvCcvlianp42NTU1
seUOCZnh4WFz+/Ztmz91oZ0+fTpWyCSVJZQv4gMAQgYIVLDFtlFon6WlJXP06NFcq4b+129JaTgR
UyjdpqYme+P3cTf4iYkJc+3aNfv/b7/9Zrq6uuxHXL161QqFQlRVVVmBlaZMISHT3Nxsvn//nvv+
9u3bWCGTVJZQvogPAAgZIFDBDggZta7cvXs3N0ZmaGjIjqfJkob/m1opol0+6npxoqmxsdH+r66Y
+fl5c+zYMfu9rq7OdjcVQq0dSkfCor+/vyQhE+02U5njhExSWUL5Ij4AIGSAQAU7IGTUveO3Ouh/
zV4qVsj4N/pCqMVHXTpOwGiszeLiYu57HK9fvzZTU1Omo6PD9Pb2bpmQiW7PUpakfBEfABAyQKCC
HRAyUdEiIaOBrcUKGbW0rK2txR6v1p5ff/0116Xkupfc9xBqxUkanBv97gYVO1pbW/O6liSi4tIL
lSUpX8QHAIQMEKhgB4RMd3e3GRsbs4NZJWI0GFazeooVMuqmcoNp9dF3zZpyjIyMmMrKSnPv3j37
/cGDB1ZMaVBtHPX19XaGkIgOLtaxGrPjxIk/AFcztdR15ufv4cOHZnBwMDfYV4Od44RMqCxJ+SI+
ACBkgEAFOyBk9KI8iRl1MekjEaPfihUyoq+vz05vVnoSEp8+fcpte/XqVd60azfY9t27d7HnVPdN
Q0NDbrq3Ew9Cs4hc3n1BoX31AkDtG82fxgFJTGlatWYmJbXwJJUlKV/EBwCEDBCoANsAbAAAIUOg
AmwDsAEAhAwQqADbAGwAACEDBCrANgAbAEDIEKgAsA3ABgAQMgQqwDYAGwBAyACBCrANwAYAEDJA
oAJsA7ABAIQMgQqwDcAGABAyQKCCvWobW2UzpaazncfjF1wHAIQMgQqwjT0rZIBrBICQIVBBmdpG
dB0hLc54/Pjx3PpAboFFoYUXr1y5YhdirKurM3Nzc7HpJJ1HCyxqzSatUVRdXW0mJyc3HTMwMGDX
OtJK2z09PXnb0hxfbBmJDwAIGSBQwR4WMlr4UKtFi+iKzbdu3TKPHz+2/09NTdnVnYsRMlpB260a
rRWmT58+nbddCzVKbGi7Vt2WUNHij2mPL6WMxAcAhAwQqGAPCxl3gy+0XcJF4iFNOknbm5ubbeuO
w61w7Whqatp0npqamtTHl1JG4gMAQgYIVLCHhUzS9qSWi1LSkWiJbtd3/6NuoLTHl5I34gMAQgYI
VICQyZyOv90XLYUIHY+QIT4AIGQIVICQ2fRbbW1tUV1Ly8vLeb+1trbmdQ0tLi7mbT958qRZW1uL
LUvoeIQM8QEAIUOgAoTMpt802Hd6etr+/+LFi9jBvv5MoJWVFTu41t/+8OFDMzg4mBus297enrf9
7t27ucG8+uh7W1tb6uMRMsQHAIQMgQoQMpt++/btm+ns7LRCpaGhwQ6yLbSfmwmkLiK14jx79mxT
2kNDQ6aystJOsdYspej2vr4+O7364MGDVgh9+vQp0/EIGeIDAEKGQAXYBmADAAgZIFABtgHYAABC
BghUgG0ANgCAkCFQAbYB2AAAQgYIVIBtADYAgJABAhVgG4ANACBkqCQCFWAbgA0AIGQIVIBtADYA
gJABAhVgGwVZWFjY1v2B+ACAkCFQAbaxpef1/9cbe7MQ3R9bJz4AIGQIVIBt/LTzZs0Ptk18AEDI
EKgA2yjIzZs37bpGVVVVZmJiItPaRB8+fLBrIR06dMiur1RXV2eePn1acF/3v/76n1A6hfbX3/X1
dXPs2DG7BpSPVsbWCtqOgYEBuyZTRUWF6enpwQYAEDJAoIJysY3h4eHcStJamLG5uTmTkGlsbLSr
UbuVqkdHR60gShIyhdLNko7//dq1a3Z17GiZJF6EFpQcHx+3aW5sbJjJyUlz584dbAAAIQMEKigH
22hqaspr0Zibmyt5tWitep1VyGRJx/++tLRkW2UkVIT+njhxwnz8+DFXPrfNUVNTgw0AIGSAQAXl
YBvqxvHRTT+rkHn9+rW5deuW6erqMg0NDanES6F006YT/X7mzBnb6iLUqqMuKr980a4pXyBhAwAI
GSBQQRkJmTSCw/9NY2rq6+vN2NiYmZmZsd1TxQiZLOlEv09NTdkxNUJjY3S8Y7+KFuIDAEKGQAX7
wjZOnTplvn79mvu+uLiYKCCWl5fzftMg4bW1tdjtaYVMlnQKfT9+/LgdG6NuJR8JGz9dbAAAIQME
Kigj23jy5ImdtaQupc+fP5v29va8fdVi8/z5c/v/ysqK7bbxt0tAuNlFEkEtLS2pxItmJ2kci2YY
pUknun+0PBrAW11dvWkgrwYC3759OzeIWN/b2tqwAQCEDBCooFxsQzN7NEPoX//6lxUT/r4SMRIz
6qKpra01z549y9v+8uVLO3hW+6hr6PHjx6mEjASHXnLnXnQXSie6f7Q8X758sdskxqL09fXZFh9t
lxBTtxU2AICQAQIVlKltYEfYAABCBghUgJAB4gMAQgYIVLDTtpF1HSQgPgAgZIBABdgGYAMACBkC
FQC2AdgAAEKGQAXYBmADAAgZIFABtgHYAABCBghUgG0ANgCAkCFQAbax/SwsLHDRiQ8ACBkgUMHe
tI3oFO7tPD92z3UCQMgQqADb2NbzYZvEBwCEDBCoYMttQ2snubWUtFL07Oysef/+vWlsbNy078bG
hjl27JhZX1+36Y2Pj9vFHnWsv7iktvkf99vIyEjB/R0DAwPmyJEjpqKiwvT09ATzWahsSfthA8QH
QMgAgQrKzDZ8QTE9PW0XbhRaBTsqAiRcfv/991x6WoBRK1ILt7hk3Pn0/fz587H7a+FKpa8VqiWY
Jicn81ayjstn9FxJ+2EDxAdAyACBCsrMNrTqtVaajjI1NWU6OjryfmtubjZ///13Lj0nSgqdo5CQ
Sdq/qanJihgfX4TE5TOaTtJ+2ADxARAyQKCCMrMNtVpom4REf39/3jZ1Ay0tLdn/3759a4VMUnoh
IZO0v1pSol1S6h5Kk08/naT9sAHiAyBkgEAFZWgbr1+/zrXA9Pb25n4fHBw0165ds/9fuXLFPHjw
YNuEjC9asuYzmnbcftgA8QEQMkCggjK2jfn5+bz9Pn/+bA4dOmRWV1ftINxv375tm5DRwNy1tbVU
ZYnmM65s0f2wAa4FIGSAQAVlZhv19fV2po+IDsAVaon597//bbq7uzMJEwkgjYn5/v17qv3v3r1r
bt++bcfJ6KPvbW1tqfLppxMqDzYAgJABAhWUkW2oG6ahoSE3JdqJAMfc3Jw9Nvqm3pAw0YwjvRTP
vRgvtL/o6+szhw8ftsdoRtSnT59S5dNPJ1QebAAAIQMEKthHtiExoUG/QHwAQMgAgQr2lG2oi0et
JMz+IT4AIGSAQAV7zjY0zuXs2bN5g3yB+ACAkAECFWAbgA0AIGSAQAXYBmADAAgZAhVgG4ANACBk
gEAF2AZgAwAIGSBQAbYB2AAAQoZABYBtADYAgJAhUAG2AdgAAEIGCFSAbQA2AICQAQIVYBuADQAg
ZAhUgG0ANgCAkAECFWAbgA0AIGSAQAXYBmADAAgZAhUAtgHYAABChkAF2AdQ9wAIGSBYATYC1DkA
QgYIWFC6nfDZPx8AQMggZADwDwBAyACBGgD/AACEDBCoAfAPAEDIEKgB8A8AQMgAgRoA/wAAhAwQ
qAHwDwBAyBCoAQD/AACEDIEaAP8AAIQMEKgB8A8AQMgAgRoA/wAAhAyBGgD/AACEDBCoAfAPAEDI
AIEaAP8AAIQMgRoA8A8AQMgQqAHwDwBAyACBGgD/AACEDBCoAfAPAEDIEKgB8A8AQMgAgRoA/wAA
hAwQqAHwDwBAyFBJ/xeo+fDhE/8BAIQMANACAACAkAFAyAAAAEIGACEDAAAIGQCEDAAAQgYAEDIA
AAgZAIQMAAAgZAAQMgAACBkAQMgAACBkABAyAACAkAFAyAAAAEIGACEDAICQAQDDGj8AAAgZAIQM
AAAgZAB+upgBAACEDABCBgAAEDIACBkAAIQMACBkAAAQMgDlLGYAAAAhA4CQAQAAhAz8vBs6n/3z
AQBAyACtEkCdAwAgZIAbGlD3AAAIGeBGBtgAACBkgJsYYAMAAAgZ4CYG2AAAAEIGuIkBNgAACBkA
bmKADQAAQga4iQE2AACAkIF9fxNbWFigIhAyAAAIGdiem9jjx48L7jc5OWlOnDhhDh48aFpaWsz8
/HxRedDxW1kObswIGQBAyAA3McvKyoppa2vbtN+bN29Ma2urWV5eNj9+/DAPHz409fX1P+1Gys2Y
awcACBngJraJjo4O8+7du037dXV1maGhodTnefbsmfnll1/MgQMHzMmTJ83s7Gzu/NH1fwrlyf9N
wun69evm8OHDprq62rYMJbXIDAwMmCNHjpiKigrT09OTKl/YAAAAQgb2+E1scHDQjI6OFtzv+PHj
mca2SCw8f/7c/j89PW1qampi8xASMsPDw+b27dtW0Hz+/NmcPn06Vsjcv3/fjI+P2303Njas6Llz
506qfGEDAAAIGdijNzF1HZ09ezZ2PwkA3fjr6urMoUOHTGdnp/n69WvseaqqquxYmzR5CAmZ5uZm
8/3799z3t2/fxgqZpqYmK2J8fLGSlC+EDAAAQgb24E1sfX3dioXV1dVEsXHt2jWztrZmhYJaPtTd
FIdEj46RsOjv7y9JyEhE+ej8cUJG+0a7r9SNlCZfCBkAAIQM7MGb2NWrV82TJ08S99P4FL9VRGIi
NPvo9evXZmpqyo676e3t3TIhE93u/++Llqz5QsgAACBkYA/exKItGNHBuOLcuXN5x0jIqIspDZqm
nTQ4N/pdM6P83zRbyhdRi4uLselpAK9ajYrJF0IGAAAhA2VyE4vup3El+kjA6DMyMmLfJROHpmZr
hpDQ4Fq/VUUC6OPHjzlx4g/A1fTvCxcu5J1fU701ENkN9m1vb48VMnfv3s0NDNZH3zWdPE2+sAEA
AIQMlKmQERIvGiyrLiWJDU3TjkPdNw0NDbarR2LBiQehWURKw3VNOUGhfWtra+2+0fNr6ndlZaWd
Vq3xOUktPH19fbYrzOXz06dPqfKFDQAAIGSAmxhgAwAACBngJgbYAAAgZAC4iQE2AAAIGeAmBtgA
AABCBriJATYAAICQAW5igA0AAEIGuIkBNgAAgJABbmKADQAAIGSAmxhgAwCAkAFIfxPbqptbqels
5/HcwLkOAICQAW5ie1bIANcIABAyUKY3sejaRePj4+b48eO5NYncoo5Ciz1euXLFLv5YV1dn5ubm
YtNJOo8Wdbx+/bpdF6m6utpMTk5uOmZgYMCur1RRUWF6enrytqU5vtgyImQAABAysIeFjBZb1ArV
IrpK9K1bt+xK2GJqasquKF2MkBkeHs6tVK1VrU+fPp23XYtDSmxo+8bGhhUqWnAy7fGllBEhAwCA
kIE9LGTcDb7QdgkXiYc06SRtb25utq07jrdv3+Ztb2pq2nSempqa1MeXUkaEDAAAQgb2sJBJ2p7U
clFKOhIt0e367n/UDZT2+FLyhpABAEDIAEImczr+dl+0FCJ0PEIGIQMACBlAyGz6rba2tqiupeXl
5bzfWltb87qGFhcX87afPHnSrK2txZYldDxCBiEDAAgZQMhs+k2Dfaenp+3/L168iB3s688EWllZ
sYNr/e0PHz40g4ODucG67e3tedvv3r2bG8yrj763tbWlPh4hg5ABAIQMIGQ2/fbt2zfT2dlphUpD
Q4MdZFtoPzcTSF1EasV59uzZprSHhoZMZWWlnWKtWUrR7X19fXZ69cGDB60Q+vTpU6bjETIIGQBA
yAA3McAGAAAQMsBNDLABAACEDHATA2wAABAywE0MsAEAAIQMcBMDbAAAACED3MQAGwAAhAwANzHA
BgAAIQPcxAAbAABAyAA3sUQWFhaK2rYV+2MDAAAIGeAmVhJ6c29cPqPbSkkLuB4AgJABbmI7mq+s
eeZGzfUBAIQM7MOb2M2bN+26RlVVVWZiYiLT2kQfPnywayEdOnTIrq9UV1dnnj59mrfv+Pi4OX78
uF17yV9QUtv8j592oW1J54pLa3193Rw7dsyuE+Wj1bO1yrZjYGDArttUUVFhenp6EDIAAAgZ2As3
seHh4dxK0lqYsbm5OZOQaWxstKtRu5WqR0dHrSDy95X4+Pjxo/3uFpSMSz/p3GnOVSita9eu2RW0
o+WWeBFadFJiS2lubGyYyclJc+fOHYQMAABCBnb7TaypqSmvtWJubq7k1aLV8uLv60RMGrESOnfo
XIXSWlpasq0yEipCf0+cOJHLl66B2+aoqalByAAAIGRgt9/E/NYRd5PPKmRev35tbt26Zbq6ukxD
Q0Om47MKmSzn8r+fOXPGtroIteqolci/BtGuKV8gIWQAABAysEeETBox4f+mMTX19fVmbGzMzMzM
2O6p7RIyWc/lf5+amrJjaoTGxuh4RzmKFoQMACBkYF/cxE6dOmW+fv2a+764uJgoDpaXl/N+0yDh
tbW12O3/2979g7QZxGEcn0VEhFJEnAqliIOI4OQQRHBwcHcQJ8FBJINbkCKSzUE6FKGIg0gRpIg4
iFBERBwECaU4iCAdRIKLOIg4XHmuvOFyefNeUpO2Sb8fEBpz75+8Pfw9vHdvrpZBptpj+a814Vhz
YzSs5FKwcfdLkAEAggwapIhtb2/bp5Y0pJTP583w8HBRW/cpox8/ftghGfd9hYPoySGFoMHBwaqC
jJ5A0lwVPUUUei90rKR9iSbwdnV1lUzk1UTgbDZbmESs16lUiiADAAQZNEIR01M7evqns7PTBgW3
bfSUkYZf3r59a/b29orePzo6shNj1UbDPltbW1UFGYUKfZFd9GV2Se+FjpW0L7m7u7PvKbD5MpmM
veOj9xXWNGxFkAEAggwasIhR8OgDAECQAUEGBBkAIMjgTxexatc4AkEGAAgyoIiBPgCAIANQxEAf
AECQAUUM9AEAIMiAIgb6AAAQZEARA30AAEEGFLH6+/btGxedIAMABBk0ZhHzH+Gu5/Ep0FwnAAQZ
UMTqejyKKEEGAAgyqHkR09pJ0VpKWgX68PDQXF5emr6+vpK2z8/Ppru72zw8PNj9ra2t2YUcta27
uKTec3+i362srMS2jywuLpr29nbT2tpq0ul08DzjPltSO/oAfzYAEGTQZEXMDRT7+/t2UUbRKth+
CFBwmZ6eLuxPiytqtWmJFpcsdzy9HhsbK9teC1dq/1p9WoFpc3OzaJXqcufpHyupHX2APxsACDJo
siKmVa+1irRvd3fXjI6OFv1uYGDAnJ+fF/YXhZK4Y8QFmaT2/f39NsS43BBS7jz9/SS1ow/wZwMA
QQZNVsR010LvKUi8f/++6D0NA11cXNh/n52d2SCTtL9QkElqrzsp/pCUhocqOU93P0nt6AP82QBA
kEETFrHT09PCHZj5+fnC75eWlszMzIz99+TkpFldXa1bkHFDS7Xn6e+7XDv6AH82ABBk0MRFLJfL
FbXL5/OmpaXF3N7e2km4j4+PdQsymph7f39f0Wfxz7PcZ/Pb0Qe4FgAIMmiyItbT02Of9BF/Aq7o
Tsz4+LiZnZ2tKpgoAGlOzNPTU0Xtl5eXTTabtfNk9KPXqVSqovN09xP6PPQBACDIoImKmIZhent7
C49ERyEgcnJyYrf1v6k3FEz0xJG+FC/6YrxQe8lkMqatrc1uoyeibm5uKjpPdz+hz0MfAACCDP6j
IqYwoUm/IMgAAEEGDVXENMSjuyQ8/UOQAQCCDBquiGmey8jISNEkXxBkAIAgA4oY6AMACDIARQz0
AQAEGVDEQB8AAIIMKGKgDwAAQQYUMdAHABBkgL9bxPwv0gNBBgAIMqhpEdOK0WNjY3U5bvTNvs1e
4Cvdh76x+OvXrwQZANQlLgFqVcT6+/vNxcXFf1s8/+Q56joPDAwQZABQl7gEqEUROz4+tl9657f9
9OmTefXqleno6DCfP3+2izhqHSStX6TFGF2Li4t2dezW1laTTqeL9uP+yNXVlb0roS/b077evXtn
vnz5knjuoW2077W1NbuUQrTGknuOlWx/eXlp+vr6So79/Pxsuru7zcPDg123SdvrGFqt+/DwMPb6
JrUTXW9dd4IMAIIM8MIiNjc3Z9bX10vaTk1N2SK+s7NjA8z09LR97a8o/fHjRxsitJyB3t/c3LQL
RpY7rsLCxsZGYZXrDx8+mNevXyeee2gbHUNBRatti3+OlWwvw8PDJaFDn02fXdyApOG4N2/exH7O
pHaikKjrTpABQJABXljEBgcHzffv30vaRqEgen1/fx+7Lw1LKRy4yhX4cnTnolruNv75VnJcf3vZ
3d01o6OjRe00DHR+fm7/rfCztbUVvL5J7UTXW9edIAOAIAO8sIhpuMUPIn7bpNe6++APIcWFBNfp
6alZWFgwExMTpre3t6ICm7RN3Pb+7yrdXsNT0Xyhs7Ozovksuruitgpv/kKa7j6S2omut4bhCDIA
CDLAC4tY3N2QaoJM6G6Kv62GsXp6euzwysHBgbm5uSm0iZtTE9qmkiBTzfZLS0tmZmbG/ntyctKs
rq6WBKLozs38/HxicIpr5wZAggwAggzwl+/IaDKrO+wUOq7m27jtr6+vgwU2tE0oyFSzfT6ft9fk
9vbWTmAut/J3LpcLnkNcO9FcIu7IACDIADUoYpqroSGU3w0yepopm80WJtLqdSqVKgpKmr/y9PRk
X2voJnpiKJorEiqwoW1CQaba7XUnZnx83MzOzhb9Xnd19ESS+BOK3X0ktRPNuWGODACCDFCDIqan
Z/Tk0e8GGclkMvauh778Tk8PaegmoieY9Pvoi/GOjo7sZGAVdxV8TYoNFdjQNqEgU+32Jycn9nf+
txJruEjza6JHvKOw4u8jqZ1ouIqnlgAQZIAaFDEVbfcOCowNYrqLUy9DQ0M27BBkABBkgBoUMT1d
w5pIv2h4THeY4p42qgUNbel6/2t9AAAIMmjYIKN5HJoTgl9zevTNu+Um+b6UrjNrLQEAQQYUMdAH
ABBkQBEDfQAACDKgiIE+AAAEGVDEQB8AQJABKGKgDwAgyIAiBvoAABBkQBEDfQAACDKgiIE+AIAg
A4oY6AMAQJABRQz0AQAgyIAiBvoAAIIMQBEDfQAAQQYUMdAHAIAgAwoZ+L8HAIIMKGjg/xwAQQYU
Nn7+nx8A+Bf9BLfDMs7NPhprAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-08-26 10:59:20 +1200" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVQAAAcyCAIAAABJjYqfAABVZ0lEQVR42u3dv65lR5n+8ZaQEIED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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-08-26 10:59:20 +1200" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2015-08-26 15:40:22 +1200" MODIFIED_BY="Helen E Nagels" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Open-entry technique versus closed-entry technique (primary port entry), outcome: 1.1 Vascular injury (major vessels and abdominal wall vessels).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAyAAAAHwCAMAAABpD/tcAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2015-08-26 15:40:22 +1200" MODIFIED_BY="Helen E Nagels" NO="5" REF_ID="CMP-001.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Open-entry technique versus closed-entry technique (primary port entry), outcome: 1.2 Visceral injury (bladder or bowel).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAx4AAAHwCAMAAAAfNUnXAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2015-08-26 15:40:27 +1200" MODIFIED_BY="Helen E Nagels" NO="6" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Direct trocar entry versus Veress needle entry (primary port entry), outcome: 2.1 Vascular injury (major vessels and abdominal wall vessels).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA44AAAFQCAMAAADHgtDQAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2015-08-26 15:40:27 +1200" MODIFIED_BY="Helen E Nagels" NO="7" REF_ID="CMP-002.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Direct trocar entry versus Veress needle entry (primary port entry), outcome: 2.2 Visceral injury (bladder or bowel).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3AAAAFACAMAAADK0W5hAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2015-08-19 16:07:13 +1200" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2015-08-19 16:07:13 +1200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-08-13 13:38:37 +1200" MODIFIED_BY="Helen E Nagels">Included studies and trocar definitions</TITLE>
<DATE_SUBMITTED>
<DATE DAY="6" MONTH="7" YEAR="2014"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2015-08-18 14:21:01 +1200" MODIFIED_BY="[Empty name]">
<P>The authors report that two RCTs (<LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>; <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>) with a total of 129 participants compared a radially expanding access device with a conventional cutting tip trocar (Summary of findings table 5). Analysis 10.8 includes only one of the studies (<LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>), although the data are available for <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK>. Furthermore the number of events in analysis 10.8 extracted for Yim is listed as 4/34, but two of these events were related to another instrument for port site closure and not trocar placement.</P>
<P>The term "standard trocars" is used but there is no consensus on what a standard trocar is. In most of the publications the exact trocar type used is specified as cutting trocars, and these have been put in the category of "standard trocars". Only in one study (<LINK REF="STD-Mettle-2000" TYPE="STUDY">Mettle 2000</LINK>) is the standard trocar a mixture of blunt and sharp trocars.</P>
<P>Most of the studies compared a specific company product (REA/STEP trocars) with standard (trocars). It is unclear what the exact benefit of the STEP trocar is, as less port site bleeding could be from the blunt tip on REA trocars and not the other aspects of the STEP system. We refer you to a recent systematic review: Antoniou SA, Antoniou GA, Koch OO, Pointner R, Granderath FA (2013) Blunt versus bladed trocars in laparoscopic surgery: a systematic review and meta-analysis of randomized trials. Surg Endosc 27:2312&#8211;2320.</P>
<P>This area is troubled by a lack of clear definitions and very poorly designed underpowered studies, and most of the analyses listed in the review cannot say anything conclusive regarding which types of laparoscopic ports should be used. Yet, we found it troublesome that the analysis is made comparing one specific company product (STEP system) to older cutting trocars.</P>
<P>We hope you will take these comments for consideration, in future reviews on this topic or during updates of this review.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2015-08-19 16:07:13 +1200" MODIFIED_BY="[Empty name]">
<P>Thank you for your comments. We have reviewed the Cochrane review and original trial reports and addressed your concerns by topic.</P>
<P>Secondary ports &#8211; Trocar site bleeding</P>
<P>The methods stated we would analyse the data utilising intention-to-treat basis. The <LINK REF="STD-Lam-2000" TYPE="STUDY">Lam 2000</LINK> study recorded no events for trocar site bleeding and we will state this more clearly in future updates. With reference to your query regarding trocar site bleeding, we have reviewed <LINK REF="STD-Yim-2001" TYPE="STUDY">Yim 2001</LINK>. Trocar site bleeding was reported in four patients out of which two happened during entry and two happened during insertion of Endoclose. As this review focuses on entry techniques, on reflection we could have excluded these latter two events from the analysis. In future updates, this will be clearly stated in the descriptive text.</P>
<P>Description of Trocars</P>
<P>There is no international consensus regarding the definition of trocars. Taking on board your comments, in future we will consistently state the broad category, subcategory, and manufacture designation to satisfy the general and special interest audience.</P>
<P>Antoniou et al Systematic Review 2013</P>
<P>The discussion of any Cochrane review will always include discussion of other published systematic reviews. This review was published in 2013 and thus could not have been included in our review, which was published the year before. We will discuss the work of Antoniou et al. in future review updates.</P>
<P>STEP System</P>
<P>We are careful to describe throughout the text the STEP system as radially expanding.</P>
<P>Again many thanks for your comments.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2014-08-12 17:10:23 +1200" MODIFIED_BY="Helen E Nagels">
<P>Flemming Bjerrum, MD, PhD Student, Department of Gynecology, The Juliane Marie Centre, University of Copenhagen</P>
<P>Gaity Ahmad, Helena O'Flynn, James MN Duffy, Kevin Phillips, Andrew Watson</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2015-08-15 15:15:48 +1200" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-10-21 14:42:09 +1300" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-12-19 15:49:56 +1300" MODIFIED_BY="[Empty name]">MDSG search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 14:42:09 +1300" MODIFIED_BY="[Empty name]">
<P>Keywords CONTAINS "laparoscopic" or "laparoscopic techniques" or "laparoscopy" or Keywords CONTAINS "laparoscopic" or "laparoscopic techniques" or "laparoscopy"</P>
<P>AND</P>
<P>Keywords CONTAINS "entry site" or "trocar" or "trocar - dilating-tip" or "trocar - non-shielded-bladed" or "trocar ports" or "Veress needle" or "pneumoperitoneum" or "direct trocar insertion" or "gas" or "gasless " or "carbon dioxide" or "single port" or" port" or Title CONTAINS "entry site" or "trocar" or "trocar - dilating-tip" or "trocar - non-shielded-bladed" or "trocar ports" or "Veress needle" or "pneumoperitoneum" or "direct trocar insertion" or "gas" or" gasless " or "carbon dioxide" or "single port" or" port"</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-08-15 15:15:48 +1200" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2011-04-01 03:15:21 +1300" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 14:46:04 +1300" MODIFIED_BY="[Empty name]">
<P>Database: EBM Reviews - Cochrane Central Register of Controlled Trials<BR/>
<BR/>
<BR/>1 exp laparoscopy/ or exp hand-assisted laparoscopy/ (3584)<BR/>2 laparoscop$.tw. (6123)<BR/>3 (pelvi$ adj2 endoscop$).tw. (2)<BR/>4 peritoneoscop$.tw. (14)<BR/>5 videolaparoscop$.tw. (19)<BR/>6 laparoendoscop$.tw. (38)<BR/>7 or/1-6 (6330)<BR/>8 entry technique$.tw. (5)<BR/>9 (Veress or veress-needle$).tw. (31)<BR/>10 trocar$.tw. (248)<BR/>11 open entr$.tw. (2)<BR/>12 closed entr$.tw. (4)<BR/>13 pneumoperiton$.tw. (379)<BR/>14 exp Pneumoperitoneum, Artificial/ (225)<BR/>15 exp posture/ or exp supine position/ (3205)<BR/>16 supine position$.tw. (1189)<BR/>17 lithotomy.tw. (66)<BR/>18 (patient$ adj2 position$).tw. (917)<BR/>19 French position$.tw. (0)<BR/>20 American position$.tw. (0)<BR/>21 (side adj2 position$).tw. (108)<BR/>22 (side adj approach$).tw. (3)<BR/>23 direct-trocar$.tw. (12)<BR/>24 gas.tw. (6086)<BR/>25 disposable instrument$.tw. (13)<BR/>26 reusable instrument$.tw. (8)<BR/>27 trendelenburg.tw. (117)<BR/>28 radially expanding.tw. (7)<BR/>29 direct vision.tw. (113)<BR/>30 (trans fundal or transfundal).tw. (2)<BR/>31 carbon dioxide.tw. (2209)<BR/>32 gasless.tw. (48)<BR/>33 infra umbilical.tw. (10)<BR/>34 infraumbilical.tw. (35)<BR/>35 TrocDoc.tw. (1)<BR/>36 lift$.tw. (992)<BR/>37 blind.tw. (134833)<BR/>38 open approach.tw. (94)<BR/>39 missile.tw. (12)<BR/>40 pyramidal.tw. (108)<BR/>41 u shaped retractor$.tw. (1)<BR/>42 intra abdominal pressure.tw. (101)<BR/>43 closed technique$.tw. (38)<BR/>44 direct entry.tw. (3)<BR/>45 single incision.tw. (141)<BR/>46 SILS.tw. (33)<BR/>47 open technique.tw. (144)<BR/>48 (lift$ adj5 abdominal wall).tw. (30)<BR/>49 port entry.tw. (4)<BR/>50 or/8-49 (146949)<BR/>51 7 and 50 (1671)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-08-15 15:15:48 +1200" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2015-03-25 16:43:09 +1300" MODIFIED_BY="Helen E Nagels">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 14:44:12 +1300" MODIFIED_BY="[Empty name]">
<P>Database: Ovid MEDLINE(R) In-Process &amp; Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) &lt;1946 to Present&gt;<BR/>
<BR/>1 exp laparoscopy/ or exp hand-assisted laparoscopy/ (71007)<BR/>2 laparoscop$.tw. (85785)<BR/>3 (pelvi$ adj2 endoscop$).tw. (56)<BR/>4 peritoneoscop$.tw. (745)<BR/>5 videolaparoscop$.tw. (336)<BR/>6 laparoendoscop$.tw. (802)<BR/>7 or/1-6 (97212)<BR/>8 entry technique$.tw. (108)<BR/>9 (Veress or veress-needle$).tw. (389)<BR/>10 trocar$.tw. (4976)<BR/>11 open entr$.tw. (38)<BR/>12 closed entr$.tw. (15)<BR/>13 pneumoperiton$.tw. (5888)<BR/>14 exp Pneumoperitoneum, Artificial/ (3895)<BR/>15 exp posture/ or exp supine position/ (63613)<BR/>16 supine position$.tw. (8809)<BR/>17 lithotomy.tw. (1052)<BR/>18 (patient$ adj2 position$).tw. (6092)<BR/>19 French position$.tw. (14)<BR/>20 American position$.tw. (13)<BR/>21 (side adj2 position$).tw. (878)<BR/>22 (side adj approach$).tw. (89)<BR/>23 direct-trocar$.tw. (50)<BR/>24 gas.tw. (196283)<BR/>25 disposable instrument$.tw. (182)<BR/>26 reusable instrument$.tw. (114)<BR/>27 trendelenburg.tw. (1200)<BR/>28 radially expanding.tw. (73)<BR/>29 direct vision.tw. (2177)<BR/>30 (trans fundal or transfundal).tw. (38)<BR/>31 carbon dioxide.tw. (35078)<BR/>32 gasless.tw. (531)<BR/>33 infra umbilical.tw. (70)<BR/>34 infraumbilical.tw. (291)<BR/>35 TrocDoc.tw. (1)<BR/>36 lift$.tw. (17668)<BR/>37 blind.tw. (153105)<BR/>38 open approach.tw. (1934)<BR/>39 missile.tw. (1410)<BR/>40 pyramidal.tw. (29903)<BR/>41 u shaped retractor$.tw. (2)<BR/>42 intra abdominal pressure.tw. (1970)<BR/>43 closed technique$.tw. (409)<BR/>44 direct entry.tw. (280)<BR/>45 single incision.tw. (1829)<BR/>46 SILS.tw. (793)<BR/>47 open technique.tw. (1634)<BR/>48 (lift$ adj5 abdominal wall).tw. (187)<BR/>49 port entry.tw. (19)<BR/>50 or/8-49 (514705)<BR/>51 7 and 50 (12673)<BR/>52 randomized controlled trial.pt. (397709)<BR/>53 controlled clinical trial.pt. (90513)<BR/>54 randomized.ab. (317063)<BR/>55 randomised.ab. (63470)<BR/>56 placebo.tw. (167443)<BR/>57 clinical trials as topic.sh. (175920)<BR/>58 randomly.ab. (227363)<BR/>59 trial.ti. (137888)<BR/>60 (crossover or cross-over or cross over).tw. (63607)<BR/>61 or/52-60 (1000190)<BR/>62 exp animals/ not humans.sh. (4079856)<BR/>63 61 not 62 (923111)<BR/>64 51 and 63 (2016)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-03-25 16:42:56 +1300" MODIFIED_BY="Helen E Nagels" NO="4">
<TITLE MODIFIED="2008-11-11 14:10:13 +1300" MODIFIED_BY="Julie A Brown">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 14:59:41 +1300" MODIFIED_BY="[Empty name]">
<P>Database: EMBASE &lt;1980 to 2011 Week 04&gt;<BR/>
<BR/>1 entry technique$.tw. (185)<BR/>2 (Veress or veress-needle$).tw. (619)<BR/>3 trocar$.tw. (8220)<BR/>4 open entr$.tw. (52)<BR/>5 closed entr$.tw. (23)<BR/>6 pneumoperiton$.tw. (7056)<BR/>7 exp body position/ or exp body posture/ (97069)<BR/>8 supine position$.tw. (11426)<BR/>9 lithotomy.tw. (1596)<BR/>10 (patient$ adj2 position$).tw. (8582)<BR/>11 French position$.tw. (47)<BR/>12 American position$.tw. (15)<BR/>13 (side adj2 position$).tw. (942)<BR/>14 (side adj approach$).tw. (104)<BR/>15 direct-trocar$.tw. (81)<BR/>16 (gas adj5 laparoscop$).tw. (304)<BR/>17 disposable instrument$.tw. (226)<BR/>18 reusable instrument$.tw. (170)<BR/>19 trendelenburg.tw. (1559)<BR/>20 radially expanding.tw. (78)<BR/>21 direct vision.tw. (2706)<BR/>22 (trans fundal or transfundal).tw. (43)<BR/>23 (carbon dioxide adj5 laparoscop$).tw. (424)<BR/>24 (gasless adj5 laparoscop$).tw. (311)<BR/>25 infra umbilical.tw. (100)<BR/>26 infraumbilical.tw. (392)<BR/>27 TrocDoc.tw. (1)<BR/>28 (lift$ adj5 laparoscop$).tw. (135)<BR/>29 (blind adj5 laparoscop$).tw. (211)<BR/>30 open approach.tw. (2736)<BR/>31 (missile adj5 laparoscop$).tw. (1)<BR/>32 (pyramidal adj5 laparoscop$).tw. (4)<BR/>33 u shaped retractor$.tw. (2)<BR/>34 intra abdominal pressure.tw. (2329)<BR/>35 or/1-34 (131856)<BR/>36 exp laparoscopic surgery/ or exp laparoscopy/ (102084)<BR/>37 laparoscop$.tw. (122126)<BR/>38 (pelvi$ adj2 endoscop$).tw. (68)<BR/>39 peritoneoscop$.tw. (797)<BR/>40 videolaparoscop$.tw. (487)<BR/>41 laparoendoscop$.tw. (1925)<BR/>42 or/36-41 (143918)<BR/>43 35 and 42 (13993)<BR/>44 Clinical Trial/ (834654)<BR/>45 Randomized Controlled Trial/ (351629)<BR/>46 exp randomization/ (63624)<BR/>47 Single Blind Procedure/ (18917)<BR/>48 Double Blind Procedure/ (115798)<BR/>49 Crossover Procedure/ (40410)<BR/>50 Placebo/ (247022)<BR/>51 Randomi?ed controlled trial$.tw. (104373)<BR/>52 Rct.tw. (14944)<BR/>53 random allocation.tw. (1341)<BR/>54 randomly allocated.tw. (20909)<BR/>55 allocated randomly.tw. (1950)<BR/>56 (allocated adj2 random).tw. (717)<BR/>57 Single blind$.tw. (14729)<BR/>58 Double blind$.tw. (143981)<BR/>59 ((treble or triple) adj blind$).tw. (396)<BR/>60 placebo$.tw. (203085)<BR/>61 prospective study/ (263630)<BR/>62 or/44-61 (1390056)<BR/>63 case study/ (28255)<BR/>64 case report.tw. (265392)<BR/>65 abstract report/ or letter/ (903531)<BR/>66 or/63-65 (1191323)<BR/>67 62 not 66 (1351975)<BR/>68 43 and 67 (1691)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2014-10-21 15:00:42 +1300" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-01-09 01:38:08 +1300" MODIFIED_BY="[Empty name]">PsycINFO search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 15:00:42 +1300" MODIFIED_BY="[Empty name]">
<P>Database: PsycINFO &lt;1806 to January Week 4 2011&gt;<BR/>
<BR/>1 laparoscop$.tw. (312)<BR/>2 entry technique$.tw. (11)<BR/>3 trocar$.tw. (7)<BR/>4 open entr$.tw. (13)<BR/>5 closed entr$.tw. (3)<BR/>6 pneumoperiton$.tw. (3)<BR/>7 exp Posture/ (4155)<BR/>8 supine position$.tw. (366)<BR/>9 lithotomy.tw. (8)<BR/>10 (patient$ adj2 position$).tw. (245)<BR/>11 trendelenburg.tw. (20)<BR/>12 direct vision.tw. (48)<BR/>13 open approach.tw. (71)<BR/>14 carbon dioxide.tw. (1375)<BR/>15 or/2-14 (6240)<BR/>16 1 and 15 (7)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;46 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;28 studies already included in the previous editions of this review&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;18 new studies included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;27 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;447 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;447 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;1237 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;420 records excluded after title/abstract sift&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;9 full-text articles excluded, with reasons:&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;7 were not RCTs&lt;/p&gt;&lt;p&gt;2 did not meet the inclusion criteria&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>